10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2019

or

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to ________

Commission file number: 001-38196

DOWDUPONT INC.

(Exact name of registrant as specified in its charter)

Delaware	81-1224539
State or other jurisdiction of incorporation or organization	(I.R.S. Employer Identification No.)

974 Centre Road, Wilmington, DE 19805

(302) 774-1000

(Name, address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

þ Yes ¨ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

þ Yes ¨ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	þ	Accelerated filer	¨
Non-accelerated filer	¨	Smaller reporting company	¨
		Emerging growth company	¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). ¨ Yes þ No

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	DWDP	New York Stock Exchange

The registrant had 2,246,387,858 shares of common stock, $0.01 par value, outstanding at April 30, 2019.

DOWDUPONT INC.

QUARTERLY REPORT ON FORM 10-Q

For the quarterly period ended March 31, 2019

TABLE OF CONTENTS

PART 1 - FINANCIAL INFORMATION		PAGE
Item 1.	Financial Statements.	5
	Consolidated Statements of Income.	5
	Consolidated Statements of Comprehensive Income.	6
	Consolidated Balance Sheets.	7
	Consolidated Statements of Cash Flows.	8
	Consolidated Statements of Equity.	9
	Notes to the Consolidated Financial Statements.	10
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations.	45
	Results of Operations.	48
	Changes in Financial Condition.	61
	Other Matters.	67
Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	69
Item 4.	Controls and Procedures.	69
PART II - OTHER INFORMATION
Item 1.	Legal Proceedings.	70
Item 1A.	Risk Factors.	72
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	72
Item 4.	Mine Safety Disclosures.	72
Item 5.	Other Information.	72
Item 6.	Exhibits.	73
SIGNATURES		75

2

DowDuPont Inc.

Throughout this Quarterly Report on Form 10-Q, except as otherwise noted by the context, the terms "Company" or "DowDuPont" used herein mean DowDuPont Inc. and its consolidated subsidiaries.

Effective as of 5:00 p.m. on April 1, 2019, DowDuPont completed the previously announced separation of its materials science business into a separate and independent public company by way of a distribution of Dow Inc. (“Dow”) through a pro rata dividend in-kind of all of the then-issued and outstanding shares of Dow’s common stock, par value $0.01 per share (the “Dow Common Stock”), to holders of the Company’s common stock, par value $0.01 per share (the “DowDuPont Common Stock”), as of the close of business on March 21, 2019 (the “Dow Distribution”). DowDuPont expects to complete the previously announced intended separation of its agriculture business into a separate and independent public company on June 1, 2019, by way of a distribution of Corteva, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“Corteva”), through a pro rata dividend in-kind of all of the then-issued and outstanding shares of Corteva’s common stock, par value $0.01 per share, to holders of DowDuPont Common Stock as of a record date to be set by the Company’s Board of Directors (the “Corteva Distribution” and, together with the Dow Distribution, the “Distributions”). Following the Corteva Distribution, DowDuPont will hold the specialty products business and operate as "DuPont." The assets and liabilities attributed to the materials science and agriculture businesses are included in the Company's consolidated balance sheets presented herein as of March 31, 2019 and December 31, 2018. Additionally, the Company's consolidated statements of income presented herein for the three months ended March 31, 2019 and 2018 include the results of operations of the materials science and agriculture businesses.

FORWARD-LOOKING STATEMENTS

This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” and similar expressions and variations or negatives of these words.

Forward-looking statements by their nature address matters that are, to varying degrees, uncertain, including statements about the Corteva Distribution. Forward-looking statements, including those related to DowDuPont’s ability to complete, or to make any filing or take any other action required to be taken to complete, the Corteva Distribution, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements also involve risks and uncertainties, many of which are beyond DowDuPont’s control. Some of the important factors that could cause DowDuPont’s actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) ability and costs to achieve all the expected benefits from the Corteva Distribution and the April 1, 2019 distribution by DowDuPont of all of the shares of common stock of Dow Inc. on a pro rata basis to the holders of DowDuPont common stock; (ii) restrictions under intellectual property cross license agreements entered into or to be entered into in connection with the Corteva Distribution and the Dow Distribution; (iii) ability to receive third-party consents required under the Separation Agreement entered into in connection with the Corteva Distribution and the Dow Distribution; (iv) non-compete restrictions under the Separation Agreement entered into in connection with the Corteva Distribution and the Dow Distribution; (v) the incurrence of significant costs in connection with the Corteva Distribution and the Dow Distribution, including increased costs from supply, service and other arrangements that, prior to the Dow Distribution, were between entities under the common control of DowDuPont; (vi) risks outside the control of DowDuPont which could impact the decision of the DowDuPont Board of Directors to proceed with the Corteva Distribution, including, among others, global economic conditions, instability in credit markets, declining consumer and business confidence, fluctuating commodity prices and interest rates, volatile foreign currency exchange rates, tax considerations, other challenges that could affect the global economy, specific market conditions in one or more of the industries of the businesses proposed to be separated, and changes in the regulatory or legal environment and the requirement to redeem $12.7 billion of DowDuPont notes if the Corteva Distribution is abandoned or delayed beyond May 1, 2020; (vii) potential liability arising from fraudulent conveyance and similar laws in connection with the Corteva Distribution and/or the Dow Distribution; (viii) disruptions or business uncertainty, including from the Corteva Distribution, could adversely impact DowDuPont’s business or financial performance and its ability to retain and hire key personnel; (ix) uncertainty as to the long-term value of DowDuPont common stock; (x) potential inability to access the capital markets; and (xi) risks to DowDuPont’s business, operations and results of operations from: the availability of and fluctuations in the cost of feedstocks and energy; balance of supply and demand and the impact of balance on prices; failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including trade disputes and retaliatory actions; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural

3

disasters and weather events and patterns which could result in a significant operational event for DowDuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce DowDuPont’s intellectual property rights; failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management’s response to any of the aforementioned factors. These risks are and will be more fully discussed in DowDuPont’s current, quarterly and annual reports and other filings made with the U.S. Securities and Exchange Commission ("SEC"), in each case, as may be amended from time to time in future filings with the SEC. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont’s or Corteva, Inc.’s consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DowDuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled “Risk Factors” (Part I, Item 1A) of DowDuPont’s 2018 Annual Report on Form 10-K and in the section titled "Risk Factors" (Part II, Item 1A of this Form 10-Q).

4

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

DowDuPont Inc.

Consolidated Statements of Income

	Three Months Ended
In millions, except per share amounts (Unaudited)	Mar 31, 2019		Mar 31, 2018
Net sales	$	19,649	$	21,510
Cost of sales	14,726		16,315
Research and development expenses	717		768
Selling, general and administrative expenses	1,672		1,714
Amortization of intangibles	474		474
Restructuring and asset related charges - net	287		262
Integration and separation costs	813		457
Equity in earnings of nonconsolidated affiliates	26		257
Sundry income (expense) - net	248		115
Interest expense and amortization of debt discount	454		350
Income from continuing operations before income taxes	780		1,542
Provision for income taxes on continuing operations	209		389
Income from continuing operations, net of tax	571		1,153
Loss from discontinued operations, net of tax	—		(5		)
Net income	571		1,148
Net income attributable to noncontrolling interests	51		44
Net income available for DowDuPont Inc. common stockholders	$	520	$	1,104
Per common share data:
Earnings per common share from continuing operations - basic	$	0.23	$	0.47
Loss per common share from discontinued operations - basic	—		—
Earnings per common share - basic	$	0.23	$	0.47
Earnings per common share from continuing operations - diluted	$	0.23	$	0.47
Loss per common share from discontinued operations - diluted	—		—
Earnings per common share - diluted	$	0.23	$	0.47
Weighted-average common shares outstanding - basic	2,250.1		2,317.0
Weighted-average common shares outstanding - diluted	2,259.2		2,334.3
Depreciation	$	957	$	953
Capital expenditures	$	1,139	$	776

See Notes to the Consolidated Financial Statements.

5

DowDuPont Inc.

Consolidated Statements of Comprehensive Income

	Three Months Ended
In millions (Unaudited)	Mar 31, 2019			Mar 31, 2018
Net income	$	571		$	1,148
Other comprehensive income (loss), net of tax
Unrealized gains (losses) on investments	67			(25		)
Cumulative translation adjustments	(97		)	1,333
Pension and other postretirement benefit plans	135			130
Derivative instruments	(75		)	17
Total other comprehensive income	30			1,455
Comprehensive income	601			2,603
Comprehensive income attributable to noncontrolling interests, net of tax	57			38
Comprehensive income attributable to DowDuPont Inc.	$	544		$	2,565

See Notes to the Consolidated Financial Statements.

6

DowDuPont Inc.

Consolidated Balance Sheets

In millions, except share and per share amounts (Unaudited)	Mar 31, 2019			Dec 31, 2018
Assets
Current Assets
Cash and cash equivalents (variable interest entities restricted - 2019: $109; 2018: $82)	$	11,543		$	13,482
Marketable securities	119			134
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2019: $204; 2018: $191)	13,963			12,376
Other	4,783			4,963
Inventories	16,604			16,621
Other current assets	2,236			2,027
Total current assets	49,248			49,603
Investments
Investment in nonconsolidated affiliates	4,687			5,204
Other investments (investments carried at fair value - 2019: $1,797; 2018: $1,699)	2,791			2,701
Noncurrent receivables	415			477
Total investments	7,893			8,382
Property
Property	75,958			75,343
Less accumulated depreciation	40,383			39,495
Net property (variable interest entities restricted - 2019: $718; 2018: $734)	35,575			35,848
Other Assets
Goodwill	58,948			59,032
Other intangible assets (net of accumulated amortization - 2019: $7,865; 2018: $7,414)	30,467			30,965
Deferred income tax assets	1,853			1,724
Deferred charges and other assets	5,801			2,476
Total other assets	97,069			94,197
Total Assets	$	189,785		$	188,030
Liabilities and Equity
Current Liabilities
Notes payable	$	2,995		$	2,165
Long-term debt due within one year	4,009			637
Accounts payable:
Trade	8,333			9,457
Other	3,735			3,656
Income taxes payable	836			857
Accrued and other current liabilities	8,672			7,943
Total current liabilities	28,580			24,715
Long-Term Debt (variable interest entities nonrecourse - 2019: $43; 2018: $75)	34,966			37,662
Other Noncurrent Liabilities
Deferred income tax liabilities	5,229			5,435
Pension and other postretirement benefits - noncurrent	15,626			15,909
Asbestos-related liabilities - noncurrent	1,133			1,142
Other noncurrent obligations	10,153			6,988
Total other noncurrent liabilities	32,141			29,474
Stockholders' Equity
Common stock (authorized 5,000,000,000 shares of $0.01 par value each; issued 2019: 2,358,630,709 shares; 2018: 2,352,430,301 shares)	24			24
Additional paid-in capital	82,125			81,960
Retained earnings	29,764			30,536
Accumulated other comprehensive loss	(12,364		)	(12,394		)
Unearned ESOP shares	(105		)	(134		)
Treasury stock at cost (2019: 112,316,990 shares; 2018: 83,452,554 shares)	(7,000		)	(5,421		)
DowDuPont's stockholders' equity	92,444			94,571
Noncontrolling interests	1,654			1,608
Total equity	94,098			96,179
Total Liabilities and Equity	$	189,785		$	188,030

See Notes to the Consolidated Financial Statements.

7

DowDuPont Inc.

Consolidated Statements of Cash Flows

	Three Months Ended
In millions (Unaudited)	Mar 31, 2019			Mar 31, 2018
Operating Activities
Net income	$	571		$	1,148
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
Depreciation and amortization	1,519			1,484
Credit for deferred income tax	(342		)	(33		)
Earnings of nonconsolidated affiliates less than dividends received	767			374
Net periodic pension benefit cost (credit)	(8		)	31
Pension contributions	(153		)	(378		)
Net gain on sales of assets, businesses and investments	(43		)	(35		)
Restructuring and asset related charges - net	287			262
Amortization of Merger-related inventory step-up	205			703
Other net loss	94			269
Changes in assets and liabilities, net of effects of acquired and divested companies:
Accounts and notes receivable	(1,643		)	(3,143		)
Inventories	(194		)	(1,170		)
Accounts payable	(732		)	405
Other assets and liabilities, net	(302		)	(2,054		)
Cash provided by (used for) operating activities	26			(2,137		)
Investing Activities
Capital expenditures	(1,139		)	(776		)
Investment in gas field developments	(25		)	(28		)
Proceeds from sales of property and businesses, net of cash divested	125			33
Proceeds from sale of ownership interests in nonconsolidated affiliates	21			—
Purchases of investments	(189		)	(758		)
Proceeds from sales and maturities of investments	212			1,376
Proceeds from interests in trade accounts receivable conduits	—			445
Other investing activities, net	(5		)	(2		)
Cash provided by (used for) investing activities	(1,000		)	290
Financing Activities
Changes in short-term notes payable	798			196
Proceeds from issuance of long-term debt	1,000			253
Payments on long-term debt	(363		)	(85		)
Purchases of treasury stock	(1,579		)	(1,000		)
Proceeds from issuance of company stock	63			108
Transaction financing, debt issuance and other costs	(13		)	—
Employee taxes paid for share-based payment arrangements	(76		)	(103		)
Distributions to noncontrolling interests	(11		)	(27		)
Dividends paid to stockholders	(851		)	(880		)
Other financing activities, net	—			(5		)
Cash used for financing activities	(1,032		)	(1,543		)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	50			208
Summary
Decrease in cash, cash equivalents and restricted cash	(1,956		)	(3,182		)
Cash, cash equivalents and restricted cash at beginning of period	14,022			14,015
Cash, cash equivalents and restricted cash at end of period	$	12,066		$	10,833
Less: Restricted cash and cash equivalents, included in "Other current assets"	523			552
Cash and cash equivalents at end of period	$	11,543		$	10,281

See Notes to the Consolidated Financial Statements.

8

DowDuPont Inc.

Consolidated Statements of Equity

In millions, except per share amounts (Unaudited)	Common Stock		Add'l Paid in Capital		Retained Earnings			Accum Other Comp Loss			Unearned ESOP			Treasury Stock			Non-controlling Interests		Total Equity
2018
Balance at Dec 31, 2017	$	23	$	81,257	$	29,211		$	(8,972	)	$	(189	)	$	(1,000	)	$	1,597	$	101,927
Adoption of accounting standards	—		—		(61		)	20			—			—			—		(41		)
Net income available for DowDuPont Inc. common stockholders	—		—		1,104			—			—			—			—		1,104
Other comprehensive income	—		—		—			1,455			—			—			—		1,455
Dividends ($0.38 per common share)	—		—		(880		)	—			—			—			—		(880		)
Common stock issued/sold	—		108		—			—			—			—			—		108
Stock-based compensation and allocation of ESOP shares	—		153		—			—			39			—			—		192
Impact of noncontrolling interests	—		—		—			—			—			—			67		67
Treasury stock purchases	—		—		—			—			—			(1,000		)	—		(1,000		)
Other	—		—		(8		)	—			—			—			—		(8		)
Balance at Mar 31, 2018	$	23	$	81,518	$	29,366		$	(7,497	)	$	(150	)	$	(2,000	)	$	1,664	$	102,924
2019
Balance at Dec 31, 2018	$	24	$	81,960	$	30,536		$	(12,394	)	$	(134	)	$	(5,421	)	$	1,608	$	96,179
Adoption of accounting standards (Notes 2, 10 and 15)	—		—		(111		)	—			—			—			—		(111		)
Net income available for DowDuPont Inc. common stockholders	—		—		520			—			—			—			—		520
Other comprehensive income	—		—		—			30			—			—			—		30
Dividends ($0.52 per common share)	—		—		(1,176		)	—			—			—			—		(1,176		)
Common stock issued/sold	—		63		—			—			—			—			—		63
Stock-based compensation and allocation of ESOP shares	—		102		—			—			29			—			—		131
Impact of noncontrolling interests	—		—		—			—			—			—			46		46
Treasury stock purchases	—		—		—			—			—			(1,579		)	—		(1,579		)
Other	—		—		(5		)	—			—			—			—		(5		)
Balance at Mar 31, 2019	$	24	$	82,125	$	29,764		$	(12,364	)	$	(105	)	$	(7,000	)	$	1,654	$	94,098

See Notes to the Consolidated Financial Statements.

9

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

Table of Contents

Note		Page
1	Summary of Significant Accounting Policies	11
2	Recent Accounting Guidance	12
3	Intended Business Separations	13
4	Revenue	13
5	Restructuring and Asset Related Charges - Net	15
6	Supplementary Information	17
7	Income Taxes	18
8	Earnings Per Share Calculations	19
9	Inventories	20
10	Nonconsolidated Affiliates	20
11	Goodwill and Other Intangible Assets	21
12	Transfers of Financial Assets	22
13	Notes Payable, Long-Term Debt and Available Credit Facilities	22
14	Commitments and Contingent Liabilities	23
15	Leases	29
16	Accumulated Other Comprehensive Loss	32
17	Noncontrolling Interests	33
18	Pension Plans and Other Postretirement Benefits	34
19	Stock-Based Compensation	34
20	Financial Instruments	35
21	Fair Value Measurements	39
22	Variable Interest Entities	41
23	Segments and Geographic Regions	42
24	Subsequent Events	43

10

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Interim Financial Statements

The accompanying unaudited interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, the interim consolidated financial statements reflect all adjustments (including normal recurring accruals) which are considered necessary for the fair statement of the results for the periods presented. Results from interim periods should not be considered indicative of results for the full year. These interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. The interim consolidated financial statements include the accounts of the Company and all of its subsidiaries in which a controlling interest is maintained.

Basis of Presentation

Effective August 31, 2017, pursuant to the merger of equals transaction contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 ("Merger Agreement"), The Dow Chemical Company ("Historical Dow") and E. I. du Pont de Nemours and Company ("Historical DuPont") each merged with subsidiaries of DowDuPont and, as a result, Historical Dow and Historical DuPont became subsidiaries of DowDuPont (the "Merger"). Prior to the Merger, DowDuPont did not conduct any business activities other than those required for its formation and matters contemplated by the Merger Agreement. Historical Dow was determined to be the accounting acquirer in the Merger.

Except as otherwise indicated by the context, the term "Historical Dow" includes Historical Dow and its consolidated subsidiaries, "Historical DuPont" includes Historical DuPont and its consolidated subsidiaries, "Union Carbide" means Union Carbide Corporation, a wholly owned subsidiary of Historical Dow, and "Dow Silicones" means Dow Silicones Corporation, a wholly owned subsidiary of Historical Dow.

Significant Accounting Policies

The Company updated its accounting policy for leases since the issuance of its Annual Report on Form 10-K for the year ended December 31, 2018 as a result of the adoption of Accounting Standards Update ("ASU") 2016-02, "Leases (Topic 842)" in the first quarter of 2019. See Notes 2 and 15 for additional information. See Note 1, "Summary of Significant Accounting Policies," to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2018 for more information on DowDuPont's other significant accounting policies.

Leases

The Company determines whether an arrangement is a lease at the inception of the arrangement based on the terms and conditions in the contract. A contract contains a lease if there is an identified asset and the Company has the right to control the asset. Operating lease right-of-use ("ROU") assets are included in "Deferred charges and other assets" on the consolidated balance sheets. Operating lease liabilities are included in "Accrued and other current liabilities" and "Other noncurrent obligations" on the consolidated balance sheets. Finance lease ROU assets are included in "Property" and the corresponding lease liabilities are included in "Long-term debt due within one year" and "Long-term debt" on the consolidated balance sheets.  

ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide the lessor's implicit rate, the Company uses its incremental borrowing rate at the commencement date in determining the present value of lease payments. Lease terms include options to extend the lease when it is reasonably certain those options will be exercised. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and lease expense is recognized on a straight-line basis over the lease term.

The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component for all asset classes. Additionally, for certain equipment leases, the portfolio approach is applied to account for the operating lease ROU assets and lease liabilities. In the consolidated statements of income, lease expense for operating lease payments is recognized on a straight-line basis over the lease term. For finance leases, interest expense is recognized on the lease liability and the ROU asset is amortized over the lease term.

11

NOTE 2 - RECENT ACCOUNTING GUIDANCE

Recently Adopted Accounting Guidance

In February 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-02, "Leases (Topic 842)," and associated ASUs related to Topic 842, which requires organizations that lease assets to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. The new guidance requires that a lessee recognize assets and liabilities for leases, and recognition, presentation and measurement in the financial statements will depend on its classification as a finance or operating lease. In addition, the new guidance requires disclosures to help investors and other financial statement users better understand the amount, timing and uncertainty of cash flows arising from leases. Lessor accounting remains largely unchanged from legacy U.S. GAAP but does contain some targeted improvements to align with the new revenue recognition guidance, "Revenue from Contracts with Customers (Topic 606)," issued in 2014.

The Company adopted the new standard in the first quarter of 2019, which allows for a modified retrospective transition approach, applying the new standard to all leases existing at the date of initial adoption. An entity may choose to use either (1) its effective date or (2) the beginning of the earliest comparative period presented in the financial statement as its date of initial application. The Company has elected to apply the transition requirements at the January 1, 2019 effective date rather than at the beginning of the earliest comparative period presented. This approach allows for a cumulative effect adjustment in the period of adoption, and prior periods are not restated and continue to be reported in accordance with historic accounting under ASC 840 "Leases". In addition, the Company has elected the package of practical expedients permitted under the transition guidance within the new standard which does not require reassessment of prior conclusions related to contracts containing a lease, lease classification and initial direct lease costs. As an accounting policy election, the Company chose to not apply the standard to certain existing land easements, excluded short-term leases (term of 12 months or less) from the balance sheet and accounts for nonlease and lease components in a contract as a single component for all asset classes. The following table summarizes the impact of adoption to the consolidated balance sheet:

Summary of Changes to the Consolidated Balance Sheet	As Reported Dec 31, 2018		Effect of Adoption of ASU 2016-02			Updated Jan 1, 2019
In millions
Assets
Net property	$	35,848	$	9		$	35,857
Deferred income tax assets	$	1,724	$	(24	)	$	1,700
Deferred charges and other assets	$	2,476	$	3,386		$	5,862
Total other assets	$	94,197	$	3,362		$	97,559
Total Assets	$	188,030	$	3,371		$	191,401
Liabilities
Long-term debt due within one year	$	637	$	1		$	638
Accrued and other current liabilities	$	7,943	$	721		$	8,664
Total current liabilities	$	24,715	$	722		$	25,437
Long-Term Debt	$	37,662	$	8		$	37,670
Other noncurrent obligations	$	6,988	$	2,569		$	9,557
Total other noncurrent liabilities	$	29,474	$	2,569		$	32,043
Stockholders' Equity
Retained earnings 1	$	30,536	$	72		$	30,608
DowDuPont's stockholders' equity	$	94,571	$	72		$	94,643
Total equity	$	96,179	$	72		$	96,251
Total Liabilities and Equity	$	188,030	$	3,371		$	191,401

1. The net impact to retained earnings was primarily a result of the recognition of a deferred gain associated with a prior sale-leaseback transaction.

The adoption of the new guidance did not have a material impact on the Company's consolidated statement of income and had no impact on the consolidation statement of cash flows.

12

Accounting Guidance Issued But Not Adopted at March 31, 2019

In August 2018, the FASB issued ASU 2018-13, "Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement," which is part of the FASB disclosure framework project to improve the effectiveness of disclosures in the notes to the financial statements. The amendments in the new guidance remove, modify and add certain disclosure requirements related to fair value measurements covered in ASC 820, "Fair Value Measurement." The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted for either the entire standard or only the requirements that modify or eliminate the disclosure requirements, with certain requirements applied prospectively, and all other requirements applied retrospectively to all periods presented. The Company is currently evaluating the impact of adopting this guidance.

In August 2018, the FASB issued ASU 2018-15, "Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract," which requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in ASC 350, "Intangibles - Goodwill and Other" to determine which implementation costs to capitalize as assets or expense as incurred. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted and an entity can elect to apply the new guidance on a prospective or retrospective basis. The Company is currently evaluating the impact of adopting this guidance.

NOTE 3 - INTENDED BUSINESS SEPARATIONS

As discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, DowDuPont previously announced its intent to separate into three independent publicly traded companies - one for each of its agriculture, materials science and specialty products businesses (the “Intended Business Separations” and the transactions to accomplish the Intended Business Separations, the “separations”). DowDuPont formed two wholly owned subsidiaries: Dow Inc. ("Dow", formerly known as Dow Holdings Inc.), to serve as a holding company for its materials science business, and Corteva, Inc., to serve as a holding company for its agriculture business. Following the separations, DowDuPont will continue to hold the specialty products business and operate as "DuPont".

Effective as of 5:00 p.m. on April 1, 2019, DowDuPont completed the distribution of Dow. DowDuPont expects to complete the intended separation of Corteva on June 1, 2019. See Note 24 for additional information.

Integration and Separation Costs

The Company incurred "Integration and separation costs," of $813 million and $457 million for the three months ended March 31, 2019 and 2018, respectively, recorded in the consolidated statements of income. These costs primarily consisted of financial advisory, information technology, legal, accounting, consulting, and other professional advisory fees associated with the preparation and execution of activities related to the Merger, post-merger integration and separation, and the ownership restructure of Dow Silicones. Integration and separation costs related to post-Merger integration and Intended Business Separation activities are expected to continue to be significant throughout 2019.

NOTE 4 - REVENUE

Revenue Recognition

The majority of the Company's revenue is derived from product sales. In the three months ended March 31, 2019, 98 percent of the Company's sales related to product sales (98 percent in the three months ended March 31, 2018) with the remaining balance primarily related to licensing of patents and technologies and Historical Dow's insurance operations. Product sales consist of sales of the Company's products to manufacturers, distributors and farmers and considers order confirmations or purchase orders, which in some cases are governed by master supply agreements, to be contracts with a customer. The Company enters into licensing arrangements in which it licenses certain rights of its patents and technology to customers. Revenue from the Company's licenses for patents and technology is derived from sales-based royalties and licensing arrangements based on billing schedules established in each contract.

Remaining Performance Obligations

Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. At March 31, 2019, the Company had remaining performance obligations related to material rights granted to customers for contract renewal options of $100 million ($102 million at December 31, 2018) and unfulfilled performance obligations for the licensing of technology of $519 million ($407 million at December 31, 2018). The Company expects revenue to be recognized for the remaining performance obligations over the next one to six years.

13

The remaining performance obligations are for product sales that have expected durations of one year or less, product sales of materials delivered through a pipeline for which the Company has elected the right to invoice practical expedient, or variable consideration attributable to royalties for licenses of patents and technology. The Company has received advance payments from customers related to long-term supply agreements and royalty payments that are deferred and recognized over the life of the contract, with remaining contract terms that range up to 22 years. The Company will have rights to future consideration for revenue recognized when product is delivered to the customer. These payments are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets.

Disaggregation of Revenue

The Company disaggregates its revenue from contracts with customers by segment and business or major product line and geographic region, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows.

Net Trade Sales by Segment and Business or Major Product Line 1	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
Crop Protection	$	1,425	$	1,495
Seed	1,972		2,313
Agriculture	$	3,397	$	3,808
Coatings & Performance Monomers	$	890	$	941
Consumer Solutions	1,365		1,363
Performance Materials & Coatings	$	2,255	$	2,304
Industrial Solutions	$	1,103	$	1,155
Polyurethanes & CAV	2,296		2,556
Other	3		4
Industrial Intermediates & Infrastructure	$	3,402	$	3,715
Hydrocarbons & Energy	$	1,380	$	1,800
Packaging and Specialty Plastics	3,730		4,210
Packaging & Specialty Plastics	$	5,110	$	6,010
Advanced Printing	$	119	$	122
Display Technologies	84		60
Interconnect Solutions	238		281
Photovoltaic & Advanced Materials	254		289
Semiconductor Technologies	383		401
Electronics & Imaging	$	1,078	$	1,153
Industrial Biosciences	$	494	$	541
Nutrition & Health	1,165		1,179
Nutrition & Biosciences	$	1,659	$	1,720
Engineering Polymers	$	663	$	668
Performance Resins	308		351
Performance Solutions	384		406
Transportation & Advanced Polymers	$	1,355	$	1,425
Aramids	$	424	$	393
Construction	327		385
TYVEK® Enterprise	310		292
Water Solutions	261		229
Safety & Construction	$	1,322	$	1,299
Corporate	$	71	$	76
Total	$	19,649	$	21,510

1. Beginning in the third quarter of 2018, DowDuPont realigned certain global businesses and product lines in preparation for the Intended Business Separations. These changes have been retrospectively reflected in the results presented.

14

Net Trade Sales by Geographic Region	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
U.S. & Canada	$	7,014	$	7,909
EMEA 1	6,269		6,919
Asia Pacific	4,639		4,790
Latin America	1,727		1,892
Total	$	19,649	$	21,510

1. Europe, Middle East and Africa.

Contract Balances

The Company receives payments from customers based upon contractual billing schedules. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets include amounts related to the Company’s contractual right to consideration for completed performance obligations not yet invoiced. Contract liabilities include payments received in advance of performance under the contract and are realized when the associated revenue is recognized under the contract. "Contract liabilities - current" primarily reflects deferred revenue from prepayments in the Agriculture segment for contracts with customers where the Company receives advance payments for product to be delivered in future periods. "Contract liabilities - noncurrent" includes advance payment for product that the Company has received from customers related to long-term supply agreements and royalty payments that are deferred and recognized over the life of the contract. The Company classifies deferred revenue as current (12 months or less) or noncurrent based on the timing of when the Company expects to recognize revenue.

Revenue recognized in the first three months of 2019 from amounts included in contract liabilities at the beginning of the period was approximately $525 million (approximately $640 million in the first three months of 2018). The increase in contract liabilities from December 31, 2018 to March 31, 2019 was primarily due to advanced payments received from customers for product supply agreements related to Agriculture and one customer related to Packaging & Specialty Plastics, partially offset by Agriculture seed deliveries to customers for the North America growing season, which were delayed due to weather conditions. In the first three months of 2019, the amount of contract assets reclassified to receivables as a result of the right to the transaction consideration becoming unconditional was insignificant (insignificant in the first three months of 2018). The Company did not recognize any asset impairment charges related to contract assets during the period.

Contract Balances	Mar 31, 2019		Dec 31, 2018
In millions
Accounts and notes receivable - Trade	$	13,963	$	12,376
Contract assets - current 1	$	62	$	85
Contract assets - noncurrent 2	$	47	$	47
Contract liabilities - current 3	$	2,266	$	2,092
Contract liabilities - noncurrent 4	$	1,767	$	1,420

1. Included in "Other current assets" in the consolidated balance sheets.

2. Included in "Deferred charges and other assets" in the consolidated balance sheets.

3. Included in "Accrued and other current liabilities" in the consolidated balance sheets.

4. Included in "Other noncurrent obligations" in the consolidated balance sheets.

NOTE 5 - RESTRUCTURING AND ASSET RELATED CHARGES - NET

Charges for restructuring programs and other asset related charges, which includes other asset impairments, were $287 million for the three months ended March 31, 2019 ($262 million for the three months ended March 31, 2018). These charges were recorded in "Restructuring and asset related charges - net" in the consolidated statements of income and consist primarily of the following:

DowDuPont Cost Synergy Program

In September and November 2017, DowDuPont approved post-merger restructuring actions under the DowDuPont Cost Synergy Program (the “Synergy Program”), which was designed to integrate and optimize the organization following the Merger and in preparation for the Intended Business Separations. The Company expects to record total pretax restructuring charges of approximately $2,200 million of which the Company recorded pretax restructuring charges of $2,027 million inception-to-date, consisting of severance and related benefit costs of $1,045 million, asset write-downs and write-offs of $695 million and costs associated with exit and disposal activities of $287 million.

15

For the three months ended March 31, 2019, the Company recorded pretax restructuring charges of $280 million of which $279 million was recorded in "Restructuring and asset related charges - net" and $1 million was recorded in "Equity in earnings of nonconsolidated affiliates" in the consolidated statements of income. The charge for the three months ended March 31, 2019 consisted of severance and related benefit costs of $112 million, asset write-downs and write-offs of $116 million, and costs associated with exit and disposal activities of $52 million. For the three months ended March 31, 2018, the Company recorded pretax restructuring charges of $260 million in "Restructuring and asset related charges - net." The charge for the three months ended March 31, 2018 consisted of severance and related benefit costs of $172 million, asset write-downs and write-offs of $48 million and costs associated with exit and disposal activities of $40 million. The Company expects to substantially complete the Synergy Program by the end of 2019.

The following table summarizes the activities related to the Synergy Program. At March 31, 2019, $464 million was included in "Accrued and other current liabilities" ($490 million at December 31, 2018) and $99 million was included in "Other noncurrent obligations" ($84 million at December 31, 2018) in the consolidated balance sheets.

Synergy Program	Severance and Related Benefit Costs			Asset Write-downs and Write-offs			Costs Associated with Exit and Disposal Activities			Total
In millions
Reserve balance at Dec 31, 2018	$	491		$	—		$	83		$	574
2019 restructuring charges	112			116			52			280
Charges against the reserve	—			(115		)	—			(115		)
Cash payments	(140		)	—			(36		)	(176		)
Reserve balance at Mar 31, 2019	$	463		$	1		$	99		$	563

Restructuring charges recorded for severance and related benefit costs were related to Corporate. The Company recorded $116 million of restructuring charges for asset write-downs and write-offs for the three months ended March 31, 2019, related to Nutrition & Biosciences ($10 million), Agriculture ($28 million), Safety & Construction ($2 million) Transportation & Advanced Polymers ($1 million), Packaging & Specialty Plastics ($1 million) and Corporate ($74 million). The asset write-downs and write-offs primarily related to the impairment of leased, non-manufacturing facilities and the write down of inventory.

The Company recorded restructuring charges of $52 million for costs associated with exit and disposal activities for the three months ended March 31, 2019, related to Agriculture ($19 million), Nutrition & Biosciences ($18 million) and Corporate ($15 million).

The Company expects to incur additional costs in the future related to its restructuring activities. Future costs are expected to include demolition costs related to closed facilities and restructuring plan implementation costs which will be recognized as incurred. The Company also expects to incur additional employee-related costs, including involuntary termination benefits, related to its other optimization activities. These costs cannot be reasonably estimated at this time.

DowDuPont Agriculture Division Restructuring Program

During the fourth quarter of 2018 and in connection with the ongoing integration activities, DowDuPont approved restructuring actions to simplify and optimize certain organizational structures within the Agriculture segment in preparation for the Intended Business Separations ("Agriculture Division Program"). As a result of these actions, the Company expects to record total pretax charges of approximately $96 million, comprised of $83 million of severance and related benefit costs, $11 million of asset write-downs and write-offs and $2 million of costs associated with exit and disposal activities.

For the three months ended March 31, 2019, DowDuPont recorded a net pretax restructuring benefit of $1 million, consisting of a favorable adjustment of $4 million to the severance and related benefit costs reserve and asset write-downs and write-offs of $3 million. The impact of these items are shown as "Restructuring and asset related charges - net" in the consolidated statements of income. The Company expects actions related to the Agriculture Division Program to be substantially complete by mid 2019.

The Company recorded pretax restructuring charges of $83 million inception-to-date under the Agriculture Division Program, consisting of severance and related benefit costs of $74 million and asset write-downs and write-offs of $9 million.

16

The following table summarizes the activities related to the Agriculture Division Program. At March 31, 2019, $58 million ($77 million at December 31, 2018) was included in "Accrued and other current liabilities" in the consolidated balance sheets.

Agriculture Division Program	Severance and Related Benefit Costs			Asset Write-downs and Write-offs			Total
(In millions)
Reserve balance at Dec 31, 2018	$	77		$	—		$	77
2019 restructuring charges and adjustments 1	(4		)	3			(1		)
Charges against the reserve	—			(3		)	(3		)
Cash payments	(15		)	—			(15		)
Reserve balance at Mar 31, 2019	$	58		$	—		$	58

1. Included in "Restructuring and asset related charges - net" in the consolidated statements of income.

Restructuring adjustments recorded for severance and related benefit costs and charges recorded for asset write-downs and write‑offs were related to Corporate and Agriculture, respectively.

NOTE 6 - SUPPLEMENTARY INFORMATION

The Company uses "Sundry income (expense) – net" to record a variety of income and expense items such as foreign currency exchange gains and losses, interest income, dividends from investments, gains and losses on sales of investments and other assets, non-operating pension and other postretirement benefit plan credits or costs, and certain litigation matters. For the three months ended March 31, 2019, "Sundry income (expense) - net" was income of $248 million (income of $115 million for the three months ended March 31, 2018).

The following table provides the most significant transactions recorded in "Sundry income (expense) - net" for the three months ended March 31, 2019 and 2018:

Sundry Income (Expense) - Net	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Non-operating pension and other postretirement benefit plan net credit	$	108		$	110
Interest income	$	75		$	55
Gains on sales of other assets and investments, net 1	$	50		$	34
Foreign exchange losses, net 2	$	(11	)	$	(148	)

1. Includes a $51 million gain related to a sale of assets by Historical DuPont and $24 million loss related to Historical Dow's sale of a joint venture in the first quarter of 2019. Includes a $20 million gain in the first quarter of 2018 related to Historical Dow's sale of its equity interest in MEGlobal.

2. Includes a $50 million foreign exchange loss in the first quarter of 2018 related to adjustments to Historical DuPont's foreign currency exchange contracts as a result of U.S. tax reform.

Cash, Cash Equivalents and Restricted Cash

The Company is required to set aside funds for various activities that arise in the normal course of business including, but not limited to, insurance contracts, legal matters and other agreements. These funds typically have legal restrictions associated with them and are deposited in an escrow account or held in a separately identifiable account by the Company. At March 31, 2019, the Company had restricted cash of $523 million ($540 million at December 31, 2018), included in "Other current assets" in the consolidated balance sheets.

Historical DuPont entered into a trust agreement in 2013 (as amended and restated in 2017), establishing and requiring Historical DuPont to fund a trust (the "Trust") for cash obligations under certain non-qualified benefit and deferred compensation plans upon a change in control event as defined in the Trust agreement. Under the Trust agreement, the consummation of the Merger was a change in control event. At March 31, 2019, $480 million of the restricted cash balance was related to the Trust ($500 million at December 31, 2018).

17

NOTE 7 - INCOME TAXES

On December 22, 2017, the Tax Cuts and Jobs Act (“The Act”) was enacted. The Act reduces the U.S. federal corporate income tax rate from 35 percent to 21 percent, requires companies to pay a one-time transition tax on earnings of foreign subsidiaries that were previously tax deferred, creates new provisions related to foreign sourced earnings, eliminates the domestic manufacturing deduction and moves towards a territorial system. At December 31, 2018, the Company had completed its accounting for the tax effects of The Act.

• As a result of The Act, the Company remeasured its U.S. federal deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which is generally 21 percent. In the first quarter of 2018, the Company recorded a charge of $17 million to “Provision for income taxes on continuing operations" in the consolidated statements of income to adjust the provisional amount related to the remeasurement of the Company's deferred tax balance.

• In the first quarter of 2018, the Company recorded an indirect impact of The Act related to prepaid tax on the intercompany sale of inventory. The amount recorded related to the inventory was a $54 million charge to "Provision for income taxes on continuing operations."

During the first and second quarters of 2019, in connection with the Intended Business Separations, the Company has and expects to continue repatriating certain funds from its foreign subsidiaries that are not needed to finance local operations or separation activities. During the three months ended March 31, 2019, the Company recorded a tax charge of $13 million associated with these repatriation activities to "Provision for income taxes on continuing operations." Beyond these expected repatriations, the Company is still asserting indefinite reinvestment related to certain investments in foreign subsidiaries.

Each year the Company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. Positions challenged by the tax authorities may be settled or appealed by the Company. As a result, there is an uncertainty in income taxes recognized in the Company’s financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. The ultimate resolution of such uncertainties is not expected to have a material impact on the Company's results of operations.

18

NOTE 8 - EARNINGS PER SHARE CALCULATIONS

The following tables provide earnings per share calculations for the three months ended March 31, 2019 and 2018:

Net Income for Earnings Per Share Calculations - Basic	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Income from continuing operations, net of tax	$	571		$	1,153
Net income attributable to noncontrolling interests	(51		)	(44		)
Net income attributable to participating securities 1	(1		)	(6		)
Income from continuing operations attributable to common stockholders	$	519		$	1,103
Loss from discontinued operations, net of tax	—			(5		)
Net income attributable to common stockholders	$	519		$	1,098

Earnings Per Share Calculations - Basic	Three Months Ended
	Mar 31, 2019		Mar 31, 2018
Dollars per share
Income from continuing operations attributable to common stockholders	$	0.23	$	0.47
Loss from discontinued operations, net of tax	—		—
Net income attributable to common stockholders	$	0.23	$	0.47

Net Income for Earnings Per Share Calculations - Diluted	Three Months Ended
	Mar 31, 2019			Mar 31, 2018
In millions
Income from continuing operations, net of tax	$	571		$	1,153
Net income attributable to noncontrolling interests	(51		)	(44		)
Net income attributable to participating securities 1	(1		)	(6		)
Income from continuing operations attributable to common stockholders	$	519		$	1,103
Loss from discontinued operations, net of tax	—			(5		)
Net income attributable to common stockholders	$	519		$	1,098

Earnings Per Share Calculations - Diluted	Three Months Ended
	Mar 31, 2019		Mar 31, 2018
Dollars per share
Income from continuing operations attributable to common stockholders	$	0.23	$	0.47
Loss from discontinued operations, net of tax	—		—
Net income attributable to common stockholders	$	0.23	$	0.47

Share Count Information	Three Months Ended
	Mar 31, 2019	Mar 31, 2018
Shares in millions
Weighted-average common shares - basic	2,250.1	2,317.0
Plus dilutive effect of equity compensation plans	9.1	17.3
Weighted-average common shares - diluted	2,259.2	2,334.3
Stock options and restricted stock units excluded from EPS calculations 2	19.2	5.3

1. Historical Dow restricted stock units are considered participating securities due to Historical Dow's practice of paying dividend equivalents on unvested shares.

2. These outstanding options to purchase shares of common stock and restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

19

NOTE 9 - INVENTORIES

The following table provides a breakdown of inventories:

Inventories	Mar 31, 2019		Dec 31, 2018
In millions
Finished goods	$	10,060	$	9,814
Work in process	3,561		3,969
Raw materials	1,461		1,419
Supplies	1,276		1,321
Total	$	16,358	$	16,523
Adjustment of inventories to a LIFO basis	246		98
Total inventories	$	16,604	$	16,621

NOTE 10 - NONCONSOLIDATED AFFILIATES

The Company's investments in companies accounted for using the equity method ("nonconsolidated affiliates"), by classification in the consolidated balance sheets, are shown in the following table:

Investments in Nonconsolidated Affiliates	Mar 31, 2019			Dec 31, 2018
In millions
Investment in nonconsolidated affiliates	$	4,687		$	5,204
Accrued and other current liabilities	(81		)	(81		)
Other noncurrent obligations	(870		)	(495		)
Net investment in nonconsolidated affiliates	$	3,736		$	4,628

HSC Group

The carrying value of the Company's investments in the HSC Group, which includes Hemlock Semiconductor L.L.C. and DC HSC Holdings LLC, was adjusted as a result of the HSC Group's adoption of Topic 606. The resulting impact to the Company's investments in the HSC Group was a reduction to "Investment in nonconsolidated affiliates" of $71 million and an increase to "Other noncurrent obligations" of $168 million, as well as an increase to "Deferred income tax assets" of $56 million and a reduction to "Retained earnings" of $183 million in the consolidated balance sheet at January 1, 2019. The following table reflects the carrying value of the HSC Group investments at March 31, 2019 and December 31, 2018:

Investment in the HSC Group		Investment
In millions	Balance Sheet Classification	Mar 31, 2019			Dec 31, 2018
Hemlock Semiconductor L.L.C.	Other noncurrent obligations	$	(658	)	$	(495	)
DC HSC Holdings LLC	Investment in nonconsolidated affiliates	$	485		$	535

EQUATE

In the first quarter of 2019, EQUATE Petrochemical Company K.S.C.C. ("EQUATE") paid a dividend of $440 million, reflected in "Earnings of nonconsolidated affiliates less than dividends received" in the consolidated statements of cash flows. As a result, the Company had a negative investment balance in EQUATE of $212 million at March 31, 2019, classified as "Other noncurrent obligations" in the consolidated balance sheets. At December 31, 2018, the Company had an investment balance in EQUATE of $131 million, classified as "Investment in nonconsolidated affiliates" in the consolidated balance sheets.

20

NOTE 11 - GOODWILL AND OTHER INTANGIBLE ASSETS

The following table reflects the carrying amounts of goodwill by reportable segment: 

Goodwill	Agri-culture		Perf. Materials & Coatings			Ind. Interm. & Infrast.			Pack. & Spec. Plastics			Elect. & Imaging			Nutrition & Biosciences			Transp. & Adv. Polymers			Safety & Const.			Total
In millions
Net goodwill at Dec 31, 2018	$	14,689	$	3,650		$	1,096		$	5,101		$	8,188		$	12,643		$	6,967		$	6,698		$	59,032
Foreign currency impact	11		(20		)	(2		)	(7		)	(3		)	(29		)	(15		)	(19		)	(84		)
Net goodwill at Mar 31, 2019	$	14,700	$	3,630		$	1,094		$	5,094		$	8,185		$	12,614		$	6,952		$	6,679		$	58,948

Other Intangible Assets

The following table provides information regarding the Company's other intangible assets:

Other Intangible Assets	Mar 31, 2019							Dec 31, 2018
In millions	Gross Carrying Amount		Accum Amort			Net		Gross Carrying Amount		Accum Amort			Net
Intangible assets with finite lives:
Developed technology 1	$	8,179	$	(2,731	)	$	5,448	$	7,761	$	(2,562	)	$	5,199
Software	1,539		(900		)	639		1,529		(876		)	653
Trademarks/tradenames	1,763		(773		)	990		1,772		(745		)	1,027
Customer-related	14,208		(3,095		)	11,113		14,236		(2,895		)	11,341
Microbial cell factories	384		(26		)	358		386		(22		)	364
Favorable supply contracts	493		(136		)	357		475		(111		)	364
Other 2	612		(204		)	408		620		(203		)	417
Total other intangible assets with finite lives	$	27,178	$	(7,865	)	$	19,313	$	26,779	$	(7,414	)	$	19,365
Intangible assets with indefinite lives:
IPR&D 1	149		—			149		594		—			594
Germplasm 3	6,265		—			6,265		6,265		—			6,265
Trademarks/tradenames	4,740		—			4,740		4,741		—			4,741
Total other intangible assets	$	38,332	$	(7,865	)	$	30,467	$	38,379	$	(7,414	)	$	30,965

1. During the first quarter of 2019, Historical DuPont announced an expanded launch of its Qrome® corn hybrids following the receipt of regulatory approval from China. As a result, Historical DuPont reclassified the amounts from indefinite-lived IPR&D to developed technology.

2. Primarily consists of sales and grower networks, marketing and manufacturing alliances and noncompetition agreements.

3. Germplasm is the pool of genetic source material and body of knowledge gained from the development and delivery stage of plant breeding. This intangible asset is expected to contribute to cash flows beyond the foreseeable future and there are no legal, regulatory, contractual or other factors which limit its useful life.

The following table provides information regarding amortization expense related to other intangible assets:

Amortization Expense	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
Other intangible assets, excluding software	$	474	$	474
Software, included in "Cost of sales"	$	25	$	23

Total estimated amortization expense for 2019 and the five succeeding fiscal years is as follows:

Estimated Amortization Expense
In millions
2019	$	2,008
2020	$	1,893
2021	$	1,851
2022	$	1,760
2023	$	1,612
2024	$	1,500

21

NOTE 12 - TRANSFERS OF FINANCIAL ASSETS

Historical Dow sold trade accounts receivable of select North American entities and qualifying trade accounts receivable of select European entities on a revolving basis to certain multi-seller commercial paper conduit entities ("conduits"). The proceeds received were comprised of cash and interests in specified assets of the conduits (the receivables sold by Historical Dow) that entitled Historical Dow to the residual cash flows of such specified assets in the conduits after the commercial paper was repaid. Neither the conduits nor the investors in those entities had recourse to other assets of Historical Dow in the event of nonpayment by the debtors.

In the fourth quarter of 2017, the Company suspended further sales of trade accounts receivable through these facilities and began reducing outstanding balances through collections of trade accounts receivable previously sold to such conduits. In September and October 2018, the North American and European facilities, respectively, were amended and the terms of the agreements changed from off-balance sheet arrangements to secured borrowing arrangements. See Note 13 for additional information on the secured borrowing arrangements.

The following represents the cash flows between Historical Dow and the conduits:

Cash Proceeds	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
Interests in conduits 1	$	—	$	445

1. Presented in "Investing Activities" in the consolidated statements of cash flows.

NOTE 13 - NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES

A summary of Historical Dow's and Historical DuPont's notes payable, long-term debt and available credit facilities can be found in Note 15 to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. If applicable, updates have been included in the respective section below.

2019 Activity

In the first three months of 2019, Historical Dow redeemed an aggregate principal amount of $72 million of International Notes at maturity.

In March 2019, Historical DuPont fully repaid $262 million of 5.75 percent coupon bonds at maturity.

DowDuPont Notes

In contemplation of the separations and distributions and in preparation to achieve the intended credit profiles of Corteva, Dow and DuPont, in the fourth quarter of 2018, DowDuPont consummated a public underwritten offer of eight series of senior unsecured notes (the "DowDuPont Notes") in an aggregate principal amount of $12.7 billion. The DowDuPont Notes are a senior unsecured obligation of the Company and will rank equally with the Company's future senior unsecured debt outstanding from time to time. On November 1, 2018, the Company announced a $3.0 billion share buyback program, which expired on March 31, 2019. In the first quarter of 2019, proceeds from the DowDuPont Notes were used to purchase $1.6 billion of shares. As a result, the share buyback program was complete at March 31, 2019.

Historical Dow Committed Credit Facilities

On March 9, 2019, Historical Dow renewed a $100 million Bilateral Revolving Credit Facility agreement, which has a maturity date in March 2020 and provides for interest at floating rates, as defined in the agreement.

Historical Dow Term Loan Facility

In connection with the ownership restructure of Dow Silicones on May 31, 2016, Dow Silicones incurred $4.5 billion of indebtedness under a certain third party credit agreement ("Historical Dow Term Loan Facility"). Historical Dow subsequently guaranteed the obligations of Dow Silicones under the Historical Dow Term Loan Facility and, as a result, the covenants and events of default applicable to the Historical Dow Term Loan Facility are substantially similar to the covenants and events of default set forth in Historical Dow's Five Year Competitive Advance and Revolving Credit Facility. In the second quarter of 2018, Dow Silicones exercised the 19 month extension option making amounts borrowed under the Historical Dow Term Loan Facility repayable on December 30, 2019. In addition, Dow Silicones amended the Historical Dow Term Loan Facility to include an additional two-year extension option, at Dow Silicones' election, upon satisfaction of certain customary conditions precedent. On April 5, 2019, Dow Silicones voluntarily repaid $2.0 billion of principal, which was classified as "Long-term debt due within one year" in the

22

consolidated balance sheets at March 31, 2019. Dow Silicones also intends to exercise the two-year extension option on the remaining principal balance of $2.5 billion.

Historical DuPont Term Loan and Revolving Credit Facilities

In March 2016, Historical DuPont entered into a credit agreement that provides for a three-year, senior unsecured term loan facility in the aggregate principal amount of $4.5 billion (as may be amended, from time to time, the "Historical DuPont Term Loan Facility") under which Historical DuPont may make up to seven term loan borrowings and amounts repaid or prepaid are not available for subsequent borrowings. The proceeds from the borrowings under the Historical DuPont Term Loan Facility were used for Historical DuPont's general corporate purposes including debt repayment, working capital and funding a portion of the Company's costs and expenses. At March 31, 2019, Historical DuPont had made six term loan borrowings in an aggregate principal amount of $3.0 billion and had unused commitments of $1.5 billion under the Historical DuPont Term Loan Facility. See Note 24 for further discussion on the repayment of the Historical DuPont Term Loan Facility in May 2019.

Historical DuPont Repurchase Facility

In February 2019, Historical DuPont entered into a new committed receivable repurchase facility of up to $1,300 million (the "2019 Repurchase Facility") which expires in December 2019. Under the 2019 Repurchase Facility, Historical DuPont may sell a portfolio of available and eligible outstanding customer notes receivables within the Agriculture segment to participating institutions and simultaneously agree to repurchase at a future date. The 2019 Repurchase Facility is considered a secured borrowing with the customer notes receivable inclusive of those that are sold and repurchased, equal to 105 percent of the outstanding amounts borrowed utilized as collateral. Borrowings under the 2019 Repurchase Facility have an interest rate of LIBOR plus 0.75 percent.

At March 31, 2019, $20 million of notes receivable, recorded in "Accounts and notes receivable - Trade," were pledged as collateral against outstanding borrowings under the 2019 Repurchase Facility of $19 million, recorded in "Notes payable" in the consolidated balance sheets.

Debt Covenants and Default Provisions

There were no material changes to the debt covenants and default provisions related to DowDuPont's, Historical Dow's and Historical DuPont's outstanding Notes, long-term debt and primary, private credit agreements for the three months ended March 31, 2019.

See Note 24 for details of actions taken to achieve credit profiles of DuPont, Corteva and Dow.

NOTE 14 - COMMITMENTS AND CONTINGENT LIABILITIES

Litigation

Asbestos-Related Matters of Union Carbide Corporation

A summary of Asbestos-Related Matters of Union Carbide Corporation can be found in Note 16 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2018.

Introduction

Union Carbide is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past four decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide’s premises, and Union Carbide’s responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem Products, Inc. (“Amchem”). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to Union Carbide’s products.

Union Carbide expects more asbestos-related suits to be filed against Union Carbide and Amchem in the future, and will aggressively defend or reasonably resolve, as appropriate, both pending and future claims.

Estimating the Asbestos-Related Liability

Since 2003, Union Carbide has engaged Ankura Consulting Group, LLC ("Ankura"), a third party actuarial specialist, to review Union Carbide's historical asbestos-related claim and resolution activity in order to assist Union Carbide's management in estimating the asbestos-related liability. Each year, Ankura has reviewed the claim and resolution activity to determine the appropriateness of updating the most recent Ankura study.

23

Based on the December 2018 Ankura review, and Union Carbide's own review of the data, Union Carbide's total asbestos-related liability through the terminal year of 2049, including asbestos-related defense and processing costs, was $1,260 million at December 31, 2018, and included in “Accrued and other current liabilities” and “Asbestos-related liabilities - noncurrent” in the consolidated balance sheets.

Each quarter, Union Carbide reviews claims filed, settled and dismissed, as well as average settlement and resolution costs by disease category. Union Carbide also considers additional quantitative and qualitative factors such as the nature of pending claims, trial experience of Union Carbide and other asbestos defendants, current spending for defense and processing costs, significant appellate rulings and legislative developments, trends in the tort system, and their respective effects on expected future resolution costs. Union Carbide's management considers all these factors in conjunction with the most recent Ankura study and determines whether a change in the estimate is warranted. Based on Union Carbide's review of 2019 activity, it was determined that no adjustment to the accrual was required at March 31, 2019.

Union Carbide's asbestos related liability for pending and future claims and defense and processing costs was $1,243 million at March 31, 2019. Approximately 17 percent of the recorded liability related to pending claims and approximately 83 percent related to future claims.

Summary

The Company's management believes the amounts recorded by Union Carbide for the asbestos-related liability (including defense and processing costs) reflect reasonable and probable estimates of the liability based upon current, known facts. However, future events, such as the number of new claims to be filed and/or received each year and the average cost of defending and disposing of each such claim, as well as the numerous uncertainties surrounding asbestos litigation in the United States over a significant period of time, could cause the actual costs for Union Carbide to be higher or lower than those projected or those recorded. Any such events could result in an increase or decrease in the recorded liability.

Because of the uncertainties described above, Union Carbide cannot estimate the full range of the cost of resolving pending and future asbestos-related claims facing Union Carbide and Amchem. As a result, it is reasonably possible that an additional cost of disposing of Union Carbide's asbestos-related claims, including future defense and processing costs, could have a material impact on the Company's results of operations and cash flows for a particular period and on the consolidated financial position.

Dow Silicones Chapter 11 Related Matters

A summary of the Dow Silicones Chapter 11 Related Matters can be found in Note 16 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2018.

Introduction

In 1995, Dow Silicones, then a 50:50 joint venture between Historical Dow and Corning Incorporated ("Corning"), voluntarily filed for protection under Chapter 11 of the U.S. Bankruptcy Code in order to resolve Dow Silicones' breast implant liabilities and related matters (the “Chapter 11 Proceeding”). Dow Silicones emerged from the Chapter 11 Proceeding on June 1, 2004 (the “Effective Date”) and is implementing the Joint Plan of Reorganization (the “Plan”). The Plan provides funding for the resolution of breast implant and other product liability litigation covered by the Chapter 11 Proceeding and provides a process for the satisfaction of commercial creditor claims in the Chapter 11 Proceeding. As of June 1, 2016, Dow Silicones is a wholly owned subsidiary of Historical Dow.

Breast Implant and Other Product Liability Claims

Under the Plan, a product liability settlement program administered by an independent claims office (the “Settlement Facility”) was created to resolve breast implant and other product liability claims. Product liability claimants rejecting the settlement program in favor of pursuing litigation must bring suit against a litigation facility (the “Litigation Facility”). Dow Silicones has an obligation to fund the Settlement Facility and the Litigation Facility over a 16-year period, commencing at the Effective Date. At March 31, 2019, Dow Silicones and its insurers have made life-to-date payments of $1,762 million to the Settlement Facility and the Settlement Facility reported an unexpended balance of $110 million.

Dow Silicones' liability for breast implant and other product liability claims ("Implant Liability") was $263 million at March 31, 2019 and December 31, 2018, of which $157 million at March 31, 2019 ($111 million at December 31, 2018) was included in "Accrued and other current liabilities" and $106 million at March 31, 2019 ($152 million at December 31, 2018) was included in "Other noncurrent obligations" in the consolidated balance sheets. Dow Silicones is not aware of circumstances that would change the factors used in estimating the Implant Liability and believes the recorded liability reflects the best estimate of the remaining funding obligations under the Plan; however, the estimate relies upon a number of significant assumptions, including: future claim filing levels in the Settlement Facility will be similar to those in a prior settlement program, which management uses to estimate future claim filing levels for the Settlement Facility; future acceptance rates, disease mix, and payment values will be materially

24

consistent with historical experience; no material negative outcomes in future controversies or disputes over Plan interpretation will occur; and the Plan will not be modified. If actual outcomes related to any of these assumptions prove to be materially different, the future liability to fund the Plan may be materially different than the amount estimated. If Dow Silicones was ultimately required to fund the full liability up to the maximum capped value, the liability would be $2,148 million at March 31, 2019.

Commercial Creditor Issues

The Plan provides that each of Dow Silicones' commercial creditors (the “Commercial Creditors”) would receive in cash the sum of (a) an amount equal to the principal amount of their claims and (b) interest on such claims. The actual amount of interest that will ultimately be paid to these Commercial Creditors is uncertain due to pending litigation between Dow Silicones and the Commercial Creditors regarding the appropriate interest rates to be applied to outstanding obligations from the 1995 bankruptcy filing date through the Effective Date, as well as the presence of any recoverable fees, costs, and expenses. Upon the Plan becoming effective, Dow Silicones paid approximately $1,500 million to the Commercial Creditors, representing principal and an amount of interest that Dow Silicones considers undisputed.

On May 10, 2017, the U.S. District Court for the Eastern District of Michigan entered a stipulated order resolving pending discovery motions and established a discovery schedule for the Commercial Creditors matter. As a result, Dow Silicones and its third party consultants conducted further analysis of the Commercial Creditors claims and defenses. This analysis indicated the estimated remaining liability to Commercial Creditors to be within a range of $77 million to $260 million. No single amount within the range appeared to be a better estimate than any other amount within the range. Therefore, Dow Silicones recorded the minimum liability within the range. At March 31, 2019, the liability related to Dow Silicones' potential obligation to its Commercial Creditors in the Chapter 11 Proceeding was $83 million and is included in "Accrued and other current liabilities" in the consolidated balance sheets ($82 million at December 31, 2018). The actual amount of interest that will be paid to these creditors is uncertain and will ultimately be resolved through continued proceedings in the District Court.

Indemnifications

In connection with the June 1, 2016 ownership restructure of Dow Silicones, Historical Dow is indemnified by Corning for 50 percent of future losses associated with certain pre-closing liabilities, including the Implant Liability and Commercial Creditors matters described above, subject to certain conditions and limits. The maximum amount of indemnified losses which may be recovered are subject to a cap that declines over time. Indemnification assets were insignificant at March 31, 2019 (zero at December 31, 2018).

Summary

The amounts recorded by Dow Silicones for the Chapter 11 related matters described above were based upon current, known facts, which management believes reflect reasonable and probable estimates of the liability. However, future events could cause the actual costs for Dow Silicones to be higher or lower than those projected or those recorded. Any such events could result in an increase or decrease in the recorded liability.

Separation of Historical DuPont's Performance Chemicals Segment

On July 1, 2015, Historical DuPont completed the separation of its Performance Chemicals segment through the spin-off of all of the issued and outstanding stock of The Chemours Company (the "Chemours Separation"). In connection with the Chemours Separation, Historical DuPont and The Chemours Company (“Chemours”) entered into a Separation agreement (as amended, the "Chemours Separation Agreement"). Pursuant to the Chemours Separation Agreement, Chemours indemnifies Historical DuPont against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the Chemours Separation. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, Historical DuPont records an indemnification asset when recovery is deemed probable. At March 31, 2019, the indemnification assets were $84 million included in "Accounts and notes receivable - Other" and $289 million included in "Noncurrent receivables" along with the corresponding liabilities of $84 million recorded in "Accrued and other current liabilities" and $289 million included in "Other noncurrent obligations" in the consolidated balance sheets.

PFOA Liabilities

Historical DuPont is a party to legal proceedings relating to the use of PFOA (collectively, perfluorooctanoic acids and its salts, including the ammonium salt) by its former Performance Chemicals segment. While it is reasonably possible that Historical DuPont could incur liabilities related to PFOA, any such liabilities are not expected to be material. Pursuant to the Chemours Separation Agreement discussed above, Historical DuPont is indemnified by Chemours for the PFOA matters discussed below and has recorded a total liability of $22 million and a total indemnification asset of $22 million at March 31, 2019, primarily related to testing drinking water in and around certain Historical DuPont sites and offering treatment or an alternative supply of drinking water if tests indicate the presence of PFOA in drinking water at or greater than the national health advisory level established from time to time by the EPA.

25

Leach Settlement and MDL Settlement

Historical DuPont has residual liabilities under its 2004 settlement of a West Virginia state court class action, Leach v. DuPont, which alleged that PFOA from Historical DuPont’s former Washington Works facility had contaminated area drinking water supplies and affected the health of area residents. The settlement class has about 80,000 members. In addition to relief that was provided to class members years ago, the settlement requires Historical DuPont to continue providing PFOA water treatment to six area water districts and private well users and to fund, through an escrow account, up to $235 million for a medical monitoring program for eligible class members. At March 31, 2019, approximately $2 million had been disbursed from the account since its establishment in 2012 and the remaining balance is approximately $1 million.

The Leach settlement permits class members to pursue personal injury claims for six health conditions (and no others) that an expert panel appointed under the settlement reported in 2012 had a “probable link” (as defined in the settlement) with PFOA: pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol. After the expert panel reported its findings, approximately 3,550 personal injury lawsuits were filed in federal and state courts in Ohio and West Virginia and consolidated in multi-district litigation in the U.S. District Court for the Southern District of Ohio (“MDL”). The MDL was settled in early 2017 for $671 million in cash, with Chemours and Historical DuPont (without indemnification from Chemours) each paying half.

Post-MDL Settlement PFOA Personal Injury Claims

The MDL settlement did not resolve claims of plaintiffs who did not have claims in the MDL or whose claims are based on diseases first diagnosed after February 11, 2017. At March 31, 2019, about 57 lawsuits were pending alleging personal injury, including kidney and testicular cancer, thyroid disease and ulcerative colitis, from exposure to PFOA through air or water, only three of which are not part of the MDL or were not otherwise filed on behalf of Leach class members.

Other PFOA Actions

Historical DuPont is a party to other PFOA lawsuits that do not involve claims for personal injury. Chemours, pursuant to the Chemours Separation Agreement, is defending and indemnifying with reservations Historical DuPont in these lawsuits.

New York. Historical DuPont is a defendant in about 52 lawsuits, including a putative class action, brought by persons who live in and around Hoosick Falls, New York. These lawsuits assert claims for medical monitoring and property damage based on alleged PFOA releases from manufacturing facilities owned and operated by co-defendants in Hoosick Falls and allege that Historical DuPont and 3M supplied some of the materials used at these facilities. Historical DuPont is also one of more than ten defendants in a lawsuit brought by the Town of East Hampton, New York alleging PFOA and perfluorooctanesulfonic acid ("PFOS") contamination of the town’s well water.

New Jersey. At December 31, 2018, two lawsuits were pending, one brought by a local water utility and the second a putative class action, against Historical DuPont alleging that PFOA from Historical DuPont’s former Chambers Works facility contaminated drinking water sources. The putative class action was dismissed without prejudice by the plaintiffs.

In late March of 2019, the New Jersey State Attorney General (the “NJAG”) filed four lawsuits against Historical DuPont, Chemours, 3M and others alleging that former Historical DuPont operations at the Chambers Works, Pompton Lakes Works, Parlin and Repauno sites in New Jersey, caused damage to the State’s natural resources. Two of these lawsuits (those involving the Chambers Works and Parlin sites) allege contamination from per- and polyfluoroalkyl substances (“PFAS”). The lawsuit related to Parlin names an additional DowDuPont subsidiary. The Ridgewood Water District in New Jersey filed suit in the first quarter of 2019 against Historical DuPont alleging losses related to the investigation, remediation and monitoring of polyfluorinated surfactants (“PFS”), including PFOA, in water supplies.

Alabama. Historical DuPont is one of more than thirty defendants in a lawsuit by a local water utility alleging contamination from perfluorinated chemicals and compounds (“PFCs”), including PFOA, used by co-defendant carpet manufacturers to make their products more stain and grease resistant.

Ohio. Historical DuPont is a defendant in three lawsuits: an action by the State of Ohio based on alleged damage to natural resources, a putative nationwide class action brought on behalf of anyone who has detectable levels of perfluorinated chemicals, including PFOA, in their blood, and an action by the City of Dayton claiming losses related to the investigation, remediation and monitoring of PFAS, including PFOA, in water supplies.

Other. Dozens of cases have been filed against 3M and other defendants primarily alleging property damage from contamination in connection with the use of firefighting foams that contain PFOS. At March 31, 2019, Historical DuPont

26

was named in 4 of these cases. Historical DuPont did not make firefighting foam and has never made or supplied PFOS or products that contained PFOS.

Chemours Separation Agreement Amendment

Concurrent with the MDL Settlement, Historical DuPont and Chemours amended the Chemours Separation Agreement to provide for a limited sharing of potential future PFOA liabilities for a five-year period that began on July 6, 2017. During that five-year period, Chemours will annually pay the first $25 million of future PFOA liabilities and, if that amount is exceeded, Historical DuPont will pay any excess amount up to the next $25 million, with Chemours annually bearing any excess liabilities above that amount. At the end of the five-year period, this limited sharing agreement will expire, and Chemours’ indemnification obligations under the Chemours Separation Agreement will continue unchanged. As part of this amendment, Chemours also agreed that it would not contest its liability for PFOA liabilities on the basis of certain ostensible defenses it had previously raised, including defenses relating to punitive damages, and would waive any such defenses with respect to PFOA liabilities. Chemours has, however, retained defenses as to whether any particular PFOA claim is within the scope of the indemnification provisions of the Chemours Separation Agreement.

There have been no charges incurred by Historical DuPont under this arrangement through March 31, 2019.

Fayetteville Works Facility, North Carolina

Prior to the separation of Chemours, Historical DuPont introduced GenX as a polymerization processing aid and a replacement for PFOA at the Fayetteville Works facility in Bladen County, North Carolina. The facility is now owned and operated by Chemours, which continues to manufacture and use GenX. In 2017, the facility became and continues to be the subject of inquiries and government investigations relating to the alleged discharge of GenX and certain similar compounds into the air and Cape Fear River.

In August 2017, the U.S. Attorney’s Office for the Eastern District of North Carolina served Historical DuPont with a grand jury subpoena for testimony and documents related to these discharges. Historical DuPont was served with additional subpoenas relating to the same issue and in the second quarter of 2018, received a subpoena expanding the scope to any PFCs discharged from the Fayetteville Works facility into the Cape Fear River. It is possible that these ongoing inquiries and investigations, including the grand jury subpoena, could result in penalties or sanctions, or that additional litigation will be instituted against Chemours, Historical DuPont, or both.

At March 31, 2019, several actions are pending in federal court against Chemours and Historical DuPont. One of these actions is a consolidated putative class action that asserts claims for medical monitoring and property damage on behalf of putative classes of property owners and residents in areas near or who draw drinking water from the Cape Fear River. Another action is a consolidated action brought by various North Carolina water authorities, including the Cape Fear Public Utility Authority and Brunswick County, that seek actual and punitive damages as well as injunctive relief. In addition, an action is pending in North Carolina state court on behalf of about 100 plaintiffs who own wells and property near the Fayetteville Works facility. The plaintiffs seek damages for nuisance allegedly caused by releases of certain PFCs from the site.

While it is reasonably possible that Historical DuPont could incur liabilities related to the actions described above, any such liabilities are not expected to be material.

Historical DuPont has an indemnification claim against Chemours with respect to current and future inquiries and claims, including lawsuits, related to the foregoing. At March 31, 2019, Chemours, with reservations, is defending and indemnifying Historical DuPont in the pending civil actions.

Other Litigation Matters

In addition to the specific matters described above, Historical Dow and Historical DuPont are parties to a number of other claims and lawsuits arising out of the normal course of business with respect to product liability, patent infringement, governmental regulation, contract and commercial litigation, and other actions. Certain of these actions purport to be class actions and seek damages in very large amounts. All such claims are being contested. Historical Dow and Historical DuPont have active risk management programs consisting of numerous insurance policies secured from many carriers at various times. These policies may provide coverage that could be utilized to minimize the financial impact, if any, of certain contingencies described above. It is the opinion of the Company’s management that the possibility is remote that the aggregate of all such other claims and lawsuits will have a material adverse impact on the results of operations, financial condition and cash flows of the Company.

27

Gain Contingency - Historical Dow v. Nova Chemicals Corporation Patent Infringement Matter

On December 9, 2010, Historical Dow filed suit in the Federal Court in Ontario, Canada ("Federal Court") alleging that Nova Chemicals Corporation ("Nova") was infringing Historical Dow's Canadian polyethylene patent 2,106,705. Nova counterclaimed on the grounds of invalidity and non-infringement. On June 29, 2017, the Federal Court issued a Confidential Supplemental Judgment, concluding that Nova must pay $645 million Canadian dollars (equivalent to $495 million U.S. dollars) to Historical Dow, plus pre- and post-judgment interest, for which Historical Dow received payment of $501 million from Nova on July 6, 2017. Although Nova is appealing portions of the damages judgment, certain portions of it are indisputable and will be owed to Historical Dow regardless of the outcome of any further appeals by Nova. At March 31, 2019, Historical Dow had $341 million ($341 million at December 31, 2018) included in "Other noncurrent obligations" in the consolidated balance sheets related to the disputed portion of the damages judgment. Historical Dow is confident of its chances of defending the entire judgment on appeal, particularly the trial court's determinations on important factual issues, which will be accorded deferential review on appeal. See Note 16 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2018 for additional information.

Environmental Matters

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current law and existing technologies. At March 31, 2019, the Company had accrued obligations of $1,197 million for probable environmental remediation and restoration costs, including $213 million for the remediation of Superfund sites. These obligations are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets. This is management’s current estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to approximately two and a half times that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the Company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. At December 31, 2018, the Company had accrued obligations of $1,201 million for probable environmental remediation and restoration costs, including $210 million for the remediation of Superfund sites.

Pursuant to the Chemours Separation Agreement, Historical DuPont is indemnified by Chemours for certain environmental matters, included in the liability of $1,197 million, that have an estimated liability of $185 million at March 31, 2019, and a potential exposure that ranges up to approximately $355 million above the current accrual. As such, Historical DuPont has recorded an indemnification asset of $185 million corresponding to its accrual balance related to these matters at March 31, 2019, including $35 million related to Superfund sites.

Guarantees

The following table provides a summary of the final expiration, maximum future payments and recorded liability reflected in the consolidated balance sheets for each type of guarantee:

Guarantees	Mar 31, 2019					Dec 31, 2018
In millions	Final Expiration	Maximum Future Payments		Recorded Liability		Final Expiration	Maximum Future Payments		Recorded Liability
Historical Dow guarantees	2023	$	4,514	$	15	2023	$	4,523	$	25
Historical DuPont guarantees	2022	239		—		2022	255		—
Total guarantees		$	4,753	$	15		$	4,778	$	25

Guarantees

Historical Dow and Historical DuPont (the "Subsidiaries") have entered into guarantee agreements arising in the ordinary course of business from relationships with customers and nonconsolidated affiliates when the Subsidiaries undertake an obligation to guarantee the performance of others (via delivery of cash or other assets) if specified triggering events occur. With guarantees, such as commercial or financial contracts, non-performance by the guaranteed party triggers the obligation of the Subsidiaries to make payments to the beneficiary of the guarantee. The majority of these guarantees relate to debt of nonconsolidated affiliates, which have expiration dates ranging from less than one year to less than four years, and trade financing transactions in Latin America, which typically expire within one year of inception. The Subsidiaries current expectation is that future payment or performance related to the non-performance of others is considered remote.

28

Historical Dow has entered into guarantee agreements ("Guarantees") related to project financing for Sadara Chemical Company ("Sadara"), a nonconsolidated affiliate. The total of an Islamic bond and additional project financing (collectively “Total Project Financing”) obtained by Sadara is approximately $12.5 billion. Sadara had $11.7 billion of Total Project Financing outstanding at March 31, 2019 ($11.7 billion at December 31, 2018). Historical Dow's guarantee of the Total Project Financing is in proportion to Historical Dow's 35 percent ownership interest in Sadara, or up to approximately $4.2 billion when the project financing is fully drawn. Sadara successfully completed an extensive operational testing program in December 2018, however, the Guarantees will be released upon the satisfactory fulfillment of certain project completion conditions, which is expected by the middle of 2019, and must occur no later than December 2020.

NOTE 15 - LEASES

The Company has operating and finance leases for sales and administrative offices, power plants, production facilities, warehouses and tanks for product storage, airplanes, railcars, motor vehicles, certain machinery and equipment, and information technology assets. The Company’s leases have remaining lease terms of 1 year to 50 years. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that the Company will exercise those options. Some leasing arrangements require variable payments that are dependent on usage, output, or may vary for other reasons, such as insurance and tax payments. The variable lease payments are not presented as part of the initial ROU asset or lease liability. The Company's lease agreements do not contain any material restrictive covenants.

The components of lease cost for operating and finance leases for the three months ended March 31, 2019 were as follows:

Lease Cost	Three Months Ended Mar 31, 2019
(In millions)
Operating lease cost	$	201
Finance lease cost
Amortization of right-of-use assets	$	41
Interest on lease liabilities	7
Total finance lease cost	$	48
Short-term lease cost	$	60
Variable lease cost	89
Sublease income	(9		)
Total lease cost	$	389

New leases entered into during the three months ended March 31, 2019 were not considered material. Supplemental cash flow information related to leases was as follows:

Other Lease Information	Three Months Ended Mar 31, 2019
(In millions)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	210
Operating cash flows from finance leases	$	7
Financing cash flows from finance leases	$	23

29

The following table summarizes the lease-related assets and liabilities recorded in the consolidated balance sheets at March 31, 2019:

Lease Position	Mar 31, 2019
(In millions)
Operating Leases
Operating lease right-of-use assets 1	$	3,287
Current operating lease liabilities 2	$	690
Noncurrent operating lease liabilities 3	2,620
Total operating lease liabilities	$	3,310
Finance Leases
Property	$	589
Accumulated depreciation	(181		)
Net Property	$	408
Long-term debt due within one year	63
Long-Term Debt	432
Total finance lease liabilities	$	495

1. Included in "Deferred charges and other assets" in the consolidated balance sheet.

2. Included in "Accrued and other current liabilities" in the consolidated balance sheet.

3. Included in "Other noncurrent obligations" in the consolidated balance sheet.

DowDuPont utilizes the incremental borrowing rate in determining the present value of lease payments unless the implicit rate is readily determinable.

Lease Term and Discount Rate	Mar 31, 2019
Weighted-average remaining lease term (years)
Operating leases	7.98
Finance leases	15.54
Weighted-average discount rate
Operating leases	3.97	%
Finance leases	6.25	%

The following table provides the maturities of lease liabilities at March 31, 2019:

Maturity of Lease Liabilities at Mar 31, 2019	Operating Leases		Finance Leases
(In millions)
2019	$	621	$	74
2020	686		78
2021	553		73
2022	450		71
2023	346		80
2024 and thereafter	1,286		315
Total future undiscounted lease payments	$	3,942	$	691
Less: Interest	632		196
Present value of lease liabilities	$	3,310	$	495

At March 31, 2019, the Company had additional leases of approximately $45 million, primarily for buildings and equipment, which had not yet commenced. These leases are expected to commence later in 2019, with lease terms of 10 years.

30

Future minimum lease payments for operating leases accounted for under ASC 840, "Leases," with remaining non-cancelable terms in excess of one year at December 31, 2018 were as follows:

Minimum Lease Commitments at Dec 31, 2018
(In millions)
2019	$	654
2020	497
2021	418
2022	363
2023	297
2024 and thereafter	1,063
Total	$	3,292

Certain of the Company's leases include residual value guarantees. These residual value guarantees are based on a percentage of lessor's asset acquisition price. The portion of residual value guarantees that are probable of payment are included in the related lease liability on the consolidated balance sheet other than certain finance leases that include the maximum residual value guarantee amount in the measurement of the related liability given the election to use the package of practical expedients at the date of adoption. The following table provides a summary of the final expiration, maximum future payment and recorded liability reflected in the consolidated balance sheets for residual value guarantees.

Lease Guarantees	Mar 31, 2019					Dec 31, 2018
(In millions)	Final Expiration	Maximum Future Payments		Recorded Liability		Final Expiration	Maximum Future Payments		Recorded Liability
Residual value guarantees	2028	$	931	$	—	2028	$	889	$	130

31

NOTE 16 - ACCUMULATED OTHER COMPREHENSIVE LOSS

The following table summarizes the activity related to each component of accumulated other comprehensive loss ("AOCL") for the three months ended March 31, 2019 and 2018:

Accumulated Other Comprehensive Loss	Unrealized Gains (Losses) on Investments			Cumulative Translation Adj			Pension and Other Postretire Benefits			Derivative Instruments			Total Accum Other Comp Loss
In millions
Balance at Jan 1, 2018	$	17		$	(1,935	)	$	(6,923	)	$	(111	)	$	(8,952	)
Other comprehensive income (loss) before reclassifications	(26		)	1,333			4			(4		)	1,307
Amounts reclassified from accumulated other comprehensive income	1			—			126			21			148
Net other comprehensive income (loss)	$	(25	)	$	1,333		$	130		$	17		$	1,455
Balance at Mar 31, 2018	$	(8	)	$	(602	)	$	(6,793	)	$	(94	)	$	(7,497	)
Balance at Jan 1, 2019	$	(51	)	$	(3,785	)	$	(8,476	)	$	(82	)	$	(12,394	)
Other comprehensive income (loss) before reclassifications	68			(79		)	(7		)	(65		)	(83		)
Amounts reclassified from accumulated other comprehensive income (loss)	(1		)	(18		)	142			(10		)	113
Net other comprehensive income (loss)	$	67		$	(97	)	$	135		$	(75	)	$	30
Balance at Mar 31, 2019	$	16		$	(3,882	)	$	(8,341	)	$	(157	)	$	(12,364	)

The tax effects on the net activity related to each component of other comprehensive income (loss) for the three months ended March 31, 2019 and 2018 were as follows:

Tax Benefit (Expense) 1	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Unrealized (losses) gains on investments	$	(18	)	$	6
Cumulative translation adjustments	(1		)	5
Pension and other postretirement benefit plans	(32		)	(30		)
Derivative instruments	24			(1		)
Tax expense from income taxes related to other comprehensive income items	$	(27	)	$	(20	)

1. Prior period amounts were updated to conform with the current year presentation.

32

A summary of the reclassifications out of AOCL for the three months ended March 31, 2019 and 2018 is provided as follows:

Reclassifications Out of Accumulated Other Comprehensive Loss	Three Months Ended						Consolidated Statements of Income Classification
	Mar 31, 2019			Mar 31, 2018
In millions
Unrealized (gains) losses on investments	$	(1	)	$	2		See (1) below
Tax benefit	—			(1		)	See (2) below
After tax	$	(1	)	$	1
Cumulative translation adjustments	$	(18	)	$	—		See (3) below
Pension and other postretirement benefit plans	$	167		$	154		See (4) below
Tax benefit	(25		)	(28		)	See (2) below
After tax	$	142		$	126
Derivative Instruments	$	(11	)	$	26		See (5) below
Tax expense (benefit)	1			(5		)	See (2) below
After tax	$	(10	)	$	21
Total reclassifications for the period, after tax	$	113		$	148

1. "Net sales" and "Sundry income (expense) - net."

2. "Provision for income taxes on continuing operations."

3. "Sundry income (expense) - net."

4. These AOCL components are included in the computation of net periodic benefit cost of the Company's defined benefit pension and other postretirement benefit plans. See Note 18 for additional information.

5. "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."

NOTE 17 - NONCONTROLLING INTERESTS

Ownership interests in the Company's subsidiaries held by parties other than the Company are presented separately from the Company's equity in the consolidated balance sheets as "Noncontrolling interests." The amount of consolidated net income attributable to the Company and the noncontrolling interests are both presented on the face of the consolidated statements of income.

The following table summarizes the activity for equity attributable to noncontrolling interests for the three months ended March 31, 2019 and 2018:

Noncontrolling Interests	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Balance at beginning of period	$	1,608		$	1,597
Net income attributable to noncontrolling interests	51			44
Distributions to noncontrolling interests	(11		)	(27		)
Noncontrolling interests from Merger 1	—			56
Cumulative translation adjustments	7			(6		)
Other	(1		)	—
Balance at end of period	$	1,654		$	1,664

1. Relates to Merger and subsequent measurement period adjustments.

33

NOTE 18 - PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS

A summary of Historical Dow and Historical DuPont's pension plans and other postretirement benefits can be found in Note 19 to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. Historical Dow and Historical DuPont did not merge their defined benefit pension and other postretirement benefit plans as a result of the Merger. The following table provides the components of net periodic benefit cost (credit) for Historical Dow and Historical DuPont's significant plans:

Net Periodic Benefit Cost (Credit) for All Significant Plans	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Defined Benefit Pension Plans:
Service cost	$	131		$	167
Interest cost	447			408
Expected return on plan assets	(713		)	(709		)
Amortization of prior service credit	(6		)	(6		)
Amortization of net loss	133			171
Net periodic benefit cost (credit)	$	(8	)	$	31
Other Postretirement Benefits:
Service cost	$	4		$	5
Interest cost	37			32
Amortization of net gain	(6		)	(6		)
Net periodic benefit cost	$	35		$	31

Net periodic benefit cost (credit), other than the service cost component, is included in "Sundry income (expense) - net" in the consolidated statements of income.

DowDuPont expects to make additional contributions in the aggregate of about $500 million by year-end 2019 to its pension plans other than the principal U.S. pension plan.

NOTE 19 - STOCK-BASED COMPENSATION

A summary of Historical Dow and Historical DuPont's stock-based compensation plans can be found in Note 20 to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. Historical Dow and Historical DuPont did not merge their equity incentive plans as a result of the Merger. The Historical Dow and Historical DuPont stock-based compensation plans were assumed by DowDuPont and continue in place with the ability to grant and issue DowDuPont Common Stock.

Historical Dow Stock Incentive Plan

Historical Dow grants stock-based compensation to employees and non-employee directors under The Dow Chemical Company Amended and Restated 2012 Stock Incentive Plan (the "2012 Plan"). In connection with the Merger, on August 31, 2017, all outstanding Historical Dow stock options and restricted stock unit awards were converted into stock options and restricted stock unit awards with respect to DowDuPont Common Stock. The stock options and restricted stock unit awards have the same terms and conditions under the applicable plans and award agreements prior to the Merger. There was minimal grant activity in the first quarter of 2019.

Historical DuPont Equity Incentive Plan

Historical DuPont grants stock-based compensation to certain employees, directors, and consultants through grants of stock options, time-vested restricted stock units ("RSUs"), and performance-based restricted stock units (“PSUs”) under the Historical DuPont Equity Incentive Plan ("Historical DuPont EIP"). The previous Historical DuPont equity awards were converted into the right to receive 1.2820 shares of DowDuPont Common Stock. The awards have the same terms and conditions as were applicable to such equity awards immediately prior to the Merger closing date. Most of these awards have been granted annually in the first quarter of each calendar year. In the first quarter of 2019, Historical DuPont granted 2.6 million RSUs with a weighted-average fair value of $52.66 per share under the Historical DuPont EIP.

34

NOTE 20 - FINANCIAL INSTRUMENTS

A summary of the Company's financial instruments, risk management policies, derivative instruments and hedging activities can be found in Note 21 of the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2018. If applicable, updates have been included in the respective section below.

The following table summarizes the fair value of financial instruments at March 31, 2019 and December 31, 2018:

Fair Value of Financial Instruments	Mar 31, 2019											Dec 31, 2018
In millions	Cost			Gain		Loss			Fair Value			Cost			Gain		Loss			Fair Value
Cash equivalents	$	7,384		$	9	$	—		$	7,393		$	9,951		$	12	$	—		$	9,963
Restricted cash equivalents 1	$	480		$	—	$	—		$	480		$	500		$	—	$	—		$	500
Marketable securities:
Available-for-sale 2	$	101		$	—	$	—		$	101		$	100		$	—	$	—		$	100
Held-to-maturity 3	18			—		—			18			34			—		—			34
Total marketable securities	$	119		$	—	$	—		$	119		$	134		$	—	$	—		$	134
Other investments:
Debt securities:
Government debt 4	$	694		$	17	$	(9	)	$	702		$	714		$	9	$	(23	)	$	700
Corporate bonds	1,051			43		(21		)	1,073			1,026			20		(63		)	983
Total debt securities	$	1,745		$	60	$	(30	)	$	1,775		$	1,740		$	29	$	(86	)	$	1,683
Equity securities 5	$	17		$	5	$	—		$	22		$	17		$	1	$	(2	)	$	16
Total other investments	$	1,762		$	65	$	(30	)	$	1,797		$	1,757		$	30	$	(88	)	$	1,699
Total cash and restricted cash equivalents, marketable securities and other investments	$	9,745		$	74	$	(30	)	$	9,789		$	12,342		$	42	$	(88	)	$	12,296
Long-term debt including debt due within one year 6	$	(38,975	)	$	102	$	(2,470	)	$	(41,343	)	$	(38,299	)	$	390	$	(1,457	)	$	(39,366	)
Derivatives relating to:
Interest rates	$	—		$	—	$	(181	)	$	(181	)	$	—		$	—	$	(64	)	$	(64	)
Foreign currency 7	—			128		(17		)	111			—			157		(49		)	108
Commodities 7	—			88		(147		)	(59		)	—			91		(178		)	(87		)
Total derivatives	$	—		$	216	$	(345	)	$	(129	)	$	—		$	248	$	(291	)	$	(43	)

1. Classified as "Other current assets" in the consolidated balance sheets.

2. Available-for-sale securities with maturities of less than one year at the time of purchase.

3. Held-to-maturity securities with maturities of more than three months to less than one year at the time of purchase.

4. U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

5. Equity securities with a readily determinable fair value.

6. Cost includes fair value adjustments of $69 million at March 31, 2019 and $78 million at December 31, 2018, related to the accounting for the Merger. Cost also includes fair value hedge adjustments of $17 million at March 31, 2019 and $18 million at December 31, 2018 on $2,290 million of debt at March 31, 2019 and December 31, 2018.

7. Presented net of cash collateral where master netting arrangements allow.

Debt Securities

The Company's investments in debt securities are primarily classified as available-for-sale. For the three months ended March 31, 2019, $35 million of marketable securities matured. The following table provides the investing results from available-for-sale securities for the three months ended March 31, 2019 and 2018:

Investing Results	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Proceeds from sales of available-for-sale securities	$	159		$	348
Gross realized gains	$	6		$	7
Gross realized losses	$	(5	)	$	(9	)

35

Equity Securities

The Company's investments in equity securities with a readily determinable fair value totaled $22 million at March 31, 2019 ($16 million at December 31, 2018). The aggregate carrying value of the Company’s investments in equity securities where fair value is not readily determinable totaled $260 million at March 31, 2019 ($258 million at December 31, 2018), reflecting the carrying value of the investments. There were no material adjustments to the carrying value of the not readily determinable investments for impairment or observable price changes for the three months ended March 31, 2019 and 2018. The net unrealized gain recognized in earnings on equity securities totaled $5 million for the three months ended March 31, 2019 ($8 million net unrealized gain for the three months ended March 31, 2018).

Derivatives

The following tables provide the fair value and balance sheet classification of derivative instruments at March 31, 2019 and December 31, 2018:

Fair Value of Derivative Instruments		Mar 31, 2019
In millions	Balance Sheet Classification	Gross		Counterparty and Cash Collateral Netting 1			Net Amounts Included in the Consolidated Balance Sheet
Asset derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other current assets	$	161	$	(89	)	$	72
Commodity contracts	Other current assets	31		(5		)	26
Commodity contracts	Deferred charges and other assets	57		(4		)	53
Total		$	249	$	(98	)	$	151
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	$	87	$	(31	)	$	56
Commodity contracts	Other current assets	8		(1		)	7
Commodity contracts	Deferred charges and other assets	4		(2		)	2
Total		$	99	$	(34	)	$	65
Total asset derivatives		$	348	$	(132	)	$	216
Liability derivatives:
Derivatives designated as hedging instruments:
Interest rate swaps	Other noncurrent obligations	$	181	$	—		$	181
Foreign currency contracts	Accrued and other current liabilities	98		(89		)	9
Commodity contracts	Accrued and other current liabilities	93		(6		)	87
Commodity contracts	Other noncurrent obligations	60		(8		)	52
Total		$	432	$	(103	)	$	329
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	37	$	(29	)	$	8
Commodity contracts	Accrued and other current liabilities	8		(4		)	4
Commodity contracts	Other noncurrent obligations	7		(3		)	4
Total		$	52	$	(36	)	$	16
Total liability derivatives		$	484	$	(139	)	$	345

1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

36

Fair Value of Derivative Instruments		Dec 31, 2018
In millions	Balance Sheet Classification	Gross		Counterparty and Cash Collateral Netting 1			Net Amounts Included in the Consolidated Balance Sheet
Asset derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other current assets	$	98	$	(42	)	$	56
Commodity contracts	Other current assets	47		(13		)	34
Commodity contracts	Deferred charges and other assets	18		(3		)	15
Total		$	163	$	(58	)	$	105
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	$	200	$	(99	)	$	101
Commodity contracts	Other current assets	41		(1		)	40
Commodity contracts	Deferred charges and other assets	4		(2		)	2
Total		$	245	$	(102	)	$	143
Total asset derivatives		$	408	$	(160	)	$	248
Liability derivatives:
Derivatives designated as hedging instruments:
Interest rate swaps	Other noncurrent obligations	$	64	$	—		$	64
Foreign currency contracts	Accrued and other current liabilities	46		(42		)	4
Commodity contracts	Accrued and other current liabilities	111		(18		)	93
Commodity contracts	Other noncurrent obligations	86		(9		)	77
Total		$	307	$	(69	)	$	238
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	124	$	(79	)	$	45
Commodity contracts	Accrued and other current liabilities	7		(4		)	3
Commodity contracts	Other noncurrent obligations	8		(3		)	5
Total		$	139	$	(86	)	$	53
Total liability derivatives		$	446	$	(155	)	$	291

1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

Assets and liabilities related to forward contracts, interest rate swaps, currency swaps, options and other conditional or exchange contracts executed with the same counterparty under a master netting arrangement are netted. Collateral accounts are netted with corresponding assets or liabilities, when applicable. The Company posted cash collateral of $20 million at March 31, 2019 ($26 million at December 31, 2018). Counterparties posted cash collateral of $2 million with the Company at March 31, 2019 ($54 million at December 31, 2018).

Net Foreign Investment Hedges

Historical Dow

For derivative instruments that are designated and qualify as net foreign investment hedges, the effective portion of the gain or loss on the derivative is included in “Cumulative Translation Adjustments” in AOCL. Historical Dow had outstanding foreign-currency denominated debt designated as a hedge of net foreign investment of $181 million at March 31, 2019 ($182 million at December 31, 2018). The results of hedges of Historical Dow’s net investment in foreign operations included in “Cumulative Translation Adjustments” in AOCL was a net loss of $36 million after tax for the three months ended March 31, 2019 (net loss of $43 million after tax for the three months ended March 31, 2018). For the three months ended March 31, 2019, Historical Dow recognized after tax gains of $86 million related to excluded components of net foreign investment hedges included in "Cumulative Translation Adjustments" in AOCL. For the three months ended March 31, 2019, gains of $25 million were amortized to “Sundry income (expense) - net” in the consolidated statements of income.

37

Fair Value Hedges

Historical Dow

Subsequent to March 31, 2019, Historical Dow entered into interest rate contracts designated as a fair value hedge of underlying fixed rate debt obligations with maturity dates extending through 2048.

Income Statement Effect of Derivative Instruments

Foreign currency derivatives not designated as hedges are used to offset foreign exchange gains or losses resulting from the underlying exposures of foreign currency denominated assets and liabilities. The amount charged on a pretax basis related to foreign currency derivatives not designated as a hedge, which was included in “Sundry income (expense) - net” in the consolidated statements of income, was a gain of $22 million for the three months ended March 31, 2019 (loss of $198 million for the three months ended March 31, 2018). The income statement effects of other derivatives were immaterial.

Reclassification from AOCL

The net after-tax amounts to be reclassified from AOCL to income within the next 12 months are a $1 million gain for interest rate contracts, a $52 million loss for commodity contracts, an $11 million gain for foreign currency contracts and a $57 million gain for excluded components.

38

NOTE 21 - FAIR VALUE MEASUREMENTS

A summary of the Company's recurring and nonrecurring fair value measurements can be found in Note 22 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2018. If applicable, updates have been included in the respective section below.

Fair Value Measurements on a Recurring Basis

The following tables summarize the bases used to measure certain assets and liabilities at fair value on a recurring basis:

Basis of Fair Value Measurements on a Recurring Basis at Mar 31, 2019	Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)		Total
In millions
Assets at fair value:
Cash equivalents 1	$	—	$	7,393	$	7,393
Restricted cash equivalents 1	—		480		480
Marketable securities 2	—		119		119
Equity securities 3	21		—		21
Debt securities: 3
Government debt 4	—		702		702
Corporate bonds	19		1,054		1,073
Derivatives relating to: 5
Foreign currency	—		247		247
Commodities	10		90		100
Total assets at fair value	$	50	$	10,085	$	10,135
Liabilities at fair value:
Long-term debt including debt due within one year 6	$	—	$	41,343	$	41,343
Derivatives relating to: 5
Interest rates	—		181		181
Foreign currency	—		134		134
Commodities	13		155		168
Total liabilities at fair value	$	13	$	41,813	$	41,826

1. Treasury bills, time deposits, and money market funds included in "Cash and cash equivalents" and money market funds included in "Other current assets" in the consolidated balance sheets and held at amortized cost, which approximates fair value.

2. Primarily time deposits with maturities of greater than three months at time of acquisition.

3. The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” in the consolidated balance sheets.

4. U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

5. See Note 20 for the classification of derivatives in the consolidated balance sheets.

6. See Note 20 for information on fair value measurements of long-term debt.

39

Basis of Fair Value Measurements on a Recurring Basis at Dec 31, 2018	Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)		Total
In millions
Assets at fair value:
Cash equivalents 1	$	—	$	9,963	$	9,963
Restricted cash equivalents 1	—		500		500
Marketable securities 2	—		134		134
Equity securities 3	16		—		16
Debt securities: 3
Government debt 4	—		700		700
Corporate bonds	—		983		983
Derivatives relating to: 5
Foreign currency	—		298		298
Commodities	17		93		110
Total assets at fair value	$	33	$	12,671	$	12,704
Liabilities at fair value:
Long-term debt including debt due within one year 6	$	—	$	39,366	$	39,366
Derivatives relating to: 5
Interest rates	—		64		64
Foreign currency	—		170		170
Commodities	23		189		212
Total liabilities at fair value	$	23	$	39,789	$	39,812

1. Treasury bills, time deposits, and money market funds included in "Cash and cash equivalents" and money market funds included in "Other current assets" in the consolidated balance sheets and held at amortized cost, which approximates fair value.

2. Primarily time deposits with maturities of greater than three months at time of acquisition.

3. The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” in the consolidated balance sheets.

4. U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

5. See Note 20 for the classification of derivatives in the consolidated balance sheets.

6. See Note 20 for information on fair value measurements of long-term debt.

For equity securities calculated at net asset value per share (or its equivalent), the Company had $121 million in private market securities and $29 million in real estate at March 31, 2019 ($120 million in private market securities and $29 million in real estate at December 31, 2018). There are no redemption restrictions and the unfunded commitments on these investments were $87 million at March 31, 2019 ($89 million at December 31, 2018).

Fair Value Measurements on a Nonrecurring Basis

As part of the Synergy Program, the Company has or will shut down a number of manufacturing, R&D and corporate facilities around the world. In the first three months of 2019, inventory associated with this plan was written down to zero. In addition, impairments of leased, non-manufacturing facilities, which were classified as Level 3 measurements, resulted in a write-down of right-of-use assets to $80 million using unobservable inputs. The impairment charges related to the Synergy Program, totaling $100 million, were included in "Restructuring and asset related charges - net" in the consolidated statements of income. See Note 5 for additional information on the Company's restructuring activities.

40

NOTE 22 - VARIABLE INTEREST ENTITIES

A summary of Historical Dow and Historical DuPont's variable interest entities ("VIEs") can be found in Note 23 to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. Historical DuPont did not hold a variable interest in any joint ventures at March 31, 2019, for which it is the primary beneficiary. In addition, the maximum exposure to loss related to the nonconsolidated VIEs for which Historical DuPont did hold a variable interest at March 31, 2019, is not considered material to the consolidated financial statements. The following discussion addresses variable interests held by Historical Dow.

Assets and Liabilities of Consolidated VIEs

The Company's consolidated financial statements include the assets, liabilities and results of operations of VIEs for which Historical Dow is the primary beneficiary. The other equity holders’ interests are reflected in "Net income attributable to noncontrolling interests" in the consolidated statements of income and "Noncontrolling interests" in the consolidated balance sheets.

The following table summarizes the carrying amounts of these entities’ assets and liabilities included in the Company’s consolidated balance sheets at March 31, 2019 and December 31, 2018:

Assets and Liabilities of Consolidated VIEs	Mar 31, 2019		Dec 31, 2018
In millions
Cash and cash equivalents	$	109	$	82
Other current assets	116		114
Net property	718		734
Other noncurrent assets	60		45
Total assets 1	$	1,003	$	975
Current liabilities	$	318	$	334
Long-term debt	43		75
Other noncurrent obligations	46		31
Total liabilities 2	$	407	$	440

1. All assets were restricted at March 31, 2019 and December 31, 2018.

2. All liabilities were nonrecourse at March 31, 2019 and December 31, 2018.

Amounts presented in the consolidated balance sheets and the preceding table as restricted assets or nonrecourse obligations relating to consolidated VIEs at March 31, 2019 and December 31, 2018, are adjusted for intercompany eliminations and parental guarantees.

Nonconsolidated VIEs

The following table summarizes the carrying amounts of assets and liabilities included in the consolidated balance sheets at March 31, 2019 and December 31, 2018, related to variable interests in joint ventures or entities for which Historical Dow is not the primary beneficiary. The Company's maximum exposure to loss is the same as the carrying amounts, unless otherwise noted below.

Carrying Amounts of Assets and Liabilities Related to Nonconsolidated VIEs		Mar 31, 2019			Dec 31, 2018
In millions	Description of asset or liability
Hemlock Semiconductor L.L.C.	Equity method investment 1	$	(658	)	$	(495	)
Silicon joint ventures	Equity method investments 2	$	96		$	100
AgroFresh Solutions, Inc.	Equity method investment 2	$	45		$	48
	Other receivable 3	$	8		$	8

1. Classified as "Other noncurrent obligations" in the consolidated balance sheets. The Company's maximum exposure to loss was zero at March 31, 2019 (zero at December 31, 2018).

2. Classified as "Investment in nonconsolidated affiliates" in the consolidated balance sheets.

3. Classified as "Accounts and notes receivable - Other" in the consolidated balance sheets.

41

NOTE 23 - SEGMENTS AND GEOGRAPHIC REGIONS

The Company's measure of profit/loss for segment reporting purposes is Operating EBITDA as this is the manner in which the Company's chief operating decision maker ("CODM") assesses performance and allocates resources. The Company defines Operating EBITDA as earnings (i.e., “Income from continuing operations before income taxes") before interest, depreciation, amortization and foreign exchange gains (losses), excluding the impact of significant items. A reconciliation of these measures is provided on the following pages.

Segment Information	Agri-culture			Perf. Materials & Coatings		Ind. Interm. & Infrast.			Pack. & Spec. Plastics		Elect. & Imaging		Nutrition & Biosciences		Transp. & Adv. Polymers		Safety & Const.		Corp.			Total
In millions
Three months ended Mar 31, 2019
Net sales	$	3,397		$	2,255	$	3,402		$	5,110	$	1,078	$	1,659	$	1,355	$	1,322	$	71		$	19,649
Operating EBITDA 1	$	667		$	481	$	448		$	993	$	385	$	390	$	414	$	411	$	(170	)	$	4,019
Equity in earnings (losses) of nonconsolidated affiliates	$	—		$	—	$	(48	)	$	38	$	29	$	4	$	2	$	7	$	(6	)	$	26
Three months ended Mar 31, 2018
Net sales	$	3,808		$	2,304	$	3,715		$	6,010	$	1,153	$	1,720	$	1,425	$	1,299	$	76		$	21,510
Operating EBITDA 1	$	891		$	586	$	654		$	1,301	$	398	$	418	$	437	$	354	$	(168	)	$	4,871
Equity in earnings (losses) of nonconsolidated affiliates	$	(1	)	$	—	$	149		$	59	$	48	$	3	$	3	$	5	$	(9	)	$	257

1. A reconciliation of "Income from continuing operations, net of tax" to Operating EBITDA is provided below.

Reconciliation of "Income from continuing operations, net of tax" to Operating EBITDA	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Income from continuing operations, net of tax	$	571		$	1,153
+ Provision for income taxes on continuing operations	209			389
Income from continuing operations before income taxes	$	780		$	1,542
+ Depreciation and amortization	1,519			1,484
- Interest income 1	75			55
+ Interest expense and amortization of debt discount	454			350
- Foreign exchange gains (losses), net 1, 2	(11		)	(98		)
- Significant items	(1,330		)	(1,452		)
Operating EBITDA	$	4,019		$	4,871

1. Included in "Sundry income (expense) - net."

2. Excludes a $50 million pretax foreign exchange loss significant item related to adjustments to Historical DuPont's foreign currency exchange contracts as a result of U.S. tax reform during the three months ended March 31, 2018.

The following tables summarize the pretax impact of significant items by segment that are excluded from Operating EBITDA above:

Significant Items by Segment for the Three Months Ended Mar 31, 2019	Agri-culture			Perf. Materials & Coatings		Ind. Interm. & Infrast.		Pack. & Spec. Plastics			Elect. & Imaging		Nutrition & Biosciences			Transp. & Adv. Polymers			Safety & Const.			Corp.			Total
In millions
Loss on divestiture 1	$	(24	)	$	—	$	—	$	—		$	—	$	—		$	—		$	—		$	—		$	(24	)
Integration and separation costs 2	—			—		—		—			—		—			—			—			(813		)	(813		)
Inventory step-up amortization 3	(205		)	—		—		—			—		—			—			—			—			(205		)
Restructuring and asset related charges - net4, 5	(50		)	—		—		(13		)	—		(27		)	(1		)	(2		)	(195		)	(288		)
Total	$	(279	)	$	—	$	—	$	(13	)	$	—	$	(27	)	$	(1	)	$	(2	)	$	(1,008	)	$	(1,330	)

1. Reflects a loss related to Historical Dow's sale of a joint venture related to actions under the Synergy Program.

2. Integration and separation costs related to the Merger, post-Merger integration and Intended Business Separation activities.

3. Includes the amortization of the fair value step-up of Historical DuPont's inventories as a result of the Merger.

4. Includes Board approved restructuring plans and asset related charges, which include other asset impairments. See Note 5 for additional information.

5. Includes a $1 million restructuring charge related to an equity affiliate of Transportation & Advanced Polymers that is reflected in "Equity in earnings of nonconsolidated affiliates" in the consolidated statement of income.

42

Significant Items by Segment for the Three Months Ended Mar 31, 2018	Agri-culture			Perf. Materials & Coatings		Ind. Interm. & Infrast.			Pack. & Spec. Plastics			Elect. & Imaging			Nutrition & Biosciences			Transp. & Adv. Polymers		Safety & Const.			Corp.			Total
In millions
Gain on sale of business/entity 1	$	—		$	—	$	20		$	—		$	—		$	—		$	—	$	—		$	—		$	20
Integration and separation costs 2	—			—		—			—			—			—			—		—			(457		)	(457		)
Inventory step-up amortization 3	(639		)	—		—			—			—			(63		)	—		(1		)	—			(703		)
Restructuring and asset related charges (credits) - net 4	(58		)	1		(11		)	(6		)	(1		)	—			1		(7		)	(181		)	(262		)
Income tax related item 5	—			—		—			—			—			—			—		—			(50		)	(50		)
Total	$	(697	)	$	1	$	9		$	(6	)	$	(1	)	$	(63	)	$	1	$	(8	)	$	(688	)	$	(1,452	)

1. Includes a gain related to Historical Dow's sale of its equity interest in MEGlobal.

2. Integration and separation costs related to the Merger, post-Merger integration and Intended Business Separation activities, and costs related to the ownership restructure of Dow Silicones.

3. Includes the fair value step-up of Historical DuPont's inventories as a result of the Merger and the acquisition of the H&N Business.

4. Includes Board approved restructuring plans and asset related charges, which includes other asset impairments. See Note 5 for additional information.

5. Includes a foreign exchange loss related to adjustments to Historical DuPont's foreign currency exchange contracts as a result of the U.S. tax reform.

NOTE 24 - SUBSEQUENT EVENTS

Dow Spin-off

Effective as of 5:00 p.m. on April 1, 2019, DowDuPont completed the distribution of Dow. Additionally, Dow commenced trading “regular way” under the symbol “DOW” on the New York Stock Exchange on April 2, 2019. Prior to the commencement of trading on April 2, 2019, the stockholders of record of the Company as of the close of business on March 21, 2019 received one share of Dow Common Stock for every three shares of DowDuPont Common Stock held by such stockholders as of March 21, 2019. The Company did not issue fractional shares of Dow Common Stock in the Dow Distribution; the Company’s stockholders received cash in lieu of fractional shares.

Immediately after the Dow Distribution, DowDuPont does not beneficially own any equity interest in Dow and will no longer consolidate Dow into its financial results. Beginning in the second quarter of 2019, Dow's historical financial results for periods prior to April 1, 2019 will be reflected in the Company's consolidated financial statements as discontinued operations. Dow represents approximately one-third of the Company's assets and just over half of the Company's net sales.

In connection with the Distributions, the Company, Dow and Corteva (together, the “Parties” and each a “Party”) entered into certain agreements that will effect the separations, provide for the allocation of DowDuPont’s assets, employees, liabilities and obligations (including its investments, property, employee benefits and tax-related assets and liabilities) among the Company, Dow, and Corteva, and provide a framework for the Company’s relationship with Dow and Corteva following the separations and Distributions. Effective April 1, 2019, the Parties entered into the following agreements:

• Separation and Distribution Agreement - The Parties entered into an agreement that sets forth, among other things, the agreements among the Parties regarding the principal transactions necessary to effect the Distributions. It also sets forth other agreements that govern certain aspects of the Parties’ ongoing relationships after the completion of the Distributions (the "Separation and Distribution Agreement").

• Tax Matters Agreement - The Parties entered into an agreement that governs their respective rights, responsibilities and obligations with respect to tax liabilities and benefits, tax attributes, the preparation and filing of tax returns, the control of audits and other tax proceedings and other matters regarding taxes.

• Employee Matters Agreement - The Parties entered into an agreement that identifies employees and employee-related liabilities (and attributable assets) to be allocated (either retained, transferred and accepted, or assigned and assumed, as applicable) to the Parties as part of the Distributions and describes when and how the relevant transfers and assignments will occur.

• Intellectual Property Cross-License Agreements - DowDuPont entered into an Intellectual Property Cross-License Agreement with Dow (the “DowDuPont-Dow IP Cross-License Agreement”). In addition, Dow and Corteva entered into an Intellectual Property Cross-License Agreement (the “Dow-Corteva IP Cross-License Agreement”). The Intellectual Property Cross-License Agreements set forth the terms and conditions under which the applicable Parties may use in their respective businesses, following each of the Distributions, certain know-how (including trade secrets), copyrights, and software, and certain patents and standards, allocated to another Party pursuant to the Separation and Distribution Agreement.

43

In connection with the intended Corteva Distribution, the Company expects to enter into additional agreements, including an intellectual property cross-license agreement with Corteva. This agreement will set forth the terms and conditions under which the Company and Corteva may use, in their respective businesses following the Corteva Distribution, certain know-how (including trade secrets), copyrights, and software, and certain patents and standards, allocated to another Party pursuant to the Separation and Distribution Agreement.

Actions to Achieve Credit Profiles of DuPont, Corteva and Dow

On April 1, 2019, prior to consummating the Dow Distribution, the Company contributed $2,024 million in cash to Dow.

On March 22, 2019, Historical DuPont issued notices of redemption in full of all of its outstanding notes (the “Make Whole Notes”) listed in the table below:

In millions	Amount
4.625% Notes due 2020	$	474
3.625% Notes due 2021	296
4.250% Notes due 2021	163
2.800% Notes due 2023	381
6.500% Debentures due 2028	57
5.600% Senior Notes due 2036	42
4.900% Notes due 2041	48
4.150% Notes due 2043	69
Total	$	1,530

The Make Whole Notes were redeemed on April 22, 2019, at the make-whole redemption prices set forth in the respective Make Whole Notes. On and after the date of redemption, the Make Whole Notes were no longer deemed outstanding, interest on the Make Whole Notes ceased to accrue and all rights of the holders of the Make Whole Notes were terminated.

On May 2, 2019, Historical DuPont terminated its Term Loan Facility and repaid the aggregate outstanding principal amount of $3 billion plus accrued and unpaid interest through and including May 1, 2019.

In contemplation of the foregoing, effective May 2, 2019, the Company fully drew the two term loan facilities it entered into in the fourth quarter of 2018 (the “DWDP Term Loan Facilities” and together with the DowDuPont Notes, the “Financings”) in the aggregate principal amount of $3 billion.

The Company funded the activities above with cash from operations and proceeds from the Financings.

44

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Effective August 31, 2017, pursuant to the merger of equals transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 ("Merger Agreement"), The Dow Chemical Company ("Historical Dow") and E. I. du Pont de Nemours and Company ("Historical DuPont") each merged with subsidiaries of DowDuPont Inc. ("DowDuPont" or the "Company") and, as a result, Historical Dow and Historical DuPont became subsidiaries of DowDuPont (the "Merger"). Prior to the Merger, DowDuPont did not conduct any business activities other than those required for its formation and matters contemplated by the Merger Agreement. Historical Dow was determined to be the accounting acquirer in the Merger. As a result, the historical financial statements of Historical Dow for periods prior to the Merger are considered to be the historical financial statements of DowDuPont.

As discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, DowDuPont previously announced its intent to separate into three, independent, publicly traded companies - one for each of its agriculture, materials science and specialty products businesses (the “Intended Business Separations” and the transactions to accomplish the Intended Business Separations, the “separations”). DowDuPont formed two wholly owned subsidiaries: Dow Inc. ("Dow", formerly known as Dow Holdings Inc.), to serve as a holding company for its materials science business, and Corteva, Inc., to serve as a holding company for its agriculture business. Following the separations, DowDuPont will continue to hold the specialty products business and operate as "DuPont".

Effective as of 5:00 p.m. on April 1, 2019, DowDuPont completed the previously announced separation of its materials science business into a separate and independent public company by way of a distribution of Dow through a pro rata dividend in-kind of all of the then-issued and outstanding shares of Dow’s common stock, par value $0.01 per share (the “Dow Common Stock”), to holders of the Company’s common stock, par value $0.01 per share (the “DowDuPont Common Stock”), as of the close of business on March 21, 2019 (the “Dow Distribution”). DowDuPont expects to complete the previously announced intended separation of its agriculture business into a separate and independent public company on June 1, 2019 by way of a distribution of Corteva, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“Corteva”), through a pro rata dividend in-kind of all of the then-issued and outstanding shares of Corteva’s common stock, par value $0.01 per share, to holders of DowDuPont Common Stock as of a record date to be set by the Company’s Board of Directors (the “Corteva Distribution” and, together with the Dow Distribution, the “Distributions”). Following the Corteva Distribution, DowDuPont will hold the specialty products business and operate as "DuPont". The assets and liabilities and results of operations attributed to the materials science and agriculture businesses are included in the Company's consolidated results as of and for the periods presented herein.

Except as otherwise indicated by the context, the term "Historical Dow" includes Historical Dow and its consolidated subsidiaries, "Historical DuPont" includes Historical DuPont and its consolidated subsidiaries, "Union Carbide" means Union Carbide Corporation, a wholly owned subsidiary of Historical Dow, and "Dow Silicones" means Dow Silicones Corporation, a wholly owned subsidiary of Historical Dow.

OVERVIEW

The following is a summary of the results from continuing operations for the three months ended March 31, 2019:

• The Company reported net sales in the first quarter of 2019 of $19.6 billion, down 9 percent from $21.5 billion in the first quarter of 2018, with net sales declines across all geographic regions and segments, except Safety & Construction. These declines were due to a decrease in local price of 4 percent, a 3 percent unfavorable currency impact and a volume decline of 2 percent.

• Local price decreased 4 percent compared with the same period last year, with decreases in all geographic regions and two segments, Packaging & Specialty Plastics and Industrial Intermediates & Infrastructure (both down 11 percent), which were partially offset by increases in Transportation & Advanced Polymers (up 7 percent), Safety & Construction (up 4 percent), Nutrition & Biosciences (up 2 percent) and Agriculture (up 1 percent). Performance Materials & Coatings and Electronics & Imaging were both flat.

• Currency had an unfavorable impact of 3 percent on sales, driven primarily by Europe, Middle East and Africa ("EMEA").

• Volume decreased 2 percent compared with the first quarter of 2018, with decreases in all operating segments, except Industrial Intermediates & Infrastructure (up 6 percent), Safety & Construction (up 4 percent) and Performance Materials & Coatings (up 1 percent). Volume decreased in U.S. & Canada (down 7 percent) and Latin America (down 1 percent), and increased in Asia Pacific (up 3 percent) and EMEA (up 1 percent).

45

• Research and development ("R&D") expenses totaled $717 million in the first quarter of 2019, down from $768 million in the first quarter of 2018. Selling, general and administrative ("SG&A") expenses were $1,672 million in the first quarter of 2019, down from $1,714 million in the first quarter of 2018. R&D and SG&A expenses decreased primarily due to synergies.

• Restructuring and asset related charges - net were $287 million in the first quarter of 2019, primarily reflecting post-merger restructuring actions under the DowDuPont Cost Synergy Program of $280 million.

• Integration and separation costs were $813 million in the first quarter of 2019, up from $457 million in the first quarter of 2018, reflecting post-Merger integration and Intended Business Separation activities.

• Equity in earnings of nonconsolidated affiliates was $26 million in the first quarter of 2019, down from $257 million in the first quarter of 2018, primarily due to increased equity losses from Sadara and lower equity earnings from the Kuwait joint ventures (due to lower monoethylene glycol prices), the Thai joint ventures and the HSC Group.

• Sundry income (expense) - net was income of $248 million in the first quarter of 2019, up from income of $115 million in the first quarter of 2018, primarily due to a decrease in foreign exchange losses.

• Net income available for common stockholders was $520 million ($0.23 per share) in the first quarter of 2019, compared with $1,104 million ($0.47 per share) in the first quarter of 2018.

• On February 14, 2019, the Company announced that its Board declared a dividend of $0.38 per share, paid on March 15, 2019, to shareholders of record on February 28, 2019.

• On March 8, 2019, the Company announced that its Board declared a dividend of $325 million ($0.14 per share), payable on May 28, 2019, to shareholders of record on April 26, 2019.

Selected Financial Data	Three Months Ended
In millions, except per share amounts	Mar 31, 2019			Mar 31, 2018
Net sales	$	19,649		$	21,510
Cost of sales ("COS")	$	14,726		$	16,315
Percent of net sales	74.9		%	75.8		%
Research and development expenses	$	717		$	768
Percent of net sales	3.6		%	3.6		%
Selling, general and administrative expenses	$	1,672		$	1,714
Percent of net sales	8.5		%	8.0		%
Effective tax rate	26.8		%	25.2		%
Net income available for common stockholders	$	520		$	1,104
Earnings per common share – basic	$	0.23		$	0.47
Earnings per common share – diluted	$	0.23		$	0.47

In addition to the financial highlights above, the following events occurred subsequent to the first quarter of 2019:

• On April 3, 2019, the Company's Board of Directors approved a reverse stock split of the Company’s common stock, subject to stockholder approval which will be determined during a special meeting of stockholders scheduled for May 23, 2019. If stockholders approve the reverse stock split, the Board of Directors will select a reverse stock split ratio of not less than 2-for-5 and not greater than 1-for-3, with an exact ratio as may be determined by the Board of Directors at a later date so that, depending on the ratio chosen, stockholders’ shares of issued and outstanding common stock will be converted at a ratio between (i) two shares of issued and outstanding common stock for every five shares of common stock owned and (ii) one share of issued and outstanding common stock for every three shares of common stock owned. The price of each common

46

share is expected to increase so that a stockholder would have fewer but higher priced shares. A reverse stock split would not have any impact on the voting and other rights of stockholders and will have no impact on the Company’s business operations or any of its outstanding indebtedness. If approved, the Company expects to implement the reverse stock split effective immediately following the Corteva Distribution. Even if the reverse stock split is approved by the Company’s stockholders, the Board of Directors may delay or abandon the reverse stock split at any time prior to the effective time of the reverse stock split if the Board of Directors determines that the reverse stock split is no longer in the best interests of the Company or its stockholders.

• On May 2, 2019, in anticipation of becoming an independent, specialty products company following the intended Corteva Distribution, DowDuPont announced changes to its management and reporting structure resulting in the creation of a new Non-Core segment ("Second Quarter Segment Realignments").

These changes result in the following being realigned to Non-Core:

•Photovoltaic and Advanced Materials business unit (including the HSC Group joint ventures: DC HSC Holdings LLC and Hemlock Semiconductor L.L.C) from the Electronics & Imaging segment;

•Biomaterials and Clean Technologies business units from the Nutrition & Biosciences segment;

•DuPont Teijin Films joint venture from the Transportation & Advanced Polymers segment; and

•Sustainable Solutions business unit from the Safety & Construction segment.

In addition, the following changes will occur:

•Consolidation of the Nutrition & Health business with the Industrial Biosciences business within the Nutrition & Biosciences reportable segment. Previously, Nutrition & Health and Industrial Biosciences were separate operating segments which did not meet the quantitative thresholds.

•Pre-commercial activities related to the Biomaterials business unit will be realigned from Corporate to Non-Core, with the remaining pre-commercial activities realigned to the Nutrition & Biosciences segment.

The changes become effective June 1, 2019 and the Company will report financial results under this new structure beginning in the second quarter of 2019.

47

RESULTS OF OPERATIONS

Summary of Sales Results	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
Net sales	$	19,649	$	21,510

The following table summarizes sales variances by segment and geographic region from the prior year:

Sales Variances by Segment and Geographic Region
	Three Months Ended Mar 31, 2019
Percentage change from prior year	Local Price & Product Mix		Currency		Volume		Portfolio & Other		Total
Agriculture	1	%	(5	)%	(7	)%	—	%	(11	)%
Performance Materials & Coatings	—		(3	)	1		—		(2	)
Industrial Intermediates & Infrastructure	(11	)	(3	)	6		—		(8	)
Packaging & Specialty Plastics	(11	)	(2	)	(2	)	—		(15	)
Electronics & Imaging	—		(1	)	(6	)	—		(7	)
Nutrition & Biosciences	2		(3	)	(2	)	(1	)	(4	)
Transportation & Advanced Polymers	7		(3	)	(9	)	—		(5	)
Safety & Construction	4		(2	)	4		(4	)	2
Total	(4	)%	(3	)%	(2	)%	—	%	(9	)%
U.S. & Canada	(4	)%	—	%	(7	)%	—	%	(11	)%
EMEA 1	(3	)	(6	)	1		(1	)	(9	)
Asia Pacific	(4	)	(2	)	3		—		(3	)
Latin America	(6	)	(2	)	(1	)	—		(9	)
Total	(4	)%	(3	)%	(2	)%	—	%	(9	)%

1. Europe, Middle East and Africa.

The Company reported net sales in the first quarter of 2019 of $19.6 billion, down 9 percent from $21.5 billion in the first quarter of 2018, primarily due to decreased selling prices, negative currency impact and lower demand. Sales declines were broad-based with decreases in most segments and all geographic regions. Local price was down 4 percent compared with the same period last year as decreases in Packaging & Specialty Plastics and Industrial Intermediates & Infrastructure (both down 11 percent) more than offset increases in Transportation & Advanced Polymers (up 7 percent), Safety & Construction (up 4 percent), Nutrition & Biosciences (up 2 percent) and Agriculture (up 1 percent). Performance Materials & Coatings and Electronics & Imaging were both flat. Local price decreased in all geographic regions. Currency unfavorably impacted sales 3 percent compared with the same period last year, driven primarily by EMEA (down 6 percent). Volume decreased 2 percent as decreases in Transportation & Advanced Polymers (down 9 percent), Agriculture (down 7 percent), Electronics & Imaging (down 6 percent) and Packaging & Specialty Plastics and Nutrition & Biosciences (both down 2 percent) more than offset gains in Industrial Intermediates & Infrastructure (up 6 percent), Safety & Construction (up 4 percent) and Performance Materials & Coatings (up 1 percent). Volume decreased in U.S. & Canada (down 7 percent) and Latin America (down 1 percent), and increased in Asia Pacific (up 3 percent) and EMEA (up 1 percent). Portfolio & Other was flat.

Cost of Sales

Cost of sales was $14.7 billion in the first quarter of 2019, down from $16.3 billion in the first quarter of 2018. Cost of sales decreased in the first quarter of 2019 primarily due to lower sales volume, lower feedstock and other raw material costs, decreased planned maintenance turnaround costs, lower commissioning expenses related to U.S. Gulf Coast growth projects and cost synergies. Cost of sales in the first quarter of 2018 was negatively impacted by a $703 million charge for the fair value step-up in Historical DuPont's inventories as a result of the Merger and the acquisition of the H&N Business, related to Agriculture ($639 million), Nutrition & Biosciences ($63 million) and Safety & Construction ($1 million); compared with a $205 million charge during the first quarter of 2019 related to Agriculture.

Cost of Sales as a percentage of net sales in the first quarter of 2019 was 74.9 percent compared with 75.8 percent in the same period last year.

48

Research and Development Expenses

R&D expenses totaled $717 million in the first quarter of 2019, down from $768 million in the first quarter of 2018. R&D expensesdecreased primarily due to synergies.

Selling, General and Administrative Expenses

SG&A expenses were $1,672 million in the first quarter of 2019, down from $1,714 million in the first quarter of 2018. SG&A expenses decreased primarily due to synergies.

Amortization of Intangibles

Amortization of intangibles was $474 million in the first quarter of 2019 and 2018. See Note 11 to the Consolidated Financial Statements for additional information on intangible assets.

Restructuring and Asset Related Charges - Net

Restructuring and asset related charges - net were $287 million in the first quarter of 2019, up from $262 million in the first quarter of 2018 and consisted primarily of the following:

DowDuPont Cost Synergy Program

In September and November 2017, DowDuPont approved post-merger restructuring actions under the DowDuPont Cost Synergy Program (the “Synergy Program”), which is designed to integrate and optimize the organization following the Merger and in preparation for the Intended Business Separations. The Company expects to record total pretax restructuring charges of approximately $2.2 billion of which $2.0 billion has been recorded inception-to-date.

For the three months ended March 31, 2019 and 2018, the Company recorded pretax restructuring charges of $280 million and $260 million, respectively. The charge for the three months ended March 31, 2019 consisted of severance and related benefit costs of $112 million, asset write-downs and write-offs of $116 million and costs associated with exit and disposal activities of $52 million. The charge for the three months ended March 31, 2018 consisted of severance and related benefit costs of $172 million, asset write-downs and write-offs of $48 million and costs associated with exit and disposal activities of $40 million. The impact of these charges is shown as "Restructuring and asset related charges - net" in the consolidated statements of income. The Company expects to substantially complete the Synergy Program by the end of 2019.

The restructuring charges for the three months ended March 31, 2019 were related to each segment as follows: $47 million in Agriculture, $28 million in Nutrition & Biosciences, $2 million in Safety & Construction, $1 million in Packaging & Specialty Plastics, $1 million in Transportation & Advanced Polymer and $201 million in Corporate.

DowDuPont Agriculture Division Restructuring Program

During the fourth quarter of 2018 and in connection with the ongoing integration activities, DowDuPont approved restructuring actions to simplify and optimize certain organizational structures within the Agriculture segment in preparation for the Intended Business Separations ("Agriculture Division Program"). As a result of these actions, the Company expects to record total pretax charges of approximately $96 million, comprised of $83 million of severance and related benefit costs, $11 million of asset write-downs and write-offs and $2 million of costs associated with exit and disposal activities. The Company has recorded restructuring charges of $83 million inception-to-date under the Agriculture Division Program.

For the three months ended March 31, 2019, DowDuPont recorded a net pretax restructuring benefit of $1 million, consisting of a favorable adjustment of $4 million to the severance and related benefit costs reserve and asset write-downs and write-offs of $3 million. The impact of these items was shown as "Restructuring and asset related charges - net" in the consolidated statements of income. The Company expects actions related to the Agriculture Division Program to be substantially complete by mid 2019.

Restructuring adjustments recorded for severance and related benefit costs and charges recorded for asset write-downs and write‑offs were related to Corporate and Agriculture, respectively.

Integration and Separation Costs

Integration and separation costs, which reflect costs related to the Merger and the ownership restructure of Dow Silicones, as well as post-Merger integration and Intended Business Separation activities, were $813 million in the first quarter of 2019, up from $457 million in the first quarter of 2018. Integration and separation costs are related to the Corporate segment.

Equity in Earnings of Nonconsolidated Affiliates

The Company's share of the earnings of nonconsolidated affiliates was $26 million in the first quarter of 2019, down from $257 million in the first quarter of 2018, primarily due to increased equity losses from Sadara and lower equity earnings from the Kuwait joint ventures (due to lower monoethylene glycol and polyethylene prices), the Thai joint ventures and the HSC Group.

49

Sundry Income (Expense) - Net

Sundry income (expense) – net includes a variety of income and expense items such as foreign currency exchange gains or losses, interest income, dividends from investments, gains and losses on sales of investments and assets, non-operating pension and other postretirement benefit plan credits or costs, and certain litigation matters. Sundry income (expense) – net in the first quarter of 2019 was income of $248 million, compared with income of $115 million in the first quarter of 2018. The first quarter of 2019 included income related to non-operating pension and other postretirement benefit plans, interest income and gains on the sale of assets and other investments, which includes a $51 million gain related to an asset sale by Historical DuPont. These gains more than offset a $24 million loss on a Historical Dow divestiture (related to Agriculture) and foreign currency exchange losses.

The first quarter of 2018 included income related to non-operating pension and other postretirement benefit plans, interest income and a $20 million gain for post-closing adjustments on Historical Dow's sale of its equity interest in MEGlobal (related to Industrial Intermediates & Infrastructure). These gains more than offset foreign currency exchange losses, which included a $50 million foreign exchange loss related to adjustments to foreign currency exchange contracts for the change in the U.S. tax rate (related to Corporate). See Notes 6 and 18 to the Consolidated Financial Statements for additional information.

Interest Expense and Amortization of Debt Discount

Interest expense and amortization of debt discount was $454 million in the first quarter of 2019, up from $350 million in the first quarter of 2018. The increase primarily relates to higher debt balances as a result of DowDuPont debt issued in the fourth quarter of 2018. See Note 13 to the Consolidated Financial Statements and the discussion of the DowDuPont Notes in Changes in Financial Condition in Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations for additional information.

Provision for Income Taxes on Continuing Operations

The Company's effective tax rate fluctuates based on, among other factors, where income is earned, the level of income relative to tax attributes and the level of equity earnings. The effective tax rate for the first quarter of 2019 was 26.8 percent, compared to 25.2 percent for the first quarter of 2018.

The tax rate in the first quarter of 2019 was unfavorably impacted by non-tax-deductible amortization of the fair value step-up in Historical DuPont’s inventories as a result of the Merger as well as non-deductible restructuring costs and tax impacts related to spin preparation activities. The tax rate was favorably impacted by net tax benefits related to the issuance of stock-based compensation as well as deferred tax remeasurement in foreign jurisdictions.

The tax rate in the first quarter of 2018 was unfavorably impacted by certain integration, separation and restructuring costs associated with the Intended Business Separations as well as non-deductible amortization of the fair value step-up in Historical DuPont’s inventories as a result of the Merger, partially offset by the tax benefits related to the issuance of stock-based compensation.

Net Income Attributable to Noncontrolling Interests

Net income attributable to noncontrolling interests was $51 million in the first quarter of 2019, up from $44 million in the first quarter of 2018.

Net Income Available for DowDuPont Inc. Common Stockholders

Net income available for common stockholders was $520 million, or $0.23 per share, in the first quarter of 2019, compared with $1,104 million, or $0.47 per share, in the first quarter of 2018. See Note 8 to the Consolidated Financial Statements for details on the Company's earnings per share calculations.

50

SEGMENT RESULTS

The Company's measure of profit/loss for segment reporting purposes is Operating EBITDA as this is the manner in which the Company's chief operating decision maker assesses performance and allocates resources. The Company defines Operating EBITDA as earnings (i.e., “Income from continuing operations before income taxes") before interest, depreciation, amortization and foreign exchange gains (losses), excluding the impact of significant items. Reconciliations of these measures can be found in Note 23 to the Consolidated Financial Statements.

AGRICULTURE

The Agriculture segment leverages the Company’s technology, customer relationships and industry knowledge to improve the quantity, quality and safety of the global food supply and the global production agriculture industry. Land available for worldwide agricultural production is increasingly limited so production growth will need to be achieved principally through improving crop yields and productivity. The segment’s two global businesses, Seed and Crop Protection, deliver a broad portfolio of products and services that are specifically targeted to achieve gains in crop yields and productivity, including well-established brands of seed products, crop chemicals, seed treatment, agronomy and digital services. R&D focuses on leveraging germplasm and plant science technology to increase farmer productivity and to enhance the value of grains and oilseeds through improved seed traits, superior seed germplasm and effective use of crop protection solutions.

Agriculture	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
Net sales	$	3,397	$	3,808
Operating EBITDA	$	667	$	891
Equity losses	$	—	$	(1	)

Agriculture	Three Months Ended
Percentage change from prior year	Mar 31, 2019
Change in Net Sales from Prior Period due to:
Local price & product mix	1	%
Currency	(5	)
Volume	(7	)
Portfolio & other	—
Total	(11	)%

Agriculture net sales were $3,397 million in the first quarter of 2019, down 11 percent from $3,808 million in the first quarter of 2018. The decrease was primarily due to a 7 percent decline in volume and a 5 percent decline in currency, partially offset by a 1 percent increase in local price.

The decline in volume was driven by weather related delays and flooding in the U.S. which impacted both Seed and Crop Protection, a change in the route to market in the Pacific Northwest, which delayed sales recognition to the second quarter, and early deliveries of seed in the fourth quarter of 2018. These declines were partially offset by favorable demand and weather conditions leading to a strong corn season in EMEA and strong demand for insecticides in Latin America and EMEA.

Unfavorable currency impacts due to the Euro, other Eastern European currencies, and the Brazilian Real were partially offset by increases in local price in Crop Protection to offset currency pressure, as well as price gains in EMEA due to changes in route to market.

Operating EBITDA was $667 million in the first quarter of 2019, compared with $891 million in the same quarter last year. Volume declines primarily driven by weather related delays in the U.S., higher input costs, and the unfavorable impact of currency were partially offset by cost synergies.

51

PERFORMANCE MATERIALS & COATINGS

Performance Materials & Coatings includes industry-leading franchises that deliver a wide array of solutions into consumer and infrastructure end-markets. The segment consists of two global businesses: Coatings & Performance Monomers and Consumer Solutions. These businesses primarily utilize the Company's acrylics-, cellulosics- and silicone-based technology platforms to serve the needs of the architectural and industrial coatings, home care and personal care end-markets. Both businesses employ materials science capabilities, global reach and unique products and technology to combine chemistry platforms to deliver differentiated offerings to customers.

Performance Materials & Coatings	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
Net sales	$	2,255	$	2,304
Operating EBITDA	$	481	$	586
Equity earnings	$	—	$	—

Performance Materials & Coatings	Three Months Ended
Percentage change from prior year	Mar 31, 2019
Change in Net Sales from Prior Period due to:
Local price & product mix	—	%
Currency	(3	)
Volume	1
Portfolio & other	—
Total	(2	)%

Performance Materials & Coatings net sales were $2,255 million in the first quarter of 2019, down from net sales of $2,304 million in the first quarter of 2018. Net sales decreased 2 percent compared with the first quarter of 2018 driven by currency headwinds, which had an unfavorable impact on sales of 3 percent, which was partially offset by a 1 percent increase in volume. Local price was flat compared with the same quarter last year. Consumer Solutions sales were flat, as volume growth was offset by local price declines in siloxanes, the shedding of low-margin business in home and personal care and the unfavorable impact of currency. Coatings & Performance Monomers sales were down, as volume improvement for vinyl acetate monomer was more than offset by a decline in volume for architectural binders and functional coatings and the unfavorable impact of currency.

Operating EBITDA was $481 million, down 18 percent from Operating EBITDA of $586 million in the first quarter of 2018, primarily due to lower prices for siloxanes and shipping restrictions from a Performance Monomers facility in Deer Park, Texas, due to a fire at a nearby third-party storage and terminal facility, which more than offset lower feedstock and other raw material costs and cost synergies.

52

INDUSTRIAL INTERMEDIATES & INFRASTRUCTURE

Industrial Intermediates & Infrastructure consists of two customer-centric global businesses - Industrial Solutions and Polyurethanes & CAV - that develop important intermediate chemicals that are essential to manufacturing processes, as well as downstream, customized materials and formulations that use advanced development technologies. These businesses primarily produce and market ethylene oxide, propylene oxide derivatives, cellulose ethers, redispersible latex powders and acrylic emulsions that are aligned to market segments as diverse as appliances, coatings, infrastructure, oil and gas and building and construction. The global scale and reach of these businesses, world-class technology and R&D capabilities and materials science expertise enable the Company to be a premier solutions provider offering customers value-add sustainable solutions to enhance comfort, energy efficiency, product effectiveness and durability across a wide range of home comfort and appliances, building and construction, adhesives and lubricant applications, among others. This segment also includes a portion of the results of EQUATE Petrochemical Company K.S.C.C. ("EQUATE"), The Kuwait Olefins Company K.S.C.C. ("TKOC"), Map Ta Phut Olefins Company Limited and Sadara, all joint ventures of the Company.

Historical Dow is responsible for marketing a majority of Sadara products outside of the Middle East zone through Historical Dow's established sales channels. As part of this arrangement, Historical Dow purchases and sells Sadara products for a marketing fee.

Industrial Intermediates & Infrastructure	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Net sales	$	3,402		$	3,715
Operating EBITDA	$	448		$	654
Equity earnings (losses)	$	(48	)	$	149

Industrial Intermediates & Infrastructure	Three Months Ended
Percentage change from prior year	Mar 31, 2019
Change in Net Sales from Prior Period due to:
Local price & product mix	(11	)%
Currency	(3	)
Volume	6
Portfolio & other	—
Total	(8	)%

Industrial Intermediates & Infrastructure net sales were $3,402 million in the first quarter of 2019, down from net sales of $3,715 million in the first quarter of 2018. Net sales decreased 8 percent compared with the same quarter last year, with volume up 6 percent, currency down 3 percent and local price down 11 percent. Local price decreased in all geographic regions and all businesses. Local price decreases were primarily driven by price declines in isocyanates. Currency had an unfavorable impact on sales of 3 percent, primarily in EMEA. Volume increased in all geographic regions and all businesses. Polyurethanes & CAV reported volume increases in all geographic regions, with double-digit volume growth in Asia Pacific. Volume growth was driven by increased supply from Sadara and higher demand for propylene glycols and industrial, comfort and energy efficiency products. Industrial Solutions reported volume gains in U.S. & Canada and EMEA, reflecting increased demand for industrial and oil and gas applications as well as strong demand for de-icing fluids, lubricants and fuels, and greater production from Sadara.

Operating EBITDA was $448 million in the first quarter of 2019, down 31 percent compared with Operating EBITDA of $654 million in the first quarter of 2018. Operating EBITDA decreased as the impact of margin compression in isocyanates products, lower equity earnings from the Kuwait joint ventures and increased equity losses from Sadara more than offset lower feedstock and other raw material costs, cost synergies and demand growth.

53

PACKAGING & SPECIALTY PLASTICS

Packaging & Specialty Plastics is a world leader in plastics and consists of two highly integrated global businesses: Hydrocarbons & Energy and Packaging and Specialty Plastics. The segment employs the industry’s broadest polyolefin product portfolio, supported by the Company’s proprietary catalyst and manufacturing process technologies, to work at the customer’s design table throughout the value chain to deliver more reliable and durable, higher performing, and more sustainable plastics to customers in food and specialty packaging; industrial and consumer packaging; health and hygiene; caps, closures and pipe applications; consumer durables; and infrastructure. This segment also includes the results of The Kuwait Styrene Company K.S.C.C. and The SCG-Dow Group, as well as a portion of the results of EQUATE, TKOC, Map Ta Phut Olefins Company Limited and Sadara, all joint ventures of the Company.

Historical Dow is responsible for marketing a majority of Sadara products outside of the Middle East zone through Historical Dow’s established sales channels. As part of this arrangement, Historical Dow purchases and sells Sadara products for a marketing fee.

Packaging & Specialty Plastics	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
Net sales	$	5,110	$	6,010
Operating EBITDA	$	993	$	1,301
Equity earnings	$	38	$	59

Packaging & Specialty Plastics	Three Months Ended
Percentage change from prior year	Mar 31, 2019
Change in Net Sales from Prior Period due to:
Local price & product mix	(11	)%
Currency	(2	)
Volume	(2	)
Portfolio & other	—
Total	(15	)%

Packaging & Specialty Plastics net sales were $5,110 million in the first quarter of 2019, down from net sales of $6,010 million in the first quarter of 2018. Net sales decreased 15 percent compared with the same quarter last year, with local price down 11 percent, volume down 2 percentand currency unfavorably impacting sales 2 percent, primarily in EMEA. Local price decreased in both businesses and across all geographic regions driven by reduced polyethylene prices and lower prices for Hydrocarbons & Energy by-products. Volume decreased across all geographic regions, except Asia Pacific, and in Hydrocarbons & Energy which more than offset volume increases in Packaging and Specialty Plastics. Volume decreased in Hydrocarbons & Energy due to increased internal consumption of ethylene on the U.S. Gulf Coast. In addition, lower volumes of by-products were available for sale due to the use of lighter feedslates. Volume increased in Packaging and Specialty Plastics driven by higher demand in Asia Pacific and EMEA, supported by new capacity adds. Packaging and Specialty Plastics volume growth was driven by increased demand for industrial and consumer packaging, food and specialty packaging and elastomer applications.

Operating EBITDA was $993 million in the first quarter of 2019, down 24 percent from Operating EBITDA of $1,301 million in the first quarter of 2018. Operating EBITDA decreased as the impact of lower selling prices, lower sales volume and reduced equity earnings, driven by lower equity earnings at the Kuwait joint ventures due to lower polyethylene pricing and increased turnaround costs, more than offset lower feedstock and other raw material costs, cost synergies, lower start-up and commissioning costs and decreased planned maintenance turnaround spending.

54

ELECTRONICS & IMAGING

The Electronics & Imaging segment is a leading global supplier of differentiated materials and systems for a broad range of consumer electronics including mobile devices, television monitors, personal computers and electronics used in a variety of industries. The segment is a leading provider of materials and solutions for the fabrication of semiconductors and integrated circuits, and also provides innovative metallization processes for metal finishing, decorative, and industrial applications. Electronics & Imaging is a leading global supplier of key materials for the manufacturing of photovoltaics and solar cells, including innovative metallization pastes and back sheet materials for the production of solar cells and solar modules and in the advanced printing and packaging graphics industry providing flexographic printing inks, photopolymer plates, and platemaking systems used in digital printing applications for textile, commercial and home-office use. In addition, the segment provides cutting-edge materials for the manufacturing of rigid and flexible displays for liquid crystal displays ("LCD"), advanced-matrix organic light emitting diode ("AMOLED"), and quantum dot ("QD") applications. The segment also includes the Company's share of the results of the HSC Group, a U.S.-based group of companies that manufacture and sell polycrystalline silicon products.

In March 2019, DowDuPont announced plans to invest more than $200 million in its Electronics & Imaging segment to increase capacity for the manufacture of KAPTON® film at its Circleville, Ohio, site due to growing global demand.

Electronics & Imaging	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
Net sales	$	1,078	$	1,153
Operating EBITDA	$	385	$	398
Equity earnings	$	29	$	48

Electronics & Imaging	Three Months Ended
Percentage change from prior year	Mar 31, 2019
Change in Net Sales from Prior Period due to:
Local price & product mix	—	%
Currency	(1	)
Volume	(6	)
Portfolio & other	—
Total	(7	)%

Electronics & Imaging net sales were $1,078 million in the first quarter of 2019, down 7 percent from $1,153 million in the first quarter of 2018. Net sales decreased due to a 6 percent volume decline and a 1 percent unfavorable currency impact, primarily in Asia Pacific and EMEA. Volume growth was driven by increased demand in display technology which was more than offset by volume declines, primarily in interconnect solutions and photovoltaic & advanced materials, due to lower demand for consumer electronics and photovoltaics, mainly in Asia Pacific.

Operating EBITDA was $385 million in the first quarter of 2019, down 3 percent compared with $398 million in the first quarter of 2018. Favorable impacts from an asset sale and cost synergies were more than offset by higher raw material costs, volume declines and lower equity earnings.

55

NUTRITION & BIOSCIENCES

Nutrition & Biosciences is an innovation-driven and customer-focused segment that provides solutions for the global food and beverage, dietary supplements, pharma, home and personal care, energy and animal nutrition markets. The segment consists of two operating segments: Nutrition & Health and Industrial Biosciences. The Nutrition & Health business is one of the world's largest producers of specialty ingredients, developing and manufacturing solutions for the global food and beverage, dietary supplements and pharmaceutical excipient markets. The Industrial Biosciences business is an industry pioneer and innovator that works with customers to improve the performance, productivity and sustainability of their products and processes through biotechnology, chemistry and engineering solutions including enzymes, biomaterials, biocides and antimicrobial solutions and process technology.

Nutrition & Biosciences	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
Net sales	$	1,659	$	1,720
Operating EBITDA	$	390	$	418
Equity earnings	$	4	$	3

Nutrition & Biosciences	Three Months Ended
Percentage change from prior year	Mar 31, 2019
Change in Net Sales from Prior Period due to:
Local price & product mix	2	%
Currency	(3	)
Volume	(2	)
Portfolio & other	(1	)
Total	(4	)%

Nutrition & Biosciences net sales were $1,659 million in the first quarter of 2019, down 4 percent from $1,720 million in the first quarter of 2018, due to a 2 percent increase in local price, which was more than offset by a 3 percent unfavorable currency impact, a 2 percent decrease in volume and a 1 percent decrease from portfolio actions. Volume gains in Nutrition & Health were more than offset by volume declines in Industrial Biosciences.Volume gains in Nutrition & Health were led by increased protein solutions and systems and texturants demand. This increase was partially offset by a decrease in probiotics due to higher than historical average sales in the first quarter of 2018. Industrial Biosciences volume declines were primarily the result of on-going challenged conditions in U.S. energy markets negatively impacting demand in bioactives and microbial control.

Operating EBITDA was $390 million in the first quarter of 2019, down 7 percent compared with $418 million in the first quarter of 2018, driven by cost savings which were more than offset by higher raw material costs and unfavorable currency impacts.

56

TRANSPORTATION & ADVANCED POLYMERS

Transportation & Advanced Polymers provides high-performance engineering resins, adhesives, lubricants and parts to engineers and designers in the transportation, electronics, healthcare, industrial and consumer end-markets to enable systems solutions for demanding applications and environments. The segment delivers a broad range of polymer-based high-performance materials in its product portfolio, including elastomers and thermoplastic and thermoset engineering polymers which are used by customers to fabricate components for mechanical, chemical and electrical systems. In addition, the segment produces innovative engineering polymer solutions, high performance parts, specialty silicones and differentiated adhesive technologies to meet customer specifications in automotive, aerospace, electronics, industrial, healthcare and consumer markets. Transportation & Advanced Polymers is a global leader of advanced materials that provides technologies that differentiate customers’ products with improved performance characteristics.

Transportation & Advanced Polymers	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
Net sales	$	1,355	$	1,425
Operating EBITDA	$	414	$	437
Equity earnings	$	2	$	3

Transportation & Advanced Polymers	Three Months Ended
Percentage change from prior year	Mar 31, 2019
Change in Net Sales from Prior Period due to:
Local price & product mix	7	%
Currency	(3	)
Volume	(9	)
Portfolio & other	—
Total	(5	)%

Transportation & Advanced Polymers net sales were $1,355 million in the first quarter of 2019, down 5 percent from $1,425 million in the first quarter of 2018. The change in net sales was due to a 7 percent increase in local price which was more than offset by a 9 percent decrease in volume and a 3 percent unfavorable currency impact, primarily in EMEA and Asia Pacific. The increase in local price, primarily in engineering polymers, reflected a tight polymer supply and higher feedstock costs. Volume declines were primarily due to decreased demand in automotive and electronics markets.

Operating EBITDA was $414 million in the first quarter of 2019, down 5 percent from $437 million in the first quarter of 2018 due to pricing gains and cost synergies, which were more than offset by higher raw material costs, volume declines and unfavorable currency impacts.

57

SAFETY & CONSTRUCTION

The Safety & Construction segment is a leading provider of engineered products and integrated systems for a number of industries including construction, worker safety, energy, oil and gas, transportation, medical devices and water purification and separation. The segment satisfies the growing global needs of businesses, governments, and consumers for solutions that make life safer, healthier, and better. By uniting market-driven science with the strength of highly regarded brands, the segment strives to bring new products and solutions to solve customers' needs faster, better and more cost effectively. The segment is a leader in safety consulting, selling training products as well as consulting services, to improve the safety, productivity, and sustainability of organizations across a range of industries.

Safety & Construction	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
Net sales	$	1,322	$	1,299
Operating EBITDA	$	411	$	354
Equity earnings	$	7	$	5

Safety & Construction	Three Months Ended
Percentage change from prior year	Mar 31, 2019
Change in Net Sales from Prior Period due to:
Local price & product mix	4	%
Currency	(2	)
Volume	4
Portfolio & other	(4	)
Total	2	%

Safety & Construction net sales were $1,322 million in the first quarter of 2019, up 2 percent from $1,299 million in the first quarter of 2018. The net sales increase was due to 4 percent volume growth and a 4 percent increase in local price, partially offset by 4 percent unfavorable portfolio actions and a 2 percent unfavorable currency impact. Volume growth in the segment was led by gains across all regions and in water, TYVEK® and KEVLAR® due to broad-based strength in industrial markets and life & personal protection and medical end-markets. These gains were partially offset by declines primarily due to weakness in the U.S. residential market.

Operating EBITDA was $411 million in the first quarter of 2019, up 16 percent compared with $354 million in the first quarter of 2018 due to cost synergies, volume growth and pricing gains, partially offset by higher raw material costs and unfavorable currency impacts.

58

CORPORATE

Corporate includes certain enterprise and governance activities (including insurance operations, environmental operations, geographic management, etc.); business incubation platforms; non-business aligned joint ventures; gains and losses on the sales of financial assets; non-business aligned litigation expenses; discontinued or non-aligned businesses and pre-commercial activities.

Corporate	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Net sales	$	71		$	76
Operating EBITDA	$	(170	)	$	(168	)
Equity losses	$	(6	)	$	(9	)

Net sales for Corporate, which primarily relate to insurance operations, were $71 million in the first quarter of 2019, compared with net sales of $76 million in the first quarter of 2018.

Operating EBITDA was a loss of $170 million in the first quarter of 2019, essentially flat compared with an Operating EBITDA loss of $168 million in the first quarter of 2018.

59

SUPPLEMENTAL DIVISION INFORMATION

Discussion of segment revenue, operating EBITDA and price/volume metrics on a divisional basis for Agriculture is based on the results of the Agriculture segment; for Materials Science is based on the combined results of the Performance Materials & Coatings segment, the Industrial Intermediates & Infrastructure segment and the Packaging & Specialty Plastics segment; and for Specialty Products is based on the combined results of the Electronics & Imaging segment, the Nutrition & Biosciences segment, the Transportation & Advanced Polymers segment and the Safety & Construction segment. The Corporate segment is not included in the division metrics. The segment disclosures have been presented in this manner for informational purposes only and should not be viewed as an indication of each division’s current or future operating results on a standalone basis assuming completion of the Intended Business Separations. See the section entitled “Segment Results” for additional qualitative analysis on segment performance.

Net Sales by Division	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
Agriculture	$	3,397	$	3,808
Performance Materials & Coatings	2,255		2,304
Industrial Intermediates & Infrastructure	3,402		3,715
Packaging & Specialty Plastics	5,110		6,010
Materials Science	$	10,767	$	12,029
Electronics & Imaging	1,078		1,153
Nutrition & Biosciences	1,659		1,720
Transportation & Advanced Polymers	1,355		1,425
Safety & Construction	1,322		1,299
Specialty Products	$	5,414	$	5,597

Net Sales Variance by Division	Three Months Ended Mar 31, 2019
	Local Price & Product Mix		Currency		Volume		Portfolio / Other		Total
Percent change from prior year
Agriculture	1	%	(5	)%	(7	)%	—	%	(11	)%
Materials Science	(9	)%	(2	)%	1	%	—	%	(10	)%
Specialty Products	3	%	(2	)%	(3	)%	(1	)%	(3	)%

Operating EBITDA by Division	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
Agriculture	$	667	$	891
Performance Materials & Coatings	481		586
Industrial Intermediates & Infrastructure	448		654
Packaging & Specialty Plastics	993		1,301
Materials Science	$	1,922	$	2,541
Electronics & Imaging	385		398
Nutrition & Biosciences	390		418
Transportation & Advanced Polymers	414		437
Safety & Construction	411		354
Specialty Products	$	1,600	$	1,607

60

CHANGES IN FINANCIAL CONDITION

The Company had cash and cash equivalents and marketable securities of $11,662 million at March 31, 2019 and $13,616 million at December 31, 2018, of which $5,539 million at March 31, 2019 and $5,820 million at December 31, 2018, was held by subsidiaries in foreign countries, including United States territories. The decrease in cash and cash equivalents held by subsidiaries in foreign countries is due to the repatriation activities discussed below. For each of its foreign subsidiaries, the Company makes an assertion regarding the amount of earnings intended for permanent reinvestment, with the balance available to be repatriated to the United States.

The Act requires companies to pay a one-time transition tax on earnings of foreign subsidiaries, a majority of which were previously considered permanently reinvested by the Company (see Note 7 to the Consolidated Financial Statements for further details of The Act). The cash held by foreign subsidiaries for permanent reinvestment is generally used to finance the subsidiaries' operational activities and future foreign investments. The Company has the ability to repatriate additional funds to the U.S., which could result in an adjustment to the tax liability for foreign withholding taxes, foreign and/or U.S. state income taxes and the impact of foreign currency movements. It is not practicable to calculate the unrecognized deferred tax liability on undistributed foreign earnings due to the complexity of the hypothetical calculation. During the first and second quarters of 2019, in connection with the Intended Business Separations, the Company has and expects to continue repatriating certain funds from its non-U.S. subsidiaries that are not needed to finance local operations or separation activities. During the three months ended March 31, 2019, the Company recorded tax expense of $13 million associated with these repatriation activities.

The Company’s cash flows from operating, investing and financing activities, as reflected in the consolidated statements of cash flows, are summarized in the following table. 

Cash Flow Summary	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Cash provided by (used for):
Operating activities	$	26		$	(2,137	)
Investing activities	(1,000		)	290
Financing activities	(1,032		)	(1,543		)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	50			208
Summary
Decrease in cash, cash equivalents and restricted cash	$	(1,956	)	$	(3,182	)
Cash, cash equivalents and restricted cash at beginning of period	14,022			14,015
Cash, cash equivalents and restricted cash at end of period	$	12,066		$	10,833
Less: Restricted cash and cash equivalents, included in "Other current assets"	523			552
Cash and cash equivalents at end of period	$	11,543		$	10,281

Cash Flows from Operating Activities

In the first three months of 2019, cash provided by operating activities was $26 million, compared with cash used for operating activities of $2,137 million in the same period last year. The increase in cash was primarily due to a decrease in cash used for working capital, higher prepayments from customer contracts, increased dividend payments received from nonconsolidated affiliates, lower pension contributions and lower tax payments.

Net Working Capital	Mar 31, 2019		Dec 31, 2018
In millions
Current assets	$	49,248	$	49,603
Current liabilities	28,580		24,715
Net working capital	$	20,668	$	24,888
Current ratio	1.72:1		2.01:1

Cash Flows from Operating Activities - Non-GAAP

The following table reconciles cash flows from operating activities to a non-GAAP measure regarding cash flows from operating activities excluding the impact of Accounting Standards Update ("ASU") 2016-15, "Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments" and related interpretive guidance for the three months ended March 31, 2018. Management believes this non-GAAP financial measure is relevant and meaningful as it presents cash flows from operating

61

activities inclusive of all trade accounts receivable collection activity, which the Company utilizes in support of its operating activities.

Cash Flows from Operating Activities Excluding the Impact of ASU 2016-15 and Additional Interpretive Guidance (non-GAAP)	Three Months Ended Mar 31, 2018
In millions
Cash flows from operating activities - Updated for impact of ASU 2016-15 and additional interpretive guidance (GAAP)	$	(2,137	)
Less: Impact of ASU 2016-15 and additional interpretive guidance	445
Cash flows from operating activities - Excluding impact of ASU 2016-15 and additional interpretive guidance (non-GAAP)	$	(1,692	)

Cash Flows from Investing Activities

In the first three months of 2019, cash used for investing activities was $1,000 million, reflecting capital expenditures and purchases of investments, which were partially offset by proceeds from sales and maturities of investments. In the first three months of 2018, cash provided by investing activities was $290 million, reflecting proceeds from sales and maturities of investments and proceeds from interests in trade accounts receivable conduits, which were partially offset by capital expenditures and purchases of investments. Capital spending was $1,139 million in the first three months of 2019, compared with $776 million in the first three months of 2018.

Cash Flows from Financing Activities

In the first three months of 2019, cash used for financing activities was $1,032 million compared with $1,543 million in the same period last year. The decrease was primarily due to an increase of proceeds from issuance of long-term debt, net of payments and an increase in notes payable, which were partially offset by an increase in purchases of treasury stock.

Free Cash Flow

The Company defines free cash flow as cash from operating activities less capital expenditures. Under this definition, free cash flow represents the cash generated by the Company from operations after investing in its asset base. Free cash flow, combined with cash balances and other sources of liquidity, represent the cash available to fund obligations and provide returns to shareholders. Free cash flow is an integral financial measure used in the Company's financial planning process. This financial measure is not recognized in accordance with U.S. GAAP and should not be viewed as an alternative to U.S. GAAP financial measures of performance. All companies do not calculate non-GAAP financial measures in the same manner and, accordingly, the Company's free cash flow definition may not be consistent with the methodologies used by other companies.

For additional information relating to the change in cash used for operating activities, see the discussion in the previous section entitled "Cash Flows from Operating Activities."

Reconciliation of "Cash From Operating Activities" to Free Cash Flow (non-GAAP)	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Cash from operating activities (GAAP)	$	26		$	(2,137	)
Capital expenditures	(1,139		)	(776		)
Free cash flow (non-GAAP)	$	(1,113	)	$	(2,913	)

Liquidity & Financial Flexibility

The Company’s primary source of incremental liquidity is cash flows from operating activities. Management expects the generation of cash from operations and the ability to access the debt capital markets and other sources of liquidity will continue to provide sufficient liquidity and financial flexibility to meet the Company’s and its subsidiaries obligations as they come due.

DowDuPont's Liquidity Sources

In November 2018, DowDuPont consummated the offering of the senior unsecured notes (the "DowDuPont Notes") in an aggregate principal amount of $12.7 billion. The offering consisted of $0.5 billion in floating rate notes due November 2020, $0.3 billion in floating rate notes due November 2023, and six tranches of fixed-rate notes: $1.5 billion due November 2020, $2.5 billion due November 2023, $1.85 billion due November 2025, $2.25 billion due November 2028, $1.65 billion due November 2038 and $2.15 billion due November 2048. The net proceeds of the offering after the underwriting discount was $12.6 billion. See Note 13 to the Consolidated Financial Statements for additional information on the interest related to the DowDuPont Notes.

62

The DowDuPont Notes will rank equally with the Company's future senior unsecured debt outstanding from time to time. The DowDuPont Notes are not guaranteed by any of the Company's subsidiaries and are nonrecourse to the assets of Dow and Corteva. Each series of DowDuPont Notes will continue to be a senior unsecured obligation of DuPont after the separations and distributions. If each of the separations and distributions has not been completed on or before May 1, 2020, or, if prior to such date, the Company has abandoned any of the separations or distributions, the Company will be required to redeem each series of DowDuPont Notes at a redemption price equal to 101 percent of the principal amount of such series of DowDuPont Notes, plus accrued and unpaid interest, if any, up to but excluding the date of redemption.

On April 1, 2019 prior to consummating the Dow Distribution, the Company contributed $2,024 million to Dow. The remaining proceeds from the DowDuPont Notes will be used to (i) reduce outstanding liabilities of Historical DuPont that would otherwise be attributed to Corteva; and (ii) further pay any related premiums, fees and expenses.

Term Loan and Revolving Credit Facilities - DowDuPont

In November 2018, the Company entered into a term loan agreement that establishes two term loan facilities in the aggregate principal amount of $3 billion, (the “DowDuPont Term Loan Facilities”) as well as a five-year $3 billion revolving credit facility (the “DowDuPont RCF”), availability of funding for each being subject to the satisfaction or waiver or certain customary conditions, including among others the consummation of the Dow Distribution. As of March 31, 2019, the DowDuPont Term Loan Facilities and DowDuPont RCF were unfunded and not yet available. The Company amended the DowDuPont RCF to become available as of May 2, 2019. The DowDuPont RCF is intended to remain unfunded.

Effective May 2, 2019, the Company fully drew the two DowDuPont Term Loan Facilities in the aggregate principal amount of $3.0 billion.

Commercial Paper - DowDuPont

In April 2019, DowDuPont authorized a $3 billion commercial paper program (the “DowDuPont Commercial Paper Program”), to become available concurrent with the DowDuPont RCF. The DowDuPont Commercial Paper Program, along with other primary sources of liquidity including cash from operations and cash and cash equivalents balances, is intended to fund the Company’s liquidity needs, including anticipated cash requirements related to working capital, capital spending, dividend payments, debt maturities and other cash needs.

Credit Ratings - DowDuPont

Coincident with the DowDuPont notes offering in November 2018, the credit rating agencies released credit ratings for DowDuPont, prospectively assuming the consummation of the separations and distributions of Dow and Corteva. The ratings for the Company are: A- with a Stable outlook from Standard & Poor’s; Baa1 with a Stable outlook from Moody’s Investors Service; and BBB+ with a Stable outlook from Fitch Ratings.

Historical DuPont's Liquidity Sources

Commercial Paper - Historical DuPont

Historical DuPont issues promissory notes under U.S. commercial paper programs. At March 31, 2019, Historical DuPont had $2,588 million of commercial paper outstanding ($1,847 million at December 31, 2018). Historical DuPont maintains access to the commercial paper market at competitive rates. Amounts outstanding under Historical DuPont's commercial paper programs during the period may be greater, or less, than the amount reported at the end of the period.

Committed Credit Facilities - Historical DuPont

In the event the Company has short-term liquidity needs, it can access liquidity through Historical DuPont's committed and available credit facilities. At March 31, 2019, Historical DuPont had total committed credit facilities of $8.8 billion with remaining available credit facilities of $5.7 billion. See Note 15 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2018, for additional information on committed and available credit facilities.

Term Loan and Revolving Credit Facilities - Historical DuPont

In March 2016, Historical DuPont entered into a credit agreement that provides for a three-year, senior unsecured term loan facility in the aggregate principal amount of $4.5 billion (as may be amended, from time to time, the "Historical DuPont Term Loan Facility") under which Historical DuPont may make up to seven term loan borrowings and amounts repaid or prepaid are not available for subsequent borrowings. The proceeds from the borrowings under the Term Loan Facility will be used for Historical DuPont's general corporate purposes including debt repayment, working capital and funding a portion of the Company's costs and expenses. The Term Loan Facility was amended in 2018 to extend the maturity date to June 2020, at which time all outstanding borrowings, including accrued but unpaid interest, become immediately due and payable, and to extend the date on which the commitment to lend terminates to June 2019. At March 31, 2019, Historical DuPont had made six term loan borrowings in an

63

aggregate principal amount of $3.0 billion and had unused commitments of $1.5 billion under the Term Loan Facility. In addition, in 2018, Historical DuPont amended its $3.0 billion revolving credit facility to extend the maturity date to June 2020.

On May 2, 2019 Historical DuPont terminated its Term Loan Facility ("the Termination") and repaid the aggregate outstanding principal amount of $3 billion plus accrued and unpaid interest through and including May 1, 2019.

In November 2018, Historical DuPont entered into a $3.0 billion five-year revolving credit facility and a $3.0 billion three-year revolving credit facility (the “2018 Revolving Credit Facilities”). Availability of funds was subject to a number of conditions, including Corteva becoming a party to the 2018 Revolving Credit Facilities and the consummation of the separation and distribution of Corteva. On May 2, 2019, the 2018 Revolving Credit Facilities were amended, making the 2018 Revolving Credit Facilities available for Historical DuPont, effective May 2, 2019. Corteva will become a party to the 2018 Revolving Credit Facilities upon the separation and distribution from DowDuPont. The 2018 Revolving Credit Facilities contain customary representations and warranties, affirmative and negative covenants and events of default that are typical for companies with similar credit ratings and generally consistent with those applicable to Historical DuPont’s existing term loan and revolving credit facilities. The 2018 Revolving Credit Facilities also contain a financial covenant requiring that the ratio of total indebtedness to total capitalization for Historical DuPont and its consolidated subsidiaries not exceed 0.60.

Committed Receivable Repurchase Facility - Historical DuPont

In February 2019, in line with seasonal agricultural working capital requirements, Historical DuPont entered into a committed receivable repurchase agreement of up to $1.3 billion (the "2019 Repurchase Facility") which expires in December 2019. From time to time, Historical DuPont and the banks modify the monthly commitment amounts to better align with working capital requirements. Under the 2019 Repurchase Facility, Historical DuPont may sell a portfolio of available and eligible outstanding customer notes receivables within the Agriculture segment to participating institutions and simultaneously agree to repurchase at a future date. See Note 13 to the Consolidated Financial Statements for additional information.

Credit Ratings - Historical DuPont

At April 30, 2019, Historical DuPont's credit ratings were: A- for a long-term rating and A-2 for a short-term rating with a Stable outlook from Standard & Poor’s; A3 for a long-term rating and P-2 for a short-term rating with a Stable outlook from Moody’s Investors Service; and A for a long-term rating and F1 for a short-term rating with a Stable outlook from Fitch Ratings. Downgrades in Historical DuPont's credit ratings would increase borrowing costs on certain indentures and could impact its ability to access debt capital markets.

Debt

The Company’s public debt instruments and primary, private credit agreements (collectively "Debt Instruments") reside with DowDuPont, as well as Historical Dow and Historical DuPont (together, the "Subsidiaries"). See Note 13 to the Consolidated Financial Statements for information related to the Subsidiaries' notes payable and long-term debt activity since December 31, 2018, including debt retired and issued. The following table reflects the debt of DowDuPont and the Subsidiaries:

Total Debt	Mar 31, 2019								Dec 31, 2018
In millions	DowDuPont1		Historical Dow		Historical DuPont		Total		DowDuPont1		Historical Dow		Historical DuPont		Total
Notes payable	$	—	$	317	$	2,678	$	2,995	$	—	$	302	$	1,863	$	2,165
Long-term debt due within one year	—		2,369		1,640		4,009		—		340		297		637
Long-term debt	12,599		17,160		5,207		34,966		12,596		19,254		5,812		37,662
Total debt	$	12,599	$	19,846	$	9,525	$	41,970	$	12,596	$	19,896	$	7,972	$	40,464

1. Represents the DowDuPont holding company.

On November 13, 2018, Historical DuPont launched a tender offer (the “Tender Offer”) to purchase $6.2 billion aggregate principal amount of its outstanding debt securities (the “Tender Notes”). The Tender Offer expired on December 11, 2018 (the “Expiration Date”). At the Expiration Date, $4,409 million aggregate principal amount of the Tender Notes had been validly tendered and was accepted for payment. In exchange for such validly tendered Tender Notes, Historical DuPont paid a total of $4,849 million, which included breakage fees and all applicable accrued and unpaid interest on such Tender Notes. DowDuPont contributed cash (generated from the offering of the DowDuPont Notes) to Historical DuPont to fund the settlement of the Tender Offer and payment of associated fees.

64

On March 22, 2019, Historical DuPont issued notices of redemption in full of all of its outstanding notes (the “Make Whole Notes”) listed in the table below:

(in millions)	Amount
4.625% Notes due 2020	$	474
3.625% Notes due 2021	296
4.250% Notes due 2021	163
2.800% Notes due 2023	381
6.500% Debentures due 2028	57
5.600% Senior Notes due 2036	42
4.900% Notes due 2041	48
4.150% Notes due 2043	69
Total	$	1,530

The Make Whole Notes were redeemed on April 22, 2019, at the make-whole redemption prices set forth in the respective Make Whole Notes. On and after the date of redemption, the Make Whole Notes were no longer deemed outstanding, interest on the Make Whole Notes ceased to accrue and all rights of the holders of the Make Whole Notes were terminated.

In connection with the expected announcement of the record date for the intended Corteva Distribution, Historical DuPont will be required to mail a notice of redemption to holders of the $1,250 million aggregate principal amount of 2.200 percent Notes due 2020 and $750 million aggregate principal amount of Floating Rate Notes due 2020 (collectively, the “SMR Notes”) setting forth the date of redemption of the SMR Notes. On the date of redemption, Historical DuPont will be required to redeem all of the SMR Notes at a redemption price equal to 100 percent of the aggregate principal amount of the SMR Notes plus accrued and unpaid interest, if any, up to but excluding the date of redemption. Following the redemption, the SMR Notes will no longer be outstanding and will cease to bear interest and all rights of the holders of the SMR Notes will terminate.

The Company expects to finance Historical DuPont’s redemption of the SMR Notes with cash from operations and the remaining proceeds from both the DWDP Term Loan Facilities and DowDuPont Notes, as well as other sources of liquidity. To achieve the intended credit profiles of Corteva and DuPont, DowDuPont expects to further de-lever Historical DuPont prior to the Corteva Distribution. In connection with both of these actions, the Company expects to issue commercial paper in the second quarter 2019. The final amount of the Company’s commercial paper issuance will depend on a number of factors including results of operations, market conditions and capital structure considerations.

Covenants and Default Provisions

The Company's indenture covenants include customary limitations on liens, sale and leaseback transactions, and mergers and consolidations, subject to certain limitations. The DowDuPont Notes also contain customary default provisions. In addition, the Company will be required to redeem all of the DowDuPont Notes at a redemption price equal to 101 percent of the principal amount of such series of DowDuPont Notes, plus accrued and unpaid interest to, but excluding, the redemption date if each of the separations and distributions has not been completed on or before May 1, 2020, or, if prior to such date, DowDuPont has abandoned the intended Corteva Distribution.

The Debt Instruments of the Subsidiaries contain, among other provisions, certain customary restrictive covenant and default provisions. Historical Dow’s Revolving Credit Agreement contains a financial covenant that Historical Dow must maintain its ratio of consolidated indebtedness to its consolidated capitalization at no greater than 0.65 to 1.00 at any time the aggregate outstanding amount of loans under Historical Dow’s Revolving Credit Agreement equals or exceeds $500 million. The ratio of Historical Dow’s consolidated indebtedness to its consolidated capitalization was 0.41 to 1.00 at March 31, 2019. Historical DuPont’s Term Loan Facility and RCF contain a financial covenant requiring that the ratio of total indebtedness to total capitalization for Historical DuPont and its consolidated subsidiaries not exceed 0.6667 to 1.00. At March 31, 2019, management believes each of the Subsidiaries were in compliance with all of their respective covenants and default provisions. For additional information on the Subsidiaries' debt covenants and default provisions, see Note 15 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2018.

65

Dividends

On February 14, 2019, the Company announced that its Board declared a dividend of $0.38 per share, paid on March 15, 2019, to shareholders of record on February 28, 2019. On March 8, 2019, the Company announced that its Board declared a dividend of $325 million ($0.14 per share) in the aggregate on a pro rata basis, payable on May 28, 2019, to shareholders of record on April 26, 2019.

Share Repurchase Programs

On November 1, 2018, the Company announced a new $3.0 billion share buyback program. The Company spent $1.4 billion in the fourth quarter of 2018 and spent the remaining $1.6 billion in the first quarter of 2019, thereby completing this share repurchase program.

See Part II, Item 2. Unregistered Sales of Equity Securities and Use of Proceeds, for additional information.

Pension Plans

DowDuPont expects to make additional contributions in the aggregate of about $500 million by year-end 2019 to its pension plans other than the principal U.S. pension plan. Any such contribution could be funded by existing cash balances and/or cash from other available sources of liquidity.

Restructuring

DowDuPont Cost Synergy Program

The activities related to the Synergy Program are expected to result in additional cash expenditures of approximately $650 million to $700 million, primarily by the end of 2019, consisting of severance and related benefit costs and costs associated with exit and disposal activities, including environmental remediation (see Note 5 to the Consolidated Financial Statements). The Company expects to incur additional costs in the future related to its restructuring activities. Future costs are expected to include demolition costs related to closed facilities and restructuring plan implementation costs; these costs will be recognized as incurred. The Company also expects to incur additional employee-related costs, including involuntary termination benefits, related to its other optimization activities. These costs cannot be reasonably estimated at this time.

Contractual Obligations

Information related to the Company’s contractual obligations, commercial commitments and expected cash requirements for interest can be found in the Company's 2018 Annual Report on Form 10-K, Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations, Liquidity and Capital Resources. Additional information related to these obligations can be found in Notes 15, 16 and 19 to the Consolidated Financial Statements in the Company’s 2018 Annual Report on Form 10-K. With the exception of increased borrowings under the Historical DuPont Term Loan Facility, in the first quarter of 2019, there have been no material changes in the Company's contractual obligations since December 31, 2018. See Note 13 to the interim Consolidated Financial Statements for further discussion of the Historical DuPont Term Loan Facility.

Off-balance Sheet Arrangements

Off-balance sheet arrangements are obligations the Company has with nonconsolidated entities related to transactions, agreements or other contractual arrangements. The Company holds variable interests in joint ventures accounted for under the equity method of accounting. The Company is not the primary beneficiary of these joint ventures and therefore is not required to consolidate the entities (see Note 22 to the Consolidated Financial Statements).

Guarantees arise in the ordinary course of business from relationships with customers and nonconsolidated affiliates when the Subsidiaries undertake an obligation to guarantee the performance of others if specific triggering events occur. The Subsidiaries had combined outstanding guarantees at March 31, 2019, of $4,753 million, compared with $4,778 million at December 31, 2018. Additional information related to the guarantees of the Subsidiaries can be found in the “Guarantees” section of Note 14 to the Consolidated Financial Statements.

Fair Value Measurements

See Note 21 to the Consolidated Financial Statements for additional information concerning fair value measurements.

66

OTHER MATTERS

Recent Accounting Guidance

See Note 2 to the Consolidated Financial Statements for a summary of recent accounting guidance.

Critical Accounting Estimates

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make judgments, assumptions and estimates that affect the amounts reported in the consolidated financial statements and accompanying notes. Note 1 to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 (“2018 10-K”) describes the significant accounting policies and methods used in the preparation of the consolidated financial statements. DowDuPont’s accounting policies that are impacted by judgments, assumptions and estimates are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Company’s 2018 10-K. Since December 31, 2018, there have been no material changes in the Company’s accounting policies that are impacted by judgments, assumptions and estimates. See the discussion in this section for information regarding the valuation of assets and impairment considerations.

Asbestos-Related Matters of Union Carbide Corporation

Union Carbide is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past four decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide’s premises, and Union Carbide’s responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem Products, Inc. ("Amchem"). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to Union Carbide’s products.

The table below provides information regarding asbestos-related claims pending against Union Carbide and Amchem based on criteria developed by Union Carbide and its external consultants.

Asbestos-Related Claim Activity	2019		2018
Claims unresolved at Jan 1	12,780		15,427
Claims filed	1,383		1,932
Claims settled, dismissed or otherwise resolved	(1,569	)	(3,026	)
Claims unresolved at Mar 31	12,594		14,333
Claimants with claims against both Union Carbide and Amchem	(4,509	)	(5,148	)
Individual claimants at Mar 31	8,085		9,185

Plaintiffs’ lawyers often sue numerous defendants in individual lawsuits or on behalf of numerous claimants. As a result, the damages alleged are not expressly identified as to Union Carbide, Amchem or any other particular defendant, even when specific damages are alleged with respect to a specific disease or injury. In fact, there are no personal injury cases in which only Union Carbide and/or Amchem are the sole named defendants. For these reasons and based upon Union Carbide’s litigation and settlement experience, Union Carbide does not consider the damages alleged against Union Carbide and Amchem to be a meaningful factor in its determination of any potential asbestos-related liability.

For additional information, see Asbestos-Related Matters of Union Carbide Corporation in Note 14 to the Consolidated Financial Statements and Part II, Item 1. Legal Proceedings.

Valuation of Assets and Impairment Considerations

As a result of the Merger and related acquisition method of accounting, Historical DuPont’s assets and liabilities were measured at fair value, and any declines in the projected cash flows could have a material, negative impact on the fair value of the Company’s reporting units and assets, particularly within the Agriculture and Specialty Products divisions, and therefore could result in an impairment.

In preparation for the intended Corteva Distribution, Historical DuPont completed the separation of the assets and liabilities related to its specialty products businesses (the “Historical DuPont Net SP Assets”) into separate legal entities. On May 1, 2019, Historical DuPont distributed those legal entities to DowDuPont (the “Internal SP Distribution”). The Internal SP Distribution triggers a re-assessment at the Historical DuPont level of the recoverability of goodwill and the overall carrying value of the Historical DuPont Net SP Assets.

67

In connection with the consummation of the intended Corteva Distribution, DowDuPont will assess the recoverability of the goodwill and the overall carrying value of the net assets of its agriculture business. In connection with DowDuPont’s Second Quarter Segment Realignments, the Company will reassess and may re-define its reporting units. See the Overview section of the MD&A for more information about the Second Quarter Segment Realignments.

Two of the Company’s current reporting units, Industrial Biosciences and Clean Technologies, are comprised solely of Historical DuPont assets and liabilities, the carrying values of which were measured at fair value in connection with the Merger. These reporting units are considered at risk for impairment given the small margin of their respective fair values over their respective carrying values as of the date of the Company’s last annual impairment test. In addition, recent unfavorable market conditions slowed demand in the biomaterials business unit in Industrial Biosciences. The carrying amount of goodwill for the Industrial Biosciences and Clean Technologies reporting units at March 31, 2019 was $3,100 million and $461 million, respectively. As part of the Second Quarter Segment Realignments, the biomaterials business unit in Industrial Biosciences and the Clean Technologies reporting unit will be included in the Non-Core segment effective June 1, 2019.

DowDuPont will assemble and review updated financial projections, including any changes to key assumptions, in connection with the Internal SP Distribution, intended Corteva Distribution and Second Quarter Segment Realignments. In connection with this activity, the outcome of which is not currently known, it is possible that non-cash impairment charges could be recorded in second quarter 2019. There can be no assurance that such charges, if any, would not be material to the Company.

68

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

See Note 20 to the Consolidated Financial Statements. See also Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk, of the Company's 2018 Annual Report on Form 10-K for information on the Company's utilization of financial instruments and an analysis of the sensitivity of these instruments.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this Quarterly Report on Form 10-Q, the Company carried out an evaluation, under the supervision and with the participation of the Company’s Disclosure Committee and the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to paragraph (b) of Exchange Act Rules 13a-15 and 15d-15. Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

There were no changes in the Company's internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 and 15d-15 that was conducted during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

In connection with the Dow Distribution and the intended Corteva Distribution, there are several processes, policies, operations, technologies and information systems that were integrated following the Merger which have been or will be replicated, transferred or separated. The Company continues to take steps to ensure that adequate controls are designed and maintained throughout this transition period.

69

DowDuPont Inc.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The Company and its subsidiaries are subject to various litigation matters, including, but not limited to, product liability, patent infringement, antitrust claims, and claims for third party property damage or personal injury stemming from alleged environmental torts. Information regarding certain of these matters is set forth below and in Note 14 to the Consolidated Financial Statements.

Litigation

Pursuant to the Separation Agreement, as of the consummation of the Dow Distribution on April 1, 2019, the Historical Dow liabilities discussed below are liabilities of Dow Inc. and, accordingly, will be reflected as discontinued operations of the Company as of the second quarter 2019.

Historical Dow

Asbestos-Related Matters of Union Carbide Corporation ("Union Carbide"), a wholly owned subsidiary of Historical Dow

No material developments regarding this matter occurred in the first quarter of 2019. For a current status of this matter, see Note 14 to the Consolidated Financial Statements; and Management’s Discussion and Analysis of Financial Condition and Results of Operations, Asbestos-Related Matters of Union Carbide Corporation.

Historical DuPont

PFOA: Environmental and Litigation Proceedings

For purposes of this report, the term PFOA means collectively perfluorooctanoic acid and its salts, including the ammonium salt and does not distinguish between the two forms. Information related to this matter is included in Note 14 to the Consolidated Financial Statements under the heading PFOA Matters.

Fayetteville Works Facility, Fayetteville, North Carolina

In August 2017, the U.S. Attorney’s Office for the Eastern District of North Carolina served Historical DuPont with a grand jury subpoena for testimony and the production of documents related to alleged discharges of GenX from the Fayetteville Works facility into the Cape Fear River. Historical DuPont has been served with additional subpoenas relating to the same issue and in the second quarter of 2018, received a subpoena expanding the scope to any perfluorinated chemicals and compounds (“PFCs”) discharged from the Fayetteville Works facility into the Cape Fear River. Additional information related to this matter is included in Note 14 to the Consolidated Financial Statements under the heading "DuPont Matters: Fayetteville Works Facility, North Carolina."

La Porte Plant, La Porte, Texas - Crop Protection - Release Incident Investigations

On November 15, 2014, there was a release of methyl mercaptan at Historical DuPont's La Porte, Texas, facility. The release occurred at the site’s Crop Protection unit resulting in four employee fatalities inside the unit. Historical DuPont continues to cooperate with governmental agencies, including the U.S. Environmental Protection Agency ("EPA"), the Chemical Safety Board and the Department of Justice ("DOJ"), which are still conducting investigations. These investigations could result in sanctions and civil or criminal penalties against Historical DuPont.

Environmental Proceedings

The Company believes it is remote that the following matters will have a material impact on its financial position, liquidity or results of operations. The description is included per Regulation S-K, Item 103(5)(c) of the Securities Exchange Act of 1934. Pursuant to the Separation Agreement, as of the consummation of the Dow Distribution on April 1, 2019, the Historical Dow liabilities discussed below are liabilities of Dow Inc. and, accordingly, will be reflected as discontinued operations of the Company as of the second quarter 2019.

Historical Dow

Freeport, Texas, Facility Matter

On July 7, 2018, Historical Dow received an informal notice that the EPA, Region 6 was contemplating filing a Notice of Violation with a proposed penalty for alleged violations uncovered during a prior inspection related to the management of hazardous wastes at Historical Dow's Freeport, Texas, manufacturing facility, pursuant to the Risk Management Plan requirements of the Clean Air Act. On March 4, 2019, the EPA and Historical Dow entered into a Consent Agreement and Final Order, which Historical Dow agreed to pay a fine of $260,349 and certify compliance with specified regulations with the EPA.

70

Union Carbide Matter - Seadrift, Texas

On March 5, 2019, Union Carbide received an informal notice that the EPA, Region 6 was contemplating filing a Notice of Violation with a proposed penalty for alleged violations uncovered during a prior inspection related to the management of hazardous materials at Union Carbide's Seadrift, Texas, manufacturing facility, pursuant to the Risk Management Plan requirements of the Clean Air Act. Discussions between the EPA and Union Carbide are ongoing.

Historical DuPont

La Porte Plant, La Porte, Texas - EPA Multimedia Inspection

The EPA conducted a multimedia inspection at the La Porte facility in January 2008. Historical DuPont, the EPA and the DOJ began discussions in the fall of 2011 relating to the management of certain materials in the facility's waste water treatment system, hazardous waste management, flare and air emissions. These discussions continue.

Sabine Plant, Orange, Texas - EPA Multimedia Inspection

In June 2012, Historical DuPont began discussions with the EPA and the DOJ related to a multimedia inspection that the EPA conducted at the Sabine facility in March 2009 and December 2015. The discussions involve the management of materials in the facility's waste water treatment system, hazardous waste management, flare and air emissions, including leak detection and repair. These discussions continue.

Divested Neoprene Facility, La Place, Louisiana - EPA Compliance Inspection

In 2016, the EPA conducted a focused compliance investigation at the Denka Performance Elastomer LLC (“Denka”) neoprene manufacturing facility in La Place, Louisiana. Historical DuPont sold the neoprene business, including this manufacturing facility, to Denka in the fourth quarter of 2015. Subsequent to this inspection, the EPA, the DOJ, the DEQ, Historical DuPont and Denka began discussions in the spring of 2017 relating to the inspection conclusions and allegations of noncompliance arising under the Clean Air Act, including leak detection and repair. These discussions, which include potential settlement options, continue. 

New Jersey Directive PFAS

On March 25, 2019, the New Jersey Department of Environmental Protection (“NJDEP”) issued a Directive and Notice to Insurers to a number of companies, including Chemours, DowDuPont and certain DowDuPont subsidiaries including Historical DuPont. Allegations against DowDuPont and its subsidiaries relate to former operations of Historical DuPont involving poly- and perfluoroalkyl substances, (“PFAS”), including PFOA and PFOA- replacement products. The NJDEP seeks past and future costs of investigating, monitoring, testing, treating, and remediating New Jersey’s drinking water and waste systems, private drinking water wells and natural resources including groundwater, surface water, soil, sediments and biota. The Directive seeks certain information as to future costs and information related to the historic uses of PFAS and replacement chemicals including “information ranging from use and discharge of the chemicals through wastewater treatment plants, air emissions, and sales of products containing the chemicals to current development, manufacture, use and release of newer chemicals in the state.”

Chemours has agreed, with reservations, to defend and indemnify Historical DuPont in this matter.

New Jersey Directive Pompton Lakes

On March 27, 2019, the NJDEP issued a Directive and Notice to Insurers for Natural Resource Damages at Pompton Lakes facility in New Jersey. The directive was issued to Historical DuPont and Chemours and it alleges that former operations at the facility by Historical DuPont have caused contamination and damage to surface and ground water, soils and sediments on and off the facility. The NJDEP is seeking $125,000 as reimbursement for the preparation of a natural resource damage assessment. Depending on the results of such assessment, the parties are notified that they may be required to pay for the restoration and replacement of any damage to such natural resources. 

Chemours has agreed, with reservations, to defend and indemnify Historical DuPont in this matter.

71

ITEM 1A. RISK FACTORS

Inability to access the debt capital markets could impair DowDuPont's liquidity, business or financial condition.

DowDuPont’s primary sources of liquidity to finance operations, including dividends on its common stock, are cash through operations, including those conducted through its subsidiaries, including Historical DuPont, DowDuPont’s direct access to the debt capital markets, and through Historical DuPont’s access to the debt capital markets. In addition, Historical DuPont has relied and continues to rely on access to the debt capital markets to finance day-to-day and long-term operations. Any limitation on the Company’s ability to raise money in the debt markets could have a substantial negative effect on liquidity. Access to the debt capital markets could be impaired as a result of the existence of material nonpublic information about the intended Corteva Distribution and other potential factors, including factors that are not specific to the Company and its subsidiaries, such as a severe disruption of the financial markets and interest rate fluctuations.

Prior to the intended Corteva Distribution, the level and quality of the respective earnings, operations, business and management, among other things, of Historical DuPont will impact its credit ratings, costs and availability of financing and those of the combined Company. A decrease in the ratings assigned to DowDuPont or Historical DuPont by the ratings agencies may negatively impact access to the debt capital markets and increase the Company’s cost of borrowing. There can be no assurance that DowDuPont and Historical DuPont will maintain their current credit worthiness or prospective credit ratings. Any actual or anticipated changes or downgrades in such credit ratings may have a negative impact on the liquidity, capital position or access to capital markets.

A detailed discussion of additional significant risks and uncertainties which may cause results and events to differ materially from is included in the section titled “Risk Factors” (Part I, Item 1A) of DowDuPont’s 2018 Annual Report on Form 10-K.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

The following table provides information regarding purchases of the Company’s common stock by the Company during the three months ended March 31, 2019:

Issuer Purchases of Equity Securities				Total number of shares purchased as part of the Company's publicly announced share repurchase program 1	Approximate dollar value of shares that may yet be purchased under the Company's publicly announced share repurchase program 1 (In millions)
Period	Total number of shares purchased	Average price paid per share
January 2019	15,721,888	$	55.53	15,721,888	$	706
February 2019	13,142,548	$	53.70	13,142,548	$	—
March 2019	—	$	—	—	$	—
First quarter 2019	28,864,436	$	54.70	28,864,436	$	—

1. On November 1, 2018, the Company announced a new $3 billion share buyback program, which was completed in the first quarter of 2019.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable

ITEM 5. OTHER INFORMATION

Not applicable.

72

ITEM 6. EXHIBITS

EXHIBIT NO.	DESCRIPTION
2.1**	Separation and Distribution Agreement, effective as of April 1, 2019, by and among DowDuPont Inc., Dow Inc. and Corteva, Inc. incorporated by reference to Exhibit 2.1 to the DowDuPont Inc. Current Report on Form 8-K filed April 2, 2019.
3.1	The Amended and Restated Bylaws of DowDuPont Inc., effective as of April 1, 2019, incorporated by reference to Exhibit 3.1 to the DowDuPont Inc. Current Report on Form 8-K filed April 2, 2019.
10.1**	Tax Matters Agreement, effective as of April 1, 2019, by and among DowDuPont Inc., Dow Inc. and Corteva, Inc. incorporated by reference to Exhibit 10.1 to the DowDuPont Inc. Current Report on Form 8-K filed April 2, 2019.
10.2**	Employee Matters Agreement, effective as of April 1, 2019, by and among DowDuPont Inc., Dow Inc. and Corteva, Inc. incorporated by reference to Exhibit 10.2 to the DowDuPont Inc. Current Report on Form 8-K filed April 2, 2019.
10.3**	Intellectual Property Cross-License Agreement, effective as of April 1, 2019, by and among DowDuPont Inc. and Dow Inc., incorporated by reference to Exhibit 10.3 to the DowDuPont Inc. Current Report on Form 8-K filed April 2, 2019.
10.4**	Intellectual Property Cross-License Agreement, effective as of April 1, 2019, by and among Dow Inc. and Corteva, Inc., incorporated by reference to Exhibit 10.4 to the DowDuPont Inc. Current Report on Form 8-K filed April 2, 2019.
23*	Ankura Consulting Group, LLC's Consent.
31.1*	Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*	Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document.
101.SCH	XBRL Taxonomy Extension Schema Document.
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB	XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document.

*Filed herewith

**Upon request of the U.S. Securities and Exchange Commission, (the “SEC”), DowDuPont hereby undertakes to furnish supplementally a copy of any omitted schedule or exhibit to such agreement; provided, however, that DowDuPont may omit confidential information pursuant to Item 601(b)(10) or request confidential treatment pursuant to Rule 24b-2 of the Exchange Act for any schedule or exhibit so furnished.

73

DowDuPont Inc.

Trademark Listing

®™ DOW, KAPTON, Qrome, TYVEK AND KEVLAR are trademarks of The Dow Chemical Company ("Historical Dow") or E. I. du Pont de Nemours and Company ("Historical DuPont") or affiliated companies of Historical Dow or Historical DuPont.

74

DowDuPont Inc.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

DOWDUPONT INC.

Registrant

Date: May 3, 2019

By:	/s/ JEANMARIE F. DESMOND
Name:	Jeanmarie F. Desmond
Title:	Chief Financial Officer
City:	Wilmington
State:	Delaware

75

EX-23

Ankura Consulting Group, LLC's Consent EXHIBIT 23

DowDuPont Inc.:

Ankura Consulting Group, LLC (“Ankura”) hereby consents to the use of Ankura's name and the reference to Ankura's reports in this Quarterly Report on Form 10-Q of DowDuPont Inc. for the period ended March 31, 2019, and the incorporation by reference thereof in the following Registration Statements of DowDuPont Inc.:

Form S-3:
Nos.	333-227202
Form S-8:
Nos.	333-220330
	333-220324

/s/ B. THOMAS FLORENCE

B. Thomas Florence

Senior Managing Director

Ankura Consulting Group, LLC

May 3, 2019

76

EX-31.1

DowDuPont Inc. EXHIBIT 31.1

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Edward D. Breen, certify that:

1. I have reviewed this quarterly report on Form 10-Q of DowDuPont Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 3, 2019

/s/ EDWARD D. BREEN

Edward D. Breen

Chief Executive Officer

77

EX-31.2

DowDuPont Inc. EXHIBIT 31.2

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Jeanmarie F. Desmond, certify that:

1. I have reviewed this quarterly report on Form 10-Q of DowDuPont Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 3, 2019

/s/ JEANMARIE F. DESMOND

Jeanmarie F. Desmond

Chief Financial Officer

78

EX-32.1

DowDuPont Inc. EXHIBIT 32.1

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

I, Edward D. Breen, Chief Executive Officer of DowDuPont Inc. (the “Company”), certify that:

1. the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2019 as filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ EDWARD D. BREEN

Edward D. Breen

Chief Executive Officer

May 3, 2019

79

EX-32.2

DowDuPont Inc. EXHIBIT 32.2

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

I, Jeanmarie F. Desmond, Chief Financial Officer of DowDuPont Inc. (the “Company”), certify that:

1. the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2019 as filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ JEANMARIE F. DESMOND

Jeanmarie F. Desmond

Chief Financial Officer

May 3, 2019

80

XML

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2019	Apr. 30, 2019
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2019
Entity Registrant Name	DowDuPont Inc.
Entity Central Index Key	0001666700
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Share Outstanding		2,246,387,858
Entity Small Business	false
Entity Emerging Growth Company	false

XML

Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Income Statement [Abstract]
Net sales	$ 19,649	$ 21,510
Cost of sales	14,726	16,315
Research and development expenses	717	768
Selling, general and administrative expenses	1,672	1,714
Amortization of intangibles	474	474
Restructuring and asset related charges - net	287	262
Integration and separation costs	813	457
Equity in earnings of nonconsolidated affiliates	26	257
Sundry income (expense) - net	248	115
Interest expense and amortization of debt discount	454	350
Income from continuing operations before income taxes	780	1,542
Provision for income taxes on continuing operations	209	389
Income from continuing operations, net of tax	571	1,153
Loss from discontinued operations, net of tax	0	(5)
Net income	571	1,148
Net income attributable to noncontrolling interests	51	44
Net income available for DowDuPont Inc. common stockholders	$ 520	$ 1,104
Per common share data:
Earnings per common share from continuing operations - basic (in dollars per share)	$ 0.23	$ 0.47
Earnings per common share from discontinued operations - basic (in dollars per share)	0.00	0.00
Net income attributable to common stockholders, basic (in dollars per share)	0.23	0.47
Earnings per common share from continuing operations - diluted (in dollars per share)	0.23	0.47
Earnings per common share from discontinued operations - diluted (in dollars per share)	0.00	0.00
Net income attributable to common stockholders, diluted (in dollars per share)	$ 0.23	$ 0.47
Weighted-average common shares outstanding - basic (in shares)	2,250.1	2,317.0
Weighted-average common shares outstanding - diluted (in shares)	2,259.2	2,334.3
Depreciation	$ 957	$ 953
Capital expenditures	$ 1,139	$ 776

XML

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Statement of Comprehensive Income [Abstract]
Net income	$ 571	$ 1,148
Other comprehensive income (loss), net of tax
Unrealized gains (losses) on investments	67	(25)
Cumulative translation adjustments	(97)	1,333
Pension and other postretirement benefit plans	135	130
Derivative instruments	(75)	17
Total other comprehensive income	30	1,455
Comprehensive income	601	2,603
Comprehensive income attributable to noncontrolling interests, net of tax	57	38
Comprehensive income attributable to DowDuPont Inc.	$ 544	$ 2,565

XML

Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Current Assets
Cash and cash equivalents (variable interest entities restricted - 2019: $109; 2018: $82)	$ 11,543	$ 13,482
Marketable securities	119	134
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2019: $204; 2018: $191)	13,963	12,376
Other	4,783	4,963
Inventories	16,604	16,621
Other current assets	2,236	2,027
Total current assets	49,248	49,603
Investments
Investment in nonconsolidated affiliates	4,687	5,204
Other investments (investments carried at fair value - 2019: $1,797; 2018: $1,699)	2,791	2,701
Noncurrent receivables	415	477
Total investments	7,893	8,382
Property
Property	75,958	75,343
Less accumulated depreciation	40,383	39,495
Net property (variable interest entities restricted - 2019: $718; 2018: $734)	35,575	35,848
Other Assets
Goodwill	58,948	59,032
Other intangible assets (net of accumulated amortization - 2019: $7,865; 2018: $7,414)	30,467	30,965
Deferred income tax assets	1,853	1,724
Deferred charges and other assets	5,801	2,476
Total other assets	97,069	94,197
Total Assets	189,785	188,030
Current Liabilities
Notes payable	2,995	2,165
Long-term debt due within one year	4,009	637
Accounts payable:
Trade	8,333	9,457
Other	3,735	3,656
Income taxes payable	836	857
Accrued and other current liabilities	8,672	7,943
Total current liabilities	28,580	24,715
Long-Term Debt (variable interest entities nonrecourse - 2019: $43; 2018: $75)	34,966	37,662
Other Noncurrent Liabilities
Deferred income tax liabilities	5,229	5,435
Pension and other postretirement benefits - noncurrent	15,626	15,909
Asbestos-related liabilities - noncurrent	1,133	1,142
Other noncurrent obligations	10,153	6,988
Total other noncurrent liabilities	32,141	29,474
Stockholders' Equity
Common stock (authorized 5,000,000,000 shares of $0.01 par value each; issued 2019: 2,358,630,709 shares; 2018: 2,352,430,301 shares)	24	24
Additional paid-in capital	82,125	81,960
Retained earnings	29,764	30,536
Accumulated other comprehensive loss	(12,364)	(12,394)
Unearned ESOP shares	(105)	(134)
Treasury stock at cost (2019: 112,316,990 shares; 2018: 83,452,554 shares)	(7,000)	(5,421)
DowDuPont's stockholders' equity	92,444	94,571
Noncontrolling interests	1,654	1,608
Total equity	94,098	96,179
Total Liabilities and Equity	$ 189,785	$ 188,030

XML

Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Trade (allowance for doubtful receivables)	$ 204	$ 191
Other investments (investments carried at fair value	1,797	1,699
Other intangible assets (accumulated amortization)	$ 7,865	$ 7,414
Common stock authorized (in shares)	5,000,000,000	5,000,000,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock issued (in shares)	2,358,630,709	2,352,430,301
Treasury stock (in shares)	112,316,990	83,452,554
Primary beneficiary | Cash and cash equivalents (variable interest entities restricted)
Pledged current assets	$ 109	$ 82
Primary beneficiary | Net property (variable interest entities restricted
Pledged noncurrent assets	718	734
Primary beneficiary | Long term debt VIE
Noncurrent Liabilities - nonrecourse	$ 43	$ 75

XML

Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Operating Activities
Net income	$ 571	$ 1,148
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
Depreciation and amortization	1,519	1,484
Credit for deferred income tax	(342)	(33)
Earnings of nonconsolidated affiliates less than dividends received	767	374
Net periodic pension benefit cost (credit)	(8)	31
Pension contributions	(153)	(378)
Net gain on sales of assets, businesses and investments	(43)	(35)
Restructuring and asset related charges - net	287	262
Amortization of Merger-related inventory step-up	205	703
Other net loss	94	269
Accounts and notes receivable	(1,643)	(3,143)
Inventories	(194)	(1,170)
Accounts payable	(732)	405
Other assets and liabilities, net	(302)	(2,054)
Cash provided by (used for) operating activities	26	(2,137)
Investing Activities
Capital expenditures	(1,139)	(776)
Investment in gas field developments	(25)	(28)
Proceeds from sales of property and businesses, net of cash divested	125	33
Proceeds from sale of ownership interests in nonconsolidated affiliates	21	0
Purchases of investments	(189)	(758)
Proceeds from sales and maturities of investments	212	1,376
Proceeds from interests in trade accounts receivable conduits	0	445
Other investing activities, net	(5)	(2)
Cash provided by (used for) investing activities	(1,000)	290
Financing Activities
Changes in short-term notes payable	798	196
Proceeds from issuance of long-term debt	1,000	253
Payments on long-term debt	(363)	(85)
Purchases of treasury stock	(1,579)	(1,000)
Proceeds from issuance of company stock	63	108
Transaction financing, debt issuance and other costs	(13)	0
Employee taxes paid for share-based payment arrangements	(76)	(103)
Distributions to noncontrolling interests	(11)	(27)
Dividends paid to stockholders	(851)	(880)
Other financing activities, net	0	(5)
Cash used for financing activities	(1,032)	(1,543)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	50	208
Decrease in cash, cash equivalents and restricted cash	(1,956)	(3,182)
Cash, cash equivalents and restricted cash at beginning of period	14,022	14,015
Cash, cash equivalents and restricted cash at end of period	12,066	10,833
Less: Restricted cash and cash equivalents, included in Other current assets	523	552
Cash and cash equivalents at end of period	$ 11,543	$ 10,281

XML

Consolidated Statements of Equity - USD ($) $ in Millions	Total	Common Stock	Add'l Paid in Capital	Retained Earnings	Total Accum Other Comp Loss	Unearned ESOP	Treasury Stock	Non-controlling Interests
Beginning balance at Dec. 31, 2017	$ 101,927	$ 23	$ 81,257	$ 29,211	$ (8,972)	$ (189)	$ (1,000)	$ 1,597
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Adoption of accounting standards	(41)			(61)	20
Net income available for DowDuPont Inc. common stockholders	1,104			1,104
Other comprehensive income	1,455				1,455
Dividends	(880)			(880)
Common stock issued/sold	108		108
Stock-based compensation and allocation of ESOP shares	192		153			39
Impact of noncontrolling interests	67							67
Treasury stock purchases	(1,000)						(1,000)
Other	(8)			(8)
Ending balance at Mar. 31, 2018	102,924	23	81,518	29,366	(7,497)	(150)	(2,000)	1,664
Beginning balance at Dec. 31, 2018	96,179	24	81,960	30,536	(12,394)	(134)	(5,421)	1,608
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Adoption of accounting standards	(111)			(111)
Net income available for DowDuPont Inc. common stockholders	520			520
Other comprehensive income	30				30
Dividends	(1,176)			(1,176)
Common stock issued/sold	63		63
Stock-based compensation and allocation of ESOP shares	131		102			29
Impact of noncontrolling interests	46							46
Treasury stock purchases	(1,579)						(1,579)
Other	(5)			(5)
Ending balance at Mar. 31, 2019	$ 94,098	$ 24	$ 82,125	$ 29,764	$ (12,364)	$ (105)	$ (7,000)	$ 1,654

XML

Consolidated Statements of Equity (Parentheticals) - $ / shares	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Statement of Stockholders' Equity [Abstract]
Common stock dividends (in dollars per share)	$ 0.52	$ 0.38

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Notes)

3 Months Ended

Mar. 31, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Significant Accounting Policies [Text Block]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Interim Financial Statements

The accompanying unaudited interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, the interim consolidated financial statements reflect all adjustments (including normal recurring accruals) which are considered necessary for the fair statement of the results for the periods presented. Results from interim periods should not be considered indicative of results for the full year. These interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. The interim consolidated financial statements include the accounts of the Company and all of its subsidiaries in which a controlling interest is maintained.

Basis of Presentation

Effective August 31, 2017, pursuant to the merger of equals transaction contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 ("Merger Agreement"), The Dow Chemical Company ("Historical Dow") and E. I. du Pont de Nemours and Company ("Historical DuPont") each merged with subsidiaries of DowDuPont and, as a result, Historical Dow and Historical DuPont became subsidiaries of DowDuPont (the "Merger"). Prior to the Merger, DowDuPont did not conduct any business activities other than those required for its formation and matters contemplated by the Merger Agreement. Historical Dow was determined to be the accounting acquirer in the Merger.

Except as otherwise indicated by the context, the term "Historical Dow" includes Historical Dow and its consolidated subsidiaries, "Historical DuPont" includes Historical DuPont and its consolidated subsidiaries, "Union Carbide" means Union Carbide Corporation, a wholly owned subsidiary of Historical Dow, and "Dow Silicones" means Dow Silicones Corporation, a wholly owned subsidiary of Historical Dow.

Significant Accounting Policies

The Company updated its accounting policy for leases since the issuance of its Annual Report on Form 10-K for the year ended December 31, 2018 as a result of the adoption of Accounting Standards Update ("ASU") 2016-02, "Leases (Topic 842)" in the first quarter of 2019. See Notes 2 and 15 for additional information. See Note 1, "Summary of Significant Accounting Policies," to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2018 for more information on DowDuPont's other significant accounting policies.

Leases

The Company determines whether an arrangement is a lease at the inception of the arrangement based on the terms and conditions in the contract. A contract contains a lease if there is an identified asset and the Company has the right to control the asset. Operating lease right-of-use ("ROU") assets are included in "Deferred charges and other assets" on the consolidated balance sheets. Operating lease liabilities are included in "Accrued and other current liabilities" and "Other noncurrent obligations" on the consolidated balance sheets. Finance lease ROU assets are included in "Property" and the corresponding lease liabilities are included in "Long-term debt due within one year" and "Long-term debt" on the consolidated balance sheets.  

ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide the lessor's implicit rate, the Company uses its incremental borrowing rate at the commencement date in determining the present value of lease payments. Lease terms include options to extend the lease when it is reasonably certain those options will be exercised. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and lease expense is recognized on a straight-line basis over the lease term.

The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component for all asset classes. Additionally, for certain equipment leases, the portfolio approach is applied to account for the operating lease ROU assets and lease liabilities. In the consolidated statements of income, lease expense for operating lease payments is recognized on a straight-line basis over the lease term. For finance leases, interest expense is recognized on the lease liability and the ROU asset is amortized over the lease term.

XML

RECENT ACCOUNTING GUIDANCE

3 Months Ended

Mar. 31, 2019

Accounting Changes and Error Corrections [Abstract]

RECENT ACCOUNTING GUIDANCE

RECENT ACCOUNTING GUIDANCE

Recently Adopted Accounting Guidance

In February 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-02, "Leases (Topic 842)," and associated ASUs related to Topic 842, which requires organizations that lease assets to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. The new guidance requires that a lessee recognize assets and liabilities for leases, and recognition, presentation and measurement in the financial statements will depend on its classification as a finance or operating lease. In addition, the new guidance requires disclosures to help investors and other financial statement users better understand the amount, timing and uncertainty of cash flows arising from leases. Lessor accounting remains largely unchanged from legacy U.S. GAAP but does contain some targeted improvements to align with the new revenue recognition guidance, "Revenue from Contracts with Customers (Topic 606)," issued in 2014.

The Company adopted the new standard in the first quarter of 2019, which allows for a modified retrospective transition approach, applying the new standard to all leases existing at the date of initial adoption. An entity may choose to use either (1) its effective date or (2) the beginning of the earliest comparative period presented in the financial statement as its date of initial application. The Company has elected to apply the transition requirements at the January 1, 2019 effective date rather than at the beginning of the earliest comparative period presented. This approach allows for a cumulative effect adjustment in the period of adoption, and prior periods are not restated and continue to be reported in accordance with historic accounting under ASC 840 "Leases". In addition, the Company has elected the package of practical expedients permitted under the transition guidance within the new standard which does not require reassessment of prior conclusions related to contracts containing a lease, lease classification and initial direct lease costs. As an accounting policy election, the Company chose to not apply the standard to certain existing land easements, excluded short-term leases (term of 12 months or less) from the balance sheet and accounts for nonlease and lease components in a contract as a single component for all asset classes. The following table summarizes the impact of adoption to the consolidated balance sheet:

Summary of Changes to the Consolidated Balance Sheet	As Reported Dec 31, 2018		Effect of Adoption of ASU 2016-02			Updated Jan 1, 2019
In millions
Assets
Net property	$	35,848	$	9		$	35,857
Deferred income tax assets	$	1,724	$	(24	)	$	1,700
Deferred charges and other assets	$	2,476	$	3,386		$	5,862
Total other assets	$	94,197	$	3,362		$	97,559
Total Assets	$	188,030	$	3,371		$	191,401
Liabilities
Long-term debt due within one year	$	637	$	1		$	638
Accrued and other current liabilities	$	7,943	$	721		$	8,664
Total current liabilities	$	24,715	$	722		$	25,437
Long-Term Debt	$	37,662	$	8		$	37,670
Other noncurrent obligations	$	6,988	$	2,569		$	9,557
Total other noncurrent liabilities	$	29,474	$	2,569		$	32,043
Stockholders' Equity
Retained earnings 1	$	30,536	$	72		$	30,608
DowDuPont's stockholders' equity	$	94,571	$	72		$	94,643
Total equity	$	96,179	$	72		$	96,251
Total Liabilities and Equity	$	188,030	$	3,371		$	191,401

1. The net impact to retained earnings was primarily a result of the recognition of a deferred gain associated with a prior sale-leaseback transaction.

The adoption of the new guidance did not have a material impact on the Company's consolidated statement of income and had no impact on the consolidation statement of cash flows.

Accounting Guidance Issued But Not Adopted at March 31, 2019

In August 2018, the FASB issued ASU 2018-13, "Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement," which is part of the FASB disclosure framework project to improve the effectiveness of disclosures in the notes to the financial statements. The amendments in the new guidance remove, modify and add certain disclosure requirements related to fair value measurements covered in ASC 820, "Fair Value Measurement." The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted for either the entire standard or only the requirements that modify or eliminate the disclosure requirements, with certain requirements applied prospectively, and all other requirements applied retrospectively to all periods presented. The Company is currently evaluating the impact of adopting this guidance.

In August 2018, the FASB issued ASU 2018-15, "Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract," which requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in ASC 350, "Intangibles - Goodwill and Other" to determine which implementation costs to capitalize as assets or expense as incurred. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted and an entity can elect to apply the new guidance on a prospective or retrospective basis. The Company is currently evaluating the impact of adopting this guidance.

XML

INTENDED BUSINESS SEPARATIONS

3 Months Ended

Mar. 31, 2019

Business Combinations [Abstract]

Intended Business Separations

INTENDED BUSINESS SEPARATIONS

As discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, DowDuPont previously announced its intent to separate into three independent publicly traded companies - one for each of its agriculture, materials science and specialty products businesses (the “Intended Business Separations” and the transactions to accomplish the Intended Business Separations, the “separations”). DowDuPont formed two wholly owned subsidiaries: Dow Inc. ("Dow", formerly known as Dow Holdings Inc.), to serve as a holding company for its materials science business, and Corteva, Inc., to serve as a holding company for its agriculture business. Following the separations, DowDuPont will continue to hold the specialty products business and operate as "DuPont".

Effective as of 5:00 p.m. on April 1, 2019, DowDuPont completed the distribution of Dow. DowDuPont expects to complete the intended separation of Corteva on June 1, 2019. See Note 24 for additional information.

Integration and Separation Costs

The Company incurred "Integration and separation costs," of $813 million and $457 million for the three months ended March 31, 2019 and 2018, respectively, recorded in the consolidated statements of income. These costs primarily consisted of financial advisory, information technology, legal, accounting, consulting, and other professional advisory fees associated with the preparation and execution of activities related to the Merger, post-merger integration and separation, and the ownership restructure of Dow Silicones. Integration and separation costs related to post-Merger integration and Intended Business Separation activities are expected to continue to be significant throughout 2019.

XML

REVENUE

3 Months Ended

Mar. 31, 2019

Revenue from Contract with Customer [Abstract]

Revenue from Contract with Customer [Text Block]

REVENUE

Revenue Recognition

The majority of the Company's revenue is derived from product sales. In the three months ended March 31, 2019, 98 percent of the Company's sales related to product sales (98 percent in the three months ended March 31, 2018) with the remaining balance primarily related to licensing of patents and technologies and Historical Dow's insurance operations. Product sales consist of sales of the Company's products to manufacturers, distributors and farmers and considers order confirmations or purchase orders, which in some cases are governed by master supply agreements, to be contracts with a customer. The Company enters into licensing arrangements in which it licenses certain rights of its patents and technology to customers. Revenue from the Company's licenses for patents and technology is derived from sales-based royalties and licensing arrangements based on billing schedules established in each contract.

Remaining Performance Obligations

Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. At March 31, 2019, the Company had remaining performance obligations related to material rights granted to customers for contract renewal options of $100 million ($102 million at December 31, 2018) and unfulfilled performance obligations for the licensing of technology of $519 million ($407 million at December 31, 2018). The Company expects revenue to be recognized for the remaining performance obligations over the next one to six years.

The remaining performance obligations are for product sales that have expected durations of one year or less, product sales of materials delivered through a pipeline for which the Company has elected the right to invoice practical expedient, or variable consideration attributable to royalties for licenses of patents and technology. The Company has received advance payments from customers related to long-term supply agreements and royalty payments that are deferred and recognized over the life of the contract, with remaining contract terms that range up to 22 years. The Company will have rights to future consideration for revenue recognized when product is delivered to the customer. These payments are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets.

Disaggregation of Revenue

The Company disaggregates its revenue from contracts with customers by segment and business or major product line and geographic region, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows.

Net Trade Sales by Segment and Business or Major Product Line 1	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
Crop Protection	$	1,425	$	1,495
Seed	1,972		2,313
Agriculture	$	3,397	$	3,808
Coatings & Performance Monomers	$	890	$	941
Consumer Solutions	1,365		1,363
Performance Materials & Coatings	$	2,255	$	2,304
Industrial Solutions	$	1,103	$	1,155
Polyurethanes & CAV	2,296		2,556
Other	3		4
Industrial Intermediates & Infrastructure	$	3,402	$	3,715
Hydrocarbons & Energy	$	1,380	$	1,800
Packaging and Specialty Plastics	3,730		4,210
Packaging & Specialty Plastics	$	5,110	$	6,010
Advanced Printing	$	119	$	122
Display Technologies	84		60
Interconnect Solutions	238		281
Photovoltaic & Advanced Materials	254		289
Semiconductor Technologies	383		401
Electronics & Imaging	$	1,078	$	1,153
Industrial Biosciences	$	494	$	541
Nutrition & Health	1,165		1,179
Nutrition & Biosciences	$	1,659	$	1,720
Engineering Polymers	$	663	$	668
Performance Resins	308		351
Performance Solutions	384		406
Transportation & Advanced Polymers	$	1,355	$	1,425
Aramids	$	424	$	393
Construction	327		385
TYVEK® Enterprise	310		292
Water Solutions	261		229
Safety & Construction	$	1,322	$	1,299
Corporate	$	71	$	76
Total	$	19,649	$	21,510

1. Beginning in the third quarter of 2018, DowDuPont realigned certain global businesses and product lines in preparation for the Intended Business Separations. These changes have been retrospectively reflected in the results presented.

Net Trade Sales by Geographic Region	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
U.S. & Canada	$	7,014	$	7,909
EMEA 1	6,269		6,919
Asia Pacific	4,639		4,790
Latin America	1,727		1,892
Total	$	19,649	$	21,510

1. Europe, Middle East and Africa.

Contract Balances

The Company receives payments from customers based upon contractual billing schedules. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets include amounts related to the Company’s contractual right to consideration for completed performance obligations not yet invoiced. Contract liabilities include payments received in advance of performance under the contract and are realized when the associated revenue is recognized under the contract. "Contract liabilities - current" primarily reflects deferred revenue from prepayments in the Agriculture segment for contracts with customers where the Company receives advance payments for product to be delivered in future periods. "Contract liabilities - noncurrent" includes advance payment for product that the Company has received from customers related to long-term supply agreements and royalty payments that are deferred and recognized over the life of the contract. The Company classifies deferred revenue as current (12 months or less) or noncurrent based on the timing of when the Company expects to recognize revenue.

Revenue recognized in the first three months of 2019 from amounts included in contract liabilities at the beginning of the period was approximately $525 million (approximately $640 million in the first three months of 2018). The increase in contract liabilities from December 31, 2018 to March 31, 2019 was primarily due to advanced payments received from customers for product supply agreements related to Agriculture and one customer related to Packaging & Specialty Plastics, partially offset by Agriculture seed deliveries to customers for the North America growing season, which were delayed due to weather conditions. In the first three months of 2019, the amount of contract assets reclassified to receivables as a result of the right to the transaction consideration becoming unconditional was insignificant (insignificant in the first three months of 2018). The Company did not recognize any asset impairment charges related to contract assets during the period.

Contract Balances	Mar 31, 2019		Dec 31, 2018
In millions
Accounts and notes receivable - Trade	$	13,963	$	12,376
Contract assets - current 1	$	62	$	85
Contract assets - noncurrent 2	$	47	$	47
Contract liabilities - current 3	$	2,266	$	2,092
Contract liabilities - noncurrent 4	$	1,767	$	1,420

1. Included in "Other current assets" in the consolidated balance sheets.

2. Included in "Deferred charges and other assets" in the consolidated balance sheets.

3. Included in "Accrued and other current liabilities" in the consolidated balance sheets.

4. Included in "Other noncurrent obligations" in the consolidated balance sheets.

XML

RESTRUCTURING AND ASSET RELATED CHARGES - NET

3 Months Ended

Mar. 31, 2019

Restructuring and Related Activities [Abstract]

RESTRUCTURING AND ASSET RELATED CHARGES

RESTRUCTURING AND ASSET RELATED CHARGES - NET

Charges for restructuring programs and other asset related charges, which includes other asset impairments, were $287 million for the three months ended March 31, 2019 ($262 million for the three months ended March 31, 2018). These charges were recorded in "Restructuring and asset related charges - net" in the consolidated statements of income and consist primarily of the following:

DowDuPont Cost Synergy Program

In September and November 2017, DowDuPont approved post-merger restructuring actions under the DowDuPont Cost Synergy Program (the “Synergy Program”), which was designed to integrate and optimize the organization following the Merger and in preparation for the Intended Business Separations. The Company expects to record total pretax restructuring charges of approximately $2,200 million of which the Company recorded pretax restructuring charges of $2,027 million inception-to-date, consisting of severance and related benefit costs of $1,045 million, asset write-downs and write-offs of $695 million and costs associated with exit and disposal activities of $287 million.

For the three months ended March 31, 2019, the Company recorded pretax restructuring charges of $280 million of which $279 million was recorded in "Restructuring and asset related charges - net" and $1 million was recorded in "Equity in earnings of nonconsolidated affiliates" in the consolidated statements of income. The charge for the three months ended March 31, 2019 consisted of severance and related benefit costs of $112 million, asset write-downs and write-offs of $116 million, and costs associated with exit and disposal activities of $52 million. For the three months ended March 31, 2018, the Company recorded pretax restructuring charges of $260 million in "Restructuring and asset related charges - net." The charge for the three months ended March 31, 2018 consisted of severance and related benefit costs of $172 million, asset write-downs and write-offs of $48 million and costs associated with exit and disposal activities of $40 million. The Company expects to substantially complete the Synergy Program by the end of 2019.

The following table summarizes the activities related to the Synergy Program. At March 31, 2019, $464 million was included in "Accrued and other current liabilities" ($490 million at December 31, 2018) and $99 million was included in "Other noncurrent obligations" ($84 million at December 31, 2018) in the consolidated balance sheets.

Synergy Program	Severance and Related Benefit Costs			Asset Write-downs and Write-offs			Costs Associated with Exit and Disposal Activities			Total
In millions
Reserve balance at Dec 31, 2018	$	491		$	—		$	83		$	574
2019 restructuring charges	112			116			52			280
Charges against the reserve	—			(115		)	—			(115		)
Cash payments	(140		)	—			(36		)	(176		)
Reserve balance at Mar 31, 2019	$	463		$	1		$	99		$	563

Restructuring charges recorded for severance and related benefit costs were related to Corporate. The Company recorded $116 million of restructuring charges for asset write-downs and write-offs for the three months ended March 31, 2019, related to Nutrition & Biosciences ($10 million), Agriculture ($28 million), Safety & Construction ($2 million) Transportation & Advanced Polymers ($1 million), Packaging & Specialty Plastics ($1 million) and Corporate ($74 million). The asset write-downs and write-offs primarily related to the impairment of leased, non-manufacturing facilities and the write down of inventory.

The Company recorded restructuring charges of $52 million for costs associated with exit and disposal activities for the three months ended March 31, 2019, related to Agriculture ($19 million), Nutrition & Biosciences ($18 million) and Corporate ($15 million).

The Company expects to incur additional costs in the future related to its restructuring activities. Future costs are expected to include demolition costs related to closed facilities and restructuring plan implementation costs which will be recognized as incurred. The Company also expects to incur additional employee-related costs, including involuntary termination benefits, related to its other optimization activities. These costs cannot be reasonably estimated at this time.

DowDuPont Agriculture Division Restructuring Program

During the fourth quarter of 2018 and in connection with the ongoing integration activities, DowDuPont approved restructuring actions to simplify and optimize certain organizational structures within the Agriculture segment in preparation for the Intended Business Separations ("Agriculture Division Program"). As a result of these actions, the Company expects to record total pretax charges of approximately $96 million, comprised of $83 million of severance and related benefit costs, $11 million of asset write-downs and write-offs and $2 million of costs associated with exit and disposal activities.

For the three months ended March 31, 2019, DowDuPont recorded a net pretax restructuring benefit of $1 million, consisting of a favorable adjustment of $4 million to the severance and related benefit costs reserve and asset write-downs and write-offs of $3 million. The impact of these items are shown as "Restructuring and asset related charges - net" in the consolidated statements of income. The Company expects actions related to the Agriculture Division Program to be substantially complete by mid 2019.

The Company recorded pretax restructuring charges of $83 million inception-to-date under the Agriculture Division Program, consisting of severance and related benefit costs of $74 million and asset write-downs and write-offs of $9 million.

The following table summarizes the activities related to the Agriculture Division Program. At March 31, 2019, $58 million ($77 million at December 31, 2018) was included in "Accrued and other current liabilities" in the consolidated balance sheets.

Agriculture Division Program	Severance and Related Benefit Costs			Asset Write-downs and Write-offs			Total
(In millions)
Reserve balance at Dec 31, 2018	$	77		$	—		$	77
2019 restructuring charges and adjustments 1	(4		)	3			(1		)
Charges against the reserve	—			(3		)	(3		)
Cash payments	(15		)	—			(15		)
Reserve balance at Mar 31, 2019	$	58		$	—		$	58

1. Included in "Restructuring and asset related charges - net" in the consolidated statements of income.

Restructuring adjustments recorded for severance and related benefit costs and charges recorded for asset write-downs and write‑offs were related to Corporate and Agriculture, respectively.

XML

SUPPLEMENTARY INFORMATION

3 Months Ended

Mar. 31, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION

The Company uses "Sundry income (expense) – net" to record a variety of income and expense items such as foreign currency exchange gains and losses, interest income, dividends from investments, gains and losses on sales of investments and other assets, non-operating pension and other postretirement benefit plan credits or costs, and certain litigation matters. For the three months ended March 31, 2019, "Sundry income (expense) - net" was income of $248 million (income of $115 million for the three months ended March 31, 2018).

The following table provides the most significant transactions recorded in "Sundry income (expense) - net" for the three months ended March 31, 2019 and 2018:

Sundry Income (Expense) - Net	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Non-operating pension and other postretirement benefit plan net credit	$	108		$	110
Interest income	$	75		$	55
Gains on sales of other assets and investments, net 1	$	50		$	34
Foreign exchange losses, net 2	$	(11	)	$	(148	)

1. Includes a $51 million gain related to a sale of assets by Historical DuPont and $24 million loss related to Historical Dow's sale of a joint venture in the first quarter of 2019. Includes a $20 million gain in the first quarter of 2018 related to Historical Dow's sale of its equity interest in MEGlobal.

2. Includes a $50 million foreign exchange loss in the first quarter of 2018 related to adjustments to Historical DuPont's foreign currency exchange contracts as a result of U.S. tax reform.

Cash, Cash Equivalents and Restricted Cash

The Company is required to set aside funds for various activities that arise in the normal course of business including, but not limited to, insurance contracts, legal matters and other agreements. These funds typically have legal restrictions associated with them and are deposited in an escrow account or held in a separately identifiable account by the Company. At March 31, 2019, the Company had restricted cash of $523 million ($540 million at December 31, 2018), included in "Other current assets" in the consolidated balance sheets.

Historical DuPont entered into a trust agreement in 2013 (as amended and restated in 2017), establishing and requiring Historical DuPont to fund a trust (the "Trust") for cash obligations under certain non-qualified benefit and deferred compensation plans upon a change in control event as defined in the Trust agreement. Under the Trust agreement, the consummation of the Merger was a change in control event. At March 31, 2019, $480 million of the restricted cash balance was related to the Trust ($500 million at December 31, 2018).

XML

INCOME TAXES

3 Months Ended

Mar. 31, 2019

Income Tax Disclosure [Abstract]

INCOME TAXES

INCOME TAXES

On December 22, 2017, the Tax Cuts and Jobs Act (“The Act”) was enacted. The Act reduces the U.S. federal corporate income tax rate from 35 percent to 21 percent, requires companies to pay a one-time transition tax on earnings of foreign subsidiaries that were previously tax deferred, creates new provisions related to foreign sourced earnings, eliminates the domestic manufacturing deduction and moves towards a territorial system. At December 31, 2018, the Company had completed its accounting for the tax effects of The Act.

• As a result of The Act, the Company remeasured its U.S. federal deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which is generally 21 percent. In the first quarter of 2018, the Company recorded a charge of $17 million to “Provision for income taxes on continuing operations" in the consolidated statements of income to adjust the provisional amount related to the remeasurement of the Company's deferred tax balance.

• In the first quarter of 2018, the Company recorded an indirect impact of The Act related to prepaid tax on the intercompany sale of inventory. The amount recorded related to the inventory was a $54 million charge to "Provision for income taxes on continuing operations."

During the first and second quarters of 2019, in connection with the Intended Business Separations, the Company has and expects to continue repatriating certain funds from its foreign subsidiaries that are not needed to finance local operations or separation activities. During the three months ended March 31, 2019, the Company recorded a tax charge of $13 million associated with these repatriation activities to "Provision for income taxes on continuing operations." Beyond these expected repatriations, the Company is still asserting indefinite reinvestment related to certain investments in foreign subsidiaries.

Each year the Company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. Positions challenged by the tax authorities may be settled or appealed by the Company. As a result, there is an uncertainty in income taxes recognized in the Company’s financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. The ultimate resolution of such uncertainties is not expected to have a material impact on the Company's results of operations.

XML

EARNINGS PER SHARE CALCULATIONS

3 Months Ended

Mar. 31, 2019

Earnings Per Share [Abstract]

EARNINGS PER SHARE CALCULATIONS

EARNINGS PER SHARE CALCULATIONS

The following tables provide earnings per share calculations for the three months ended March 31, 2019 and 2018:

Net Income for Earnings Per Share Calculations - Basic	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Income from continuing operations, net of tax	$	571		$	1,153
Net income attributable to noncontrolling interests	(51		)	(44		)
Net income attributable to participating securities 1	(1		)	(6		)
Income from continuing operations attributable to common stockholders	$	519		$	1,103
Loss from discontinued operations, net of tax	—			(5		)
Net income attributable to common stockholders	$	519		$	1,098

Earnings Per Share Calculations - Basic	Three Months Ended
	Mar 31, 2019		Mar 31, 2018
Dollars per share
Income from continuing operations attributable to common stockholders	$	0.23	$	0.47
Loss from discontinued operations, net of tax	—		—
Net income attributable to common stockholders	$	0.23	$	0.47

Net Income for Earnings Per Share Calculations - Diluted	Three Months Ended
	Mar 31, 2019			Mar 31, 2018
In millions
Income from continuing operations, net of tax	$	571		$	1,153
Net income attributable to noncontrolling interests	(51		)	(44		)
Net income attributable to participating securities 1	(1		)	(6		)
Income from continuing operations attributable to common stockholders	$	519		$	1,103
Loss from discontinued operations, net of tax	—			(5		)
Net income attributable to common stockholders	$	519		$	1,098

Earnings Per Share Calculations - Diluted	Three Months Ended
	Mar 31, 2019		Mar 31, 2018
Dollars per share
Income from continuing operations attributable to common stockholders	$	0.23	$	0.47
Loss from discontinued operations, net of tax	—		—
Net income attributable to common stockholders	$	0.23	$	0.47

Share Count Information	Three Months Ended
	Mar 31, 2019	Mar 31, 2018
Shares in millions
Weighted-average common shares - basic	2,250.1	2,317.0
Plus dilutive effect of equity compensation plans	9.1	17.3
Weighted-average common shares - diluted	2,259.2	2,334.3
Stock options and restricted stock units excluded from EPS calculations 2	19.2	5.3

1. Historical Dow restricted stock units are considered participating securities due to Historical Dow's practice of paying dividend equivalents on unvested shares.

2. These outstanding options to purchase shares of common stock and restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

XML

INVENTORIES

3 Months Ended

Mar. 31, 2019

Inventory Disclosure [Abstract]

INVENTORIES

INVENTORIES

The following table provides a breakdown of inventories:

Inventories	Mar 31, 2019		Dec 31, 2018
In millions
Finished goods	$	10,060	$	9,814
Work in process	3,561		3,969
Raw materials	1,461		1,419
Supplies	1,276		1,321
Total	$	16,358	$	16,523
Adjustment of inventories to a LIFO basis	246		98
Total inventories	$	16,604	$	16,621

XML

NONCONSOLIDATED AFFILIATES (Notes)

3 Months Ended

Mar. 31, 2019

Equity Method Investments and Joint Ventures [Abstract]

NONCONSOLIDATED AFFILIATES

NONCONSOLIDATED AFFILIATES

The Company's investments in companies accounted for using the equity method ("nonconsolidated affiliates"), by classification in the consolidated balance sheets, are shown in the following table:

Investments in Nonconsolidated Affiliates	Mar 31, 2019			Dec 31, 2018
In millions
Investment in nonconsolidated affiliates	$	4,687		$	5,204
Accrued and other current liabilities	(81		)	(81		)
Other noncurrent obligations	(870		)	(495		)
Net investment in nonconsolidated affiliates	$	3,736		$	4,628

HSC Group

The carrying value of the Company's investments in the HSC Group, which includes Hemlock Semiconductor L.L.C. and DC HSC Holdings LLC, was adjusted as a result of the HSC Group's adoption of Topic 606. The resulting impact to the Company's investments in the HSC Group was a reduction to "Investment in nonconsolidated affiliates" of $71 million and an increase to "Other noncurrent obligations" of $168 million, as well as an increase to "Deferred income tax assets" of $56 million and a reduction to "Retained earnings" of $183 million in the consolidated balance sheet at January 1, 2019. The following table reflects the carrying value of the HSC Group investments at March 31, 2019 and December 31, 2018:

Investment in the HSC Group		Investment
In millions	Balance Sheet Classification	Mar 31, 2019			Dec 31, 2018
Hemlock Semiconductor L.L.C.	Other noncurrent obligations	$	(658	)	$	(495	)
DC HSC Holdings LLC	Investment in nonconsolidated affiliates	$	485		$	535

EQUATE

In the first quarter of 2019, EQUATE Petrochemical Company K.S.C.C. ("EQUATE") paid a dividend of $440 million, reflected in "Earnings of nonconsolidated affiliates less than dividends received" in the consolidated statements of cash flows. As a result, the Company had a negative investment balance in EQUATE of $212 million at March 31, 2019, classified as "Other noncurrent obligations" in the consolidated balance sheets. At December 31, 2018, the Company had an investment balance in EQUATE of $131 million, classified as "Investment in nonconsolidated affiliates" in the consolidated balance sheets.

XML

GOODWILL AND OTHER INTANGIBLE ASSETS

3 Months Ended

Mar. 31, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND OTHER INTANGIBLE ASSETS

GOODWILL AND OTHER INTANGIBLE ASSETS

The following table reflects the carrying amounts of goodwill by reportable segment: 

Goodwill	Agri-culture		Perf. Materials & Coatings			Ind. Interm. & Infrast.			Pack. & Spec. Plastics			Elect. & Imaging			Nutrition & Biosciences			Transp. & Adv. Polymers			Safety & Const.			Total
In millions
Net goodwill at Dec 31, 2018	$	14,689	$	3,650		$	1,096		$	5,101		$	8,188		$	12,643		$	6,967		$	6,698		$	59,032
Foreign currency impact	11		(20		)	(2		)	(7		)	(3		)	(29		)	(15		)	(19		)	(84		)
Net goodwill at Mar 31, 2019	$	14,700	$	3,630		$	1,094		$	5,094		$	8,185		$	12,614		$	6,952		$	6,679		$	58,948

Other Intangible Assets

The following table provides information regarding the Company's other intangible assets:

Other Intangible Assets	Mar 31, 2019							Dec 31, 2018
In millions	Gross Carrying Amount		Accum Amort			Net		Gross Carrying Amount		Accum Amort			Net
Intangible assets with finite lives:
Developed technology 1	$	8,179	$	(2,731	)	$	5,448	$	7,761	$	(2,562	)	$	5,199
Software	1,539		(900		)	639		1,529		(876		)	653
Trademarks/tradenames	1,763		(773		)	990		1,772		(745		)	1,027
Customer-related	14,208		(3,095		)	11,113		14,236		(2,895		)	11,341
Microbial cell factories	384		(26		)	358		386		(22		)	364
Favorable supply contracts	493		(136		)	357		475		(111		)	364
Other 2	612		(204		)	408		620		(203		)	417
Total other intangible assets with finite lives	$	27,178	$	(7,865	)	$	19,313	$	26,779	$	(7,414	)	$	19,365
Intangible assets with indefinite lives:
IPR&D 1	149		—			149		594		—			594
Germplasm 3	6,265		—			6,265		6,265		—			6,265
Trademarks/tradenames	4,740		—			4,740		4,741		—			4,741
Total other intangible assets	$	38,332	$	(7,865	)	$	30,467	$	38,379	$	(7,414	)	$	30,965

1. During the first quarter of 2019, Historical DuPont announced an expanded launch of its Qrome® corn hybrids following the receipt of regulatory approval from China. As a result, Historical DuPont reclassified the amounts from indefinite-lived IPR&D to developed technology.

2. Primarily consists of sales and grower networks, marketing and manufacturing alliances and noncompetition agreements.

3. Germplasm is the pool of genetic source material and body of knowledge gained from the development and delivery stage of plant breeding. This intangible asset is expected to contribute to cash flows beyond the foreseeable future and there are no legal, regulatory, contractual or other factors which limit its useful life.

The following table provides information regarding amortization expense related to other intangible assets:

Amortization Expense	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
Other intangible assets, excluding software	$	474	$	474
Software, included in "Cost of sales"	$	25	$	23

Total estimated amortization expense for 2019 and the five succeeding fiscal years is as follows:

Estimated Amortization Expense
In millions
2019	$	2,008
2020	$	1,893
2021	$	1,851
2022	$	1,760
2023	$	1,612
2024	$	1,500

XML

TRANSFERS OF FINANCIAL ASSETS

3 Months Ended

Mar. 31, 2019

Transfers and Servicing [Abstract]

TRANSFERS OF FINANCIAL ASSETS

TRANSFERS OF FINANCIAL ASSETS

Historical Dow sold trade accounts receivable of select North American entities and qualifying trade accounts receivable of select European entities on a revolving basis to certain multi-seller commercial paper conduit entities ("conduits"). The proceeds received were comprised of cash and interests in specified assets of the conduits (the receivables sold by Historical Dow) that entitled Historical Dow to the residual cash flows of such specified assets in the conduits after the commercial paper was repaid. Neither the conduits nor the investors in those entities had recourse to other assets of Historical Dow in the event of nonpayment by the debtors.

In the fourth quarter of 2017, the Company suspended further sales of trade accounts receivable through these facilities and began reducing outstanding balances through collections of trade accounts receivable previously sold to such conduits. In September and October 2018, the North American and European facilities, respectively, were amended and the terms of the agreements changed from off-balance sheet arrangements to secured borrowing arrangements. See Note 13 for additional information on the secured borrowing arrangements.

The following represents the cash flows between Historical Dow and the conduits:

Cash Proceeds	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
Interests in conduits 1	$	—	$	445

1. Presented in "Investing Activities" in the consolidated statements of cash flows.

XML

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES

3 Months Ended

Mar. 31, 2019

Debt Disclosure [Abstract]

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES

A summary of Historical Dow's and Historical DuPont's notes payable, long-term debt and available credit facilities can be found in Note 15 to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. If applicable, updates have been included in the respective section below.

2019 Activity

In the first three months of 2019, Historical Dow redeemed an aggregate principal amount of $72 million of International Notes at maturity.

In March 2019, Historical DuPont fully repaid $262 million of 5.75 percent coupon bonds at maturity.

DowDuPont Notes

In contemplation of the separations and distributions and in preparation to achieve the intended credit profiles of Corteva, Dow and DuPont, in the fourth quarter of 2018, DowDuPont consummated a public underwritten offer of eight series of senior unsecured notes (the "DowDuPont Notes") in an aggregate principal amount of $12.7 billion. The DowDuPont Notes are a senior unsecured obligation of the Company and will rank equally with the Company's future senior unsecured debt outstanding from time to time. On November 1, 2018, the Company announced a $3.0 billion share buyback program, which expired on March 31, 2019. In the first quarter of 2019, proceeds from the DowDuPont Notes were used to purchase $1.6 billion of shares. As a result, the share buyback program was complete at March 31, 2019.

Historical Dow Committed Credit Facilities

On March 9, 2019, Historical Dow renewed a $100 million Bilateral Revolving Credit Facility agreement, which has a maturity date in March 2020 and provides for interest at floating rates, as defined in the agreement.

Historical Dow Term Loan Facility

In connection with the ownership restructure of Dow Silicones on May 31, 2016, Dow Silicones incurred $4.5 billion of indebtedness under a certain third party credit agreement ("Historical Dow Term Loan Facility"). Historical Dow subsequently guaranteed the obligations of Dow Silicones under the Historical Dow Term Loan Facility and, as a result, the covenants and events of default applicable to the Historical Dow Term Loan Facility are substantially similar to the covenants and events of default set forth in Historical Dow's Five Year Competitive Advance and Revolving Credit Facility. In the second quarter of 2018, Dow Silicones exercised the 19 month extension option making amounts borrowed under the Historical Dow Term Loan Facility repayable on December 30, 2019. In addition, Dow Silicones amended the Historical Dow Term Loan Facility to include an additional two-year extension option, at Dow Silicones' election, upon satisfaction of certain customary conditions precedent. On April 5, 2019, Dow Silicones voluntarily repaid $2.0 billion of principal, which was classified as "Long-term debt due within one year" in the consolidated balance sheets at March 31, 2019. Dow Silicones also intends to exercise the two-year extension option on the remaining principal balance of $2.5 billion.

Historical DuPont Term Loan and Revolving Credit Facilities

In March 2016, Historical DuPont entered into a credit agreement that provides for a three-year, senior unsecured term loan facility in the aggregate principal amount of $4.5 billion (as may be amended, from time to time, the "Historical DuPont Term Loan Facility") under which Historical DuPont may make up to seven term loan borrowings and amounts repaid or prepaid are not available for subsequent borrowings. The proceeds from the borrowings under the Historical DuPont Term Loan Facility were used for Historical DuPont's general corporate purposes including debt repayment, working capital and funding a portion of the Company's costs and expenses. At March 31, 2019, Historical DuPont had made six term loan borrowings in an aggregate principal amount of $3.0 billion and had unused commitments of $1.5 billion under the Historical DuPont Term Loan Facility. See Note 24 for further discussion on the repayment of the Historical DuPont Term Loan Facility in May 2019.

Historical DuPont Repurchase Facility

In February 2019, Historical DuPont entered into a new committed receivable repurchase facility of up to $1,300 million (the "2019 Repurchase Facility") which expires in December 2019. Under the 2019 Repurchase Facility, Historical DuPont may sell a portfolio of available and eligible outstanding customer notes receivables within the Agriculture segment to participating institutions and simultaneously agree to repurchase at a future date. The 2019 Repurchase Facility is considered a secured borrowing with the customer notes receivable inclusive of those that are sold and repurchased, equal to 105 percent of the outstanding amounts borrowed utilized as collateral. Borrowings under the 2019 Repurchase Facility have an interest rate of LIBOR plus 0.75 percent.

At March 31, 2019, $20 million of notes receivable, recorded in "Accounts and notes receivable - Trade," were pledged as collateral against outstanding borrowings under the 2019 Repurchase Facility of $19 million, recorded in "Notes payable" in the consolidated balance sheets.

Debt Covenants and Default Provisions

There were no material changes to the debt covenants and default provisions related to DowDuPont's, Historical Dow's and Historical DuPont's outstanding Notes, long-term debt and primary, private credit agreements for the three months ended March 31, 2019.

See Note 24 for details of actions taken to achieve credit profiles of DuPont, Corteva and Dow.

XML

COMMITMENTS AND CONTINGENT LIABILITIES

3 Months Ended

Mar. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENT LIABILITIES

COMMITMENTS AND CONTINGENT LIABILITIES

Litigation

Asbestos-Related Matters of Union Carbide Corporation

A summary of Asbestos-Related Matters of Union Carbide Corporation can be found in Note 16 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2018.

Introduction

Union Carbide is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past four decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide’s premises, and Union Carbide’s responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem Products, Inc. (“Amchem”). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to Union Carbide’s products.

Union Carbide expects more asbestos-related suits to be filed against Union Carbide and Amchem in the future, and will aggressively defend or reasonably resolve, as appropriate, both pending and future claims.

Estimating the Asbestos-Related Liability

Since 2003, Union Carbide has engaged Ankura Consulting Group, LLC ("Ankura"), a third party actuarial specialist, to review Union Carbide's historical asbestos-related claim and resolution activity in order to assist Union Carbide's management in estimating the asbestos-related liability. Each year, Ankura has reviewed the claim and resolution activity to determine the appropriateness of updating the most recent Ankura study.

Based on the December 2018 Ankura review, and Union Carbide's own review of the data, Union Carbide's total asbestos-related liability through the terminal year of 2049, including asbestos-related defense and processing costs, was $1,260 million at December 31, 2018, and included in “Accrued and other current liabilities” and “Asbestos-related liabilities - noncurrent” in the consolidated balance sheets.

Each quarter, Union Carbide reviews claims filed, settled and dismissed, as well as average settlement and resolution costs by disease category. Union Carbide also considers additional quantitative and qualitative factors such as the nature of pending claims, trial experience of Union Carbide and other asbestos defendants, current spending for defense and processing costs, significant appellate rulings and legislative developments, trends in the tort system, and their respective effects on expected future resolution costs. Union Carbide's management considers all these factors in conjunction with the most recent Ankura study and determines whether a change in the estimate is warranted. Based on Union Carbide's review of 2019 activity, it was determined that no adjustment to the accrual was required at March 31, 2019.

Union Carbide's asbestos related liability for pending and future claims and defense and processing costs was $1,243 million at March 31, 2019. Approximately 17 percent of the recorded liability related to pending claims and approximately 83 percent related to future claims.

Summary

The Company's management believes the amounts recorded by Union Carbide for the asbestos-related liability (including defense and processing costs) reflect reasonable and probable estimates of the liability based upon current, known facts. However, future events, such as the number of new claims to be filed and/or received each year and the average cost of defending and disposing of each such claim, as well as the numerous uncertainties surrounding asbestos litigation in the United States over a significant period of time, could cause the actual costs for Union Carbide to be higher or lower than those projected or those recorded. Any such events could result in an increase or decrease in the recorded liability.

Because of the uncertainties described above, Union Carbide cannot estimate the full range of the cost of resolving pending and future asbestos-related claims facing Union Carbide and Amchem. As a result, it is reasonably possible that an additional cost of disposing of Union Carbide's asbestos-related claims, including future defense and processing costs, could have a material impact on the Company's results of operations and cash flows for a particular period and on the consolidated financial position.

Dow Silicones Chapter 11 Related Matters

A summary of the Dow Silicones Chapter 11 Related Matters can be found in Note 16 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2018.

Introduction

In 1995, Dow Silicones, then a 50:50 joint venture between Historical Dow and Corning Incorporated ("Corning"), voluntarily filed for protection under Chapter 11 of the U.S. Bankruptcy Code in order to resolve Dow Silicones' breast implant liabilities and related matters (the “Chapter 11 Proceeding”). Dow Silicones emerged from the Chapter 11 Proceeding on June 1, 2004 (the “Effective Date”) and is implementing the Joint Plan of Reorganization (the “Plan”). The Plan provides funding for the resolution of breast implant and other product liability litigation covered by the Chapter 11 Proceeding and provides a process for the satisfaction of commercial creditor claims in the Chapter 11 Proceeding. As of June 1, 2016, Dow Silicones is a wholly owned subsidiary of Historical Dow.

Breast Implant and Other Product Liability Claims

Under the Plan, a product liability settlement program administered by an independent claims office (the “Settlement Facility”) was created to resolve breast implant and other product liability claims. Product liability claimants rejecting the settlement program in favor of pursuing litigation must bring suit against a litigation facility (the “Litigation Facility”). Dow Silicones has an obligation to fund the Settlement Facility and the Litigation Facility over a 16-year period, commencing at the Effective Date. At March 31, 2019, Dow Silicones and its insurers have made life-to-date payments of $1,762 million to the Settlement Facility and the Settlement Facility reported an unexpended balance of $110 million.

Dow Silicones' liability for breast implant and other product liability claims ("Implant Liability") was $263 million at March 31, 2019 and December 31, 2018, of which $157 million at March 31, 2019 ($111 million at December 31, 2018) was included in "Accrued and other current liabilities" and $106 million at March 31, 2019 ($152 million at December 31, 2018) was included in "Other noncurrent obligations" in the consolidated balance sheets. Dow Silicones is not aware of circumstances that would change the factors used in estimating the Implant Liability and believes the recorded liability reflects the best estimate of the remaining funding obligations under the Plan; however, the estimate relies upon a number of significant assumptions, including: future claim filing levels in the Settlement Facility will be similar to those in a prior settlement program, which management uses to estimate future claim filing levels for the Settlement Facility; future acceptance rates, disease mix, and payment values will be materially consistent with historical experience; no material negative outcomes in future controversies or disputes over Plan interpretation will occur; and the Plan will not be modified. If actual outcomes related to any of these assumptions prove to be materially different, the future liability to fund the Plan may be materially different than the amount estimated. If Dow Silicones was ultimately required to fund the full liability up to the maximum capped value, the liability would be $2,148 million at March 31, 2019.

Commercial Creditor Issues

The Plan provides that each of Dow Silicones' commercial creditors (the “Commercial Creditors”) would receive in cash the sum of (a) an amount equal to the principal amount of their claims and (b) interest on such claims. The actual amount of interest that will ultimately be paid to these Commercial Creditors is uncertain due to pending litigation between Dow Silicones and the Commercial Creditors regarding the appropriate interest rates to be applied to outstanding obligations from the 1995 bankruptcy filing date through the Effective Date, as well as the presence of any recoverable fees, costs, and expenses. Upon the Plan becoming effective, Dow Silicones paid approximately $1,500 million to the Commercial Creditors, representing principal and an amount of interest that Dow Silicones considers undisputed.

On May 10, 2017, the U.S. District Court for the Eastern District of Michigan entered a stipulated order resolving pending discovery motions and established a discovery schedule for the Commercial Creditors matter. As a result, Dow Silicones and its third party consultants conducted further analysis of the Commercial Creditors claims and defenses. This analysis indicated the estimated remaining liability to Commercial Creditors to be within a range of $77 million to $260 million. No single amount within the range appeared to be a better estimate than any other amount within the range. Therefore, Dow Silicones recorded the minimum liability within the range. At March 31, 2019, the liability related to Dow Silicones' potential obligation to its Commercial Creditors in the Chapter 11 Proceeding was $83 million and is included in "Accrued and other current liabilities" in the consolidated balance sheets ($82 million at December 31, 2018). The actual amount of interest that will be paid to these creditors is uncertain and will ultimately be resolved through continued proceedings in the District Court.

Indemnifications

In connection with the June 1, 2016 ownership restructure of Dow Silicones, Historical Dow is indemnified by Corning for 50 percent of future losses associated with certain pre-closing liabilities, including the Implant Liability and Commercial Creditors matters described above, subject to certain conditions and limits. The maximum amount of indemnified losses which may be recovered are subject to a cap that declines over time. Indemnification assets were insignificant at March 31, 2019 (zero at December 31, 2018).

Summary

The amounts recorded by Dow Silicones for the Chapter 11 related matters described above were based upon current, known facts, which management believes reflect reasonable and probable estimates of the liability. However, future events could cause the actual costs for Dow Silicones to be higher or lower than those projected or those recorded. Any such events could result in an increase or decrease in the recorded liability.

Separation of Historical DuPont's Performance Chemicals Segment

On July 1, 2015, Historical DuPont completed the separation of its Performance Chemicals segment through the spin-off of all of the issued and outstanding stock of The Chemours Company (the "Chemours Separation"). In connection with the Chemours Separation, Historical DuPont and The Chemours Company (“Chemours”) entered into a Separation agreement (as amended, the "Chemours Separation Agreement"). Pursuant to the Chemours Separation Agreement, Chemours indemnifies Historical DuPont against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the Chemours Separation. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, Historical DuPont records an indemnification asset when recovery is deemed probable. At March 31, 2019, the indemnification assets were $84 million included in "Accounts and notes receivable - Other" and $289 million included in "Noncurrent receivables" along with the corresponding liabilities of $84 million recorded in "Accrued and other current liabilities" and $289 million included in "Other noncurrent obligations" in the consolidated balance sheets.

PFOA Liabilities

Historical DuPont is a party to legal proceedings relating to the use of PFOA (collectively, perfluorooctanoic acids and its salts, including the ammonium salt) by its former Performance Chemicals segment. While it is reasonably possible that Historical DuPont could incur liabilities related to PFOA, any such liabilities are not expected to be material. Pursuant to the Chemours Separation Agreement discussed above, Historical DuPont is indemnified by Chemours for the PFOA matters discussed below and has recorded a total liability of $22 million and a total indemnification asset of $22 million at March 31, 2019, primarily related to testing drinking water in and around certain Historical DuPont sites and offering treatment or an alternative supply of drinking water if tests indicate the presence of PFOA in drinking water at or greater than the national health advisory level established from time to time by the EPA.

Leach Settlement and MDL Settlement

Historical DuPont has residual liabilities under its 2004 settlement of a West Virginia state court class action, Leach v. DuPont, which alleged that PFOA from Historical DuPont’s former Washington Works facility had contaminated area drinking water supplies and affected the health of area residents. The settlement class has about 80,000 members. In addition to relief that was provided to class members years ago, the settlement requires Historical DuPont to continue providing PFOA water treatment to six area water districts and private well users and to fund, through an escrow account, up to $235 million for a medical monitoring program for eligible class members. At March 31, 2019, approximately $2 million had been disbursed from the account since its establishment in 2012 and the remaining balance is approximately $1 million.

The Leach settlement permits class members to pursue personal injury claims for six health conditions (and no others) that an expert panel appointed under the settlement reported in 2012 had a “probable link” (as defined in the settlement) with PFOA: pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol. After the expert panel reported its findings, approximately 3,550 personal injury lawsuits were filed in federal and state courts in Ohio and West Virginia and consolidated in multi-district litigation in the U.S. District Court for the Southern District of Ohio (“MDL”). The MDL was settled in early 2017 for $671 million in cash, with Chemours and Historical DuPont (without indemnification from Chemours) each paying half.

Post-MDL Settlement PFOA Personal Injury Claims

The MDL settlement did not resolve claims of plaintiffs who did not have claims in the MDL or whose claims are based on diseases first diagnosed after February 11, 2017. At March 31, 2019, about 57 lawsuits were pending alleging personal injury, including kidney and testicular cancer, thyroid disease and ulcerative colitis, from exposure to PFOA through air or water, only three of which are not part of the MDL or were not otherwise filed on behalf of Leach class members.

Other PFOA Actions

Historical DuPont is a party to other PFOA lawsuits that do not involve claims for personal injury. Chemours, pursuant to the Chemours Separation Agreement, is defending and indemnifying with reservations Historical DuPont in these lawsuits.

New York. Historical DuPont is a defendant in about 52 lawsuits, including a putative class action, brought by persons who live in and around Hoosick Falls, New York. These lawsuits assert claims for medical monitoring and property damage based on alleged PFOA releases from manufacturing facilities owned and operated by co-defendants in Hoosick Falls and allege that Historical DuPont and 3M supplied some of the materials used at these facilities. Historical DuPont is also one of more than ten defendants in a lawsuit brought by the Town of East Hampton, New York alleging PFOA and perfluorooctanesulfonic acid ("PFOS") contamination of the town’s well water.

New Jersey. At December 31, 2018, two lawsuits were pending, one brought by a local water utility and the second a putative class action, against Historical DuPont alleging that PFOA from Historical DuPont’s former Chambers Works facility contaminated drinking water sources. The putative class action was dismissed without prejudice by the plaintiffs.

In late March of 2019, the New Jersey State Attorney General (the “NJAG”) filed four lawsuits against Historical DuPont, Chemours, 3M and others alleging that former Historical DuPont operations at the Chambers Works, Pompton Lakes Works, Parlin and Repauno sites in New Jersey, caused damage to the State’s natural resources. Two of these lawsuits (those involving the Chambers Works and Parlin sites) allege contamination from per- and polyfluoroalkyl substances (“PFAS”). The lawsuit related to Parlin names an additional DowDuPont subsidiary. The Ridgewood Water District in New Jersey filed suit in the first quarter of 2019 against Historical DuPont alleging losses related to the investigation, remediation and monitoring of polyfluorinated surfactants (“PFS”), including PFOA, in water supplies.

Alabama. Historical DuPont is one of more than thirty defendants in a lawsuit by a local water utility alleging contamination from perfluorinated chemicals and compounds (“PFCs”), including PFOA, used by co-defendant carpet manufacturers to make their products more stain and grease resistant.

Ohio. Historical DuPont is a defendant in three lawsuits: an action by the State of Ohio based on alleged damage to natural resources, a putative nationwide class action brought on behalf of anyone who has detectable levels of perfluorinated chemicals, including PFOA, in their blood, and an action by the City of Dayton claiming losses related to the investigation, remediation and monitoring of PFAS, including PFOA, in water supplies.

Other. Dozens of cases have been filed against 3M and other defendants primarily alleging property damage from contamination in connection with the use of firefighting foams that contain PFOS. At March 31, 2019, Historical DuPont was named in 4 of these cases. Historical DuPont did not make firefighting foam and has never made or supplied PFOS or products that contained PFOS.

Chemours Separation Agreement Amendment

Concurrent with the MDL Settlement, Historical DuPont and Chemours amended the Chemours Separation Agreement to provide for a limited sharing of potential future PFOA liabilities for a five-year period that began on July 6, 2017. During that five-year period, Chemours will annually pay the first $25 million of future PFOA liabilities and, if that amount is exceeded, Historical DuPont will pay any excess amount up to the next $25 million, with Chemours annually bearing any excess liabilities above that amount. At the end of the five-year period, this limited sharing agreement will expire, and Chemours’ indemnification obligations under the Chemours Separation Agreement will continue unchanged. As part of this amendment, Chemours also agreed that it would not contest its liability for PFOA liabilities on the basis of certain ostensible defenses it had previously raised, including defenses relating to punitive damages, and would waive any such defenses with respect to PFOA liabilities. Chemours has, however, retained defenses as to whether any particular PFOA claim is within the scope of the indemnification provisions of the Chemours Separation Agreement.

There have been no charges incurred by Historical DuPont under this arrangement through March 31, 2019.

Fayetteville Works Facility, North Carolina

Prior to the separation of Chemours, Historical DuPont introduced GenX as a polymerization processing aid and a replacement for PFOA at the Fayetteville Works facility in Bladen County, North Carolina. The facility is now owned and operated by Chemours, which continues to manufacture and use GenX. In 2017, the facility became and continues to be the subject of inquiries and government investigations relating to the alleged discharge of GenX and certain similar compounds into the air and Cape Fear River.

In August 2017, the U.S. Attorney’s Office for the Eastern District of North Carolina served Historical DuPont with a grand jury subpoena for testimony and documents related to these discharges. Historical DuPont was served with additional subpoenas relating to the same issue and in the second quarter of 2018, received a subpoena expanding the scope to any PFCs discharged from the Fayetteville Works facility into the Cape Fear River. It is possible that these ongoing inquiries and investigations, including the grand jury subpoena, could result in penalties or sanctions, or that additional litigation will be instituted against Chemours, Historical DuPont, or both.

At March 31, 2019, several actions are pending in federal court against Chemours and Historical DuPont. One of these actions is a consolidated putative class action that asserts claims for medical monitoring and property damage on behalf of putative classes of property owners and residents in areas near or who draw drinking water from the Cape Fear River. Another action is a consolidated action brought by various North Carolina water authorities, including the Cape Fear Public Utility Authority and Brunswick County, that seek actual and punitive damages as well as injunctive relief. In addition, an action is pending in North Carolina state court on behalf of about 100 plaintiffs who own wells and property near the Fayetteville Works facility. The plaintiffs seek damages for nuisance allegedly caused by releases of certain PFCs from the site.

While it is reasonably possible that Historical DuPont could incur liabilities related to the actions described above, any such liabilities are not expected to be material.

Historical DuPont has an indemnification claim against Chemours with respect to current and future inquiries and claims, including lawsuits, related to the foregoing. At March 31, 2019, Chemours, with reservations, is defending and indemnifying Historical DuPont in the pending civil actions.

Other Litigation Matters

In addition to the specific matters described above, Historical Dow and Historical DuPont are parties to a number of other claims and lawsuits arising out of the normal course of business with respect to product liability, patent infringement, governmental regulation, contract and commercial litigation, and other actions. Certain of these actions purport to be class actions and seek damages in very large amounts. All such claims are being contested. Historical Dow and Historical DuPont have active risk management programs consisting of numerous insurance policies secured from many carriers at various times. These policies may provide coverage that could be utilized to minimize the financial impact, if any, of certain contingencies described above. It is the opinion of the Company’s management that the possibility is remote that the aggregate of all such other claims and lawsuits will have a material adverse impact on the results of operations, financial condition and cash flows of the Company.

Gain Contingency - Historical Dow v. Nova Chemicals Corporation Patent Infringement Matter

On December 9, 2010, Historical Dow filed suit in the Federal Court in Ontario, Canada ("Federal Court") alleging that Nova Chemicals Corporation ("Nova") was infringing Historical Dow's Canadian polyethylene patent 2,106,705. Nova counterclaimed on the grounds of invalidity and non-infringement. On June 29, 2017, the Federal Court issued a Confidential Supplemental Judgment, concluding that Nova must pay $645 million Canadian dollars (equivalent to $495 million U.S. dollars) to Historical Dow, plus pre- and post-judgment interest, for which Historical Dow received payment of $501 million from Nova on July 6, 2017. Although Nova is appealing portions of the damages judgment, certain portions of it are indisputable and will be owed to Historical Dow regardless of the outcome of any further appeals by Nova. At March 31, 2019, Historical Dow had $341 million ($341 million at December 31, 2018) included in "Other noncurrent obligations" in the consolidated balance sheets related to the disputed portion of the damages judgment. Historical Dow is confident of its chances of defending the entire judgment on appeal, particularly the trial court's determinations on important factual issues, which will be accorded deferential review on appeal. See Note 16 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2018 for additional information.

Environmental Matters

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current law and existing technologies. At March 31, 2019, the Company had accrued obligations of $1,197 million for probable environmental remediation and restoration costs, including $213 million for the remediation of Superfund sites. These obligations are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets. This is management’s current estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to approximately two and a half times that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the Company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. At December 31, 2018, the Company had accrued obligations of $1,201 million for probable environmental remediation and restoration costs, including $210 million for the remediation of Superfund sites.

Pursuant to the Chemours Separation Agreement, Historical DuPont is indemnified by Chemours for certain environmental matters, included in the liability of $1,197 million, that have an estimated liability of $185 million at March 31, 2019, and a potential exposure that ranges up to approximately $355 million above the current accrual. As such, Historical DuPont has recorded an indemnification asset of $185 million corresponding to its accrual balance related to these matters at March 31, 2019, including $35 million related to Superfund sites.

Guarantees

The following table provides a summary of the final expiration, maximum future payments and recorded liability reflected in the consolidated balance sheets for each type of guarantee:

Guarantees	Mar 31, 2019					Dec 31, 2018
In millions	Final Expiration	Maximum Future Payments		Recorded Liability		Final Expiration	Maximum Future Payments		Recorded Liability
Historical Dow guarantees	2023	$	4,514	$	15	2023	$	4,523	$	25
Historical DuPont guarantees	2022	239		—		2022	255		—
Total guarantees		$	4,753	$	15		$	4,778	$	25

Guarantees

Historical Dow and Historical DuPont (the "Subsidiaries") have entered into guarantee agreements arising in the ordinary course of business from relationships with customers and nonconsolidated affiliates when the Subsidiaries undertake an obligation to guarantee the performance of others (via delivery of cash or other assets) if specified triggering events occur. With guarantees, such as commercial or financial contracts, non-performance by the guaranteed party triggers the obligation of the Subsidiaries to make payments to the beneficiary of the guarantee. The majority of these guarantees relate to debt of nonconsolidated affiliates, which have expiration dates ranging from less than one year to less than four years, and trade financing transactions in Latin America, which typically expire within one year of inception. The Subsidiaries current expectation is that future payment or performance related to the non-performance of others is considered remote.

Historical Dow has entered into guarantee agreements ("Guarantees") related to project financing for Sadara Chemical Company ("Sadara"), a nonconsolidated affiliate. The total of an Islamic bond and additional project financing (collectively “Total Project Financing”) obtained by Sadara is approximately $12.5 billion. Sadara had $11.7 billion of Total Project Financing outstanding at March 31, 2019 ($11.7 billion at December 31, 2018). Historical Dow's guarantee of the Total Project Financing is in proportion to Historical Dow's 35 percent ownership interest in Sadara, or up to approximately $4.2 billion when the project financing is fully drawn. Sadara successfully completed an extensive operational testing program in December 2018, however, the Guarantees will be released upon the satisfactory fulfillment of certain project completion conditions, which is expected by the middle of 2019, and must occur no later than December 2020.

XML

LEASES (Notes)

3 Months Ended

Mar. 31, 2019

Leases [Abstract]

Leases of Lessee Disclosure [Text Block]

LEASES

The Company has operating and finance leases for sales and administrative offices, power plants, production facilities, warehouses and tanks for product storage, airplanes, railcars, motor vehicles, certain machinery and equipment, and information technology assets. The Company’s leases have remaining lease terms of 1 year to 50 years. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that the Company will exercise those options. Some leasing arrangements require variable payments that are dependent on usage, output, or may vary for other reasons, such as insurance and tax payments. The variable lease payments are not presented as part of the initial ROU asset or lease liability. The Company's lease agreements do not contain any material restrictive covenants.

The components of lease cost for operating and finance leases for the three months ended March 31, 2019 were as follows:

Lease Cost	Three Months Ended Mar 31, 2019
(In millions)
Operating lease cost	$	201
Finance lease cost
Amortization of right-of-use assets	$	41
Interest on lease liabilities	7
Total finance lease cost	$	48
Short-term lease cost	$	60
Variable lease cost	89
Sublease income	(9		)
Total lease cost	$	389

New leases entered into during the three months ended March 31, 2019 were not considered material. Supplemental cash flow information related to leases was as follows:

Other Lease Information	Three Months Ended Mar 31, 2019
(In millions)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	210
Operating cash flows from finance leases	$	7
Financing cash flows from finance leases	$	23

The following table summarizes the lease-related assets and liabilities recorded in the consolidated balance sheets at March 31, 2019:

Lease Position	Mar 31, 2019
(In millions)
Operating Leases
Operating lease right-of-use assets 1	$	3,287
Current operating lease liabilities 2	$	690
Noncurrent operating lease liabilities 3	2,620
Total operating lease liabilities	$	3,310
Finance Leases
Property	$	589
Accumulated depreciation	(181		)
Net Property	$	408
Long-term debt due within one year	63
Long-Term Debt	432
Total finance lease liabilities	$	495

1. Included in "Deferred charges and other assets" in the consolidated balance sheet.

2. Included in "Accrued and other current liabilities" in the consolidated balance sheet.

3. Included in "Other noncurrent obligations" in the consolidated balance sheet.

DowDuPont utilizes the incremental borrowing rate in determining the present value of lease payments unless the implicit rate is readily determinable.

Lease Term and Discount Rate	Mar 31, 2019
Weighted-average remaining lease term (years)
Operating leases	7.98
Finance leases	15.54
Weighted-average discount rate
Operating leases	3.97	%
Finance leases	6.25	%

The following table provides the maturities of lease liabilities at March 31, 2019:

Maturity of Lease Liabilities at Mar 31, 2019	Operating Leases		Finance Leases
(In millions)
2019	$	621	$	74
2020	686		78
2021	553		73
2022	450		71
2023	346		80
2024 and thereafter	1,286		315
Total future undiscounted lease payments	$	3,942	$	691
Less: Interest	632		196
Present value of lease liabilities	$	3,310	$	495

At March 31, 2019, the Company had additional leases of approximately $45 million, primarily for buildings and equipment, which had not yet commenced. These leases are expected to commence later in 2019, with lease terms of 10 years.

Future minimum lease payments for operating leases accounted for under ASC 840, "Leases," with remaining non-cancelable terms in excess of one year at December 31, 2018 were as follows:

Minimum Lease Commitments at Dec 31, 2018
(In millions)
2019	$	654
2020	497
2021	418
2022	363
2023	297
2024 and thereafter	1,063
Total	$	3,292

Certain of the Company's leases include residual value guarantees. These residual value guarantees are based on a percentage of lessor's asset acquisition price. The portion of residual value guarantees that are probable of payment are included in the related lease liability on the consolidated balance sheet other than certain finance leases that include the maximum residual value guarantee amount in the measurement of the related liability given the election to use the package of practical expedients at the date of adoption. The following table provides a summary of the final expiration, maximum future payment and recorded liability reflected in the consolidated balance sheets for residual value guarantees.

Lease Guarantees	Mar 31, 2019					Dec 31, 2018
(In millions)	Final Expiration	Maximum Future Payments		Recorded Liability		Final Expiration	Maximum Future Payments		Recorded Liability
Residual value guarantees	2028	$	931	$	—	2028	$	889	$	130

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS

3 Months Ended

Mar. 31, 2019

Equity [Abstract]

ACCUMULATED OTHER COMPREHENSIVE LOSS

ACCUMULATED OTHER COMPREHENSIVE LOSS

The following table summarizes the activity related to each component of accumulated other comprehensive loss ("AOCL") for the three months ended March 31, 2019 and 2018:

Accumulated Other Comprehensive Loss	Unrealized Gains (Losses) on Investments			Cumulative Translation Adj			Pension and Other Postretire Benefits			Derivative Instruments			Total Accum Other Comp Loss
In millions
Balance at Jan 1, 2018	$	17		$	(1,935	)	$	(6,923	)	$	(111	)	$	(8,952	)
Other comprehensive income (loss) before reclassifications	(26		)	1,333			4			(4		)	1,307
Amounts reclassified from accumulated other comprehensive income	1			—			126			21			148
Net other comprehensive income (loss)	$	(25	)	$	1,333		$	130		$	17		$	1,455
Balance at Mar 31, 2018	$	(8	)	$	(602	)	$	(6,793	)	$	(94	)	$	(7,497	)
Balance at Jan 1, 2019	$	(51	)	$	(3,785	)	$	(8,476	)	$	(82	)	$	(12,394	)
Other comprehensive income (loss) before reclassifications	68			(79		)	(7		)	(65		)	(83		)
Amounts reclassified from accumulated other comprehensive income (loss)	(1		)	(18		)	142			(10		)	113
Net other comprehensive income (loss)	$	67		$	(97	)	$	135		$	(75	)	$	30
Balance at Mar 31, 2019	$	16		$	(3,882	)	$	(8,341	)	$	(157	)	$	(12,364	)

The tax effects on the net activity related to each component of other comprehensive income (loss) for the three months ended March 31, 2019 and 2018 were as follows:

Tax Benefit (Expense) 1	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Unrealized (losses) gains on investments	$	(18	)	$	6
Cumulative translation adjustments	(1		)	5
Pension and other postretirement benefit plans	(32		)	(30		)
Derivative instruments	24			(1		)
Tax expense from income taxes related to other comprehensive income items	$	(27	)	$	(20	)

1. Prior period amounts were updated to conform with the current year presentation.

A summary of the reclassifications out of AOCL for the three months ended March 31, 2019 and 2018 is provided as follows:

Reclassifications Out of Accumulated Other Comprehensive Loss	Three Months Ended						Consolidated Statements of Income Classification
	Mar 31, 2019			Mar 31, 2018
In millions
Unrealized (gains) losses on investments	$	(1	)	$	2		See (1) below
Tax benefit	—			(1		)	See (2) below
After tax	$	(1	)	$	1
Cumulative translation adjustments	$	(18	)	$	—		See (3) below
Pension and other postretirement benefit plans	$	167		$	154		See (4) below
Tax benefit	(25		)	(28		)	See (2) below
After tax	$	142		$	126
Derivative Instruments	$	(11	)	$	26		See (5) below
Tax expense (benefit)	1			(5		)	See (2) below
After tax	$	(10	)	$	21
Total reclassifications for the period, after tax	$	113		$	148

1. "Net sales" and "Sundry income (expense) - net."

2. "Provision for income taxes on continuing operations."

3. "Sundry income (expense) - net."

4. These AOCL components are included in the computation of net periodic benefit cost of the Company's defined benefit pension and other postretirement benefit plans. See Note 18 for additional information.

5. "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."

XML

NONCONTROLLING INTERESTS

3 Months Ended

Mar. 31, 2019

Noncontrolling Interest [Abstract]

NONCONTROLLING INTERESTS

NONCONTROLLING INTERESTS

Ownership interests in the Company's subsidiaries held by parties other than the Company are presented separately from the Company's equity in the consolidated balance sheets as "Noncontrolling interests." The amount of consolidated net income attributable to the Company and the noncontrolling interests are both presented on the face of the consolidated statements of income.

The following table summarizes the activity for equity attributable to noncontrolling interests for the three months ended March 31, 2019 and 2018:

Noncontrolling Interests	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Balance at beginning of period	$	1,608		$	1,597
Net income attributable to noncontrolling interests	51			44
Distributions to noncontrolling interests	(11		)	(27		)
Noncontrolling interests from Merger 1	—			56
Cumulative translation adjustments	7			(6		)
Other	(1		)	—
Balance at end of period	$	1,654		$	1,664

1. Relates to Merger and subsequent measurement period adjustments.

XML

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS

3 Months Ended

Mar. 31, 2019

Retirement Benefits [Abstract]

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS

A summary of Historical Dow and Historical DuPont's pension plans and other postretirement benefits can be found in Note 19 to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. Historical Dow and Historical DuPont did not merge their defined benefit pension and other postretirement benefit plans as a result of the Merger. The following table provides the components of net periodic benefit cost (credit) for Historical Dow and Historical DuPont's significant plans:

Net Periodic Benefit Cost (Credit) for All Significant Plans	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Defined Benefit Pension Plans:
Service cost	$	131		$	167
Interest cost	447			408
Expected return on plan assets	(713		)	(709		)
Amortization of prior service credit	(6		)	(6		)
Amortization of net loss	133			171
Net periodic benefit cost (credit)	$	(8	)	$	31
Other Postretirement Benefits:
Service cost	$	4		$	5
Interest cost	37			32
Amortization of net gain	(6		)	(6		)
Net periodic benefit cost	$	35		$	31

Net periodic benefit cost (credit), other than the service cost component, is included in "Sundry income (expense) - net" in the consolidated statements of income.

DowDuPont expects to make additional contributions in the aggregate of about $500 million by year-end 2019 to its pension plans other than the principal U.S. pension plan.

XML

STOCK-BASED COMPENSATION

3 Months Ended

Mar. 31, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION

A summary of Historical Dow and Historical DuPont's stock-based compensation plans can be found in Note 20 to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. Historical Dow and Historical DuPont did not merge their equity incentive plans as a result of the Merger. The Historical Dow and Historical DuPont stock-based compensation plans were assumed by DowDuPont and continue in place with the ability to grant and issue DowDuPont Common Stock.

Historical Dow Stock Incentive Plan

Historical Dow grants stock-based compensation to employees and non-employee directors under The Dow Chemical Company Amended and Restated 2012 Stock Incentive Plan (the "2012 Plan"). In connection with the Merger, on August 31, 2017, all outstanding Historical Dow stock options and restricted stock unit awards were converted into stock options and restricted stock unit awards with respect to DowDuPont Common Stock. The stock options and restricted stock unit awards have the same terms and conditions under the applicable plans and award agreements prior to the Merger. There was minimal grant activity in the first quarter of 2019.

Historical DuPont Equity Incentive Plan

Historical DuPont grants stock-based compensation to certain employees, directors, and consultants through grants of stock options, time-vested restricted stock units ("RSUs"), and performance-based restricted stock units (“PSUs”) under the Historical DuPont Equity Incentive Plan ("Historical DuPont EIP"). The previous Historical DuPont equity awards were converted into the right to receive 1.2820 shares of DowDuPont Common Stock. The awards have the same terms and conditions as were applicable to such equity awards immediately prior to the Merger closing date. Most of these awards have been granted annually in the first quarter of each calendar year. In the first quarter of 2019, Historical DuPont granted 2.6 million RSUs with a weighted-average fair value of $52.66 per share under the Historical DuPont EIP.

XML

FINANCIAL INSTRUMENTS

3 Months Ended

Mar. 31, 2019

Investments, All Other Investments [Abstract]

FINANCIAL INSTRUMENTS

FINANCIAL INSTRUMENTS

A summary of the Company's financial instruments, risk management policies, derivative instruments and hedging activities can be found in Note 21 of the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2018. If applicable, updates have been included in the respective section below.

The following table summarizes the fair value of financial instruments at March 31, 2019 and December 31, 2018:

Fair Value of Financial Instruments	Mar 31, 2019											Dec 31, 2018
In millions	Cost			Gain		Loss			Fair Value			Cost			Gain		Loss			Fair Value
Cash equivalents	$	7,384		$	9	$	—		$	7,393		$	9,951		$	12	$	—		$	9,963
Restricted cash equivalents 1	$	480		$	—	$	—		$	480		$	500		$	—	$	—		$	500
Marketable securities:
Available-for-sale 2	$	101		$	—	$	—		$	101		$	100		$	—	$	—		$	100
Held-to-maturity 3	18			—		—			18			34			—		—			34
Total marketable securities	$	119		$	—	$	—		$	119		$	134		$	—	$	—		$	134
Other investments:
Debt securities:
Government debt 4	$	694		$	17	$	(9	)	$	702		$	714		$	9	$	(23	)	$	700
Corporate bonds	1,051			43		(21		)	1,073			1,026			20		(63		)	983
Total debt securities	$	1,745		$	60	$	(30	)	$	1,775		$	1,740		$	29	$	(86	)	$	1,683
Equity securities 5	$	17		$	5	$	—		$	22		$	17		$	1	$	(2	)	$	16
Total other investments	$	1,762		$	65	$	(30	)	$	1,797		$	1,757		$	30	$	(88	)	$	1,699
Total cash and restricted cash equivalents, marketable securities and other investments	$	9,745		$	74	$	(30	)	$	9,789		$	12,342		$	42	$	(88	)	$	12,296
Long-term debt including debt due within one year 6	$	(38,975	)	$	102	$	(2,470	)	$	(41,343	)	$	(38,299	)	$	390	$	(1,457	)	$	(39,366	)
Derivatives relating to:
Interest rates	$	—		$	—	$	(181	)	$	(181	)	$	—		$	—	$	(64	)	$	(64	)
Foreign currency 7	—			128		(17		)	111			—			157		(49		)	108
Commodities 7	—			88		(147		)	(59		)	—			91		(178		)	(87		)
Total derivatives	$	—		$	216	$	(345	)	$	(129	)	$	—		$	248	$	(291	)	$	(43	)

1. Classified as "Other current assets" in the consolidated balance sheets.

2. Available-for-sale securities with maturities of less than one year at the time of purchase.

3. Held-to-maturity securities with maturities of more than three months to less than one year at the time of purchase.

4. U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

5. Equity securities with a readily determinable fair value.

6. Cost includes fair value adjustments of $69 million at March 31, 2019 and $78 million at December 31, 2018, related to the accounting for the Merger. Cost also includes fair value hedge adjustments of $17 million at March 31, 2019 and $18 million at December 31, 2018 on $2,290 million of debt at March 31, 2019 and December 31, 2018.

7. Presented net of cash collateral where master netting arrangements allow.

Debt Securities

The Company's investments in debt securities are primarily classified as available-for-sale. For the three months ended March 31, 2019, $35 million of marketable securities matured. The following table provides the investing results from available-for-sale securities for the three months ended March 31, 2019 and 2018:

Investing Results	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Proceeds from sales of available-for-sale securities	$	159		$	348
Gross realized gains	$	6		$	7
Gross realized losses	$	(5	)	$	(9	)

Equity Securities

The Company's investments in equity securities with a readily determinable fair value totaled $22 million at March 31, 2019 ($16 million at December 31, 2018). The aggregate carrying value of the Company’s investments in equity securities where fair value is not readily determinable totaled $260 million at March 31, 2019 ($258 million at December 31, 2018), reflecting the carrying value of the investments. There were no material adjustments to the carrying value of the not readily determinable investments for impairment or observable price changes for the three months ended March 31, 2019 and 2018. The net unrealized gain recognized in earnings on equity securities totaled $5 million for the three months ended March 31, 2019 ($8 million net unrealized gain for the three months ended March 31, 2018).

Derivatives

The following tables provide the fair value and balance sheet classification of derivative instruments at March 31, 2019 and December 31, 2018:

Fair Value of Derivative Instruments		Mar 31, 2019
In millions	Balance Sheet Classification	Gross		Counterparty and Cash Collateral Netting 1			Net Amounts Included in the Consolidated Balance Sheet
Asset derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other current assets	$	161	$	(89	)	$	72
Commodity contracts	Other current assets	31		(5		)	26
Commodity contracts	Deferred charges and other assets	57		(4		)	53
Total		$	249	$	(98	)	$	151
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	$	87	$	(31	)	$	56
Commodity contracts	Other current assets	8		(1		)	7
Commodity contracts	Deferred charges and other assets	4		(2		)	2
Total		$	99	$	(34	)	$	65
Total asset derivatives		$	348	$	(132	)	$	216
Liability derivatives:
Derivatives designated as hedging instruments:
Interest rate swaps	Other noncurrent obligations	$	181	$	—		$	181
Foreign currency contracts	Accrued and other current liabilities	98		(89		)	9
Commodity contracts	Accrued and other current liabilities	93		(6		)	87
Commodity contracts	Other noncurrent obligations	60		(8		)	52
Total		$	432	$	(103	)	$	329
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	37	$	(29	)	$	8
Commodity contracts	Accrued and other current liabilities	8		(4		)	4
Commodity contracts	Other noncurrent obligations	7		(3		)	4
Total		$	52	$	(36	)	$	16
Total liability derivatives		$	484	$	(139	)	$	345

1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

Fair Value of Derivative Instruments		Dec 31, 2018
In millions	Balance Sheet Classification	Gross		Counterparty and Cash Collateral Netting 1			Net Amounts Included in the Consolidated Balance Sheet
Asset derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other current assets	$	98	$	(42	)	$	56
Commodity contracts	Other current assets	47		(13		)	34
Commodity contracts	Deferred charges and other assets	18		(3		)	15
Total		$	163	$	(58	)	$	105
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	$	200	$	(99	)	$	101
Commodity contracts	Other current assets	41		(1		)	40
Commodity contracts	Deferred charges and other assets	4		(2		)	2
Total		$	245	$	(102	)	$	143
Total asset derivatives		$	408	$	(160	)	$	248
Liability derivatives:
Derivatives designated as hedging instruments:
Interest rate swaps	Other noncurrent obligations	$	64	$	—		$	64
Foreign currency contracts	Accrued and other current liabilities	46		(42		)	4
Commodity contracts	Accrued and other current liabilities	111		(18		)	93
Commodity contracts	Other noncurrent obligations	86		(9		)	77
Total		$	307	$	(69	)	$	238
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	124	$	(79	)	$	45
Commodity contracts	Accrued and other current liabilities	7		(4		)	3
Commodity contracts	Other noncurrent obligations	8		(3		)	5
Total		$	139	$	(86	)	$	53
Total liability derivatives		$	446	$	(155	)	$	291

1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

Assets and liabilities related to forward contracts, interest rate swaps, currency swaps, options and other conditional or exchange contracts executed with the same counterparty under a master netting arrangement are netted. Collateral accounts are netted with corresponding assets or liabilities, when applicable. The Company posted cash collateral of $20 million at March 31, 2019 ($26 million at December 31, 2018). Counterparties posted cash collateral of $2 million with the Company at March 31, 2019 ($54 million at December 31, 2018).

Net Foreign Investment Hedges

Historical Dow

For derivative instruments that are designated and qualify as net foreign investment hedges, the effective portion of the gain or loss on the derivative is included in “Cumulative Translation Adjustments” in AOCL. Historical Dow had outstanding foreign-currency denominated debt designated as a hedge of net foreign investment of $181 million at March 31, 2019 ($182 million at December 31, 2018). The results of hedges of Historical Dow’s net investment in foreign operations included in “Cumulative Translation Adjustments” in AOCL was a net loss of $36 million after tax for the three months ended March 31, 2019 (net loss of $43 million after tax for the three months ended March 31, 2018). For the three months ended March 31, 2019, Historical Dow recognized after tax gains of $86 million related to excluded components of net foreign investment hedges included in "Cumulative Translation Adjustments" in AOCL. For the three months ended March 31, 2019, gains of $25 million were amortized to “Sundry income (expense) - net” in the consolidated statements of income.

Fair Value Hedges

Historical Dow

Subsequent to March 31, 2019, Historical Dow entered into interest rate contracts designated as a fair value hedge of underlying fixed rate debt obligations with maturity dates extending through 2048.

Income Statement Effect of Derivative Instruments

Foreign currency derivatives not designated as hedges are used to offset foreign exchange gains or losses resulting from the underlying exposures of foreign currency denominated assets and liabilities. The amount charged on a pretax basis related to foreign currency derivatives not designated as a hedge, which was included in “Sundry income (expense) - net” in the consolidated statements of income, was a gain of $22 million for the three months ended March 31, 2019 (loss of $198 million for the three months ended March 31, 2018). The income statement effects of other derivatives were immaterial.

Reclassification from AOCL

The net after-tax amounts to be reclassified from AOCL to income within the next 12 months are a $1 million gain for interest rate contracts, a $52 million loss for commodity contracts, an $11 million gain for foreign currency contracts and a $57 million gain for excluded components.

XML

FAIR VALUE MEASUREMENTS

3 Months Ended

Mar. 31, 2019

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS

A summary of the Company's recurring and nonrecurring fair value measurements can be found in Note 22 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2018. If applicable, updates have been included in the respective section below.

Fair Value Measurements on a Recurring Basis

The following tables summarize the bases used to measure certain assets and liabilities at fair value on a recurring basis:

Basis of Fair Value Measurements on a Recurring Basis at Mar 31, 2019	Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)		Total
In millions
Assets at fair value:
Cash equivalents 1	$	—	$	7,393	$	7,393
Restricted cash equivalents 1	—		480		480
Marketable securities 2	—		119		119
Equity securities 3	21		—		21
Debt securities: 3
Government debt 4	—		702		702
Corporate bonds	19		1,054		1,073
Derivatives relating to: 5
Foreign currency	—		247		247
Commodities	10		90		100
Total assets at fair value	$	50	$	10,085	$	10,135
Liabilities at fair value:
Long-term debt including debt due within one year 6	$	—	$	41,343	$	41,343
Derivatives relating to: 5
Interest rates	—		181		181
Foreign currency	—		134		134
Commodities	13		155		168
Total liabilities at fair value	$	13	$	41,813	$	41,826

1. Treasury bills, time deposits, and money market funds included in "Cash and cash equivalents" and money market funds included in "Other current assets" in the consolidated balance sheets and held at amortized cost, which approximates fair value.

2. Primarily time deposits with maturities of greater than three months at time of acquisition.

3. The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” in the consolidated balance sheets.

4. U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

5. See Note 20 for the classification of derivatives in the consolidated balance sheets.

6. See Note 20 for information on fair value measurements of long-term debt.

Basis of Fair Value Measurements on a Recurring Basis at Dec 31, 2018	Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)		Total
In millions
Assets at fair value:
Cash equivalents 1	$	—	$	9,963	$	9,963
Restricted cash equivalents 1	—		500		500
Marketable securities 2	—		134		134
Equity securities 3	16		—		16
Debt securities: 3
Government debt 4	—		700		700
Corporate bonds	—		983		983
Derivatives relating to: 5
Foreign currency	—		298		298
Commodities	17		93		110
Total assets at fair value	$	33	$	12,671	$	12,704
Liabilities at fair value:
Long-term debt including debt due within one year 6	$	—	$	39,366	$	39,366
Derivatives relating to: 5
Interest rates	—		64		64
Foreign currency	—		170		170
Commodities	23		189		212
Total liabilities at fair value	$	23	$	39,789	$	39,812

1. Treasury bills, time deposits, and money market funds included in "Cash and cash equivalents" and money market funds included in "Other current assets" in the consolidated balance sheets and held at amortized cost, which approximates fair value.

2. Primarily time deposits with maturities of greater than three months at time of acquisition.

3. The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” in the consolidated balance sheets.

4. U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

5. See Note 20 for the classification of derivatives in the consolidated balance sheets.

6. See Note 20 for information on fair value measurements of long-term debt.

For equity securities calculated at net asset value per share (or its equivalent), the Company had $121 million in private market securities and $29 million in real estate at March 31, 2019 ($120 million in private market securities and $29 million in real estate at December 31, 2018). There are no redemption restrictions and the unfunded commitments on these investments were $87 million at March 31, 2019 ($89 million at December 31, 2018).

Fair Value Measurements on a Nonrecurring Basis

As part of the Synergy Program, the Company has or will shut down a number of manufacturing, R&D and corporate facilities around the world. In the first three months of 2019, inventory associated with this plan was written down to zero. In addition, impairments of leased, non-manufacturing facilities, which were classified as Level 3 measurements, resulted in a write-down of right-of-use assets to $80 million using unobservable inputs. The impairment charges related to the Synergy Program, totaling $100 million, were included in "Restructuring and asset related charges - net" in the consolidated statements of income. See Note 5 for additional information on the Company's restructuring activities.

XML

VARIABLE INTEREST ENTITIES

3 Months Ended

Mar. 31, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

VARIABLE INTEREST ENTITIES

VARIABLE INTEREST ENTITIES

A summary of Historical Dow and Historical DuPont's variable interest entities ("VIEs") can be found in Note 23 to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. Historical DuPont did not hold a variable interest in any joint ventures at March 31, 2019, for which it is the primary beneficiary. In addition, the maximum exposure to loss related to the nonconsolidated VIEs for which Historical DuPont did hold a variable interest at March 31, 2019, is not considered material to the consolidated financial statements. The following discussion addresses variable interests held by Historical Dow.

Assets and Liabilities of Consolidated VIEs

The Company's consolidated financial statements include the assets, liabilities and results of operations of VIEs for which Historical Dow is the primary beneficiary. The other equity holders’ interests are reflected in "Net income attributable to noncontrolling interests" in the consolidated statements of income and "Noncontrolling interests" in the consolidated balance sheets.

The following table summarizes the carrying amounts of these entities’ assets and liabilities included in the Company’s consolidated balance sheets at March 31, 2019 and December 31, 2018:

Assets and Liabilities of Consolidated VIEs	Mar 31, 2019		Dec 31, 2018
In millions
Cash and cash equivalents	$	109	$	82
Other current assets	116		114
Net property	718		734
Other noncurrent assets	60		45
Total assets 1	$	1,003	$	975
Current liabilities	$	318	$	334
Long-term debt	43		75
Other noncurrent obligations	46		31
Total liabilities 2	$	407	$	440

1. All assets were restricted at March 31, 2019 and December 31, 2018.

2. All liabilities were nonrecourse at March 31, 2019 and December 31, 2018.

Amounts presented in the consolidated balance sheets and the preceding table as restricted assets or nonrecourse obligations relating to consolidated VIEs at March 31, 2019 and December 31, 2018, are adjusted for intercompany eliminations and parental guarantees.

Nonconsolidated VIEs

The following table summarizes the carrying amounts of assets and liabilities included in the consolidated balance sheets at March 31, 2019 and December 31, 2018, related to variable interests in joint ventures or entities for which Historical Dow is not the primary beneficiary. The Company's maximum exposure to loss is the same as the carrying amounts, unless otherwise noted below.

Carrying Amounts of Assets and Liabilities Related to Nonconsolidated VIEs		Mar 31, 2019			Dec 31, 2018
In millions	Description of asset or liability
Hemlock Semiconductor L.L.C.	Equity method investment 1	$	(658	)	$	(495	)
Silicon joint ventures	Equity method investments 2	$	96		$	100
AgroFresh Solutions, Inc.	Equity method investment 2	$	45		$	48
	Other receivable 3	$	8		$	8

1. Classified as "Other noncurrent obligations" in the consolidated balance sheets. The Company's maximum exposure to loss was zero at March 31, 2019 (zero at December 31, 2018).

2. Classified as "Investment in nonconsolidated affiliates" in the consolidated balance sheets.

3. Classified as "Accounts and notes receivable - Other" in the consolidated balance sheets.

XML

SEGMENTS AND GEOGRAPHIC REGIONS

3 Months Ended

Mar. 31, 2019

Segment Reporting [Abstract]

SEGMENTS AND GEOGRAPHIC REGIONS

SEGMENTS AND GEOGRAPHIC REGIONS

The Company's measure of profit/loss for segment reporting purposes is Operating EBITDA as this is the manner in which the Company's chief operating decision maker ("CODM") assesses performance and allocates resources. The Company defines Operating EBITDA as earnings (i.e., “Income from continuing operations before income taxes") before interest, depreciation, amortization and foreign exchange gains (losses), excluding the impact of significant items. A reconciliation of these measures is provided on the following pages.

Segment Information	Agri-culture			Perf. Materials & Coatings		Ind. Interm. & Infrast.			Pack. & Spec. Plastics		Elect. & Imaging		Nutrition & Biosciences		Transp. & Adv. Polymers		Safety & Const.		Corp.			Total
In millions
Three months ended Mar 31, 2019
Net sales	$	3,397		$	2,255	$	3,402		$	5,110	$	1,078	$	1,659	$	1,355	$	1,322	$	71		$	19,649
Operating EBITDA 1	$	667		$	481	$	448		$	993	$	385	$	390	$	414	$	411	$	(170	)	$	4,019
Equity in earnings (losses) of nonconsolidated affiliates	$	—		$	—	$	(48	)	$	38	$	29	$	4	$	2	$	7	$	(6	)	$	26
Three months ended Mar 31, 2018
Net sales	$	3,808		$	2,304	$	3,715		$	6,010	$	1,153	$	1,720	$	1,425	$	1,299	$	76		$	21,510
Operating EBITDA 1	$	891		$	586	$	654		$	1,301	$	398	$	418	$	437	$	354	$	(168	)	$	4,871
Equity in earnings (losses) of nonconsolidated affiliates	$	(1	)	$	—	$	149		$	59	$	48	$	3	$	3	$	5	$	(9	)	$	257

1. A reconciliation of "Income from continuing operations, net of tax" to Operating EBITDA is provided below.

Reconciliation of "Income from continuing operations, net of tax" to Operating EBITDA	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Income from continuing operations, net of tax	$	571		$	1,153
+ Provision for income taxes on continuing operations	209			389
Income from continuing operations before income taxes	$	780		$	1,542
+ Depreciation and amortization	1,519			1,484
- Interest income 1	75			55
+ Interest expense and amortization of debt discount	454			350
- Foreign exchange gains (losses), net 1, 2	(11		)	(98		)
- Significant items	(1,330		)	(1,452		)
Operating EBITDA	$	4,019		$	4,871

1. Included in "Sundry income (expense) - net."

2. Excludes a $50 million pretax foreign exchange loss significant item related to adjustments to Historical DuPont's foreign currency exchange contracts as a result of U.S. tax reform during the three months ended March 31, 2018.

The following tables summarize the pretax impact of significant items by segment that are excluded from Operating EBITDA above:

Significant Items by Segment for the Three Months Ended Mar 31, 2019	Agri-culture			Perf. Materials & Coatings		Ind. Interm. & Infrast.		Pack. & Spec. Plastics			Elect. & Imaging		Nutrition & Biosciences			Transp. & Adv. Polymers			Safety & Const.			Corp.			Total
In millions
Loss on divestiture 1	$	(24	)	$	—	$	—	$	—		$	—	$	—		$	—		$	—		$	—		$	(24	)
Integration and separation costs 2	—			—		—		—			—		—			—			—			(813		)	(813		)
Inventory step-up amortization 3	(205		)	—		—		—			—		—			—			—			—			(205		)
Restructuring and asset related charges - net4, 5	(50		)	—		—		(13		)	—		(27		)	(1		)	(2		)	(195		)	(288		)
Total	$	(279	)	$	—	$	—	$	(13	)	$	—	$	(27	)	$	(1	)	$	(2	)	$	(1,008	)	$	(1,330	)

1. Reflects a loss related to Historical Dow's sale of a joint venture related to actions under the Synergy Program.

2. Integration and separation costs related to the Merger, post-Merger integration and Intended Business Separation activities.

3. Includes the amortization of the fair value step-up of Historical DuPont's inventories as a result of the Merger.

4. Includes Board approved restructuring plans and asset related charges, which include other asset impairments. See Note 5 for additional information.

5. Includes a $1 million restructuring charge related to an equity affiliate of Transportation & Advanced Polymers that is reflected in "Equity in earnings of nonconsolidated affiliates" in the consolidated statement of income.

Significant Items by Segment for the Three Months Ended Mar 31, 2018	Agri-culture			Perf. Materials & Coatings		Ind. Interm. & Infrast.			Pack. & Spec. Plastics			Elect. & Imaging			Nutrition & Biosciences			Transp. & Adv. Polymers		Safety & Const.			Corp.			Total
In millions
Gain on sale of business/entity 1	$	—		$	—	$	20		$	—		$	—		$	—		$	—	$	—		$	—		$	20
Integration and separation costs 2	—			—		—			—			—			—			—		—			(457		)	(457		)
Inventory step-up amortization 3	(639		)	—		—			—			—			(63		)	—		(1		)	—			(703		)
Restructuring and asset related charges (credits) - net 4	(58		)	1		(11		)	(6		)	(1		)	—			1		(7		)	(181		)	(262		)
Income tax related item 5	—			—		—			—			—			—			—		—			(50		)	(50		)
Total	$	(697	)	$	1	$	9		$	(6	)	$	(1	)	$	(63	)	$	1	$	(8	)	$	(688	)	$	(1,452	)

1. Includes a gain related to Historical Dow's sale of its equity interest in MEGlobal.

2. Integration and separation costs related to the Merger, post-Merger integration and Intended Business Separation activities, and costs related to the ownership restructure of Dow Silicones.

3. Includes the fair value step-up of Historical DuPont's inventories as a result of the Merger and the acquisition of the H&N Business.

4. Includes Board approved restructuring plans and asset related charges, which includes other asset impairments. See Note 5 for additional information.

5. Includes a foreign exchange loss related to adjustments to Historical DuPont's foreign currency exchange contracts as a result of the U.S. tax reform.

XML

SUBSEQUENT EVENTS (Notes)

3 Months Ended

Mar. 31, 2019

Subsequent Event [Line Items]

Subsequent Events [Text Block]

NOTE 24 - SUBSEQUENT EVENTS

Dow Spin-off

Effective as of 5:00 p.m. on April 1, 2019, DowDuPont completed the distribution of Dow. Additionally, Dow commenced trading “regular way” under the symbol “DOW” on the New York Stock Exchange on April 2, 2019. Prior to the commencement of trading on April 2, 2019, the stockholders of record of the Company as of the close of business on March 21, 2019 received one share of Dow Common Stock for every three shares of DowDuPont Common Stock held by such stockholders as of March 21, 2019. The Company did not issue fractional shares of Dow Common Stock in the Dow Distribution; the Company’s stockholders received cash in lieu of fractional shares.

Immediately after the Dow Distribution, DowDuPont does not beneficially own any equity interest in Dow and will no longer consolidate Dow into its financial results. Beginning in the second quarter of 2019, Dow's historical financial results for periods prior to April 1, 2019 will be reflected in the Company's consolidated financial statements as discontinued operations. Dow represents approximately one-third of the Company's assets and just over half of the Company's net sales.

In connection with the Distributions, the Company, Dow and Corteva (together, the “Parties” and each a “Party”) entered into certain agreements that will effect the separations, provide for the allocation of DowDuPont’s assets, employees, liabilities and obligations (including its investments, property, employee benefits and tax-related assets and liabilities) among the Company, Dow, and Corteva, and provide a framework for the Company’s relationship with Dow and Corteva following the separations and Distributions. Effective April 1, 2019, the Parties entered into the following agreements:

• Separation and Distribution Agreement - The Parties entered into an agreement that sets forth, among other things, the agreements among the Parties regarding the principal transactions necessary to effect the Distributions. It also sets forth other agreements that govern certain aspects of the Parties’ ongoing relationships after the completion of the Distributions (the "Separation and Distribution Agreement").

• Tax Matters Agreement - The Parties entered into an agreement that governs their respective rights, responsibilities and obligations with respect to tax liabilities and benefits, tax attributes, the preparation and filing of tax returns, the control of audits and other tax proceedings and other matters regarding taxes.

• Employee Matters Agreement - The Parties entered into an agreement that identifies employees and employee-related liabilities (and attributable assets) to be allocated (either retained, transferred and accepted, or assigned and assumed, as applicable) to the Parties as part of the Distributions and describes when and how the relevant transfers and assignments will occur.

• Intellectual Property Cross-License Agreements - DowDuPont entered into an Intellectual Property Cross-License Agreement with Dow (the “DowDuPont-Dow IP Cross-License Agreement”). In addition, Dow and Corteva entered into an Intellectual Property Cross-License Agreement (the “Dow-Corteva IP Cross-License Agreement”). The Intellectual Property Cross-License Agreements set forth the terms and conditions under which the applicable Parties may use in their respective businesses, following each of the Distributions, certain know-how (including trade secrets), copyrights, and software, and certain patents and standards, allocated to another Party pursuant to the Separation and Distribution Agreement.

In connection with the intended Corteva Distribution, the Company expects to enter into additional agreements, including an intellectual property cross-license agreement with Corteva. This agreement will set forth the terms and conditions under which the Company and Corteva may use, in their respective businesses following the Corteva Distribution, certain know-how (including trade secrets), copyrights, and software, and certain patents and standards, allocated to another Party pursuant to the Separation and Distribution Agreement.

Actions to Achieve Credit Profiles of DuPont, Corteva and Dow

On April 1, 2019, prior to consummating the Dow Distribution, the Company contributed $2,024 million in cash to Dow.

On March 22, 2019, Historical DuPont issued notices of redemption in full of all of its outstanding notes (the “Make Whole Notes”) listed in the table below:

In millions	Amount
4.625% Notes due 2020	$	474
3.625% Notes due 2021	296
4.250% Notes due 2021	163
2.800% Notes due 2023	381
6.500% Debentures due 2028	57
5.600% Senior Notes due 2036	42
4.900% Notes due 2041	48
4.150% Notes due 2043	69
Total	$	1,530

The Make Whole Notes were redeemed on April 22, 2019, at the make-whole redemption prices set forth in the respective Make Whole Notes. On and after the date of redemption, the Make Whole Notes were no longer deemed outstanding, interest on the Make Whole Notes ceased to accrue and all rights of the holders of the Make Whole Notes were terminated.

On May 2, 2019, Historical DuPont terminated its Term Loan Facility and repaid the aggregate outstanding principal amount of $3 billion plus accrued and unpaid interest through and including May 1, 2019.

In contemplation of the foregoing, effective May 2, 2019, the Company fully drew the two term loan facilities it entered into in the fourth quarter of 2018 (the “DWDP Term Loan Facilities” and together with the DowDuPont Notes, the “Financings”) in the aggregate principal amount of $3 billion.

The Company funded the activities above with cash from operations and proceeds from the Financings.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

3 Months Ended

Mar. 31, 2019

Leases [Abstract]

Basis of Accounting, Policy [Policy Text Block]

Interim Financial Statements

The accompanying unaudited interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, the interim consolidated financial statements reflect all adjustments (including normal recurring accruals) which are considered necessary for the fair statement of the results for the periods presented. Results from interim periods should not be considered indicative of results for the full year. These interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. The interim consolidated financial statements include the accounts of the Company and all of its subsidiaries in which a controlling interest is maintained.

Basis of Presentation

Effective August 31, 2017, pursuant to the merger of equals transaction contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 ("Merger Agreement"), The Dow Chemical Company ("Historical Dow") and E. I. du Pont de Nemours and Company ("Historical DuPont") each merged with subsidiaries of DowDuPont and, as a result, Historical Dow and Historical DuPont became subsidiaries of DowDuPont (the "Merger"). Prior to the Merger, DowDuPont did not conduct any business activities other than those required for its formation and matters contemplated by the Merger Agreement. Historical Dow was determined to be the accounting acquirer in the Merger.

Except as otherwise indicated by the context, the term "Historical Dow" includes Historical Dow and its consolidated subsidiaries, "Historical DuPont" includes Historical DuPont and its consolidated subsidiaries, "Union Carbide" means Union Carbide Corporation, a wholly owned subsidiary of Historical Dow, and "Dow Silicones" means Dow Silicones Corporation, a wholly owned subsidiary of Historical Dow.

Lessee, Leases [Policy Text Block]

Leases

The Company determines whether an arrangement is a lease at the inception of the arrangement based on the terms and conditions in the contract. A contract contains a lease if there is an identified asset and the Company has the right to control the asset. Operating lease right-of-use ("ROU") assets are included in "Deferred charges and other assets" on the consolidated balance sheets. Operating lease liabilities are included in "Accrued and other current liabilities" and "Other noncurrent obligations" on the consolidated balance sheets. Finance lease ROU assets are included in "Property" and the corresponding lease liabilities are included in "Long-term debt due within one year" and "Long-term debt" on the consolidated balance sheets.  

ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide the lessor's implicit rate, the Company uses its incremental borrowing rate at the commencement date in determining the present value of lease payments. Lease terms include options to extend the lease when it is reasonably certain those options will be exercised. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and lease expense is recognized on a straight-line basis over the lease term.

The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component for all asset classes. Additionally, for certain equipment leases, the portfolio approach is applied to account for the operating lease ROU assets and lease liabilities. In the consolidated statements of income, lease expense for operating lease payments is recognized on a straight-line basis over the lease term. For finance leases, interest expense is recognized on the lease liability and the ROU asset is amortized over the lease term.

XML

RECENT ACCOUNTING GUIDANCE (Policies)

3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

New Accounting Pronouncements, Policy [Policy Text Block]

Recently Adopted Accounting Guidance

In February 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-02, "Leases (Topic 842)," and associated ASUs related to Topic 842, which requires organizations that lease assets to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. The new guidance requires that a lessee recognize assets and liabilities for leases, and recognition, presentation and measurement in the financial statements will depend on its classification as a finance or operating lease. In addition, the new guidance requires disclosures to help investors and other financial statement users better understand the amount, timing and uncertainty of cash flows arising from leases. Lessor accounting remains largely unchanged from legacy U.S. GAAP but does contain some targeted improvements to align with the new revenue recognition guidance, "Revenue from Contracts with Customers (Topic 606)," issued in 2014.

The Company adopted the new standard in the first quarter of 2019, which allows for a modified retrospective transition approach, applying the new standard to all leases existing at the date of initial adoption. An entity may choose to use either (1) its effective date or (2) the beginning of the earliest comparative period presented in the financial statement as its date of initial application. The Company has elected to apply the transition requirements at the January 1, 2019 effective date rather than at the beginning of the earliest comparative period presented. This approach allows for a cumulative effect adjustment in the period of adoption, and prior periods are not restated and continue to be reported in accordance with historic accounting under ASC 840 "Leases". In addition, the Company has elected the package of practical expedients permitted under the transition guidance within the new standard which does not require reassessment of prior conclusions related to contracts containing a lease, lease classification and initial direct lease costs. As an accounting policy election, the Company chose to not apply the standard to certain existing land easements, excluded short-term leases (term of 12 months or less) from the balance sheet and accounts for nonlease and lease components in a contract as a single component for all asset classes. The following table summarizes the impact of adoption to the consolidated balance sheet:

Summary of Changes to the Consolidated Balance Sheet	As Reported Dec 31, 2018		Effect of Adoption of ASU 2016-02			Updated Jan 1, 2019
In millions
Assets
Net property	$	35,848	$	9		$	35,857
Deferred income tax assets	$	1,724	$	(24	)	$	1,700
Deferred charges and other assets	$	2,476	$	3,386		$	5,862
Total other assets	$	94,197	$	3,362		$	97,559
Total Assets	$	188,030	$	3,371		$	191,401
Liabilities
Long-term debt due within one year	$	637	$	1		$	638
Accrued and other current liabilities	$	7,943	$	721		$	8,664
Total current liabilities	$	24,715	$	722		$	25,437
Long-Term Debt	$	37,662	$	8		$	37,670
Other noncurrent obligations	$	6,988	$	2,569		$	9,557
Total other noncurrent liabilities	$	29,474	$	2,569		$	32,043
Stockholders' Equity
Retained earnings 1	$	30,536	$	72		$	30,608
DowDuPont's stockholders' equity	$	94,571	$	72		$	94,643
Total equity	$	96,179	$	72		$	96,251
Total Liabilities and Equity	$	188,030	$	3,371		$	191,401

1. The net impact to retained earnings was primarily a result of the recognition of a deferred gain associated with a prior sale-leaseback transaction.

The adoption of the new guidance did not have a material impact on the Company's consolidated statement of income and had no impact on the consolidation statement of cash flows.

Accounting Guidance Issued But Not Adopted at March 31, 2019

In August 2018, the FASB issued ASU 2018-13, "Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement," which is part of the FASB disclosure framework project to improve the effectiveness of disclosures in the notes to the financial statements. The amendments in the new guidance remove, modify and add certain disclosure requirements related to fair value measurements covered in ASC 820, "Fair Value Measurement." The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted for either the entire standard or only the requirements that modify or eliminate the disclosure requirements, with certain requirements applied prospectively, and all other requirements applied retrospectively to all periods presented. The Company is currently evaluating the impact of adopting this guidance.

In August 2018, the FASB issued ASU 2018-15, "Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract," which requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in ASC 350, "Intangibles - Goodwill and Other" to determine which implementation costs to capitalize as assets or expense as incurred. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted and an entity can elect to apply the new guidance on a prospective or retrospective basis. The Company is currently evaluating the impact of adopting this guidance.

XML

RECENT ACCOUNTING GUIDANCE (Tables)

3 Months Ended

Mar. 31, 2019

Accounting Standards Update 2016-02 [Member] | Opening Balance Adjustment [Member]

New Accounting Pronouncements or Change in Accounting Principle [Line Items]

Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]

Summary of Changes to the Consolidated Balance Sheet	As Reported Dec 31, 2018		Effect of Adoption of ASU 2016-02			Updated Jan 1, 2019
In millions
Assets
Net property	$	35,848	$	9		$	35,857
Deferred income tax assets	$	1,724	$	(24	)	$	1,700
Deferred charges and other assets	$	2,476	$	3,386		$	5,862
Total other assets	$	94,197	$	3,362		$	97,559
Total Assets	$	188,030	$	3,371		$	191,401
Liabilities
Long-term debt due within one year	$	637	$	1		$	638
Accrued and other current liabilities	$	7,943	$	721		$	8,664
Total current liabilities	$	24,715	$	722		$	25,437
Long-Term Debt	$	37,662	$	8		$	37,670
Other noncurrent obligations	$	6,988	$	2,569		$	9,557
Total other noncurrent liabilities	$	29,474	$	2,569		$	32,043
Stockholders' Equity
Retained earnings 1	$	30,536	$	72		$	30,608
DowDuPont's stockholders' equity	$	94,571	$	72		$	94,643
Total equity	$	96,179	$	72		$	96,251
Total Liabilities and Equity	$	188,030	$	3,371		$	191,401

1. The net impact to retained earnings was primarily a result of the recognition of a deferred gain associated with a prior sale-leaseback transaction.

XML

REVENUE (Tables)

3 Months Ended

Mar. 31, 2019

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue [Table Text Block]

The Company disaggregates its revenue from contracts with customers by segment and business or major product line and geographic region, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows.

Net Trade Sales by Segment and Business or Major Product Line 1	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
Crop Protection	$	1,425	$	1,495
Seed	1,972		2,313
Agriculture	$	3,397	$	3,808
Coatings & Performance Monomers	$	890	$	941
Consumer Solutions	1,365		1,363
Performance Materials & Coatings	$	2,255	$	2,304
Industrial Solutions	$	1,103	$	1,155
Polyurethanes & CAV	2,296		2,556
Other	3		4
Industrial Intermediates & Infrastructure	$	3,402	$	3,715
Hydrocarbons & Energy	$	1,380	$	1,800
Packaging and Specialty Plastics	3,730		4,210
Packaging & Specialty Plastics	$	5,110	$	6,010
Advanced Printing	$	119	$	122
Display Technologies	84		60
Interconnect Solutions	238		281
Photovoltaic & Advanced Materials	254		289
Semiconductor Technologies	383		401
Electronics & Imaging	$	1,078	$	1,153
Industrial Biosciences	$	494	$	541
Nutrition & Health	1,165		1,179
Nutrition & Biosciences	$	1,659	$	1,720
Engineering Polymers	$	663	$	668
Performance Resins	308		351
Performance Solutions	384		406
Transportation & Advanced Polymers	$	1,355	$	1,425
Aramids	$	424	$	393
Construction	327		385
TYVEK® Enterprise	310		292
Water Solutions	261		229
Safety & Construction	$	1,322	$	1,299
Corporate	$	71	$	76
Total	$	19,649	$	21,510

1. Beginning in the third quarter of 2018, DowDuPont realigned certain global businesses and product lines in preparation for the Intended Business Separations. These changes have been retrospectively reflected in the results presented.

Net Trade Sales by Geographic Region	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
U.S. & Canada	$	7,014	$	7,909
EMEA 1	6,269		6,919
Asia Pacific	4,639		4,790
Latin America	1,727		1,892
Total	$	19,649	$	21,510

1. Europe, Middle East and Africa.

Contract with Customer, Asset and Liability [Table Text Block]

Contract Balances	Mar 31, 2019		Dec 31, 2018
In millions
Accounts and notes receivable - Trade	$	13,963	$	12,376
Contract assets - current 1	$	62	$	85
Contract assets - noncurrent 2	$	47	$	47
Contract liabilities - current 3	$	2,266	$	2,092
Contract liabilities - noncurrent 4	$	1,767	$	1,420

1. Included in "Other current assets" in the consolidated balance sheets.

2. Included in "Deferred charges and other assets" in the consolidated balance sheets.

3. Included in "Accrued and other current liabilities" in the consolidated balance sheets.

4. Included in "Other noncurrent obligations" in the consolidated balance sheets.

XML

RESTRUCTURING AND ASSET RELATED CHARGES - NET (Tables)

3 Months Ended

Mar. 31, 2019

DowDuPont Agricultural Division Restructuring Program

Restructuring Cost and Reserve [Line Items]

Schedule of restructuring reserve activity

The following table summarizes the activities related to the Agriculture Division Program. At March 31, 2019, $58 million ($77 million at December 31, 2018) was included in "Accrued and other current liabilities" in the consolidated balance sheets.

Agriculture Division Program	Severance and Related Benefit Costs			Asset Write-downs and Write-offs			Total
(In millions)
Reserve balance at Dec 31, 2018	$	77		$	—		$	77
2019 restructuring charges and adjustments 1	(4		)	3			(1		)
Charges against the reserve	—			(3		)	(3		)
Cash payments	(15		)	—			(15		)
Reserve balance at Mar 31, 2019	$	58		$	—		$	58

1. Included in "Restructuring and asset related charges - net" in the consolidated statements of income.

DowDuPont Cost Synergy Program

Restructuring Cost and Reserve [Line Items]

Schedule of restructuring reserve activity

The following table summarizes the activities related to the Synergy Program. At March 31, 2019, $464 million was included in "Accrued and other current liabilities" ($490 million at December 31, 2018) and $99 million was included in "Other noncurrent obligations" ($84 million at December 31, 2018) in the consolidated balance sheets.

Synergy Program	Severance and Related Benefit Costs			Asset Write-downs and Write-offs			Costs Associated with Exit and Disposal Activities			Total
In millions
Reserve balance at Dec 31, 2018	$	491		$	—		$	83		$	574
2019 restructuring charges	112			116			52			280
Charges against the reserve	—			(115		)	—			(115		)
Cash payments	(140		)	—			(36		)	(176		)
Reserve balance at Mar 31, 2019	$	463		$	1		$	99		$	563

XML

SUPPLEMENTARY INFORMATION (Tables)

3 Months Ended

Mar. 31, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of sundry income (expense), net

The following table provides the most significant transactions recorded in "Sundry income (expense) - net" for the three months ended March 31, 2019 and 2018:

Sundry Income (Expense) - Net	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Non-operating pension and other postretirement benefit plan net credit	$	108		$	110
Interest income	$	75		$	55
Gains on sales of other assets and investments, net 1	$	50		$	34
Foreign exchange losses, net 2	$	(11	)	$	(148	)

1. Includes a $51 million gain related to a sale of assets by Historical DuPont and $24 million loss related to Historical Dow's sale of a joint venture in the first quarter of 2019. Includes a $20 million gain in the first quarter of 2018 related to Historical Dow's sale of its equity interest in MEGlobal.

2. Includes a $50 million foreign exchange loss in the first quarter of 2018 related to adjustments to Historical DuPont's foreign currency exchange contracts as a result of U.S. tax reform.

XML

EARNINGS PER SHARE CALCULATIONS (Tables)

3 Months Ended

Mar. 31, 2019

Earnings Per Share [Abstract]

Schedule of Earnings Per Share

The following tables provide earnings per share calculations for the three months ended March 31, 2019 and 2018:

Net Income for Earnings Per Share Calculations - Basic	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Income from continuing operations, net of tax	$	571		$	1,153
Net income attributable to noncontrolling interests	(51		)	(44		)
Net income attributable to participating securities 1	(1		)	(6		)
Income from continuing operations attributable to common stockholders	$	519		$	1,103
Loss from discontinued operations, net of tax	—			(5		)
Net income attributable to common stockholders	$	519		$	1,098

Earnings Per Share Calculations - Basic	Three Months Ended
	Mar 31, 2019		Mar 31, 2018
Dollars per share
Income from continuing operations attributable to common stockholders	$	0.23	$	0.47
Loss from discontinued operations, net of tax	—		—
Net income attributable to common stockholders	$	0.23	$	0.47

Net Income for Earnings Per Share Calculations - Diluted	Three Months Ended
	Mar 31, 2019			Mar 31, 2018
In millions
Income from continuing operations, net of tax	$	571		$	1,153
Net income attributable to noncontrolling interests	(51		)	(44		)
Net income attributable to participating securities 1	(1		)	(6		)
Income from continuing operations attributable to common stockholders	$	519		$	1,103
Loss from discontinued operations, net of tax	—			(5		)
Net income attributable to common stockholders	$	519		$	1,098

Earnings Per Share Calculations - Diluted	Three Months Ended
	Mar 31, 2019		Mar 31, 2018
Dollars per share
Income from continuing operations attributable to common stockholders	$	0.23	$	0.47
Loss from discontinued operations, net of tax	—		—
Net income attributable to common stockholders	$	0.23	$	0.47

Share Count Information	Three Months Ended
	Mar 31, 2019	Mar 31, 2018
Shares in millions
Weighted-average common shares - basic	2,250.1	2,317.0
Plus dilutive effect of equity compensation plans	9.1	17.3
Weighted-average common shares - diluted	2,259.2	2,334.3
Stock options and restricted stock units excluded from EPS calculations 2	19.2	5.3

1. Historical Dow restricted stock units are considered participating securities due to Historical Dow's practice of paying dividend equivalents on unvested shares.

2. These outstanding options to purchase shares of common stock and restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

XML

INVENTORIES (Tables)

3 Months Ended

Mar. 31, 2019

Inventory Disclosure [Abstract]

Schedule of inventory

The following table provides a breakdown of inventories:

Inventories	Mar 31, 2019		Dec 31, 2018
In millions
Finished goods	$	10,060	$	9,814
Work in process	3,561		3,969
Raw materials	1,461		1,419
Supplies	1,276		1,321
Total	$	16,358	$	16,523
Adjustment of inventories to a LIFO basis	246		98
Total inventories	$	16,604	$	16,621

XML

NONCONSOLIDATED AFFILIATES NONCONSOLIDATED AFFILIATES (Tables)

3 Months Ended

Mar. 31, 2019

Equity Method Investments and Joint Ventures [Abstract]

Nonconsolidated Affiliates - Investments [Table Text Block]

The Company's investments in companies accounted for using the equity method ("nonconsolidated affiliates"), by classification in the consolidated balance sheets, are shown in the following table:

Investments in Nonconsolidated Affiliates	Mar 31, 2019			Dec 31, 2018
In millions
Investment in nonconsolidated affiliates	$	4,687		$	5,204
Accrued and other current liabilities	(81		)	(81		)
Other noncurrent obligations	(870		)	(495		)
Net investment in nonconsolidated affiliates	$	3,736		$	4,628

Nonconsolidated Affiliates - HSC Group Investments [Table Text Block]

The following table reflects the carrying value of the HSC Group investments at March 31, 2019 and December 31, 2018:

Investment in the HSC Group		Investment
In millions	Balance Sheet Classification	Mar 31, 2019			Dec 31, 2018
Hemlock Semiconductor L.L.C.	Other noncurrent obligations	$	(658	)	$	(495	)
DC HSC Holdings LLC	Investment in nonconsolidated affiliates	$	485		$	535

XML

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)

3 Months Ended

Mar. 31, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of goodwill

Goodwill	Agri-culture		Perf. Materials & Coatings			Ind. Interm. & Infrast.			Pack. & Spec. Plastics			Elect. & Imaging			Nutrition & Biosciences			Transp. & Adv. Polymers			Safety & Const.			Total
In millions
Net goodwill at Dec 31, 2018	$	14,689	$	3,650		$	1,096		$	5,101		$	8,188		$	12,643		$	6,967		$	6,698		$	59,032
Foreign currency impact	11		(20		)	(2		)	(7		)	(3		)	(29		)	(15		)	(19		)	(84		)
Net goodwill at Mar 31, 2019	$	14,700	$	3,630		$	1,094		$	5,094		$	8,185		$	12,614		$	6,952		$	6,679		$	58,948

Schedule of other finite intangible assets

The following table provides information regarding the Company's other intangible assets:

Other Intangible Assets	Mar 31, 2019							Dec 31, 2018
In millions	Gross Carrying Amount		Accum Amort			Net		Gross Carrying Amount		Accum Amort			Net
Intangible assets with finite lives:
Developed technology 1	$	8,179	$	(2,731	)	$	5,448	$	7,761	$	(2,562	)	$	5,199
Software	1,539		(900		)	639		1,529		(876		)	653
Trademarks/tradenames	1,763		(773		)	990		1,772		(745		)	1,027
Customer-related	14,208		(3,095		)	11,113		14,236		(2,895		)	11,341
Microbial cell factories	384		(26		)	358		386		(22		)	364
Favorable supply contracts	493		(136		)	357		475		(111		)	364
Other 2	612		(204		)	408		620		(203		)	417
Total other intangible assets with finite lives	$	27,178	$	(7,865	)	$	19,313	$	26,779	$	(7,414	)	$	19,365
Intangible assets with indefinite lives:
IPR&D 1	149		—			149		594		—			594
Germplasm 3	6,265		—			6,265		6,265		—			6,265
Trademarks/tradenames	4,740		—			4,740		4,741		—			4,741
Total other intangible assets	$	38,332	$	(7,865	)	$	30,467	$	38,379	$	(7,414	)	$	30,965

1. During the first quarter of 2019, Historical DuPont announced an expanded launch of its Qrome® corn hybrids following the receipt of regulatory approval from China. As a result, Historical DuPont reclassified the amounts from indefinite-lived IPR&D to developed technology.

2. Primarily consists of sales and grower networks, marketing and manufacturing alliances and noncompetition agreements.

3. Germplasm is the pool of genetic source material and body of knowledge gained from the development and delivery stage of plant breeding. This intangible asset is expected to contribute to cash flows beyond the foreseeable future and there are no legal, regulatory, contractual or other factors which limit its useful life.

Schedule of other indefinite intangible assets

The following table provides information regarding the Company's other intangible assets:

Other Intangible Assets	Mar 31, 2019							Dec 31, 2018
In millions	Gross Carrying Amount		Accum Amort			Net		Gross Carrying Amount		Accum Amort			Net
Intangible assets with finite lives:
Developed technology 1	$	8,179	$	(2,731	)	$	5,448	$	7,761	$	(2,562	)	$	5,199
Software	1,539		(900		)	639		1,529		(876		)	653
Trademarks/tradenames	1,763		(773		)	990		1,772		(745		)	1,027
Customer-related	14,208		(3,095		)	11,113		14,236		(2,895		)	11,341
Microbial cell factories	384		(26		)	358		386		(22		)	364
Favorable supply contracts	493		(136		)	357		475		(111		)	364
Other 2	612		(204		)	408		620		(203		)	417
Total other intangible assets with finite lives	$	27,178	$	(7,865	)	$	19,313	$	26,779	$	(7,414	)	$	19,365
Intangible assets with indefinite lives:
IPR&D 1	149		—			149		594		—			594
Germplasm 3	6,265		—			6,265		6,265		—			6,265
Trademarks/tradenames	4,740		—			4,740		4,741		—			4,741
Total other intangible assets	$	38,332	$	(7,865	)	$	30,467	$	38,379	$	(7,414	)	$	30,965

1. During the first quarter of 2019, Historical DuPont announced an expanded launch of its Qrome® corn hybrids following the receipt of regulatory approval from China. As a result, Historical DuPont reclassified the amounts from indefinite-lived IPR&D to developed technology.

2. Primarily consists of sales and grower networks, marketing and manufacturing alliances and noncompetition agreements.

3. Germplasm is the pool of genetic source material and body of knowledge gained from the development and delivery stage of plant breeding. This intangible asset is expected to contribute to cash flows beyond the foreseeable future and there are no legal, regulatory, contractual or other factors which limit its useful life.

Schedule of amortization expense

The following table provides information regarding amortization expense related to other intangible assets:

Amortization Expense	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
Other intangible assets, excluding software	$	474	$	474
Software, included in "Cost of sales"	$	25	$	23

Schedule of estimated future amortization expense

Total estimated amortization expense for 2019 and the five succeeding fiscal years is as follows:

Estimated Amortization Expense
In millions
2019	$	2,008
2020	$	1,893
2021	$	1,851
2022	$	1,760
2023	$	1,612
2024	$	1,500

XML

TRANSFERS OF FINANCIAL ASSETS (Tables)

3 Months Ended

Mar. 31, 2019

Transfers and Servicing [Abstract]

Schedule of Cash Proceeds

The following represents the cash flows between Historical Dow and the conduits:

Cash Proceeds	Three Months Ended
In millions	Mar 31, 2019		Mar 31, 2018
Interests in conduits 1	$	—	$	445

1. Presented in "Investing Activities" in the consolidated statements of cash flows.

XML

COMMITMENTS AND CONTINGENT LIABILITIES (Tables)

3 Months Ended

Mar. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Schedule of Guarantor Obligations

The following table provides a summary of the final expiration, maximum future payments and recorded liability reflected in the consolidated balance sheets for each type of guarantee:

Guarantees	Mar 31, 2019					Dec 31, 2018
In millions	Final Expiration	Maximum Future Payments		Recorded Liability		Final Expiration	Maximum Future Payments		Recorded Liability
Historical Dow guarantees	2023	$	4,514	$	15	2023	$	4,523	$	25
Historical DuPont guarantees	2022	239		—		2022	255		—
Total guarantees		$	4,753	$	15		$	4,778	$	25

XML

LEASES (Tables)

3 Months Ended

Mar. 31, 2019

Leases [Abstract]

Components of Lease Expense [Table Text Block]

Lease Cost	Three Months Ended Mar 31, 2019
(In millions)
Operating lease cost	$	201
Finance lease cost
Amortization of right-of-use assets	$	41
Interest on lease liabilities	7
Total finance lease cost	$	48
Short-term lease cost	$	60
Variable lease cost	89
Sublease income	(9		)
Total lease cost	$	389

Schedule of Supplemental Cash Flow Information Related to Leases [Table Text Block]

Other Lease Information	Three Months Ended Mar 31, 2019
(In millions)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	210
Operating cash flows from finance leases	$	7
Financing cash flows from finance leases	$	23

Schedule of Lease Assets and Liabilities [Table Text Block]

Lease Position	Mar 31, 2019
(In millions)
Operating Leases
Operating lease right-of-use assets 1	$	3,287
Current operating lease liabilities 2	$	690
Noncurrent operating lease liabilities 3	2,620
Total operating lease liabilities	$	3,310
Finance Leases
Property	$	589
Accumulated depreciation	(181		)
Net Property	$	408
Long-term debt due within one year	63
Long-Term Debt	432
Total finance lease liabilities	$	495

1. Included in "Deferred charges and other assets" in the consolidated balance sheet.

2. Included in "Accrued and other current liabilities" in the consolidated balance sheet.

3. Included in "Other noncurrent obligations" in the consolidated balance sheet.

Lease Terms and Discount Rates [Table Text Block]

Lease Term and Discount Rate	Mar 31, 2019
Weighted-average remaining lease term (years)
Operating leases	7.98
Finance leases	15.54
Weighted-average discount rate
Operating leases	3.97	%
Finance leases	6.25	%

Maturities of Lease Liabilities [Table Text Block]

Maturity of Lease Liabilities at Mar 31, 2019	Operating Leases		Finance Leases
(In millions)
2019	$	621	$	74
2020	686		78
2021	553		73
2022	450		71
2023	346		80
2024 and thereafter	1,286		315
Total future undiscounted lease payments	$	3,942	$	691
Less: Interest	632		196
Present value of lease liabilities	$	3,310	$	495

Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]

Future minimum lease payments for operating leases accounted for under ASC 840, "Leases," with remaining non-cancelable terms in excess of one year at December 31, 2018 were as follows:

Minimum Lease Commitments at Dec 31, 2018
(In millions)
2019	$	654
2020	497
2021	418
2022	363
2023	297
2024 and thereafter	1,063
Total	$	3,292

Lease Guarantees [Table Text Block]

Lease Guarantees	Mar 31, 2019					Dec 31, 2018
(In millions)	Final Expiration	Maximum Future Payments		Recorded Liability		Final Expiration	Maximum Future Payments		Recorded Liability
Residual value guarantees	2028	$	931	$	—	2028	$	889	$	130

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)

3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Schedule of Components of Other Comprehensive Income (Loss)

The following table summarizes the activity related to each component of accumulated other comprehensive loss ("AOCL") for the three months ended March 31, 2019 and 2018:

Accumulated Other Comprehensive Loss	Unrealized Gains (Losses) on Investments			Cumulative Translation Adj			Pension and Other Postretire Benefits			Derivative Instruments			Total Accum Other Comp Loss
In millions
Balance at Jan 1, 2018	$	17		$	(1,935	)	$	(6,923	)	$	(111	)	$	(8,952	)
Other comprehensive income (loss) before reclassifications	(26		)	1,333			4			(4		)	1,307
Amounts reclassified from accumulated other comprehensive income	1			—			126			21			148
Net other comprehensive income (loss)	$	(25	)	$	1,333		$	130		$	17		$	1,455
Balance at Mar 31, 2018	$	(8	)	$	(602	)	$	(6,793	)	$	(94	)	$	(7,497	)
Balance at Jan 1, 2019	$	(51	)	$	(3,785	)	$	(8,476	)	$	(82	)	$	(12,394	)
Other comprehensive income (loss) before reclassifications	68			(79		)	(7		)	(65		)	(83		)
Amounts reclassified from accumulated other comprehensive income (loss)	(1		)	(18		)	142			(10		)	113
Net other comprehensive income (loss)	$	67		$	(97	)	$	135		$	(75	)	$	30
Balance at Mar 31, 2019	$	16		$	(3,882	)	$	(8,341	)	$	(157	)	$	(12,364	)

The tax effects on the net activity related to each component of other comprehensive income (loss) for the three months ended March 31, 2019 and 2018 were as follows:

Tax Benefit (Expense) 1	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Unrealized (losses) gains on investments	$	(18	)	$	6
Cumulative translation adjustments	(1		)	5
Pension and other postretirement benefit plans	(32		)	(30		)
Derivative instruments	24			(1		)
Tax expense from income taxes related to other comprehensive income items	$	(27	)	$	(20	)

1. Prior period amounts were updated to conform with the current year presentation.

Schedule of Reclassifications Out of Accumulated Other Comprehensive Income

A summary of the reclassifications out of AOCL for the three months ended March 31, 2019 and 2018 is provided as follows:

Reclassifications Out of Accumulated Other Comprehensive Loss	Three Months Ended						Consolidated Statements of Income Classification
	Mar 31, 2019			Mar 31, 2018
In millions
Unrealized (gains) losses on investments	$	(1	)	$	2		See (1) below
Tax benefit	—			(1		)	See (2) below
After tax	$	(1	)	$	1
Cumulative translation adjustments	$	(18	)	$	—		See (3) below
Pension and other postretirement benefit plans	$	167		$	154		See (4) below
Tax benefit	(25		)	(28		)	See (2) below
After tax	$	142		$	126
Derivative Instruments	$	(11	)	$	26		See (5) below
Tax expense (benefit)	1			(5		)	See (2) below
After tax	$	(10	)	$	21
Total reclassifications for the period, after tax	$	113		$	148

1. "Net sales" and "Sundry income (expense) - net."

2. "Provision for income taxes on continuing operations."

3. "Sundry income (expense) - net."

4. These AOCL components are included in the computation of net periodic benefit cost of the Company's defined benefit pension and other postretirement benefit plans. See Note 18 for additional information.

5. "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount.

XML

NONCONTROLLING INTERESTS (Tables)

3 Months Ended

Mar. 31, 2019

Noncontrolling Interest [Abstract]

Schedule Of Noncontrolling Interest

The following table summarizes the activity for equity attributable to noncontrolling interests for the three months ended March 31, 2019 and 2018:

Noncontrolling Interests	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Balance at beginning of period	$	1,608		$	1,597
Net income attributable to noncontrolling interests	51			44
Distributions to noncontrolling interests	(11		)	(27		)
Noncontrolling interests from Merger 1	—			56
Cumulative translation adjustments	7			(6		)
Other	(1		)	—
Balance at end of period	$	1,654		$	1,664

1. Relates to Merger and subsequent measurement period adjustments.

XML

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Tables)

3 Months Ended

Mar. 31, 2019

Retirement Benefits [Abstract]

Schedule of net periodic benefit costs

The following table provides the components of net periodic benefit cost (credit) for Historical Dow and Historical DuPont's significant plans:

Net Periodic Benefit Cost (Credit) for All Significant Plans	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Defined Benefit Pension Plans:
Service cost	$	131		$	167
Interest cost	447			408
Expected return on plan assets	(713		)	(709		)
Amortization of prior service credit	(6		)	(6		)
Amortization of net loss	133			171
Net periodic benefit cost (credit)	$	(8	)	$	31
Other Postretirement Benefits:
Service cost	$	4		$	5
Interest cost	37			32
Amortization of net gain	(6		)	(6		)
Net periodic benefit cost	$	35		$	31

XML

FINANCIAL INSTRUMENTS (Tables)

3 Months Ended

Mar. 31, 2019

Investments, All Other Investments [Abstract]

Schedule of the fair value of financial instruments

The following table summarizes the fair value of financial instruments at March 31, 2019 and December 31, 2018:

Fair Value of Financial Instruments	Mar 31, 2019											Dec 31, 2018
In millions	Cost			Gain		Loss			Fair Value			Cost			Gain		Loss			Fair Value
Cash equivalents	$	7,384		$	9	$	—		$	7,393		$	9,951		$	12	$	—		$	9,963
Restricted cash equivalents 1	$	480		$	—	$	—		$	480		$	500		$	—	$	—		$	500
Marketable securities:
Available-for-sale 2	$	101		$	—	$	—		$	101		$	100		$	—	$	—		$	100
Held-to-maturity 3	18			—		—			18			34			—		—			34
Total marketable securities	$	119		$	—	$	—		$	119		$	134		$	—	$	—		$	134
Other investments:
Debt securities:
Government debt 4	$	694		$	17	$	(9	)	$	702		$	714		$	9	$	(23	)	$	700
Corporate bonds	1,051			43		(21		)	1,073			1,026			20		(63		)	983
Total debt securities	$	1,745		$	60	$	(30	)	$	1,775		$	1,740		$	29	$	(86	)	$	1,683
Equity securities 5	$	17		$	5	$	—		$	22		$	17		$	1	$	(2	)	$	16
Total other investments	$	1,762		$	65	$	(30	)	$	1,797		$	1,757		$	30	$	(88	)	$	1,699
Total cash and restricted cash equivalents, marketable securities and other investments	$	9,745		$	74	$	(30	)	$	9,789		$	12,342		$	42	$	(88	)	$	12,296
Long-term debt including debt due within one year 6	$	(38,975	)	$	102	$	(2,470	)	$	(41,343	)	$	(38,299	)	$	390	$	(1,457	)	$	(39,366	)
Derivatives relating to:
Interest rates	$	—		$	—	$	(181	)	$	(181	)	$	—		$	—	$	(64	)	$	(64	)
Foreign currency 7	—			128		(17		)	111			—			157		(49		)	108
Commodities 7	—			88		(147		)	(59		)	—			91		(178		)	(87		)
Total derivatives	$	—		$	216	$	(345	)	$	(129	)	$	—		$	248	$	(291	)	$	(43	)

1. Classified as "Other current assets" in the consolidated balance sheets.

2. Available-for-sale securities with maturities of less than one year at the time of purchase.

3. Held-to-maturity securities with maturities of more than three months to less than one year at the time of purchase.

4. U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

5. Equity securities with a readily determinable fair value.

6. Cost includes fair value adjustments of $69 million at March 31, 2019 and $78 million at December 31, 2018, related to the accounting for the Merger. Cost also includes fair value hedge adjustments of $17 million at March 31, 2019 and $18 million at December 31, 2018 on $2,290 million of debt at March 31, 2019 and December 31, 2018.

7. Presented net of cash collateral where master netting arrangements allow.

Schedule of investing results

The Company's investments in debt securities are primarily classified as available-for-sale. For the three months ended March 31, 2019, $35 million of marketable securities matured. The following table provides the investing results from available-for-sale securities for the three months ended March 31, 2019 and 2018:

Investing Results	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Proceeds from sales of available-for-sale securities	$	159		$	348
Gross realized gains	$	6		$	7
Gross realized losses	$	(5	)	$	(9	)

Schedule of fair value of derivative instruments using Level 2 inputs

The following tables provide the fair value and balance sheet classification of derivative instruments at March 31, 2019 and December 31, 2018:

Fair Value of Derivative Instruments		Mar 31, 2019
In millions	Balance Sheet Classification	Gross		Counterparty and Cash Collateral Netting 1			Net Amounts Included in the Consolidated Balance Sheet
Asset derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other current assets	$	161	$	(89	)	$	72
Commodity contracts	Other current assets	31		(5		)	26
Commodity contracts	Deferred charges and other assets	57		(4		)	53
Total		$	249	$	(98	)	$	151
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	$	87	$	(31	)	$	56
Commodity contracts	Other current assets	8		(1		)	7
Commodity contracts	Deferred charges and other assets	4		(2		)	2
Total		$	99	$	(34	)	$	65
Total asset derivatives		$	348	$	(132	)	$	216
Liability derivatives:
Derivatives designated as hedging instruments:
Interest rate swaps	Other noncurrent obligations	$	181	$	—		$	181
Foreign currency contracts	Accrued and other current liabilities	98		(89		)	9
Commodity contracts	Accrued and other current liabilities	93		(6		)	87
Commodity contracts	Other noncurrent obligations	60		(8		)	52
Total		$	432	$	(103	)	$	329
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	37	$	(29	)	$	8
Commodity contracts	Accrued and other current liabilities	8		(4		)	4
Commodity contracts	Other noncurrent obligations	7		(3		)	4
Total		$	52	$	(36	)	$	16
Total liability derivatives		$	484	$	(139	)	$	345

1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

Fair Value of Derivative Instruments		Dec 31, 2018
In millions	Balance Sheet Classification	Gross		Counterparty and Cash Collateral Netting 1			Net Amounts Included in the Consolidated Balance Sheet
Asset derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other current assets	$	98	$	(42	)	$	56
Commodity contracts	Other current assets	47		(13		)	34
Commodity contracts	Deferred charges and other assets	18		(3		)	15
Total		$	163	$	(58	)	$	105
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	$	200	$	(99	)	$	101
Commodity contracts	Other current assets	41		(1		)	40
Commodity contracts	Deferred charges and other assets	4		(2		)	2
Total		$	245	$	(102	)	$	143
Total asset derivatives		$	408	$	(160	)	$	248
Liability derivatives:
Derivatives designated as hedging instruments:
Interest rate swaps	Other noncurrent obligations	$	64	$	—		$	64
Foreign currency contracts	Accrued and other current liabilities	46		(42		)	4
Commodity contracts	Accrued and other current liabilities	111		(18		)	93
Commodity contracts	Other noncurrent obligations	86		(9		)	77
Total		$	307	$	(69	)	$	238
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	124	$	(79	)	$	45
Commodity contracts	Accrued and other current liabilities	7		(4		)	3
Commodity contracts	Other noncurrent obligations	8		(3		)	5
Total		$	139	$	(86	)	$	53
Total liability derivatives		$	446	$	(155	)	$	291

1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

XML

FAIR VALUE MEASUREMENTS (Tables)

3 Months Ended

Mar. 31, 2019

Fair Value Disclosures [Abstract]

Schedule of the fair value of assets and liabilities measured on a recurring basis

The following tables summarize the bases used to measure certain assets and liabilities at fair value on a recurring basis:

Basis of Fair Value Measurements on a Recurring Basis at Mar 31, 2019	Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)		Total
In millions
Assets at fair value:
Cash equivalents 1	$	—	$	7,393	$	7,393
Restricted cash equivalents 1	—		480		480
Marketable securities 2	—		119		119
Equity securities 3	21		—		21
Debt securities: 3
Government debt 4	—		702		702
Corporate bonds	19		1,054		1,073
Derivatives relating to: 5
Foreign currency	—		247		247
Commodities	10		90		100
Total assets at fair value	$	50	$	10,085	$	10,135
Liabilities at fair value:
Long-term debt including debt due within one year 6	$	—	$	41,343	$	41,343
Derivatives relating to: 5
Interest rates	—		181		181
Foreign currency	—		134		134
Commodities	13		155		168
Total liabilities at fair value	$	13	$	41,813	$	41,826

1. Treasury bills, time deposits, and money market funds included in "Cash and cash equivalents" and money market funds included in "Other current assets" in the consolidated balance sheets and held at amortized cost, which approximates fair value.

2. Primarily time deposits with maturities of greater than three months at time of acquisition.

3. The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” in the consolidated balance sheets.

4. U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

5. See Note 20 for the classification of derivatives in the consolidated balance sheets.

6. See Note 20 for information on fair value measurements of long-term debt.

Basis of Fair Value Measurements on a Recurring Basis at Dec 31, 2018	Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)		Total
In millions
Assets at fair value:
Cash equivalents 1	$	—	$	9,963	$	9,963
Restricted cash equivalents 1	—		500		500
Marketable securities 2	—		134		134
Equity securities 3	16		—		16
Debt securities: 3
Government debt 4	—		700		700
Corporate bonds	—		983		983
Derivatives relating to: 5
Foreign currency	—		298		298
Commodities	17		93		110
Total assets at fair value	$	33	$	12,671	$	12,704
Liabilities at fair value:
Long-term debt including debt due within one year 6	$	—	$	39,366	$	39,366
Derivatives relating to: 5
Interest rates	—		64		64
Foreign currency	—		170		170
Commodities	23		189		212
Total liabilities at fair value	$	23	$	39,789	$	39,812

1. Treasury bills, time deposits, and money market funds included in "Cash and cash equivalents" and money market funds included in "Other current assets" in the consolidated balance sheets and held at amortized cost, which approximates fair value.

2. Primarily time deposits with maturities of greater than three months at time of acquisition.

3. The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” in the consolidated balance sheets.

4. U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

5. See Note 20 for the classification of derivatives in the consolidated balance sheets.

6. See Note 20 for information on fair value measurements of long-term debt.

XML

VARIABLE INTEREST ENTITIES (Tables)

3 Months Ended

Mar. 31, 2019

Variable Interest Entity, Primary Beneficiary, Aggregated Disclosure [Member]

Variable Interest Entity [Line Items]

Schedule of assets and liabilities of Consolidated VIEs

The following table summarizes the carrying amounts of these entities’ assets and liabilities included in the Company’s consolidated balance sheets at March 31, 2019 and December 31, 2018:

Assets and Liabilities of Consolidated VIEs	Mar 31, 2019		Dec 31, 2018
In millions
Cash and cash equivalents	$	109	$	82
Other current assets	116		114
Net property	718		734
Other noncurrent assets	60		45
Total assets 1	$	1,003	$	975
Current liabilities	$	318	$	334
Long-term debt	43		75
Other noncurrent obligations	46		31
Total liabilities 2	$	407	$	440

1. All assets were restricted at March 31, 2019 and December 31, 2018.

2. All liabilities were nonrecourse at March 31, 2019 and December 31, 2018.

XML

VARIABLE INTEREST ENTITIES Nonconsolidated Variable Interest Entities (Tables)

3 Months Ended

Mar. 31, 2018

Variable Interest Entity, Not Primary Beneficiary, Aggregated Disclosure [Member]

Variable Interest Entity [Line Items]

Schedule of Variable Interest Entities [Table Text Block]

The Company's maximum exposure to loss is the same as the carrying amounts, unless otherwise noted below.

Carrying Amounts of Assets and Liabilities Related to Nonconsolidated VIEs		Mar 31, 2019			Dec 31, 2018
In millions	Description of asset or liability
Hemlock Semiconductor L.L.C.	Equity method investment 1	$	(658	)	$	(495	)
Silicon joint ventures	Equity method investments 2	$	96		$	100
AgroFresh Solutions, Inc.	Equity method investment 2	$	45		$	48
	Other receivable 3	$	8		$	8

1. Classified as "Other noncurrent obligations" in the consolidated balance sheets. The Company's maximum exposure to loss was zero at March 31, 2019 (zero at December 31, 2018).

2. Classified as "Investment in nonconsolidated affiliates" in the consolidated balance sheets.

3. Classified as "Accounts and notes receivable - Other" in the consolidated balance sheets.

XML

SEGMENTS AND GEOGRAPHIC REGIONS (Tables)

3 Months Ended

Mar. 31, 2019

Segment Reporting Information [Line Items]

Schedule of Operating Segment Information

Segment Information	Agri-culture			Perf. Materials & Coatings		Ind. Interm. & Infrast.			Pack. & Spec. Plastics		Elect. & Imaging		Nutrition & Biosciences		Transp. & Adv. Polymers		Safety & Const.		Corp.			Total
In millions
Three months ended Mar 31, 2019
Net sales	$	3,397		$	2,255	$	3,402		$	5,110	$	1,078	$	1,659	$	1,355	$	1,322	$	71		$	19,649
Operating EBITDA 1	$	667		$	481	$	448		$	993	$	385	$	390	$	414	$	411	$	(170	)	$	4,019
Equity in earnings (losses) of nonconsolidated affiliates	$	—		$	—	$	(48	)	$	38	$	29	$	4	$	2	$	7	$	(6	)	$	26
Three months ended Mar 31, 2018
Net sales	$	3,808		$	2,304	$	3,715		$	6,010	$	1,153	$	1,720	$	1,425	$	1,299	$	76		$	21,510
Operating EBITDA 1	$	891		$	586	$	654		$	1,301	$	398	$	418	$	437	$	354	$	(168	)	$	4,871
Equity in earnings (losses) of nonconsolidated affiliates	$	(1	)	$	—	$	149		$	59	$	48	$	3	$	3	$	5	$	(9	)	$	257

1. A reconciliation of "Income from continuing operations, net of tax" to Operating EBITDA is provided below.

Reconciliation of Income from Continuing Operations, net of tax to Pro Forma Operating EBITDA

Reconciliation of "Income from continuing operations, net of tax" to Operating EBITDA	Three Months Ended
In millions	Mar 31, 2019			Mar 31, 2018
Income from continuing operations, net of tax	$	571		$	1,153
+ Provision for income taxes on continuing operations	209			389
Income from continuing operations before income taxes	$	780		$	1,542
+ Depreciation and amortization	1,519			1,484
- Interest income 1	75			55
+ Interest expense and amortization of debt discount	454			350
- Foreign exchange gains (losses), net 1, 2	(11		)	(98		)
- Significant items	(1,330		)	(1,452		)
Operating EBITDA	$	4,019		$	4,871

1. Included in "Sundry income (expense) - net."

2. Excludes a $50 million pretax foreign exchange loss significant item related to adjustments to Historical DuPont's foreign currency exchange contracts as a result of U.S. tax reform during the three months ended March 31, 2018.

Schedule of Certain Items by Segment

The following tables summarize the pretax impact of significant items by segment that are excluded from Operating EBITDA above:

Significant Items by Segment for the Three Months Ended Mar 31, 2019	Agri-culture			Perf. Materials & Coatings		Ind. Interm. & Infrast.		Pack. & Spec. Plastics			Elect. & Imaging		Nutrition & Biosciences			Transp. & Adv. Polymers			Safety & Const.			Corp.			Total
In millions
Loss on divestiture 1	$	(24	)	$	—	$	—	$	—		$	—	$	—		$	—		$	—		$	—		$	(24	)
Integration and separation costs 2	—			—		—		—			—		—			—			—			(813		)	(813		)
Inventory step-up amortization 3	(205		)	—		—		—			—		—			—			—			—			(205		)
Restructuring and asset related charges - net4, 5	(50		)	—		—		(13		)	—		(27		)	(1		)	(2		)	(195		)	(288		)
Total	$	(279	)	$	—	$	—	$	(13	)	$	—	$	(27	)	$	(1	)	$	(2	)	$	(1,008	)	$	(1,330	)

1. Reflects a loss related to Historical Dow's sale of a joint venture related to actions under the Synergy Program.

2. Integration and separation costs related to the Merger, post-Merger integration and Intended Business Separation activities.

3. Includes the amortization of the fair value step-up of Historical DuPont's inventories as a result of the Merger.

4. Includes Board approved restructuring plans and asset related charges, which include other asset impairments. See Note 5 for additional information.

5. Includes a $1 million restructuring charge related to an equity affiliate of Transportation & Advanced Polymers that is reflected in "Equity in earnings of nonconsolidated affiliates" in the consolidated statement of income.

Significant Items by Segment for the Three Months Ended Mar 31, 2018	Agri-culture			Perf. Materials & Coatings		Ind. Interm. & Infrast.			Pack. & Spec. Plastics			Elect. & Imaging			Nutrition & Biosciences			Transp. & Adv. Polymers		Safety & Const.			Corp.			Total
In millions
Gain on sale of business/entity 1	$	—		$	—	$	20		$	—		$	—		$	—		$	—	$	—		$	—		$	20
Integration and separation costs 2	—			—		—			—			—			—			—		—			(457		)	(457		)
Inventory step-up amortization 3	(639		)	—		—			—			—			(63		)	—		(1		)	—			(703		)
Restructuring and asset related charges (credits) - net 4	(58		)	1		(11		)	(6		)	(1		)	—			1		(7		)	(181		)	(262		)
Income tax related item 5	—			—		—			—			—			—			—		—			(50		)	(50		)
Total	$	(697	)	$	1	$	9		$	(6	)	$	(1	)	$	(63	)	$	1	$	(8	)	$	(688	)	$	(1,452	)

1. Includes a gain related to Historical Dow's sale of its equity interest in MEGlobal.

2. Integration and separation costs related to the Merger, post-Merger integration and Intended Business Separation activities, and costs related to the ownership restructure of Dow Silicones.

3. Includes the fair value step-up of Historical DuPont's inventories as a result of the Merger and the acquisition of the H&N Business.

4. Includes Board approved restructuring plans and asset related charges, which includes other asset impairments. See Note 5 for additional information.

5. Includes a foreign exchange loss related to adjustments to Historical DuPont's foreign currency exchange contracts as a result of the U.S. tax reform.

XML

SUBSEQUENT EVENTS Subsequent Events (Tables)

3 Months Ended

Mar. 31, 2019

Subsequent Event [Line Items]

Schedule of Long-term Debt Instruments [Table Text Block]

In millions	Amount
4.625% Notes due 2020	$	474
3.625% Notes due 2021	296
4.250% Notes due 2021	163
2.800% Notes due 2023	381
6.500% Debentures due 2028	57
5.600% Senior Notes due 2036	42
4.900% Notes due 2041	48
4.150% Notes due 2043	69
Total	$	1,530

XML

RECENT ACCOUNTING GUIDANCE Leasing ASU - Balance Sheet Impact (Details) - USD ($) $ in Millions	Mar. 31, 2019	Jan. 01, 2019	Dec. 31, 2018	Mar. 31, 2018	Dec. 31, 2017
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net property	$ 35,575		$ 35,848
Deferred income tax assets	1,853		1,724
Deferred charges and other assets	5,801		2,476
Total other assets	97,069		94,197
Total Assets	189,785		188,030
Long-term debt due within one year	4,009		637
Accrued and other current liabilities	8,672		7,943
Total current liabilities	28,580		24,715
Long-Term Debt	34,966		37,662
Other noncurrent obligations	10,153		6,988
Total other noncurrent liabilities	32,141		29,474
Retained earnings	29,764		30,536
DowDuPont's stockholders' equity	92,444		94,571
Total equity	94,098		96,179	$ 102,924	$ 101,927
Total Liabilities and Equity	$ 189,785		$ 188,030
Accounting Standards Update 2016-02 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net property		$ 9
Deferred income tax assets		(24)
Deferred charges and other assets		3,386
Total other assets		3,362
Total Assets		3,371
Long-term debt due within one year		1
Accrued and other current liabilities		721
Total current liabilities		722
Long-Term Debt		8
Other noncurrent obligations		2,569
Total other noncurrent liabilities		2,569
Retained earnings		72
DowDuPont's stockholders' equity		72
Total equity		72
Total Liabilities and Equity		3,371
Updated [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net property		35,857
Deferred income tax assets		1,700
Deferred charges and other assets		5,862
Total other assets		97,559
Total Assets		191,401
Long-term debt due within one year		638
Accrued and other current liabilities		8,664
Total current liabilities		25,437
Long-Term Debt		37,670
Other noncurrent obligations		9,557
Total other noncurrent liabilities		32,043
Retained earnings		30,608
DowDuPont's stockholders' equity		94,643
Total equity		96,251
Total Liabilities and Equity		$ 191,401

XML

INTENDED BUSINESS SEPARATIONS - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Intended Business Separations [Line Items]
Integration and separation costs	$ 813	$ 457

XML

REVENUE (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Revenue, Performance Obligation, Description of Timing	22 years
Net sales	$ 19,649	$ 21,510
Contract with Customer, Liability, Revenue Recognized	525	640
Accounts and notes receivable - Trade	13,963		$ 12,376
Contract assets - current 1	62		85
Contract assets - noncurrent 2	47		47
Contract liabilities - current 3	2,266		2,092
Contract liabilities - noncurrent 4	1,767		1,420
U.S. & Canada
Net sales	7,014	7,909
EMEA
Net sales	6,269	6,919
Asia Pacific
Net sales	4,639	4,790
Latin America
Net sales	1,727	1,892
Agriculture
Net sales	3,397	3,808
Agriculture | Crop Protection
Net sales	1,425	1,495
Agriculture | Seed
Net sales	1,972	2,313
Performance Materials & Coatings
Net sales	2,255	2,304
Performance Materials & Coatings | Coatings & Performance Monomers
Net sales	890	941
Performance Materials & Coatings | Consumer Solutions
Net sales	1,365	1,363
Industrial Intermediates & Infrastructure
Net sales	3,402	3,715
Industrial Intermediates & Infrastructure | Industrial Solutions
Net sales	1,103	1,155
Industrial Intermediates & Infrastructure | Polyurethanes & CAV
Net sales	2,296	2,556
Industrial Intermediates & Infrastructure | Other
Net sales	3	4
Packaging & Specialty Plastics
Net sales	5,110	6,010
Packaging & Specialty Plastics | Hydrocarbons & Energy
Net sales	1,380	1,800
Packaging & Specialty Plastics | Packaging and Specialty Plastics
Net sales	3,730	4,210
Electronics & Imaging
Net sales	1,078	1,153
Electronics & Imaging | Advanced Printing
Net sales	119	122
Electronics & Imaging | Display Technologies
Net sales	84	60
Electronics & Imaging | Interconnect Solutions
Net sales	238	281
Electronics & Imaging | Photovoltaic & Advanced Materials
Net sales	254	289
Electronics & Imaging | Semiconductor Technologies
Net sales	383	401
Nutrition & Biosciences
Net sales	1,659	1,720
Nutrition & Biosciences | Industrial Biosciences
Net sales	494	541
Nutrition & Biosciences | Nutrition & Health
Net sales	1,165	1,179
Transportation & Advanced Polymers
Net sales	1,355	1,425
Transportation & Advanced Polymers | Engineering Polymers
Net sales	663	668
Transportation & Advanced Polymers | Performance Resins
Net sales	308	351
Transportation & Advanced Polymers | Performance Solutions
Net sales	384	406
Safety & Construction
Net sales	1,322	1,299
Safety & Construction | Aramids
Net sales	424	393
Safety & Construction | Construction
Net sales	327	385
Safety & Construction | Tyvek Enterprise
Net sales	310	292
Safety & Construction | Water Solutions
Net sales	261	229
Corporate
Net sales	$ 71	$ 76
Product [Member]
Revenue, Percentage from Products and Service Transferred to Customers	98.00%	98.00%
Material Rights Granted to Customers [Member]
Revenue, Remaining Performance Obligation, Amount	$ 100		102
Licensing of Technology [Member]
Revenue, Remaining Performance Obligation, Amount	$ 519		$ 407

XML

RESTRUCTURING AND ASSET RELATED CHARGES - NET DowDuPont Cost Synergy Program (Details) - USD ($) $ in Millions	3 Months Ended		19 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2019	Dec. 31, 2018	Nov. 01, 2017
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	$ 287	$ 262
DowDuPont Cost Synergy Program
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	563		$ 563	$ 574
Restructuring and asset related charges - net	280	260	2,027
Charges Against Reserve	(115)
Payments for Restructuring	(176)
Restructuring and Related Cost, Expected Cost					$ 2,200
DowDuPont Cost Synergy Program | Restructuring and Asset Related Charges, Net [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	279
DowDuPont Cost Synergy Program | Equity in earnings of nonconsolidated affiliates
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	1
DowDuPont Cost Synergy Program | Other Noncurrent Liabilities [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	99		99	84
DowDuPont Cost Synergy Program | Accrued And Other Current Liabilities [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	464		464	490
DowDuPont Cost Synergy Program | Severance and Related Benefit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	463		463	491
Restructuring and asset related charges - net	112	172	1,045
Charges Against Reserve	0
Payments for Restructuring	(140)
DowDuPont Cost Synergy Program | Severance and Related Benefit Costs | Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Accrual Adjustment	112
DowDuPont Cost Synergy Program | Asset Write-downs and Write-offs
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	1		1	0
Restructuring and asset related charges - net	116	48	695
Charges Against Reserve	(115)
Payments for Restructuring	0
DowDuPont Cost Synergy Program | Asset Write-downs and Write-offs | Agriculture
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	28
DowDuPont Cost Synergy Program | Asset Write-downs and Write-offs | Safety & Construction
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	2
DowDuPont Cost Synergy Program | Asset Write-downs and Write-offs | Transportation & Advanced Polymers Segment [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	1
DowDuPont Cost Synergy Program | Asset Write-downs and Write-offs | Packaging and Specialty Plastics
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	1
DowDuPont Cost Synergy Program | Asset Write-downs and Write-offs | Nutrition & Biosciences Segment [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	10
DowDuPont Cost Synergy Program | Asset Write-downs and Write-offs | Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	74
DowDuPont Cost Synergy Program | Costs Associated With Exit Or Disposal Activities
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	99		99	$ 83
Restructuring and asset related charges - net	52	$ 40	$ 287
Charges Against Reserve	0
Payments for Restructuring	(36)
DowDuPont Cost Synergy Program | Costs Associated With Exit Or Disposal Activities | Agriculture
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	19
DowDuPont Cost Synergy Program | Costs Associated With Exit Or Disposal Activities | Nutrition & Biosciences Segment [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	18
DowDuPont Cost Synergy Program | Costs Associated With Exit Or Disposal Activities | Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	$ 15

XML

RESTRUCTURING AND ASSET RELATED CHARGES - NET DowDuPont Agriculture Division Restructuring Program (Details) - USD ($) $ in Millions	3 Months Ended		4 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2019	Dec. 31, 2018	Nov. 30, 2018
Restructuring Cost and Reserve [Line Items]
Restructuring, asset related charges and adjustments (benefit)	$ 287	$ 262
DowDuPont Agricultural Division Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost					$ 96
Restructuring, asset related charges and adjustments (benefit)	(1)		$ 83
Charges Against Reserve	(3)
Payments for Restructuring	(15)
Restructuring Reserve	58		58	$ 77
DowDuPont Agricultural Division Restructuring Program | Accrued And Other Current Liabilities [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve				77
DowDuPont Agricultural Division Restructuring Program | Severance and Related Benefit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost					83
Restructuring, asset related charges and adjustments (benefit)	(4)		74
Charges Against Reserve	0
Payments for Restructuring	(15)
Restructuring Reserve	58		58	77
DowDuPont Agricultural Division Restructuring Program | Severance and Related Benefit Costs | Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring, asset related charges and adjustments (benefit)	(4)
DowDuPont Agricultural Division Restructuring Program | Asset Write-downs and Write-offs
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost					11
Restructuring, asset related charges and adjustments (benefit)	3		9
Charges Against Reserve	(3)
Payments for Restructuring	0
Restructuring Reserve	0		$ 0	$ 0
DowDuPont Agricultural Division Restructuring Program | Asset Write-downs and Write-offs | Agriculture
Restructuring Cost and Reserve [Line Items]
Restructuring, asset related charges and adjustments (benefit)	$ 3
DowDuPont Agricultural Division Restructuring Program | Costs Associated With Exit Or Disposal Activities
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost					$ 2

XML

RESTRUCTURING AND ASSET RELATED CHARGES - NET Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Restructuring and Related Activities [Abstract]
Restructuring and asset related charges - net	$ 287	$ 262

XML

SUPPLEMENTARY INFORMATION - Summary of Sundry Income (Expense) - Net (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Schedule Of Sundry Income (Expense) [Line Items]
Nonoperating Income (Expense)	$ 248	$ 115
Non-operating pension and other postretirement benefit plan net credit	108	110
Interest income	75	55
Gains on sales of other assets and investments, net	50	34
Foreign exchange gains (losses), net	(11)	(148)
MEGlobal [Member]
Schedule Of Sundry Income (Expense) [Line Items]
Gains on sales of other assets and investments, net		20
DuPont
Schedule Of Sundry Income (Expense) [Line Items]
Gains on sales of other assets and investments, net	51
DuPont | Foreign Exchange Contract [Member]
Schedule Of Sundry Income (Expense) [Line Items]
Foreign exchange gains (losses), net		$ 50
Dow [Member]
Schedule Of Sundry Income (Expense) [Line Items]
Gains on sales of other assets and investments, net	$ (24)

XML

SUPPLEMENTARY INFORMATION - Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Cash and Cash Equivalents [Line Items]
Restricted cash and cash equivalents 1	$ 523	$ 540
DuPont Trust Agreement [Member]
Cash and Cash Equivalents [Line Items]
Restricted cash and cash equivalents 1	$ 480	$ 500

XML

INCOME TAXES - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Income Tax Contingency [Line Items]
Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Benefit (Expense)		$ 17
Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Indirect Impact on Inventory, Provisional Income Tax Expense		$ 54
Repatriation [Member]
Income Tax Contingency [Line Items]
Other Tax Expense	$ 13

XML

EARNINGS PER SHARE CALCULATIONS - Summary of Net Income for EPS Calculations, Basic (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Earnings Per Share [Abstract]
Income from continuing operations, net of tax	$ 571	$ 1,153
Net income attributable to noncontrolling interests	(51)	(44)
Net income attributable to participating securities	(1)	(6)
Net income attributable to DowDuPont Inc.	519	1,103
Loss from discontinued operations, net of tax	0	(5)
Net income available for DowDuPont Inc. common stockholders	$ 519	$ 1,098

XML

EARNINGS PER SHARE CALCULATIONS - Summary of EPS Calculations, Basic (Details) - $ / shares	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Earnings Per Share [Abstract]
Earnings per common share from continuing operations - basic (in dollars per share)	$ 0.23	$ 0.47
Earnings per common share from discontinued operations - basic (in dollars per share)	0.00	0.00
Net income attributable to common stockholders, basic (in dollars per share)	$ 0.23	$ 0.47

XML

EARNINGS PER SHARE CALCULATIONS - Summary of Net Income for EPS Calculations, Diluted (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Earnings Per Share [Abstract]
Income from continuing operations, net of tax	$ 571	$ 1,153
Net income attributable to noncontrolling interests	(51)	(44)
Net income attributable to participating securities	(1)	(6)
Net income attributable to DowDuPont Inc.	519	1,103
Loss from discontinued operations, net of tax	0	(5)
Net income attributable to common stockholders	$ 519	$ 1,098

XML

EARNINGS PER SHARE CALCULATIONS - Summary of EPS Calculations, Diluted (Details) - $ / shares	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Earnings Per Share [Abstract]
Earnings per common share from continuing operations - diluted (in dollars per share)	$ 0.23	$ 0.47
Earnings per common share from discontinued operations - diluted (in dollars per share)	0.00	0.00
Net income attributable to common stockholders, diluted (in dollars per share)	$ 0.23	$ 0.47

XML

EARNINGS PER SHARE CALCULATIONS - Summary of Count Information (Details) - shares shares in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Earnings Per Share [Abstract]
Weighted-average common shares - basic (in shares)	2,250.1	2,317.0
Plus dilutive effect of equity compensation plans (in shares)	9.1	17.3
Weighted-average common shares - diluted (in shares)	2,259.2	2,334.3
Stock options and deferred stock awards excluded from EPS calculations (in shares)	19.2	5.3

XML

INVENTORIES (Summary of Inventory) (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Inventory Disclosure [Abstract]
Finished goods	$ 10,060	$ 9,814
Work in process	3,561	3,969
Raw materials	1,461	1,419
Supplies	1,276	1,321
Total	16,358	16,523
Adjustment of inventories to a LIFO basis	246	98
Total inventories	$ 16,604	$ 16,621

XML

NONCONSOLIDATED AFFILIATES NONCONSOLIDATED AFFILIATES (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Jan. 01, 2019	Dec. 31, 2018
Schedule of Equity Method Investments [Line Items]
Investment in nonconsolidated affiliates	$ 4,687		$ 5,204
Accrued And Other Current Liabilities	(81)		(81)
Other noncurrent obligations	(870)		(495)
Net investment in nonconsolidated affiliates	3,736		4,628
Hemlock Semiconductor L.L.C.
Schedule of Equity Method Investments [Line Items]
Other noncurrent obligations	(658)		(495)
DC HSC Holdings LLC [Member]
Schedule of Equity Method Investments [Line Items]
Investment in nonconsolidated affiliates	485		535
EQUATE Petrochemical Company K.S.C. [Member]
Schedule of Equity Method Investments [Line Items]
Investment in nonconsolidated affiliates			$ 131
Other noncurrent obligations	(212)
Proceeds from Equity Method Investment, Distribution	$ 440
Accounting Standards Update 2014-09 [Member] | Equity Method Investments | HSC Group [Member]
Schedule of Equity Method Investments [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets		$ 71
Accounting Standards Update 2014-09 [Member] | Other noncurrent obligations | HSC Group [Member]
Schedule of Equity Method Investments [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets		168
Accounting Standards Update 2014-09 [Member] | Deferred Tax Asset [Domain] | HSC Group [Member]
Schedule of Equity Method Investments [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets		56
Accounting Standards Update 2014-09 [Member] | Retained Earnings | HSC Group [Member]
Schedule of Equity Method Investments [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets		$ 183

XML

GOODWILL AND OTHER INTANGIBLE ASSETS - Summary of Goodwill (Details) $ in Millions	3 Months Ended
	Mar. 31, 2019 USD ($)
Goodwill [Roll Forward]
Net goodwill, beginning of period	$ 59,032
Foreign currency impact	(84)
Net goodwill, end of period	58,948
Agriculture
Goodwill [Roll Forward]
Net goodwill, beginning of period	14,689
Foreign currency impact	11
Net goodwill, end of period	14,700
Performance Materials & Coatings
Goodwill [Roll Forward]
Net goodwill, beginning of period	3,650
Foreign currency impact	(20)
Net goodwill, end of period	3,630
Industrial Intermediates & Infrastructure
Goodwill [Roll Forward]
Net goodwill, beginning of period	1,096
Foreign currency impact	(2)
Net goodwill, end of period	1,094
Packaging & Specialty Plastics
Goodwill [Roll Forward]
Net goodwill, beginning of period	5,101
Foreign currency impact	(7)
Net goodwill, end of period	5,094
Electronics & Imaging
Goodwill [Roll Forward]
Net goodwill, beginning of period	8,188
Foreign currency impact	(3)
Net goodwill, end of period	8,185
Nutrition & Biosciences
Goodwill [Roll Forward]
Net goodwill, beginning of period	12,643
Foreign currency impact	(29)
Net goodwill, end of period	12,614
Transportation & Advanced Polymers
Goodwill [Roll Forward]
Net goodwill, beginning of period	6,967
Foreign currency impact	(15)
Net goodwill, end of period	6,952
Safety & Construction
Goodwill [Roll Forward]
Net goodwill, beginning of period	6,698
Foreign currency impact	(19)
Net goodwill, end of period	$ 6,679

XML

GOODWILL AND OTHER INTANGIBLE ASSETS - Summary of Other Intangible Assets (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Finite other intangible assets, gross carrying amount	$ 27,178	$ 26,779
Finite other intangible assets, accumulated amortization	(7,865)	(7,414)
Finite other intangible assets, net	19,313	19,365
Indefinite-lived Intangible Assets [Line Items]
Other intangible assets, gross carrying amount	38,332	38,379
Other intangible assets, net	30,467	30,965
In-process research and development
Indefinite-lived Intangible Assets [Line Items]
Indefinite other intangible asset, carrying amount	149	594
Germplasm
Indefinite-lived Intangible Assets [Line Items]
Indefinite other intangible asset, carrying amount	6,265	6,265
Trademarks / tradenames
Indefinite-lived Intangible Assets [Line Items]
Indefinite other intangible asset, carrying amount	4,740	4,741
Developed technology 1
Finite-Lived Intangible Assets [Line Items]
Finite other intangible assets, gross carrying amount	8,179	7,761
Finite other intangible assets, accumulated amortization	(2,731)	(2,562)
Finite other intangible assets, net	5,448	5,199
Software
Finite-Lived Intangible Assets [Line Items]
Finite other intangible assets, gross carrying amount	1,539	1,529
Finite other intangible assets, accumulated amortization	(900)	(876)
Finite other intangible assets, net	639	653
Trademarks / tradenames
Finite-Lived Intangible Assets [Line Items]
Finite other intangible assets, gross carrying amount	1,763	1,772
Finite other intangible assets, accumulated amortization	(773)	(745)
Finite other intangible assets, net	990	1,027
Customer-related
Finite-Lived Intangible Assets [Line Items]
Finite other intangible assets, gross carrying amount	14,208	14,236
Finite other intangible assets, accumulated amortization	(3,095)	(2,895)
Finite other intangible assets, net	11,113	11,341
Microbial cell factories
Finite-Lived Intangible Assets [Line Items]
Finite other intangible assets, gross carrying amount	384	386
Finite other intangible assets, accumulated amortization	(26)	(22)
Finite other intangible assets, net	358	364
Favorable Supply Contracts
Finite-Lived Intangible Assets [Line Items]
Finite other intangible assets, gross carrying amount	493	475
Finite other intangible assets, accumulated amortization	(136)	(111)
Finite other intangible assets, net	357	364
Other Intangible Assets
Finite-Lived Intangible Assets [Line Items]
Finite other intangible assets, gross carrying amount	612	620
Finite other intangible assets, accumulated amortization	(204)	(203)
Finite other intangible assets, net	$ 408	$ 417

XML

GOODWILL AND OTHER INTANGIBLE ASSETS - Summary of Amortization Expense (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Amortization of intangibles	$ 474	$ 474
Other intangible assets, excluding software
Finite-Lived Intangible Assets [Line Items]
Amortization of intangibles	474	474
Software, included in Cost of sales
Finite-Lived Intangible Assets [Line Items]
Amortization of intangibles	$ 25	$ 23

XML

GOODWILL AND OTHER INTANGIBLE ASSETS - Summary of Future Amortization Expense (Details) $ in Millions	Mar. 31, 2019 USD ($)
Estimated Amortization Expense for Next Five Years
2019	$ 2,008
2020	1,893
2021	1,851
2022	1,760
2023	1,612
2024	$ 1,500

XML

TRANSFERS OF FINANCIAL ASSETS (Summary of Cash Proceeds) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Transfers and Servicing [Abstract]
Interests in conduits 1	$ 0	$ 445

XML

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES - Notes Payable and Long-Term Debt Additional Information (Details) - Loans Payable - USD ($) $ in Millions	Mar. 31, 2019	Jul. 15, 2018
DuPont | Six Percent Bonds, Final Maturity, Current Year [Member]
Debt Instrument [Line Items]
Debt Instrument, Repurchased Face Amount	$ 262
Stated interest rate		5.75%
Dow [Member] | Five Point Seven Zero Percent Notes Due 2018 [Member]
Debt Instrument [Line Items]
Debt Instrument, Repurchased Face Amount	$ 72

XML

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES - DowDuPont Notes (Details) (Details) - USD ($) $ in Billions	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Stock Repurchase Program, Authorized Amount		$ 3.0
Stock Repurchased During Period, Value	$ 1.6
Senior Unsecured Notes [Member] | DowDuPont Notes [Member]
Debt Instrument [Line Items]
Principal amount		$ 12.7

XML

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES - Dow Term Loan and Revolving Credit Facilities (Details) - USD ($) $ in Millions			3 Months Ended	12 Months Ended
	Apr. 05, 2019	May 31, 2016	Jun. 30, 2018	Dec. 31, 2018	Mar. 31, 2019
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due August 2020 [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity					$ 100
Dow [Member] | Term Loan Facility [Member] | DCC Term Loan Facility [Member]
Debt Instrument [Line Items]
Proceeds from Lines of Credit		$ 4,500
Line Of Credit Facility, Term Extension Option, Period			19 months
Line Of Credit Facility, Term Extension, Period			2 years
Repayments of Long-term Debt	$ 2,000
Long-term Line of Credit					$ 2,500
Dow [Member] | Revolving Credit Facility [Member] | Five Year Competitive Advance and Revolving Credit Facility
Debt Instrument [Line Items]
Debt Instrument, Term				5 years

XML

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES - DuPont Term Loan and Revolving Credit Facilities (Details) - DuPont $ in Millions		50 Months Ended
	Feb. 07, 2019 USD ($)	Jun. 01, 2020	Mar. 31, 2019 USD ($)	Mar. 22, 2016 USD ($) borrowing
Term Loan Facility | DuPont Term Loan Facility
Debt Instrument [Line Items]
Maximum borrowing capacity				$ 4,500
Line Of Credit Facility, Number Of Borrowings			6
Outstanding borrowings			$ 3,000
Line of Credit Facility, Remaining Borrowing Capacity			1,500
Maximum | Term Loan Facility | DuPont Term Loan Facility
Debt Instrument [Line Items]
Line Of Credit Facility, Number Of Borrowings | borrowing				7
Scenario, Forecast [Member] | Term Loan Facility | DuPont Term Loan Facility
Debt Instrument [Line Items]
Term		3 years
Securities Sold under Agreements to Repurchase [Member] | Repurchase Facility [Member]
Debt Instrument [Line Items]
Short-term Debt			19
Maximum borrowing capacity	$ 1,300
Debt Instrument, Collateral Amount, Percentage	105.00%
Pledged Financial Instruments, Not Separately Reported, Loans Receivable Pledged as Collateral			$ 20
London Interbank Offered Rate (LIBOR) [Member] | Securities Sold under Agreements to Repurchase [Member] | Repurchase Facility [Member]
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	0.75%

XML

COMMITMENTS AND CONTINGENT LIABILITIES - Asbestos-Related Matters of Union Carbide Corporation Additional Information (Details) - Union Carbide - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Loss Contingencies [Line Items]
Percentage of recorded liability related to pending claims	17.00%
Percentage of recorded liability related to future claims	83.00%
Asbestos-Related Matters
Loss Contingencies [Line Items]
Liability for asbestos-related pending and future claims	$ 1,243	$ 1,260

XML

COMMITMENTS AND CONTINGENT LIABILITIES - Separation of DuPont's Performance Chemicals Segment (Details) - Indemnification agreement - Chemours - DuPont $ in Millions	Mar. 31, 2019 USD ($)
Loss Contingencies [Line Items]
Indemnification asset	$ 185
Accounts and notes receivable - Other
Loss Contingencies [Line Items]
Indemnification asset	84
Noncurrent Receivables
Loss Contingencies [Line Items]
Indemnification asset	289
Accrued and other current liabilities
Loss Contingencies [Line Items]
Accrual for environmental, litigation, workers compensation and other Loss Contingencies	84
Other noncurrent obligations
Loss Contingencies [Line Items]
Indemnification Liabilities	$ 289

XML

COMMITMENTS AND CONTINGENT LIABILITIES - PFOA (Details) $ in Millions	3 Months Ended		12 Months Ended	21 Months Ended	60 Months Ended	87 Months Ended
	Mar. 31, 2019 USD ($) disease claim	Mar. 31, 2017 USD ($)	Dec. 31, 2004 USD ($) plaintiff	Mar. 31, 2019 USD ($) disease claim	Jul. 06, 2022	Mar. 31, 2019 USD ($) disease claim	Jan. 01, 2012 water_district
DuPont | PFOA Matters | Chemours
Loss Contingencies [Line Items]
Total accrual balance	$ 22			$ 22		$ 22
Indemnification asset	22			22		22
DuPont | PFOA Matters | Leach v. DuPont
Loss Contingencies [Line Items]
Number of residents | plaintiff			80,000
Number of water districts receiving water treatment | water_district							6
Medical monitoring program threshold (up to $235 million)			$ 235
Medical monitoring program escrow disbursements to date (less than $1 million)						2
Escrow Account Balance	$ 1			$ 1		$ 1
DuPont | PFOA Matters | MDL
Loss Contingencies [Line Items]
Number of human diseases which the C8 Science Panel determined a probable link exists | disease	6			6		6
Number of lawsuits | claim	3,550			3,550		3,550
Limited sharing of potential future liabilities maximum annual threshold	$ 25
Loss Contingency, Limited Sharing Of Potential Future Liabilities, Costs Incurred				$ 0
DuPont | PFOA Matters | MDL | Chemours
Loss Contingencies [Line Items]
Third party initial limited sharing of potential future liabilities threshold	$ 25
DuPont | PFOA Matters | MDL | Scenario, Forecast [Member]
Loss Contingencies [Line Items]
Period for limited sharing of potential future PFOA liabilities					5 years
DuPont | PFOA Matters | MDL | NORTH CAROLINA
Loss Contingencies [Line Items]
Loss Contingency, Number Of Additional Plaintiffs	100
DuPont | PFOA Matters | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Number of lawsuits	57			57		57
DuPont | PFOA Matters | PFOA Matters: Drinking Water Actions [Member] | NEW YORK
Loss Contingencies [Line Items]
Number of lawsuits	52			52		52
DuPont | PFOA Matters | PFOA Matters: Drinking Water Actions [Member] | NEW JERSEY
Loss Contingencies [Line Items]
Number of lawsuits	2			2		2
DuPont | PFOA Matters | PFOA Matters: Drinking Water Actions [Member] | OHIO
Loss Contingencies [Line Items]
Number of lawsuits	3			3		3
DuPont | PFOA Matters | Firefighting Foam [Member]
Loss Contingencies [Line Items]
Number of lawsuits	4			4		4
DuPont | Brought by NJAG [Member] | PFOA Matters: Drinking Water Actions [Member] | NEW JERSEY | Initially filed [Member]
Loss Contingencies [Line Items]
Number of lawsuits	4			4		4
DuPont | Not part of MDL or filed on behalf of Leach class members [Member] | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Number of lawsuits	3			3		3
DuPont And Chemours | PFOA Matters | MDL
Loss Contingencies [Line Items]
Settlement amount		$ 671

XML

COMMITMENTS AND CONTINGENT LIABILITIES - Dow Silicones Chapter 11 Related Matters Additional Information (Details) - USD ($) $ in Millions	Jun. 01, 2016	Jun. 01, 2004	Mar. 31, 2019	Dec. 31, 2018	Jun. 30, 2017	Dec. 31, 1995
Dow Silicones Corporation [Member]
Product Liability Contingency [Line Items]
Indemnification percentage	50.00%
Dow Silicones Corporation [Member] | Commercial Creditors Litigation
Product Liability Contingency [Line Items]
Payments for legal settlements		$ 1,500
Accrued interest			$ 83	$ 82
Dow Silicones Corporation [Member] | Breast Implant and Other Products Liability Claims
Product Liability Contingency [Line Items]
Obligation period		16 years
Payments for product liabilities			1,762
Unexpended balance			110
Product liability			263	263
Liability maximum capped amount			2,148
Dow Silicones Corporation [Member]
Product Liability Contingency [Line Items]
Ownership Interest						50.00%
Minimum | Dow Silicones Corporation [Member] | Commercial Creditors Litigation
Product Liability Contingency [Line Items]
Loss Contingency, Estimate of Possible Loss					$ 77
Maximum | Dow Silicones Corporation [Member] | Commercial Creditors Litigation
Product Liability Contingency [Line Items]
Loss Contingency, Estimate of Possible Loss					$ 260
Accrued And Other Current Liabilities [Member] | Dow Silicones Corporation [Member] | Breast Implant and Other Products Liability Claims
Product Liability Contingency [Line Items]
Product liability			157	111
Other Noncurrent Obligations [Member] | Dow Silicones Corporation [Member] | Breast Implant and Other Products Liability Claims
Product Liability Contingency [Line Items]
Product liability			$ 106	$ 152

XML

COMMITMENTS AND CONTINGENT LIABILITIES - Summary of Gain Contingency - Dow v. Nova Chemicals Corporation Patent infringement (Details) - Dow v. Nova Chemicals Corporation Patent Infringement Matter $ in Millions, $ in Millions	Jul. 06, 2017 USD ($)	Jun. 29, 2017 USD ($)	Jun. 29, 2017 CAD ($)	Mar. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)
Gain Contingencies [Line Items]
Settlement amount		$ 495	$ 645
Proceeds from settlements	$ 501
Estimated liability				$ 341	$ 341

XML

COMMITMENTS AND CONTINGENT LIABILITIES - Environmental Matters Additional Information (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Other Environmental Matters
Site Contingency [Line Items]
Accrued obligations for environmental matters	$ 1,197	$ 1,201
Other Environmental Matters | Chemours | DuPont
Site Contingency [Line Items]
Accrued obligations for environmental matters	185
Potential exposure above the current accrual	355
Other Environmental Matters | Superfund sites
Site Contingency [Line Items]
Accrued obligations for environmental matters	213	$ 210
Other Environmental Matters | Superfund sites | Chemours | DuPont
Site Contingency [Line Items]
Accrued obligations for environmental matters	35
Indemnification agreement | Chemours | DuPont
Site Contingency [Line Items]
Indemnification asset	$ 185

XML

COMMITMENTS AND CONTINGENT LIABILITIES - Summary of Guarantees (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Guarantor Obligations [Line Items]
Long-term debt	$ 38,975	$ 38,299
Sadara
Guarantor Obligations [Line Items]
Ownership Interest	35.00%
Sadara | Total Project Financing
Guarantor Obligations [Line Items]
Principal amount	$ 12,500
Long-term debt	11,700	11,700
Guarantees | Sadara
Guarantor Obligations [Line Items]
Maximum Future Payments	$ 4,200
Guarantees | Minimum
Guarantor Obligations [Line Items]
Expiration period	1 year
Guarantees | Maximum
Guarantor Obligations [Line Items]
Expiration period	4 years
Guarantees | Dow
Guarantor Obligations [Line Items]
Maximum Future Payments	$ 4,514	4,523
Recorded Liability	15	25
Guarantees | DuPont
Guarantor Obligations [Line Items]
Maximum Future Payments	239	255
Recorded Liability	$ 0	$ 0
Trade financing transactions | Latin America
Guarantor Obligations [Line Items]
Expiration period	1 year

XML

LEASES Components of Lease Expense (Details) $ in Millions	3 Months Ended
	Mar. 31, 2019 USD ($)
Leases [Abstract]
Operating Lease Cost	$ 201
Finance Lease, Amoritzation of right-of-use assets	41
Finance Lease, Interest on lease liability	7
Finance Lease Cost	48
Short-term Lease Cost	60
Variable Lease Cost	89
Sublease Income	(9)
Total Lease Cost	$ 389

XML

LEASES Supplemental Cash Flow Information Related to Leases (Details) $ in Millions	3 Months Ended
	Mar. 31, 2019 USD ($)
Leases [Abstract]
Operating cash flows from operating leases	$ 210
Operating cash flows from finance leases	7
Financing cash flows from finance leases	$ 23

XML

LEASES Schedule of Lease Assets and Liabilities (Details) $ in Millions	Mar. 31, 2019 USD ($)
Leases [Abstract]
Operating Lease Right-of-Use Assets	$ 3,287
Current Operating Lease Liabilities	690
Noncurrent Operating Lease Liabilities	2,620
Total Operating Lease Liabilities	3,310
Finance Lease, Right-of-Use Asset, Gross	589
Finance Lease, Right-of-Use Asset, Accumulated Depreciation	(181)
Finance Lease, Right-of-Use Asset	408
Finance Lease, Liability, Current	63
Finance Lease, Liability, Noncurrent	432
Total Finance Lease Liability	$ 495

XML

LEASES Maturities of Lease Liabilities (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Leases [Abstract]
Operating Lease Liability, 2019	$ 621
Operating Lease Liability, 2020	686
Operating Lease Liability, 2021	553
Operating Lease Liability, 2022	450
Operating Lease Liability, 2023	346
Operating Lease Liability, 2024 and thereafter	1,286
Operating Lease Liability, Total Undiscounted	3,942
Operating Lease, Liability, Undiscounted Excess Amount	632
Total Operating Lease Liabilities	3,310
Finance Lease Liability, 2019	74
Finance Lease Liability, 2020	78
Finance Lease Liability, 2021	73
Finance Lease Liability, 2022	71
Finance Lease Liability, 2023	80
Finance Lease Liability, 2024 and thereafter	315
Finance Lease Liability, Total Undiscounted	691
Finance Lease, Liability, Undiscounted Excess Amount	196
Total Finance Lease Liability	$ 495
Future Minimum Lease Payments 2019		$ 654
Future Minimum Lease Payments 2020		497
Future Minimum Lease Payments 2021		418
Future Minimum Lease Payments 2022		363
Future Minimum Lease Payments 2023		297
Future Minimum Lease Payments 2024 and thereafter		1,063
Total Future Minimum Lease Payments		$ 3,292

XML

LEASES Lease Term, Discount Rate, Other Lease Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Lessee, Lease, Description [Line Items]
Lessee, Additional Leases Not yet Commenced, Assumptions and Judgment, Amount	$ 45
Lessee, Lease Not yet Commenced, Term of Contract	10 years
Operating Lease, Weighted Average Remaining Lease Term	7 years 356 days
Finance Lease, Weighted Average Remaining Lease Term	15 years 197 days
Operating Lease, Weighted Average Discount Rate, Percent	3.97%
Finance Lease, Weighted Average Discount Rate, Percent	6.25%
Residual Value Guarantees [Member]
Lessee, Lease, Description [Line Items]
Guarantor Obligations, Maximum Exposure, Undiscounted	$ 931	$ 889
Guarantor Obligations, Current Carrying Value	$ 0	$ 130
Minimum [Member]
Lessee, Lease, Description [Line Items]
Lessee, Remaining Lease Term	1 year
Maximum [Member]
Lessee, Lease, Description [Line Items]
Lessee, Remaining Lease Term	50 years

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS - Summary of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Jan. 01, 2019	Dec. 31, 2018	Jan. 01, 2018	Dec. 31, 2017
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	$ 94,098	$ 102,924		$ 96,179		$ 101,927
Other comprehensive income (loss) before reclassifications	(83)	1,307
Amounts reclassified from accumulated other comprehensive income (loss)	113	148
Total other comprehensive income	30	1,455
Ending balance	94,098	102,924
Tax expense from income taxes related to other comprehensive income items	(27)	(20)
Unrealized Gains (Losses) on Investments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	16	(8)	$ (51)		$ 17
Other comprehensive income (loss) before reclassifications	68	(26)
Amounts reclassified from accumulated other comprehensive income (loss)	(1)	1
Total other comprehensive income	67	(25)
Ending balance	16	(8)
Tax expense from income taxes related to other comprehensive income items	(18)	6
Cumulative translation adjustments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(3,882)	(602)	(3,785)		(1,935)
Other comprehensive income (loss) before reclassifications	(79)	1,333
Amounts reclassified from accumulated other comprehensive income (loss)	(18)	0
Total other comprehensive income	(97)	1,333
Ending balance	(3,882)	(602)
Tax expense from income taxes related to other comprehensive income items	(1)	5
Pension and other postretirement benefit plans
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(8,341)	(6,793)	(8,476)		(6,923)
Other comprehensive income (loss) before reclassifications	(7)	4
Amounts reclassified from accumulated other comprehensive income (loss)	142	126
Total other comprehensive income	135	130
Ending balance	(8,341)	(6,793)
Tax expense from income taxes related to other comprehensive income items	(32)	(30)
Derivative Instruments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(157)	(94)	(82)		(111)
Other comprehensive income (loss) before reclassifications	(65)	(4)
Amounts reclassified from accumulated other comprehensive income (loss)	(10)	21
Total other comprehensive income	(75)	17
Ending balance	(157)	(94)
Tax expense from income taxes related to other comprehensive income items	24	(1)
Total Accum Other Comp Loss
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(12,364)	(7,497)	$ (12,394)	$ (12,394)	$ (8,952)	$ (8,972)
Total other comprehensive income	30	1,455
Ending balance	$ (12,364)	$ (7,497)

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS - Summary of Reclassifications Out of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total reclassifications for the period (net of tax)	$ (113)	$ (148)
Sundry income (expense) - net	248	115
Unrealized (gains) losses on investments
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total reclassifications for the period (net of tax)	1	(1)
Cumulative translation adjustments
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total reclassifications for the period (net of tax)	18	0
Pension and other postretirement benefit plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total reclassifications for the period (net of tax)	(142)	(126)
Derivative Instruments
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total reclassifications for the period (net of tax)	10	(21)
Reclassification out of Accumulated Other Comprehensive Loss
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total reclassifications for the period (net of tax)	113	148
Reclassification out of Accumulated Other Comprehensive Loss | Unrealized (gains) losses on investments
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total before tax	(1)	2
Tax benefit	0	(1)
Total reclassifications for the period (net of tax)	(1)	1
Reclassification out of Accumulated Other Comprehensive Loss | Cumulative translation adjustments
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Sundry income (expense) - net	(18)	0
Reclassification out of Accumulated Other Comprehensive Loss | Pension and other postretirement benefit plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total before tax	167	154
Tax benefit	(25)	(28)
Total reclassifications for the period (net of tax)	142	126
Reclassification out of Accumulated Other Comprehensive Loss | Derivative Instruments
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total before tax	(11)	26
Tax benefit	1	(5)
Total reclassifications for the period (net of tax)	$ (10)	$ 21

XML

NONCONTROLLING INTERESTS - Summary of Noncontrolling Interests (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]
Balance at beginning of period	$ 1,608	$ 1,597
Net income attributable to noncontrolling interests	51	44
Distributions to noncontrolling interests	(11)	(27)
Cumulative translation adjustments	7	(6)
Other	(1)	0
Balance at end of period	1,654	1,664
Merger
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]
Acquisition of noncontrolling interests	$ 0	$ 56

XML

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Summary of Net Periodic Benefit Costs) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Defined Benefit Plan Disclosure [Line Items]
Net periodic benefit cost (credit)	$ 108	$ 110
Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year	500
Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	131	167
Interest cost	447	408
Expected return on plan assets	713	709
Amortization of prior service credit	(6)	(6)
Amortization of net gain (loss)	(133)	(171)
Net periodic benefit cost (credit)	(8)	31
Other Postretirement Benefits Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	4	5
Interest cost	37	32
Amortization of net gain (loss)	6	6
Net periodic benefit cost (credit)	$ 35	$ 31

XML

STOCK-BASED COMPENSATION (DuPont) (Details) - $ / shares		3 Months Ended
	Aug. 31, 2017	Mar. 31, 2019
DuPont Equity And Incentive Plan [Member] | RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares Granted in Period		2,600,000
Weighted Average Grant Date Fair Value (in dollars per share)		$ 52.66
Common Stock | Merger
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, conversion ratio (in shares)	1.2820

XML

FINANCIAL INSTRUMENTS (Summary of Fair Value of Financial Instruments) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Debt Securities, Available-for-sale [Line Items]
Cash Equivalents, at Carrying Value	$ 7,384		$ 9,951
Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax	9		12
Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax	0		0
Cash Equivalents, Fair Value	7,393		9,963
Money Market Funds, at Carrying Value	480		500
Money Market Funds, Accumulated Gross Unrealized Gain, Before Tax	0		0
Money Market Funds, Accumulated Gross Unrealized Loss, Before Tax	0		0
Money Market Funds, Fair Value	480		500
Available-for-sale Debt Securities, Amortized Cost Basis, Noncurrent	1,745		1,740
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, Noncurrent, before Tax	60		29
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, Noncurrent, before Tax	30		86
Debt Securities, Available-for-sale, Noncurrent	1,775		1,683
Equity Securities, Amortized Cost Basis	17		17
Equity Securities, Accumulated Gross Unrealized Gain, Before Tax	5		1
Equity Securities, Accumulated Gross Unrealized Loss, Before Tax	0		2
Equity Securities, Fair Value	22		16
Other Investments and Securities, at Cost	1,762		1,757
Other Investments and Securities, Accumulated Gross Unrealized Gain, Before Tax	65		30
Other Investments and Securities, Accumulated Gross Unrealized Loss, Before Tax	30		88
Other Investments	1,797		1,699
Cash and Restricted Cash Equivalents, Marketable Securities and Other Investments, Amortized Cost Basis	9,745		12,342
Cash and Restricted Cash Equivalents, Marketable Securities and Other Investments, Accumulated Gross Unrealized Gain, Before Tax	74		42
Cash and Restricted Cash Equivalents, Marketable Securities and Other Investments, Accumulated Gross Unrealized Loss, Before Tax	30		88
Cash and Restricted Cash Equivalents, Marketable Securities and Other Investments, Fair Value	9,789		12,296
Long-term debt	38,975		38,299
Long Term Debt, Accumulated Gross Unrealized Gain, Before Tax	102		390
Long Term Debt, Accumulated Gross Unrealized Loss, Before Tax	2,470		1,457
Long-term Debt	41,343		39,366
Derivative Assets (Liabilities), Accumulated Gross Unrealized Gain, Before Tax	216		248
Derivative Assets (Liabilities), Accumulated Gross Unrealized Loss, Before Tax	345		291
Derivative Assets (Liabilities), at Fair Value, Net	(129)		(43)
Proceeds from Sale and Maturity of Held-to-maturity Securities	35
Proceeds from sales of available-for-sale securities	159	$ 348
Gross realized gains	6	7
Gross realized losses	5	9
Cost Method Investments	260		258
Equity Securities, Net Unrealized Gain	5	$ 8
Interest Rate Swap [Member]
Debt Securities, Available-for-sale [Line Items]
Derivative Assets (Liabilities), Accumulated Gross Unrealized Gain, Before Tax	0		0
Derivative Assets (Liabilities), Accumulated Gross Unrealized Loss, Before Tax	181		64
Derivative Assets (Liabilities), at Fair Value, Net	(181)		(64)
Foreign Exchange Contract [Member]
Debt Securities, Available-for-sale [Line Items]
Derivative Assets (Liabilities), Accumulated Gross Unrealized Gain, Before Tax	128		157
Derivative Assets (Liabilities), Accumulated Gross Unrealized Loss, Before Tax	17		49
Derivative Assets (Liabilities), at Fair Value, Net	111		108
Commodity Contract [Member]
Debt Securities, Available-for-sale [Line Items]
Derivative Assets (Liabilities), Accumulated Gross Unrealized Gain, Before Tax	88		91
Derivative Assets (Liabilities), Accumulated Gross Unrealized Loss, Before Tax	147		178
Derivative Assets (Liabilities), at Fair Value, Net	(59)		(87)
US Treasury and Government [Member]
Debt Securities, Available-for-sale [Line Items]
Available-for-sale Debt Securities, Amortized Cost Basis, Noncurrent	694		714
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, Noncurrent, before Tax	17		9
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, Noncurrent, before Tax	9		23
Debt Securities, Available-for-sale, Noncurrent	702		700
Corporate Debt Securities [Member]
Debt Securities, Available-for-sale [Line Items]
Available-for-sale Debt Securities, Amortized Cost Basis, Noncurrent	1,051		1,026
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, Noncurrent, before Tax	43		20
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, Noncurrent, before Tax	21		63
Debt Securities, Available-for-sale, Noncurrent	1,073		983
Merger
Debt Securities, Available-for-sale [Line Items]
Long Term Debt, Accumulated Fair Value Adjustment	69		78
Debt [Member]
Debt Securities, Available-for-sale [Line Items]
Long Term Debt, Accumulated Fair Value Adjustment	17		18
Derivative, Notional Amount	2,290		2,290
Marketable Securities [Member]
Debt Securities, Available-for-sale [Line Items]
Available-for-sale Debt Securities, Amortized Cost Basis, Current	101		100
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, Current, before Tax	0		0
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, Current, before Tax	0		0
Debt Securities, Available-for-sale, Current	101		100
Debt Securities, Held-to-maturity	18		34
Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain	0		0
Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss	0		0
Debt Securities, Held-to-maturity, Fair Value	18		34
Marketable Securities	119		134
Investment Owned, Unrecognized Unrealized Appreciation	0		0
Investment Owned, Unrecognized Unrealized Depreciation	0		0
Marketable Securities, Current	$ 119		$ 134

XML

FINANCIAL INSTRUMENTS (Derivatives) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Derivatives, Fair Value [Line Items]
Derivative Assets	$ 348		$ 408
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	132		160
Derivative Asset	216		248
Derivative Liabilities	484		446
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	139		155
Derivative Liability	345		291
Derivative Liability, Collateral, Right to Reclaim Cash, Offset	20		26
Derivative Asset, Collateral, Obligation to Return Cash, Offset	2		54
Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net	1
Price Risk Cash Flow Hedge Unrealized Gain (Loss) to be Reclassified During Next 12 Months	(52)
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months	11
Hedge Gain (Loss) to be Reclassified During Next 12 Months, Excluded Components, Net	57
Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Assets	249		163
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	98		58
Derivative Asset	151		105
Derivative Liabilities	432		307
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	103		69
Derivative Liability	329		238
Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative Assets	161		98
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	89		42
Derivative Asset	72		56
Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Accrued and other current liabilities
Derivatives, Fair Value [Line Items]
Derivative Liabilities	98		46
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	89		42
Derivative Liability	9		4
Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative Assets	31		47
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	5		13
Derivative Asset	26		34
Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Deferred Charges And Other Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative Assets	57		18
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	4		3
Derivative Asset	53		15
Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Other noncurrent obligations
Derivatives, Fair Value [Line Items]
Derivative Liabilities	60		86
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	8		9
Derivative Liability	52		77
Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Accrued and other current liabilities
Derivatives, Fair Value [Line Items]
Derivative Liabilities	93		111
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	6		18
Derivative Liability	87		93
Designated as Hedging Instrument [Member] | Interest Rate Swap [Member] | Other noncurrent obligations
Derivatives, Fair Value [Line Items]
Derivative Liabilities	181		64
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	0		0
Derivative Liability	181		64
Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Assets	99		245
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	34		102
Derivative Asset	65		143
Derivative Liabilities	52		139
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	36		86
Derivative Liability	16		53
Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Nonoperating Income (Expense) [Member]
Derivatives, Fair Value [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	22	$ (198)
Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative Assets	87		200
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	31		99
Derivative Asset	56		101
Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Accrued and other current liabilities
Derivatives, Fair Value [Line Items]
Derivative Liabilities	37		124
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	29		79
Derivative Liability	8		45
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative Assets	8		41
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	1		1
Derivative Asset	7		40
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Deferred Charges And Other Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative Assets	4		4
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	2		2
Derivative Asset	2		2
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Other noncurrent obligations
Derivatives, Fair Value [Line Items]
Derivative Liabilities	7		8
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	3		3
Derivative Liability	4		5
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Accrued and other current liabilities
Derivatives, Fair Value [Line Items]
Derivative Liabilities	8		7
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	4		4
Derivative Liability	4		3
Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Notional Amount	181		182
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax	(36)		$ (43)
AOCI, Derivative Qualifying as Hedge, Excluded Component, after Tax	86
Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax	$ 25

XML

FINANCIAL INSTRUMENTS (Additional Information) (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Debt Securities, Available-for-sale [Line Items]
Securities for Reverse Repurchase Agreements	$ 0	$ 0
Debt [Member]
Debt Securities, Available-for-sale [Line Items]
Derivative, Notional Amount	$ 2,290,000,000	$ 2,290,000,000

XML

FAIR VALUE MEASUREMENTS - Summary of Recurring Measured Fair Values (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets	$ 348	$ 408
Long-term Debt	41,343	39,366
Derivative Liabilities	484	446
Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	7,393	9,963
Restricted Cash Equivalents	480	500
Marketable securities	119	134
Equity Securities	21	16
Total assets at fair value	10,135	12,704
Long-term Debt	41,343	39,366
Total liabilities at fair value	41,826	39,812
Recurring | Interest Rate Swap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities	181	64
Recurring | Foreign Exchange Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets	247	298
Derivative Liabilities	134	170
Recurring | Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets	100	110
Derivative Liabilities	168	212
Recurring | US Treasury and Government [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities	702	700
Recurring | Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities	1,073	983
Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Restricted Cash Equivalents	0	0
Marketable securities	0	0
Equity Securities	21	16
Total assets at fair value	50	33
Long-term Debt	0	0
Total liabilities at fair value	13	23
Recurring | Level 1 | Interest Rate Swap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities	0	0
Recurring | Level 1 | Foreign Exchange Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets	0	0
Derivative Liabilities	0	0
Recurring | Level 1 | Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets	10	17
Derivative Liabilities	13	23
Recurring | Level 1 | US Treasury and Government [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities	0	0
Recurring | Level 1 | Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities	19	0
Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	7,393	9,963
Restricted Cash Equivalents	480	500
Marketable securities	119	134
Equity Securities	0	0
Total assets at fair value	10,085	12,671
Long-term Debt	41,343	39,366
Total liabilities at fair value	41,813	39,789
Recurring | Level 2 | Interest Rate Swap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities	181	64
Recurring | Level 2 | Foreign Exchange Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets	247	298
Derivative Liabilities	134	170
Recurring | Level 2 | Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets	90	93
Derivative Liabilities	155	189
Recurring | Level 2 | US Treasury and Government [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities	702	700
Recurring | Level 2 | Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities	$ 1,054	$ 983

XML

FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS - Fair Value Measurements on a Nonrecurring Basis (Details) - Fair Value, Measurements, Nonrecurring [Member] $ in Millions	3 Months Ended
	Mar. 31, 2019 USD ($)
Inventories [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets at fair value	$ 0
Property, Plant and Equipment | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets at fair value	80
Restructuring and asset related charges - net
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Impairment Charges	$ 100

XML

FAIR VALUE MEASUREMENTS Additional information (Details) - Fair Value Measured at Net Asset Value Per Share [Member] - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Private Market Securities and Real Estate [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Underfunded commitments on investments	$ 87	$ 89
Real Estate [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets at fair value	29	29
Private Market Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets at fair value	$ 121	$ 120

XML

VARIABLE INTEREST ENTITIES - Assets And Liabilities Of Consolidated VIEs (Details) - Primary beneficiary - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Variable Interest Entity [Line Items]
Total assets	$ 1,003	$ 975
Total liabilities	407	440
Cash and cash equivalents (variable interest entities restricted)
Variable Interest Entity [Line Items]
Pledged current assets	109	82
Other Current Assets [Member]
Variable Interest Entity [Line Items]
Pledged current assets	116	114
Net property (variable interest entities restricted
Variable Interest Entity [Line Items]
Noncurrent assets	718	734
Other noncurrent assets
Variable Interest Entity [Line Items]
Noncurrent assets	60	45
Current liabilities
Variable Interest Entity [Line Items]
Current liabilities	318	334
Long term debt VIE
Variable Interest Entity [Line Items]
Noncurrent liabilities	43	75
Other noncurrent obligations
Variable Interest Entity [Line Items]
Noncurrent liabilities	$ 46	$ 31

XML

VARIABLE INTEREST ENTITIES - Additional Information (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Variable Interest Entity [Line Items]
Investment basis	$ 870	$ 495
Maximum exposure to loss	0	0
Equity method investment	4,687	5,204
Hemlock Semiconductor L.L.C.
Variable Interest Entity [Line Items]
Investment basis	658	495
Not primary beneficiary | Hemlock Semiconductor L.L.C.
Variable Interest Entity [Line Items]
Investment basis	(658)	(495)
Not primary beneficiary | Silicon joint ventures
Variable Interest Entity [Line Items]
Equity method investment	96	100
Not primary beneficiary | AgroFresh Solutions, Inc.
Variable Interest Entity [Line Items]
Equity method investment	45	48
Other Receivables	8	8
Not primary beneficiary | Dow | Hemlock Semiconductor L.L.C.
Variable Interest Entity [Line Items]
Maximum exposure to loss	$ 0	$ 0

XML

SEGMENTS AND GEOGRAPHIC REGIONS - Summary of Operating Segment Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Segment Reporting Information [Line Items]
Net sales	$ 19,649	$ 21,510
Operating EBITDA	4,019	4,871
Equity in earnings (losses) of nonconsolidated affiliates	26	257
Agriculture
Segment Reporting Information [Line Items]
Net sales	3,397	3,808
Operating EBITDA	667	891
Equity in earnings (losses) of nonconsolidated affiliates	0	(1)
Performance Materials & Coatings
Segment Reporting Information [Line Items]
Net sales	2,255	2,304
Operating EBITDA	481	586
Equity in earnings (losses) of nonconsolidated affiliates	0	0
Industrial Intermediates & Infrastructure
Segment Reporting Information [Line Items]
Net sales	3,402	3,715
Operating EBITDA	448	654
Equity in earnings (losses) of nonconsolidated affiliates	(48)	149
Packaging & Specialty Plastics
Segment Reporting Information [Line Items]
Net sales	5,110	6,010
Operating EBITDA	993	1,301
Equity in earnings (losses) of nonconsolidated affiliates	38	59
Electronics & Imaging
Segment Reporting Information [Line Items]
Net sales	1,078	1,153
Operating EBITDA	385	398
Equity in earnings (losses) of nonconsolidated affiliates	29	48
Nutrition & Biosciences
Segment Reporting Information [Line Items]
Net sales	1,659	1,720
Operating EBITDA	390	418
Equity in earnings (losses) of nonconsolidated affiliates	4	3
Transportation & Advanced Polymers
Segment Reporting Information [Line Items]
Net sales	1,355	1,425
Operating EBITDA	414	437
Equity in earnings (losses) of nonconsolidated affiliates	2	3
Safety & Construction
Segment Reporting Information [Line Items]
Net sales	1,322	1,299
Operating EBITDA	411	354
Equity in earnings (losses) of nonconsolidated affiliates	7	5
Corporate
Segment Reporting Information [Line Items]
Net sales	71	76
Operating EBITDA	(170)	(168)
Equity in earnings (losses) of nonconsolidated affiliates	$ (6)	$ (9)

XML

SEGMENTS AND GEOGRAPHIC REGIONS - Summary of Reconciliation of Operating EBITDA (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Segment Reporting Information [Line Items]
Income from continuing operations, net of tax	$ 571	$ 1,153
Provision for income taxes on continuing operations	209	389
Income from continuing operations before income taxes	780	1,542
Depreciation and amortization	1,519	1,484
Interest income	75	55
Interest expense and amortization of debt discount	454	350
Foreign exchange gains (losses)	(11)	(98)
Significant items	(1,330)	(1,452)
Operating EBITDA	4,019	4,871
Foreign exchange gains (losses), net	$ (11)	(148)
Foreign Exchange Contract [Member] | DuPont
Segment Reporting Information [Line Items]
Foreign exchange gains (losses), net		$ 50

XML

SEGMENTS AND GEOGRAPHIC REGIONS - Summary of Certain Items by Segment (Details) - USD ($) $ in Millions	3 Months Ended		19 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2019
(Loss on divestiture)/Gain on sale of business	$ (24)	$ 20
Integration and separation costs	813	457
Inventory step-up amortization	205	703
Restructuring, Settlement and Impairment Provisions, Including Adjustments	288	262
Income Tax Related Items		50
Significant items	1,330	1,452
Restructuring and asset related charges - net	287	262
DowDuPont Cost Synergy Program
Restructuring and asset related charges - net	280	260	$ 2,027
DowDuPont Cost Synergy Program | Equity In Earnings of Nonconsolidated Affiliates [Member]
Restructuring and asset related charges - net	1
Agriculture
(Loss on divestiture)/Gain on sale of business	(24)	0
Integration and separation costs	0	0
Inventory step-up amortization	205	639
Restructuring, Settlement and Impairment Provisions, Including Adjustments	50	58
Income Tax Related Items		0
Significant items	279	697
Performance Materials & Coatings Segment [Member]
(Loss on divestiture)/Gain on sale of business	0	0
Integration and separation costs	0	0
Inventory step-up amortization	0	0
Restructuring, Settlement and Impairment Provisions, Including Adjustments	0	(1)
Income Tax Related Items		0
Significant items	0	(1)
Industrial Intermediates & Infrastructure Segment [Member]
(Loss on divestiture)/Gain on sale of business	0	20
Integration and separation costs	0	0
Inventory step-up amortization	0	0
Restructuring, Settlement and Impairment Provisions, Including Adjustments	0	11
Income Tax Related Items		0
Significant items	0	(9)
Packaging & Specialty Plastics Segment [Member]
(Loss on divestiture)/Gain on sale of business	0	0
Integration and separation costs	0	0
Inventory step-up amortization	0	0
Restructuring, Settlement and Impairment Provisions, Including Adjustments	13	6
Income Tax Related Items		0
Significant items	13	6
Electronics & Imaging Segment [Member]
(Loss on divestiture)/Gain on sale of business	0	0
Integration and separation costs	0	0
Inventory step-up amortization	0	0
Restructuring, Settlement and Impairment Provisions, Including Adjustments	0	1
Income Tax Related Items		0
Significant items	0	1
Nutrition & Biosciences Segment [Member]
(Loss on divestiture)/Gain on sale of business	0	0
Integration and separation costs	0	0
Inventory step-up amortization	0	63
Restructuring, Settlement and Impairment Provisions, Including Adjustments	27	0
Income Tax Related Items		0
Significant items	27	63
Transportation & Advanced Polymers Segment [Member]
(Loss on divestiture)/Gain on sale of business	0	0
Integration and separation costs	0	0
Inventory step-up amortization	0	0
Restructuring, Settlement and Impairment Provisions, Including Adjustments	1	(1)
Income Tax Related Items		0
Significant items	1	(1)
Safety & Construction Segment [Member]
(Loss on divestiture)/Gain on sale of business	0	0
Integration and separation costs	0	0
Inventory step-up amortization	0	1
Restructuring, Settlement and Impairment Provisions, Including Adjustments	2	7
Income Tax Related Items		0
Significant items	2	8
Corporate
(Loss on divestiture)/Gain on sale of business	0	0
Integration and separation costs	813	457
Inventory step-up amortization	0	0
Restructuring, Settlement and Impairment Provisions, Including Adjustments	195	181
Income Tax Related Items		50
Significant items	$ 1,008	$ 688

XML

SUBSEQUENT EVENTS Dow Contribution (Details) $ in Millions	Apr. 01, 2019 USD ($)
Subsequent Event [Member]
Subsequent Event [Line Items]
Contributions to DOW	$ 2,024

XML

SUBSEQUENT EVENTS Debt Transactions (Details) - USD ($) $ in Millions	May 02, 2019	Mar. 22, 2019
DuPont [Member]
Subsequent Event [Line Items]
Long-term Debt, Gross		$ 1,530
Term Loan Facility [Member] | DuPont [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Repayments of Long-term Debt	$ 3,000
DWDP Term Loan Facility [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Proceeds from Issuance of Long-term Debt	$ 3,000
4.625% Notes due 2020 [Domain]
Subsequent Event [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		4.625%
4.625% Notes due 2020 [Domain] | DuPont [Member]
Subsequent Event [Line Items]
Long-term Debt, Gross		$ 474
3.625% Notes due 2021 [Domain]
Subsequent Event [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		3.625%
3.625% Notes due 2021 [Domain] | DuPont [Member]
Subsequent Event [Line Items]
Long-term Debt, Gross		$ 296
4.250% Notes due 2021 [Domain]
Subsequent Event [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		4.25%
4.250% Notes due 2021 [Domain] | DuPont [Member]
Subsequent Event [Line Items]
Long-term Debt, Gross		$ 163
2.800% Notes due 2023 [Domain]
Subsequent Event [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		2.80%
2.800% Notes due 2023 [Domain] | DuPont [Member]
Subsequent Event [Line Items]
Long-term Debt, Gross		$ 381
6.500% Debentures due 2028 [Domain]
Subsequent Event [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		6.50%
6.500% Debentures due 2028 [Domain] | DuPont [Member]
Subsequent Event [Line Items]
Long-term Debt, Gross		$ 57
5.600% Senior Notes due 2036 [Domain]
Subsequent Event [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		5.60%
5.600% Senior Notes due 2036 [Domain] | DuPont [Member]
Subsequent Event [Line Items]
Long-term Debt, Gross		$ 42
4.900% Notes due 2041 [Domain]
Subsequent Event [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		4.90%
4.900% Notes due 2041 [Domain] | DuPont [Member]
Subsequent Event [Line Items]
Long-term Debt, Gross		$ 48
4.150% Notes due 2043 [Domain]
Subsequent Event [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		4.15%
4.150% Notes due 2043 [Domain] | DuPont [Member]
Subsequent Event [Line Items]
Long-term Debt, Gross		$ 69